{"meta":{"query_hash":"d7116a3a9363","filters":{"venue":"Leukemia Research"},"cohort_total":253,"direct_labels_cover":0,"predictions_cover":253,"exported":253,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d7116a3a9363","api":"https://metacan.xera.ac/api/v1/cohort?venue=Leukemia+Research"},"results":[{"id":"W10996203","doi":"10.1016/s0145-2126(00)00059-x","title":"Designing an International Greenhouse Gas Emissions Trading System","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Climate Change Policy and Economics","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Kyoto Protocol; Clean Development Mechanism; Greenhouse gas; Emissions trading; United Nations Framework Convention on Climate Change; Business; Montreal Protocol; Carbon offset; Natural resource economics; European union; International trade; Climate change mitigation; Environmental economics; Economics","score_opus":0.2966553023168457,"score_gpt":0.36064517112069233,"score_spread":0.0639898688038466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W10996203","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.112011,0.00023246104,0.7550203,0.0032483113,0.000353924,0.00094540085,0.00059776445,0.0033479608,0.12424289],"genre_scores_gemma":[0.7507121,0.00014518373,0.23517106,0.00033094073,0.00006790886,0.00036706374,0.00043940012,0.00021615546,0.012550193],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9989706,0.0003893502,0.00005695926,0.00022971268,0.00018950006,0.00016394265],"domain_scores_gemma":[0.999393,0.00016942607,0.000055958564,0.00013082211,0.00015821628,0.00009256413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029486963,0.0004901521,0.00045757322,0.00083555275,0.001091906,0.0026590088,0.0012266862,0.0014874147,0.015470799],"category_scores_gemma":[0.0028673278,0.000370798,0.000529321,0.0009065161,0.00078947016,0.0030343365,0.0024695366,0.0008822309,0.0016858933],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003464147,0.000378818,0.0067626545,0.00010905152,0.00011488976,0.00055273814,0.00031621425,0.47590867,0.009858114,0.3392082,0.011709966,0.15473425],"study_design_scores_gemma":[0.00012551893,0.00018206915,0.0014157515,0.00003556735,0.000046919457,0.000118025826,0.00039233716,0.86233115,0.005191904,0.09764027,0.03247263,0.000047907957],"about_ca_topic_score_codex":0.005753773,"about_ca_topic_score_gemma":0.004405947,"teacher_disagreement_score":0.015470799,"about_ca_system_score_codex":0.0019640399,"about_ca_system_score_gemma":0.0026790116,"threshold_uncertainty_score":0.05175501},"labels":[],"label_agreement":null},{"id":"W1142333440","doi":"10.1016/j.leukres.2015.08.012","title":"A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Randomized controlled trial; Aerobic exercise; Induction chemotherapy; Quality of life (healthcare); Physical therapy; Internal medicine; Grip strength; Myeloid leukemia; Chemotherapy","score_opus":0.04461839989931244,"score_gpt":0.3640978572054129,"score_spread":0.31947945730610045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1142333440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980119,0.0039120545,0.0011533999,0.0020828615,0.0012305778,0.007194307,0.0016665047,0.00017370096,0.0024676127],"genre_scores_gemma":[0.9701146,0.003240936,0.0026273234,0.0027213334,0.0008465815,0.014375732,0.0015940904,0.00003185638,0.0044475477],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992986,0.00038414064,0.000045948636,0.0001414941,0.000027980494,0.0001018487],"domain_scores_gemma":[0.9988875,0.0003552749,0.00022891222,0.00010241972,0.00005556422,0.00037032747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013026989,0.001911186,0.0038828568,0.00038047112,0.00064200565,0.00092042505,0.0009532215,0.0018304703,0.014041648],"category_scores_gemma":[0.0022104017,0.000606022,0.002234842,0.000505712,0.0012607012,0.0009534336,0.0005947985,0.00400719,0.0010841143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98663723,0.0057105655,0.00024302039,0.00038639456,0.0006034399,0.000011690592,0.000021516855,0.00019870074,0.00066066184,0.00006440259,0.00046481309,0.004997531],"study_design_scores_gemma":[0.97969556,0.018917235,0.0006015306,0.000019532192,0.00032802275,0.000004685812,0.000010406532,0.0001031947,0.000056977624,0.00005333729,0.00020517745,0.0000042763554],"about_ca_topic_score_codex":0.0016924662,"about_ca_topic_score_gemma":0.003227535,"teacher_disagreement_score":0.014041648,"about_ca_system_score_codex":0.0007537072,"about_ca_system_score_gemma":0.0012971108,"threshold_uncertainty_score":0.046974063},"labels":[],"label_agreement":null},{"id":"W1608094604","doi":"10.1016/j.leukres.2015.04.018","title":"Identification of prognostic subgroups among acute myeloid leukemia patients with intermediate risk cytogenetics using a flow-cytometry-based assessment of ABC-transporter function","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cytogenetics; Mitoxantrone; Internal medicine; Myeloid leukemia; NPM1; Oncology; Medicine; Leukemia; Multivariate analysis; Flow cytometry; Chemotherapy; Biology; Immunology; Karyotype; Gene; Chromosome; Genetics","score_opus":0.0411452183642174,"score_gpt":0.34695582293462646,"score_spread":0.30581060457040904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608094604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990939,0.00013835859,0.00028169056,0.000045850637,0.000006253752,0.000009909826,0.000101653095,0.000007303717,0.00031507137],"genre_scores_gemma":[0.9995529,0.000030735508,0.00014953651,0.000014328264,0.000009692086,0.000007516504,0.00016372188,0.0000018651338,0.000069653564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980587,0.000037608166,0.000024140672,0.000040671104,0.00003380414,0.000057797355],"domain_scores_gemma":[0.9995413,0.00012670847,0.0001362544,0.000032797998,0.00007440763,0.00008856313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004191785,0.0003091997,0.00045172358,0.0010741645,0.0003684925,0.00079174497,0.00030420496,0.00046933003,0.0011698534],"category_scores_gemma":[0.0014103303,0.00008973982,0.0002487416,0.0007236394,0.0002615018,0.0004602015,0.0004649236,0.0003965565,0.00030238702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010299775,0.000049092767,0.9847875,0.000011308815,0.000039163802,0.00011032251,0.00009674894,0.00014875674,0.0066003483,0.00014348316,0.00014120102,0.0068420824],"study_design_scores_gemma":[0.000058428916,0.00049481663,0.9910719,0.000010324122,0.00012525394,0.0008299214,0.0005487926,0.0029562693,0.0024868513,0.00075897283,0.0006426859,0.000015740214],"about_ca_topic_score_codex":0.000731133,"about_ca_topic_score_gemma":0.000731103,"teacher_disagreement_score":0.0011698534,"about_ca_system_score_codex":0.00029948412,"about_ca_system_score_gemma":0.00025707923,"threshold_uncertainty_score":0.0039135814},"labels":[],"label_agreement":null},{"id":"W1963543962","doi":"10.1016/j.leukres.2009.02.015","title":"Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature","year":2009,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Survivin; Medicine; Lymphoma; Angiogenesis; Vascular endothelial growth factor; Diffuse large B-cell lymphoma; Internal medicine; Beta-2 microglobulin; Gastroenterology; Proportional hazards model; Pathology; VEGF receptors; Cancer","score_opus":0.032765040611274596,"score_gpt":0.3325268069805384,"score_spread":0.29976176636926377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963543962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009248511,0.99865556,0.000045309494,0.000047004603,0.000019594021,0.0000042701245,0.000028039796,0.0000024523765,0.00027296058],"genre_scores_gemma":[0.0060757133,0.993343,0.00023281829,0.000096456555,0.000043423668,0.000005191374,0.000057068395,8.764079e-7,0.00014541108],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996878,0.00004887296,0.00011768979,0.000047737452,0.000080272475,0.000017563503],"domain_scores_gemma":[0.9995364,0.00026143793,0.00012217864,0.000009793022,0.000054698343,0.000015610598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048286398,0.0006519896,0.0018928049,0.0046615214,0.000235469,0.0007612845,0.00069102104,0.00052131317,0.0012988365],"category_scores_gemma":[0.0009123594,0.0002673199,0.0007238883,0.0041765445,0.00044899687,0.0009978105,0.00038144115,0.0003944297,0.00033343385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003111119,0.000054567452,0.0060649645,0.07050886,0.00073893723,0.007920291,0.00026751368,0.00025048872,0.0029836183,0.00042871395,0.007533297,0.9029377],"study_design_scores_gemma":[0.0002652836,0.0006921343,0.06646567,0.05952914,0.012458102,0.18803874,0.00176635,0.0004126247,0.0050369524,0.0017404585,0.6634065,0.00018803406],"about_ca_topic_score_codex":0.0015049293,"about_ca_topic_score_gemma":0.00309848,"teacher_disagreement_score":0.0046615214,"about_ca_system_score_codex":0.00040455707,"about_ca_system_score_gemma":0.00087958615,"threshold_uncertainty_score":0.0043450594},"labels":[],"label_agreement":null},{"id":"W1964125608","doi":"10.1016/j.leukres.2012.11.013","title":"Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University; University Health Network","funders":"Canadian Institutes of Health Research; Ministerul Cercetării, Inovării şi Digitalizării","keywords":"Myeloid leukemia; Cancer-related fatigue; Medicine; Cytokine; Tumor necrosis factor alpha; Internal medicine; Chemokine; Myeloid; Oncology; Leukemia; Immunology; Cancer; Gastroenterology; Inflammation","score_opus":0.1157119307328995,"score_gpt":0.3813353205692868,"score_spread":0.26562338983638734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964125608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908626,0.00041572982,0.000042051477,0.00005582494,0.000008666608,0.000006830464,0.00011703882,0.000002191788,0.00026531264],"genre_scores_gemma":[0.9995511,0.00009873444,0.00005039122,0.000039438168,0.000015125051,0.000008250731,0.00013744192,5.5078914e-7,0.00009897428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997008,0.000101572055,0.00005031405,0.00003812681,0.000050135008,0.00005905567],"domain_scores_gemma":[0.99858284,0.00036587453,0.00063782727,0.00004283736,0.00014233004,0.00022829854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037801775,0.00027316794,0.00049302354,0.0005114702,0.0003623969,0.000474838,0.00016941915,0.0004540473,0.00085682847],"category_scores_gemma":[0.002213118,0.0001795432,0.0003519734,0.00072944775,0.00021399198,0.0003447682,0.0002541203,0.00063628884,0.00014597904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058135437,0.00007599879,0.9970228,0.000015494208,0.0000743101,0.00009222183,0.000056650602,0.000065860346,0.00055944547,0.0000066189878,0.00005058643,0.001398459],"study_design_scores_gemma":[0.000015629155,0.0002847904,0.999091,0.0000034068082,0.00003249403,0.00018036965,0.0001043191,0.00011972317,0.00008155252,0.00001154221,0.000072031435,0.0000031075247],"about_ca_topic_score_codex":0.0010434461,"about_ca_topic_score_gemma":0.0015389622,"teacher_disagreement_score":0.0010434461,"about_ca_system_score_codex":0.00029108243,"about_ca_system_score_gemma":0.00016868218,"threshold_uncertainty_score":0.0028663278},"labels":[],"label_agreement":null},{"id":"W1964315239","doi":"10.1016/s0145-2126(02)00062-0","title":"Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5− CLL","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"CD5; Lymphocytosis; Chronic lymphocytic leukemia; Prolymphocytic leukemia; Medicine; Leukemia; Monoclonal; Pathology; Immunology; Lymphoma; Antibody; Monoclonal antibody","score_opus":0.05402939586775175,"score_gpt":0.3108194792010493,"score_spread":0.25679008333329756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964315239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963207,0.0011516348,0.0003301055,0.000037580754,0.000013221319,0.000019689225,0.00003785167,0.0000129935825,0.0020762626],"genre_scores_gemma":[0.99886405,0.00033514513,0.00043896853,0.000023285034,0.000023184015,0.00001220695,0.00013583756,0.0000032324845,0.0001641005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962413,0.000064445856,0.00008736254,0.00003846579,0.000052119212,0.00013349099],"domain_scores_gemma":[0.9993217,0.00019916419,0.00013800003,0.000051690087,0.000088557696,0.0002010322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007496957,0.00048192823,0.00036750897,0.0017948202,0.0004824083,0.0011763362,0.0004976129,0.0007254854,0.0017340761],"category_scores_gemma":[0.0014075307,0.00032623045,0.0002625941,0.00077265344,0.00064282335,0.0007666631,0.00090337236,0.00035341718,0.00047672604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007295586,0.00016503881,0.5730928,0.0006410604,0.00008607005,0.034547735,0.0012470222,0.00022511602,0.34879804,0.002426641,0.00040273703,0.03107223],"study_design_scores_gemma":[0.0003200447,0.002322428,0.76990414,0.00022931205,0.0003700688,0.13227645,0.0025938544,0.0035593768,0.07693237,0.0015698154,0.00986233,0.00005973764],"about_ca_topic_score_codex":0.00088528596,"about_ca_topic_score_gemma":0.0013042067,"teacher_disagreement_score":0.0017948202,"about_ca_system_score_codex":0.00033170433,"about_ca_system_score_gemma":0.00034452655,"threshold_uncertainty_score":0.0058010817},"labels":[],"label_agreement":null},{"id":"W1966423882","doi":"10.1016/j.leukres.2008.06.027","title":"Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Research; State Key Laboratory of Polymer Physics and Chemistry; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Plasma cell leukemia; Leukemia; Chromosome; Cancer research; Biology; Genetics; Medicine; Immunology; Bone marrow; Gene","score_opus":0.12189593627991017,"score_gpt":0.4022160662119751,"score_spread":0.2803201299320649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966423882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963737,0.0004479311,0.00009085157,0.00020952564,0.000007773857,0.000011884379,0.00024605228,0.000011879325,0.0026005274],"genre_scores_gemma":[0.99929833,0.00012740838,0.00010077689,0.00002734366,0.00002074269,0.000004591001,0.00018931615,0.0000016807996,0.00022978893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997002,0.00008386489,0.00003492117,0.000054541335,0.000064813685,0.000061629915],"domain_scores_gemma":[0.99883527,0.0003893448,0.00043743057,0.00004802895,0.0000933506,0.0001965219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037953467,0.00035803503,0.0002679788,0.0018011482,0.00042287292,0.00048347795,0.00038039658,0.00067657366,0.0033272393],"category_scores_gemma":[0.0022848914,0.0001989453,0.00015034761,0.0010173566,0.00049071515,0.0005594738,0.00030854536,0.00040881385,0.00034142568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002301833,0.00019660297,0.96190476,0.000045882483,0.000049193884,0.009278691,0.0001761647,0.00023796674,0.0153824985,0.00037236634,0.0007207508,0.009333236],"study_design_scores_gemma":[0.00005407324,0.00033791814,0.9678555,0.000009736863,0.000045339715,0.028070498,0.00025871227,0.0003652921,0.0015513689,0.0004084795,0.0010308019,0.000012269932],"about_ca_topic_score_codex":0.0012888765,"about_ca_topic_score_gemma":0.0013002624,"teacher_disagreement_score":0.0033272393,"about_ca_system_score_codex":0.00033135884,"about_ca_system_score_gemma":0.00035688846,"threshold_uncertainty_score":0.01113075},"labels":[],"label_agreement":null},{"id":"W1968363559","doi":"10.1016/j.leukres.2013.08.001","title":"Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Stromal cell; PI3K/AKT/mTOR pathway; Cytokine; Cancer research; Chronic lymphocytic leukemia; Signal transduction; Cell biology; CD40; Focal adhesion; Biology; Immunology; Chemistry; Leukemia; Cytotoxic T cell; In vitro","score_opus":0.016017212918031244,"score_gpt":0.2880966235796338,"score_spread":0.2720794106616025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968363559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556977,0.0015919098,0.0006960752,0.00006707923,0.0000203807,0.000013786852,0.000077854085,0.000035559926,0.0019275837],"genre_scores_gemma":[0.9967128,0.0008742264,0.00046082117,0.000040266295,0.000019099814,0.00002019999,0.00020043549,0.0000063975017,0.0016658145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997774,0.000042304455,0.000012203997,0.000016626635,0.000042695046,0.000108884415],"domain_scores_gemma":[0.99993587,0.000015083012,0.000014991477,0.000007066502,0.000004361903,0.000022530921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009095683,0.00029569623,0.00020320869,0.00015193231,0.00013187324,0.00028144527,0.00013549378,0.00011317382,0.002067922],"category_scores_gemma":[0.00010002203,0.00009410614,0.00021247732,0.000086439126,0.00011408931,0.00012184777,0.00029098,0.00041888052,0.000384771],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032395934,0.000088575514,0.00042386533,0.000045209155,0.0000083748155,0.00006598451,0.000019073876,0.000053850104,0.99515426,0.000093778064,0.0000838437,0.0036392668],"study_design_scores_gemma":[0.000057997873,0.0013529157,0.011476955,0.000010824073,0.00003074782,0.0005667684,0.000037015838,0.0009642305,0.9811755,0.000061119834,0.004261418,0.0000045820475],"about_ca_topic_score_codex":0.0005385777,"about_ca_topic_score_gemma":0.00070435595,"teacher_disagreement_score":0.002067922,"about_ca_system_score_codex":0.00017404644,"about_ca_system_score_gemma":0.00015115949,"threshold_uncertainty_score":0.006917894},"labels":[],"label_agreement":null},{"id":"W1969714189","doi":"10.1016/j.leukres.2009.03.019","title":"Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital","funders":"BC Cancer Agency","keywords":"Cytopenia; Myelodysplastic syndromes; Progenitor cell; Bone marrow; Haematopoiesis; Dysplasia; Lineage (genetic); Progenitor; Peripheral blood; Medicine; Cancer research; Pathology; Internal medicine; Immunology; Stem cell; Biology; Genetics; Gene","score_opus":0.08105111945671498,"score_gpt":0.3819588372743892,"score_spread":0.3009077178176742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969714189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998444,0.00035155314,0.00029984425,0.000021026888,0.0000032020753,0.000007749573,0.00011889651,0.000010793007,0.0007429991],"genre_scores_gemma":[0.9989825,0.00014649428,0.00032482645,0.000013863431,0.0000044346543,0.0000069376383,0.00022874695,0.0000049177206,0.00028733548],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999871,0.000026467624,0.000026617652,0.000022891822,0.000032762353,0.000020290141],"domain_scores_gemma":[0.9997241,0.00009943051,0.00006791069,0.000031615724,0.000026536823,0.000050281742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017149108,0.00015366229,0.00014835192,0.0008773462,0.0001239882,0.0003410342,0.0001943812,0.00023355946,0.001514296],"category_scores_gemma":[0.00058733695,0.00010365654,0.000108901695,0.00022003059,0.00023074618,0.00014846852,0.0002969834,0.00023243694,0.00023740067],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013679302,0.00006423518,0.12220095,0.00007044769,0.000042532967,0.0023193117,0.00024026945,0.00014506742,0.85917825,0.0010110576,0.00012903991,0.013230918],"study_design_scores_gemma":[0.00008686609,0.0010322257,0.7039142,0.000027619404,0.000115364586,0.029715521,0.00047992062,0.0012369504,0.2581386,0.0007526422,0.0044884454,0.000011667455],"about_ca_topic_score_codex":0.00030768674,"about_ca_topic_score_gemma":0.00040927963,"teacher_disagreement_score":0.001514296,"about_ca_system_score_codex":0.00010746796,"about_ca_system_score_gemma":0.000091099704,"threshold_uncertainty_score":0.0050657988},"labels":[],"label_agreement":null},{"id":"W1971236526","doi":"10.1016/j.leukres.2013.01.001","title":"High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cytarabine; Mitoxantrone; Etoposide; Medicine; Internal medicine; Daunorubicin; Cytogenetics; Regimen; Multivariate analysis; Oncology; Leukemia; Surgery; Gastroenterology; Chemotherapy; Biology","score_opus":0.03875802131210687,"score_gpt":0.3175527483247753,"score_spread":0.27879472701266844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971236526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841485,0.01144213,0.00059118145,0.00030689314,0.00014197885,0.00006340216,0.0003320397,0.000087625674,0.002886305],"genre_scores_gemma":[0.9945505,0.0025599948,0.000625418,0.0001833399,0.00014513562,0.000020571835,0.0010715462,0.000025387371,0.00081823487],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99989855,0.000029126908,0.0000100105035,0.000022446631,0.000016453674,0.000023360155],"domain_scores_gemma":[0.99962425,0.00008236763,0.00005821804,0.00007106109,0.000027986198,0.00013597375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036993582,0.00028752626,0.0011706399,0.00017106123,0.00021679838,0.00045416242,0.00024071975,0.00025033636,0.0031301975],"category_scores_gemma":[0.00063670805,0.000091416296,0.00036330076,0.0003697202,0.00017686383,0.00038321453,0.00020636126,0.0009971965,0.00067303656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.103115775,0.0029756376,0.071650766,0.00051463215,0.00081388094,0.00037520856,0.00021258561,0.0021715953,0.076873824,0.00043108326,0.0052001146,0.73566496],"study_design_scores_gemma":[0.021274608,0.086729504,0.81627196,0.0002517956,0.0018422444,0.006662534,0.00022637745,0.0033005488,0.034372807,0.0009813859,0.02799643,0.000089802576],"about_ca_topic_score_codex":0.0007556356,"about_ca_topic_score_gemma":0.0019485098,"teacher_disagreement_score":0.0031301975,"about_ca_system_score_codex":0.0003015435,"about_ca_system_score_gemma":0.00038913634,"threshold_uncertainty_score":0.010471582},"labels":[],"label_agreement":null},{"id":"W1971888832","doi":"10.1016/j.leukres.2010.07.015","title":"What are RBC-transfusion-dependence and -independence?","year":2010,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Independence (probability theory); Medicine; Erythropoiesis; Anemia; Intensive care medicine; Interval (graph theory); Transfusion therapy; Blood transfusion; Internal medicine; Statistics; Mathematics","score_opus":0.06272011493768677,"score_gpt":0.36454207019617724,"score_spread":0.3018219552584905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971888832","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004052752,0.00803752,0.00010398149,0.9773722,0.005171124,0.000008169064,0.000065604145,0.000007621525,0.005180994],"genre_scores_gemma":[0.08816879,0.019022046,0.0006191451,0.7857725,0.09824103,0.000054368473,0.0001436913,0.000018325567,0.007960044],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971501,0.0013638141,0.00050424883,0.00018779656,0.0005298625,0.00026407448],"domain_scores_gemma":[0.9884063,0.0077509116,0.0010565515,0.00023466574,0.001176824,0.0013746801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036012083,0.00037479936,0.001509967,0.0006635898,0.0018568132,0.0019858482,0.00097474933,0.016239138,0.0047214134],"category_scores_gemma":[0.024585102,0.00046066122,0.0006709928,0.00091162696,0.002109191,0.0043504545,0.00073947356,0.015704637,0.0018536038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009029655,0.0004450229,0.04280535,0.0005546822,0.00020991804,0.023514891,0.0005967222,0.00022437012,0.0006686436,0.019337017,0.772546,0.1381944],"study_design_scores_gemma":[0.00089357485,0.000576608,0.058575753,0.0025948028,0.00045178228,0.09529865,0.0045516132,0.0018089351,0.00097649393,0.09489826,0.7391219,0.00025158445],"about_ca_topic_score_codex":0.0033635597,"about_ca_topic_score_gemma":0.006653509,"teacher_disagreement_score":0.016239138,"about_ca_system_score_codex":0.0033867673,"about_ca_system_score_gemma":0.0025625033,"threshold_uncertainty_score":0.02457285},"labels":[],"label_agreement":null},{"id":"W1972241790","doi":"10.1016/j.leukres.2015.01.015","title":"Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Research Board; University of Calgary; World Health Organization","keywords":"Lymphocytosis; Incidence (geometry); Chronic lymphocytic leukemia; Medicine; Population; Leukemia; Demography; Immunology; Internal medicine; Environmental health","score_opus":0.04314567899309261,"score_gpt":0.32430468315694544,"score_spread":0.2811590041638528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972241790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652111,0.004361187,0.0002855258,0.0012965116,0.00010615943,0.00009469158,0.013634347,0.00011289378,0.014897546],"genre_scores_gemma":[0.98775613,0.002511759,0.0003263204,0.00026329284,0.00003459914,0.000024538325,0.0033838856,0.000018873096,0.00568065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882525,0.000088403016,0.000083429804,0.000121138466,0.00046203044,0.00041974217],"domain_scores_gemma":[0.9971194,0.00013180677,0.0003749955,0.00006379847,0.0014913566,0.00081851037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004961478,0.0005163131,0.00043551283,0.0036419844,0.0019673111,0.0014649335,0.0022817783,0.00081521366,0.0049677948],"category_scores_gemma":[0.0018319653,0.0005512751,0.00066981826,0.0055999667,0.0008536909,0.00041558605,0.0009466634,0.0009332409,0.00065465574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117629854,0.000037938564,0.98931366,0.000046819918,0.000070208174,0.00030716573,0.0002874601,0.00027965702,0.00029183162,0.00029011726,0.003775903,0.005181724],"study_design_scores_gemma":[0.000015262221,0.00002231714,0.99683493,0.00003997587,0.000025397005,0.00024246023,0.0010893275,0.00026618308,0.000049535975,0.000030436582,0.0013723534,0.000011807189],"about_ca_topic_score_codex":0.99606436,"about_ca_topic_score_gemma":0.99726367,"teacher_disagreement_score":0.03162116,"about_ca_system_score_codex":0.03162116,"about_ca_system_score_gemma":0.039521597,"threshold_uncertainty_score":0.22942865},"labels":[],"label_agreement":null},{"id":"W1972578692","doi":"10.1016/j.leukres.2009.04.009","title":"Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; CDKN2A; CpG site; Cancer research; DNA methylation; Biology; Biomarker; Oncology; Medicine; Internal medicine; Genetics; Cancer; Gene; Gene expression","score_opus":0.03828348548014472,"score_gpt":0.3431067613303727,"score_spread":0.304823275850228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972578692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568695,0.00090669945,0.0013258667,0.00007685688,0.00001748117,0.000006533358,0.00025145593,0.000045753106,0.0016824102],"genre_scores_gemma":[0.998468,0.000113856906,0.00020794103,0.000015114397,0.0000039532138,0.0000047162093,0.00019331969,0.00000753536,0.0009856874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982196,0.000024484658,0.0000134762295,0.00004447264,0.000053647313,0.000041956177],"domain_scores_gemma":[0.99978024,0.00005713414,0.0000345636,0.00004656029,0.000023946757,0.000057546342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001778448,0.00013086747,0.00017253109,0.0004097274,0.00022615,0.0002992917,0.00021760397,0.00021298113,0.0033017993],"category_scores_gemma":[0.00036641993,0.00014670899,0.00016658081,0.00018892298,0.00034394307,0.00015225078,0.00018678201,0.0004099968,0.0003533094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018576017,0.000018357878,0.0015864373,0.000013325791,0.000010948948,0.00011436737,0.0000144841015,0.000050866893,0.99546224,0.00021387004,0.000053420164,0.002275962],"study_design_scores_gemma":[0.000038833106,0.0002600391,0.07604385,0.000005877814,0.00004233015,0.0026055977,0.000079965524,0.0013855024,0.9169511,0.00038296595,0.0021951245,0.000008775198],"about_ca_topic_score_codex":0.0018129349,"about_ca_topic_score_gemma":0.0024515933,"teacher_disagreement_score":0.0033017993,"about_ca_system_score_codex":0.0003180781,"about_ca_system_score_gemma":0.000300883,"threshold_uncertainty_score":0.011045635},"labels":[],"label_agreement":null},{"id":"W1972727429","doi":"10.1016/j.leukres.2011.06.035","title":"Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Methadone; Apoptosis; Medicine; Leukemia; Pharmacology; Programmed cell death; Opioid; Cytotoxicity; Population; Cancer research; Oncology; Immunology; Internal medicine; Biology; Receptor; In vitro","score_opus":0.027659181922956765,"score_gpt":0.29046731096596873,"score_spread":0.262808129043012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972727429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995518,0.0025309292,0.0004732217,0.0001846842,0.000027902459,0.000025526178,0.00014251392,0.000023930053,0.0010733337],"genre_scores_gemma":[0.9976853,0.0011606049,0.0003927517,0.000038920487,0.0000073401225,0.000029495817,0.00015642904,0.0000022694812,0.0005267707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987626,0.000037779813,0.000011991207,0.000008856497,0.000025970538,0.00003911357],"domain_scores_gemma":[0.99992573,0.000020684949,0.000017403696,0.000013458208,0.00000848601,0.000014305845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016170346,0.00018008208,0.00023270746,0.00015902452,0.00017675947,0.00029222635,0.00015361322,0.0001557918,0.0012741575],"category_scores_gemma":[0.00014378484,0.000094030875,0.00017552954,0.00017053228,0.0001330772,0.00018373568,0.00015255946,0.00063470623,0.00013870714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026543697,0.0006799983,0.0021206667,0.00021788468,0.000046612502,0.00025901824,0.00017572242,0.0004455695,0.96701986,0.0010254512,0.00063785515,0.024716992],"study_design_scores_gemma":[0.00064425974,0.0057783844,0.022704395,0.00004219026,0.000098881435,0.0011035141,0.00037256605,0.0018632362,0.95800817,0.00026720736,0.00910473,0.000012472463],"about_ca_topic_score_codex":0.0005777043,"about_ca_topic_score_gemma":0.0020676209,"teacher_disagreement_score":0.0012741575,"about_ca_system_score_codex":0.00023753197,"about_ca_system_score_gemma":0.0003272896,"threshold_uncertainty_score":0.004262507},"labels":[],"label_agreement":null},{"id":"W1974101399","doi":"10.1016/j.leukres.2011.05.001","title":"Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Macrocytosis; Medicine; Myelodysplastic syndromes; Internal medicine; Bone marrow; Red blood cell distribution width; International Prognostic Scoring System; Bone marrow examination; Gastroenterology; Anemia","score_opus":0.06880836050930669,"score_gpt":0.31004931206278535,"score_spread":0.24124095155347866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974101399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274857,0.00051029405,0.010691644,0.00022722938,0.000119262586,0.00028952092,0.00062531815,0.00015155229,0.00463668],"genre_scores_gemma":[0.992184,0.00008363475,0.006468306,0.00006524977,0.00004280682,0.0001375623,0.00067554123,0.000016984723,0.0003259848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958617,0.001881242,0.00061526656,0.00034947912,0.0010688666,0.00022337736],"domain_scores_gemma":[0.9810178,0.011377308,0.0020157269,0.0010866806,0.0037585292,0.0007439805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00848822,0.0008375068,0.00064927724,0.0026762495,0.0006432324,0.0012379705,0.0009510326,0.0010074433,0.001336026],"category_scores_gemma":[0.023077114,0.00027713642,0.0006006901,0.0011011683,0.0007733646,0.00085267675,0.0009779354,0.00091382454,0.00068916904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010238938,0.00020877951,0.9706984,0.00005114596,0.00012185854,0.00016714948,0.00017779332,0.0014823446,0.0032327508,0.00039972304,0.00095523114,0.021481017],"study_design_scores_gemma":[0.0003673047,0.0035626427,0.93299204,0.000067384484,0.00026477975,0.0032101893,0.0004811375,0.048228156,0.007182684,0.0009360622,0.0026363973,0.00007122537],"about_ca_topic_score_codex":0.0010259618,"about_ca_topic_score_gemma":0.0009113893,"teacher_disagreement_score":0.00848822,"about_ca_system_score_codex":0.000466802,"about_ca_system_score_gemma":0.0007853747,"threshold_uncertainty_score":0.044890523},"labels":[],"label_agreement":null},{"id":"W1974511383","doi":"10.1016/j.leukres.2010.05.002","title":"Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Bortezomib; Multiple myeloma; Internal medicine; Refractory (planetary science); Medicine; Fluorescence in situ hybridization; Cytogenetics; Oncology; Adverse effect; Gastroenterology; Biology; Chromosome","score_opus":0.030969004063272687,"score_gpt":0.3650718684054194,"score_spread":0.3341028643421467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974511383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951261,0.0024784976,0.00006455947,0.0005659635,0.00003022773,0.000010344578,0.00026474937,0.000011787849,0.0014477636],"genre_scores_gemma":[0.9989932,0.00032426324,0.000045166456,0.00012753064,0.00004174721,0.0000036972772,0.00023565536,0.0000040980667,0.00022456046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996705,0.00013656668,0.000024686819,0.000042937016,0.0000669806,0.000058391997],"domain_scores_gemma":[0.99895537,0.0003704558,0.00032077846,0.000037593454,0.00007972101,0.00023610983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005115009,0.00028057268,0.000626961,0.0003922186,0.00036562904,0.00048631075,0.0002666929,0.00035734707,0.001674908],"category_scores_gemma":[0.0022798465,0.00011757742,0.0004260657,0.0004991633,0.00021039402,0.00032879546,0.0002381002,0.00048817348,0.00015508896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026226461,0.00029858912,0.89837426,0.000105399624,0.0006313468,0.0018729611,0.00014409059,0.00143214,0.0091059115,0.00014532711,0.0014267894,0.060236774],"study_design_scores_gemma":[0.00025732722,0.0023064846,0.9936454,0.000010635312,0.0003935143,0.0014835814,0.00008766195,0.00035152154,0.00054312765,0.00012263564,0.00078876805,0.000009249588],"about_ca_topic_score_codex":0.003087874,"about_ca_topic_score_gemma":0.005153987,"teacher_disagreement_score":0.003087874,"about_ca_system_score_codex":0.0006656059,"about_ca_system_score_gemma":0.0005183245,"threshold_uncertainty_score":0.006139815},"labels":[],"label_agreement":null},{"id":"W1974934205","doi":"10.1016/j.leukres.2008.06.030","title":"Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Genotype; Apoptosis; Internal medicine; Oncology; Immunology; Leukemia; Cancer research; Medicine; Biology; Genetics; Gene","score_opus":0.08583140411174466,"score_gpt":0.3598572648351422,"score_spread":0.2740258607233975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974934205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988254,0.0004867639,0.00018361432,0.00012504953,0.000010348089,0.0000070152746,0.00007598386,0.0000030590525,0.00028279985],"genre_scores_gemma":[0.9993586,0.00012463183,0.0001840945,0.000028339087,0.000018271492,0.0000052515006,0.00006871733,0.0000019142544,0.00021030329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996655,0.00016060806,0.000024613395,0.00005523678,0.000045682977,0.000048407917],"domain_scores_gemma":[0.9985447,0.0007192414,0.00031414977,0.000076156175,0.0001498261,0.00019599032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085401844,0.00026411342,0.0003711,0.00076553406,0.0004797866,0.000376373,0.0003848581,0.0005221626,0.0014257221],"category_scores_gemma":[0.0022642596,0.00016048888,0.00024150297,0.0007881007,0.0004165334,0.00029846368,0.00019679639,0.00055574236,0.00017162506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00439572,0.00021600565,0.9662141,0.00004898603,0.00011583404,0.0006039909,0.00021559364,0.00008138106,0.021442667,0.00018823789,0.00013470728,0.0063427347],"study_design_scores_gemma":[0.00035648642,0.0024320558,0.984903,0.000019255389,0.0003181252,0.002629781,0.00044033822,0.0008743343,0.0056347544,0.0005470544,0.001829077,0.0000157105],"about_ca_topic_score_codex":0.0018319704,"about_ca_topic_score_gemma":0.0010554991,"teacher_disagreement_score":0.0018319704,"about_ca_system_score_codex":0.00027525157,"about_ca_system_score_gemma":0.0003392109,"threshold_uncertainty_score":0.004769504},"labels":[],"label_agreement":null},{"id":"W1978209348","doi":"10.1016/j.leukres.2011.01.002","title":"Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Innovation; Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Institut national de la recherche scientifique","keywords":"Myeloid leukemia; Acute promyelocytic leukemia; Gene isoform; Leukemia; Cancer research; Myeloid; Medicine; Wilms' tumor; Gene; Biology; Internal medicine; Immunology; Genetics; Retinoic acid","score_opus":0.044220017657999246,"score_gpt":0.3507350368077484,"score_spread":0.30651501914974916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978209348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989874,0.00017615968,0.00007013808,0.000023105624,0.0000022298846,0.000004415475,0.00018873544,0.000003842397,0.00054385234],"genre_scores_gemma":[0.99950075,0.000106491396,0.000036560574,0.000010684056,0.0000068538434,0.000004110924,0.00017296275,0.0000018796712,0.00015970587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996277,0.000075314354,0.000052314408,0.00009228482,0.000054426553,0.00009793697],"domain_scores_gemma":[0.99869907,0.00027706972,0.00057530456,0.000059124526,0.00013709722,0.0002522876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034837253,0.00018297798,0.000259356,0.0014563986,0.00042191404,0.0005971333,0.00030099117,0.00037301212,0.0021139332],"category_scores_gemma":[0.0017099858,0.00019979388,0.0001854424,0.0012219754,0.00042800646,0.0004996686,0.0003092215,0.00031412335,0.00043059775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003782355,0.00003065571,0.9930661,0.000009658083,0.000009185877,0.0004996955,0.00008074786,0.000027874217,0.0041765682,0.000041636686,0.00006269869,0.001616952],"study_design_scores_gemma":[0.000004166881,0.00011590726,0.994341,0.000004309382,0.00001541769,0.00413155,0.000340309,0.00011800963,0.00058396446,0.000049090067,0.00029090018,0.000005311692],"about_ca_topic_score_codex":0.0008445555,"about_ca_topic_score_gemma":0.0005573196,"teacher_disagreement_score":0.0021139332,"about_ca_system_score_codex":0.00019473903,"about_ca_system_score_gemma":0.00017581631,"threshold_uncertainty_score":0.0070718527},"labels":[],"label_agreement":null},{"id":"W1978698022","doi":"10.1016/s0145-2126(02)00078-4","title":"Microsatellite mutations of transforming growth factor-β receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Calgary; University of Saskatchewan","funders":"","keywords":"Biology; DNA mismatch repair; DNA methylation; Frameshift mutation; Microsatellite instability; Molecular biology; CpG site; Coding region; Epigenetics; Genetics; Microsatellite; Gene; Cancer research; Mutation; DNA repair; Gene expression; Allele","score_opus":0.07022919313065507,"score_gpt":0.3229667732685162,"score_spread":0.25273758013786113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978698022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978667,0.000490233,0.000848462,0.000025207817,0.000010066269,0.000010618258,0.00017863867,0.000054515756,0.00051552476],"genre_scores_gemma":[0.9981823,0.00021831846,0.00038250038,0.00001099838,0.000005894722,0.000011375243,0.00037914913,0.00001655955,0.00079283665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979454,0.00003651048,0.000027531525,0.00004544916,0.000046915982,0.000049011862],"domain_scores_gemma":[0.99949384,0.00009734767,0.00021190562,0.0000652611,0.000029854209,0.00010177829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020138957,0.0003006757,0.00026978712,0.0008902429,0.0002025112,0.0003226825,0.00020224857,0.00030079525,0.0031475183],"category_scores_gemma":[0.00041768074,0.00039949786,0.00029133924,0.00032904698,0.0002984392,0.00024867852,0.0003216116,0.00048927683,0.0006885372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004069016,0.000028094088,0.0034955759,0.000021295195,0.00002240561,0.00023750063,0.000039530132,0.000037080026,0.99419147,0.0001342219,0.000040416886,0.0013455398],"study_design_scores_gemma":[0.00013853543,0.0007714332,0.13582315,0.000009564277,0.0001232492,0.008270885,0.00014643186,0.00085155334,0.850902,0.00029411569,0.0026560929,0.000012909245],"about_ca_topic_score_codex":0.00052412855,"about_ca_topic_score_gemma":0.00072467903,"teacher_disagreement_score":0.0031475183,"about_ca_system_score_codex":0.00021857879,"about_ca_system_score_gemma":0.00016430666,"threshold_uncertainty_score":0.0105294585},"labels":[],"label_agreement":null},{"id":"W1980393873","doi":"10.1016/j.leukres.2013.02.009","title":"Symptom burden and supportive care in patients with acute leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Sadness; Referral; Psychosocial; Acute leukemia; Population; Palliative care; Anger; Leukemia; Psychiatry; Physical therapy; Pediatrics; Intensive care medicine; Internal medicine; Family medicine; Nursing","score_opus":0.05923042890475087,"score_gpt":0.40838790978477907,"score_spread":0.3491574808800282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980393873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932969,0.0031070097,0.000022777362,0.0012872267,0.000020994597,0.000008637481,0.00021077383,0.0000012554171,0.0020445038],"genre_scores_gemma":[0.99852943,0.00094882573,0.00003540554,0.00015336392,0.000032187625,0.0000050893454,0.00018022135,7.723662e-7,0.0001147702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993111,0.0003206669,0.00010104119,0.000040342708,0.000113306756,0.00011358784],"domain_scores_gemma":[0.9967758,0.00070603454,0.0016432273,0.000036130234,0.0002062875,0.00063246477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068939175,0.00013679077,0.0003715875,0.0006816468,0.0006707314,0.0009992012,0.00028701767,0.00041986338,0.002067789],"category_scores_gemma":[0.008120897,0.00012994431,0.00036593364,0.0012642768,0.00034849078,0.0010182264,0.0010477039,0.00078223133,0.00010669195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013880765,0.00009090596,0.9927377,0.00005001719,0.000065273234,0.00012293817,0.0005194293,0.000076254815,0.000055146716,0.00008145044,0.00039145048,0.0056706746],"study_design_scores_gemma":[0.000010436043,0.00009142591,0.99729186,0.0000390798,0.00003067994,0.00020135722,0.0017091141,0.00011232502,0.000014724804,0.00008698989,0.00040584628,0.0000060266443],"about_ca_topic_score_codex":0.0060804407,"about_ca_topic_score_gemma":0.01065886,"teacher_disagreement_score":0.0060804407,"about_ca_system_score_codex":0.00070035964,"about_ca_system_score_gemma":0.00079841027,"threshold_uncertainty_score":0.012090087},"labels":[],"label_agreement":null},{"id":"W1980590287","doi":"10.1016/j.leukres.2012.07.013","title":"Dasatinib inhibits leukaemic cell survival by decreasing PRH/Hhex phosphorylation resulting in increased repression of VEGF signalling genes","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Wellcome Trust","keywords":"Dasatinib; Psychological repression; Phosphorylation; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Transcription factor; Cancer research; Biology; Myeloid leukemia; Chemistry; Signal transduction; Molecular biology; Gene; Tyrosine kinase; Gene expression; Biochemistry","score_opus":0.06927618701549326,"score_gpt":0.36445768919430604,"score_spread":0.2951815021788128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980590287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918001,0.0036111346,0.0013137228,0.00029055338,0.000055452398,0.00003728455,0.00032016,0.00010032202,0.0024712707],"genre_scores_gemma":[0.9967982,0.00093030825,0.00075242337,0.00003711727,0.000011893343,0.00001639559,0.00021327232,0.000006392671,0.0012339765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980587,0.00003518522,0.00002789444,0.000025167912,0.00006107075,0.00004494211],"domain_scores_gemma":[0.999943,0.000012274448,0.000017484264,0.000006448544,0.0000058581213,0.000014881786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117963966,0.0002024498,0.00043499505,0.00013513198,0.0001331827,0.00023985351,0.00015857148,0.00016058318,0.0021939927],"category_scores_gemma":[0.00016839839,0.00008843101,0.00014139854,0.000121039586,0.00021590886,0.00015499537,0.00013901034,0.00048653077,0.00032831435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048595274,0.00009216386,0.0003391381,0.00011127776,0.000022597187,0.00006258144,0.000012914153,0.00015607756,0.9919022,0.0001680845,0.00018294535,0.006464027],"study_design_scores_gemma":[0.00013540317,0.000800354,0.004705911,0.0000028277043,0.00001746872,0.0005805831,0.00002541839,0.0005177531,0.9894517,0.00007514404,0.0036821885,0.000005307364],"about_ca_topic_score_codex":0.00026106584,"about_ca_topic_score_gemma":0.00071857916,"teacher_disagreement_score":0.0021939927,"about_ca_system_score_codex":0.0002458622,"about_ca_system_score_gemma":0.00021722275,"threshold_uncertainty_score":0.0073395967},"labels":[],"label_agreement":null},{"id":"W1980656001","doi":"10.1016/j.leukres.2011.05.023","title":"CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Medicine; Minimal residual disease; Bone marrow; Oncology; Internal medicine; Cohort; Disease; Overall survival","score_opus":0.06316909539166278,"score_gpt":0.34194616434308045,"score_spread":0.2787770689514177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980656001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823219,0.009603179,0.0014106103,0.0010121319,0.000108877124,0.000036846515,0.0020990558,0.00011548755,0.0032918816],"genre_scores_gemma":[0.99158734,0.0022651046,0.0017993876,0.00012444444,0.00016958371,0.000043746848,0.0032196944,0.000030282103,0.0007604434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994741,0.00011952763,0.00006700009,0.000095378564,0.00013596332,0.000108122294],"domain_scores_gemma":[0.9981224,0.0005660321,0.0006208964,0.00009481726,0.00029939142,0.00029645587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007060146,0.0006606719,0.00091187324,0.001253612,0.00042102748,0.001679291,0.0005570018,0.0006191959,0.0026122464],"category_scores_gemma":[0.004097296,0.00020902675,0.00038395464,0.0020715827,0.00035318613,0.001032384,0.00053327077,0.0010970387,0.0009581439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016961193,0.000042896696,0.94812673,0.00013338456,0.00012977904,0.00069201767,0.00004771605,0.00053392834,0.0047831004,0.00019464908,0.002422863,0.0411968],"study_design_scores_gemma":[0.00016559518,0.0006350704,0.95904166,0.00009600884,0.0005775509,0.008462925,0.00036879946,0.004227345,0.0123935975,0.0016182852,0.012375114,0.00003805643],"about_ca_topic_score_codex":0.0010992142,"about_ca_topic_score_gemma":0.0014562018,"teacher_disagreement_score":0.0026122464,"about_ca_system_score_codex":0.0005800602,"about_ca_system_score_gemma":0.00059903896,"threshold_uncertainty_score":0.008738816},"labels":[],"label_agreement":null},{"id":"W1980663284","doi":"10.1016/j.leukres.2008.07.015","title":"Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Michael Smith Health Research BC","keywords":"Imatinib; Myeloid leukemia; Internal medicine; Medicine; Odds ratio; Gastroenterology; Trough (economics); Trough level; Oncology","score_opus":0.061519008866460737,"score_gpt":0.34157451335812333,"score_spread":0.2800555044916626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980663284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988611,0.0003608634,0.00010253968,0.000051273528,0.000004699296,0.000003739616,0.00009334865,0.0000059106064,0.00051664974],"genre_scores_gemma":[0.9993212,0.000090466696,0.000088386456,0.000023804505,0.000013683603,0.0000041539415,0.00022608576,0.0000035711407,0.00022859595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996112,0.00013058863,0.00005687274,0.000050697643,0.000088546694,0.000062124935],"domain_scores_gemma":[0.9946091,0.0019185791,0.0024114214,0.000230106,0.00019700301,0.000633673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008166996,0.00018612068,0.00037037334,0.0004291839,0.00015575971,0.00036716578,0.00023031076,0.00036772588,0.0014288294],"category_scores_gemma":[0.003902098,0.00017188118,0.0002725093,0.00044257948,0.00028294872,0.00046799763,0.00024081134,0.00055709714,0.00034112766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006852652,0.00012734836,0.96077937,0.000034614877,0.00017435417,0.00015910047,0.00008242075,0.00050852535,0.016345907,0.00007285991,0.0002267307,0.014635974],"study_design_scores_gemma":[0.000035007368,0.0005120356,0.99775535,0.0000024791163,0.000041456868,0.00046446477,0.000031884636,0.00027707257,0.00061355095,0.000048978556,0.00021338815,0.0000044282738],"about_ca_topic_score_codex":0.000424867,"about_ca_topic_score_gemma":0.0007826254,"teacher_disagreement_score":0.0014288294,"about_ca_system_score_codex":0.0002069678,"about_ca_system_score_gemma":0.00020218745,"threshold_uncertainty_score":0.004779935},"labels":[],"label_agreement":null},{"id":"W1981161460","doi":"10.1016/j.leukres.2009.01.010","title":"p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Intramedullary rod; Multiple myeloma; Bone marrow; Medicine; Pathology; Medullary cavity; Proliferation index; Plasmacytoma; Immunohistochemistry; Internal medicine; Anatomy","score_opus":0.09732688832183028,"score_gpt":0.4157256430816742,"score_spread":0.3183987547598439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981161460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668115,0.0018727304,0.00057846645,0.000054628403,0.00001533412,0.0000055857754,0.00015494744,0.000038262307,0.0005988781],"genre_scores_gemma":[0.9989278,0.00028222153,0.0002117973,0.00001150811,0.000015665157,0.0000044220633,0.00014626919,0.0000050430654,0.00039522673],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997532,0.000049088612,0.000026178968,0.000047916274,0.00008160228,0.000042004773],"domain_scores_gemma":[0.99874675,0.00022586143,0.0005838054,0.00011760862,0.00015537994,0.00017063749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003317448,0.0002475296,0.0004108701,0.001535529,0.00034989897,0.0005477844,0.00031824186,0.00042238404,0.002281014],"category_scores_gemma":[0.0011128373,0.0002879334,0.00028727445,0.0008406594,0.00033857088,0.00040743075,0.00037960924,0.0005745238,0.00038551175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055864225,0.00023521968,0.28747645,0.00018900953,0.00023473418,0.0032601068,0.00016800761,0.00022164908,0.68497837,0.00023835353,0.00043322396,0.016978495],"study_design_scores_gemma":[0.000036984908,0.0003744031,0.9531492,0.000010239609,0.000090676,0.0059566163,0.000100779806,0.00045090175,0.0386213,0.00017800953,0.0010196193,0.000011254164],"about_ca_topic_score_codex":0.0004757416,"about_ca_topic_score_gemma":0.0005373068,"teacher_disagreement_score":0.002281014,"about_ca_system_score_codex":0.00026079913,"about_ca_system_score_gemma":0.00014568327,"threshold_uncertainty_score":0.0076307654},"labels":[],"label_agreement":null},{"id":"W1981572464","doi":"10.1016/j.leukres.2006.03.029","title":"Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; Daunorubicin; Cytarabine; Etoposide; Bone marrow; Troglitazone; Pharmacology; Leukemia; Chemistry; Medicine; In vitro; Immunology; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.024792458038532843,"score_gpt":0.3256734553512945,"score_spread":0.30088099731276163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981572464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97936034,0.0120730465,0.0013352078,0.00049051346,0.0003684706,0.00020071874,0.00072817254,0.00025113905,0.0051924586],"genre_scores_gemma":[0.9913134,0.003995697,0.0015163171,0.00009504571,0.00010737036,0.00011133204,0.0006277415,0.000030347504,0.0022027239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945885,0.00018036622,0.00006104722,0.00005690368,0.00011668753,0.00012618772],"domain_scores_gemma":[0.99969006,0.00009287367,0.000031772786,0.00005640604,0.00003771903,0.00009105804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041772015,0.0008345975,0.0015900689,0.0010525956,0.0005838686,0.00076774624,0.00061832933,0.00057587604,0.0028717783],"category_scores_gemma":[0.0004647215,0.0004506789,0.0008562583,0.000880571,0.00045833908,0.0004321721,0.00061451906,0.0012419582,0.00087310106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01216292,0.0014474657,0.0025510516,0.00062133395,0.0003596319,0.0005853133,0.00029576547,0.0024624125,0.94085705,0.0004474729,0.0022626102,0.035947062],"study_design_scores_gemma":[0.0014678577,0.013281647,0.0141496025,0.00007130551,0.00051750336,0.0012601605,0.0002779082,0.001708332,0.9499025,0.0002629622,0.01704889,0.000051304018],"about_ca_topic_score_codex":0.0013865426,"about_ca_topic_score_gemma":0.0053698067,"teacher_disagreement_score":0.0028717783,"about_ca_system_score_codex":0.00049563136,"about_ca_system_score_gemma":0.000836011,"threshold_uncertainty_score":0.009607077},"labels":[],"label_agreement":null},{"id":"W1983100070","doi":"10.1016/s0145-2126(06)80002-0","title":"Principles of maintenance therapy","year":2006,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Maintenance therapy; Medicine; Rituximab; Asymptomatic; Follicular lymphoma; Disease; Randomized controlled trial; Internal medicine; Oncology; Intensive care medicine; Lymphoma; Surgery; Chemotherapy","score_opus":0.3289401216310138,"score_gpt":0.481570942499759,"score_spread":0.1526308208687452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983100070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022277795,0.99186337,0.0012679424,0.001665677,0.0005970675,0.000031273554,0.00004331328,0.000031915104,0.0042767804],"genre_scores_gemma":[0.004736875,0.9839341,0.0031125743,0.0027345538,0.001058204,0.00010035833,0.00012112201,0.000009142275,0.0041929963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953043,0.00012241269,0.00007392233,0.000081623555,0.00015545248,0.00003621875],"domain_scores_gemma":[0.99972767,0.00012202896,0.000057478544,0.000017747667,0.000054067925,0.000021013142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009231054,0.00087115064,0.001428226,0.0021110233,0.0003984388,0.0015793429,0.0018052033,0.0014083405,0.005050235],"category_scores_gemma":[0.0009751507,0.0002520944,0.0008153221,0.0011327816,0.0013233577,0.0016388944,0.0011001487,0.0028698428,0.002737007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014290086,0.000141887,0.00027945562,0.010015458,0.00009194303,0.00022905765,0.00011252641,0.00028813406,0.0009882499,0.016041782,0.040994607,0.930674],"study_design_scores_gemma":[0.00005883781,0.00011691055,0.0007964176,0.00418949,0.00009000146,0.0017204162,0.00003958374,0.000091260845,0.0003502039,0.005350009,0.9871803,0.000016563694],"about_ca_topic_score_codex":0.0010551744,"about_ca_topic_score_gemma":0.0016234398,"teacher_disagreement_score":0.005050235,"about_ca_system_score_codex":0.0011281951,"about_ca_system_score_gemma":0.001871326,"threshold_uncertainty_score":0.016894758},"labels":[],"label_agreement":null},{"id":"W1985662900","doi":"10.1016/j.leukres.2012.05.020","title":"Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Myeloid leukemia; Quality of life (healthcare); Chemotherapy; Young adult; Gerontology; Pediatrics; Internal medicine","score_opus":0.07527798105685493,"score_gpt":0.3864335675960221,"score_spread":0.3111555865391672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985662900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998678,0.00057233736,0.00003309924,0.000091173,0.000020708552,0.000003275241,0.00013732698,0.000001387102,0.00046261193],"genre_scores_gemma":[0.99919134,0.0002864712,0.000034629462,0.000063349005,0.000034398927,0.0000031648592,0.0001970973,0.0000013674512,0.00018823898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996811,0.000083114544,0.000045398952,0.000045387224,0.000046685058,0.00009824849],"domain_scores_gemma":[0.9969848,0.00035704597,0.0018709059,0.00008867635,0.00012321559,0.00057535287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003102663,0.00020010349,0.0003373575,0.00050758553,0.00033111506,0.000635873,0.00020416985,0.0004766442,0.0016533061],"category_scores_gemma":[0.0026831208,0.00016226026,0.0006956271,0.0008663404,0.00019403805,0.0003851736,0.0003860774,0.00057360815,0.00015810782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019362412,0.000047035228,0.9977436,0.000010517873,0.000062465944,0.000075909455,0.00004724193,0.00002977642,0.0002197986,0.000010137432,0.00005730006,0.0015026568],"study_design_scores_gemma":[0.0000026623165,0.00004479034,0.99971145,0.0000030612375,0.000018766326,0.00005483166,0.00006249044,0.000021607533,0.000011856674,0.0000103018465,0.0000567574,0.0000014984431],"about_ca_topic_score_codex":0.005871453,"about_ca_topic_score_gemma":0.008242266,"teacher_disagreement_score":0.005871453,"about_ca_system_score_codex":0.00024068257,"about_ca_system_score_gemma":0.0003347528,"threshold_uncertainty_score":0.011674523},"labels":[],"label_agreement":null},{"id":"W1986612400","doi":"10.1016/s0145-2126(99)00188-5","title":"All trans retinoic acid induces apoptosis in acute promyelocytic NB4 cells when combined with isoquinolinediol, a poly(ADP-ribose) polymerase inhibitor","year":2000,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Hospital for Sick Children; SickKids Foundation","funders":"Cancer Research Society","keywords":"Poly ADP ribose polymerase; Acute promyelocytic leukemia; Apoptosis; Retinoic acid; DNA fragmentation; Molecular biology; Cellular differentiation; Tretinoin; Chemistry; Acute monocytic leukemia; Biology; Cancer research; Leukemia; Polymerase; Biochemistry; Programmed cell death; Immunology; DNA","score_opus":0.018808746916901518,"score_gpt":0.2855546692322381,"score_spread":0.26674592231533656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986612400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799621,0.008101979,0.0029279762,0.00043001864,0.00017223324,0.00010149181,0.001129301,0.0002505274,0.0069243847],"genre_scores_gemma":[0.98547924,0.0042729783,0.0024872832,0.00008964831,0.000037532773,0.000084001826,0.001381158,0.000036526802,0.0061317105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994809,0.0001265879,0.00008006276,0.000053312855,0.00013401726,0.00012506133],"domain_scores_gemma":[0.99959785,0.00010384659,0.000060609927,0.00010204811,0.00006600714,0.00006956263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003568582,0.0006056628,0.0008817893,0.00085711834,0.0005349248,0.00062636577,0.00041570276,0.00048114706,0.002153867],"category_scores_gemma":[0.0003272194,0.00034460047,0.00067304843,0.0006895304,0.00048278185,0.00043227285,0.0002994216,0.0011166235,0.0009401329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018860629,0.00014843013,0.00054452784,0.0001037861,0.000048383317,0.00024578176,0.000091871116,0.0002215844,0.9926791,0.00026052535,0.0001922489,0.0035776955],"study_design_scores_gemma":[0.00014393785,0.0008072909,0.0017577029,0.000009925576,0.000048690326,0.0002499647,0.00008283862,0.0003901682,0.99331117,0.00009461297,0.0030982115,0.000005538357],"about_ca_topic_score_codex":0.0028473185,"about_ca_topic_score_gemma":0.003561431,"teacher_disagreement_score":0.0028473185,"about_ca_system_score_codex":0.00077961636,"about_ca_system_score_gemma":0.0007785139,"threshold_uncertainty_score":0.0072054267},"labels":[],"label_agreement":null},{"id":"W1989503397","doi":"10.1016/j.leukres.2005.05.014","title":"Viscum album agglutinin-I (VAA-I) induces apoptosis and degradation of cytoskeletal proteins in human leukemia PLB-985 and X-CGD cells via caspases: Lamin B1 is a novel target of VAA-I","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Apoptosis; Biology; Caspase; Cytoskeleton; Molecular biology; Cell culture; Cell biology; Programmed cell death; Lamin; Cell; Biochemistry; Genetics","score_opus":0.029486022539367177,"score_gpt":0.29872084006899485,"score_spread":0.2692348175296277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989503397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959145,0.0013068165,0.0014717873,0.00007868434,0.000014818792,0.000015498135,0.00019327064,0.000051446932,0.0009531472],"genre_scores_gemma":[0.9978065,0.00039006243,0.0004776812,0.000017958826,0.000004499917,0.000013699002,0.00031930258,0.000006036135,0.00096425903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998864,0.000023235803,0.00001165196,0.000017548038,0.000020639327,0.00004046684],"domain_scores_gemma":[0.9999298,0.000014017273,0.000019285668,0.0000131732595,0.0000062855543,0.00001734329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011515266,0.00032544605,0.00017273388,0.00024918618,0.00023244823,0.00028875918,0.00021591052,0.0003033844,0.001073811],"category_scores_gemma":[0.000107434455,0.00012940544,0.00027034793,0.00023364945,0.00017217577,0.00020744391,0.00017545575,0.00049343234,0.00035073154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003307207,0.00003509115,0.0003557416,0.000023073157,0.000008856658,0.00008964386,0.000013708462,0.000061666695,0.99812037,0.00015908806,0.000031163752,0.00077086536],"study_design_scores_gemma":[0.000034326906,0.00040611444,0.0071838675,0.0000036135705,0.000018330395,0.00045521432,0.000029835312,0.00079526094,0.9896825,0.00006582327,0.0013227899,0.0000023235666],"about_ca_topic_score_codex":0.0006957312,"about_ca_topic_score_gemma":0.0006659961,"teacher_disagreement_score":0.001073811,"about_ca_system_score_codex":0.00041355574,"about_ca_system_score_gemma":0.00015649752,"threshold_uncertainty_score":0.0035922527},"labels":[],"label_agreement":null},{"id":"W1990362267","doi":"10.1016/j.leukres.2012.10.010","title":"Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Myelodysplastic syndromes; Immune system; Bone marrow; Flow cytometry; Medicine; Stem cell; Immunology; Dendritic cell; Bone marrow failure; Biology; Haematopoiesis; Cell biology","score_opus":0.018762837993635997,"score_gpt":0.26590736032765533,"score_spread":0.24714452233401935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990362267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986815,0.00059971586,0.00006427116,0.00008893381,0.000007489924,0.000003990285,0.000117536685,0.000006680036,0.0004299088],"genre_scores_gemma":[0.9993407,0.00017046792,0.000067496476,0.000049910326,0.000017334958,0.0000044523167,0.0001401593,0.000002421082,0.00020697794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979466,0.00005400023,0.000023157661,0.00003856728,0.00004751653,0.000042060754],"domain_scores_gemma":[0.99924064,0.00014080708,0.00042500315,0.000027409807,0.00005664579,0.00010940025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016665643,0.00030301328,0.0004108832,0.0007155522,0.0003521545,0.0005086986,0.0002853239,0.00059044384,0.0018038909],"category_scores_gemma":[0.0017057818,0.00019591926,0.00019022876,0.0005918347,0.00027875399,0.00024428684,0.0002468494,0.0005170911,0.00024521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009416085,0.000079339865,0.97973734,0.000036080964,0.00007345138,0.0010085157,0.00012311895,0.00007446342,0.009733207,0.0000731905,0.00029826557,0.007821369],"study_design_scores_gemma":[0.000027231725,0.00021912203,0.9949551,0.000008230711,0.00007128921,0.0030445345,0.00016414675,0.00012712202,0.00073158037,0.00011225629,0.00053398067,0.0000053492763],"about_ca_topic_score_codex":0.00097429444,"about_ca_topic_score_gemma":0.00088314555,"teacher_disagreement_score":0.0018038909,"about_ca_system_score_codex":0.00018419174,"about_ca_system_score_gemma":0.00014870173,"threshold_uncertainty_score":0.0060346723},"labels":[],"label_agreement":null},{"id":"W1991554870","doi":"10.1016/j.leukres.2014.08.008","title":"Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canadian Blood Services; University of Alberta","funders":"University of Alberta; Alberta Innovates; Alberta Innovates - Health Solutions; Canadian Blood Services","keywords":"CD44; Gene silencing; Myeloid leukemia; Cancer research; Stem cell; Leukemia; Jurkat cells; Chemistry; Biology; Cell biology; Cell; Immunology; Biochemistry; Immune system; T cell","score_opus":0.020268339546957215,"score_gpt":0.2966030288540788,"score_spread":0.2763346893071216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991554870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073225,0.0007119189,0.0059392783,0.00009247294,0.00003823534,0.000036558074,0.00009548353,0.00008648128,0.0022672103],"genre_scores_gemma":[0.99329525,0.00028973474,0.0031278199,0.00003578844,0.0000068609615,0.000033865075,0.000106945365,0.000012340419,0.0030914873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998648,0.000019152816,0.000009592646,0.00003360065,0.000041255902,0.000031660576],"domain_scores_gemma":[0.99996865,0.000009862174,0.0000071502523,0.0000046041428,0.000005489121,0.0000042339207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001383985,0.00018687733,0.00017618146,0.00012677426,0.00014396071,0.00023665694,0.00017404227,0.00028967854,0.0006480044],"category_scores_gemma":[0.00008699398,0.00010220615,0.00017488786,0.00012337293,0.00013746195,0.00012560839,0.00011112318,0.00030957488,0.0001701957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003091645,0.0000131956085,0.00003284965,0.000015090798,0.000002068829,0.000018992763,0.000010237857,0.00009378105,0.99864846,0.00015353733,0.000029346906,0.0009516441],"study_design_scores_gemma":[0.000009387394,0.00010431383,0.00040615065,0.0000011717374,0.000009410206,0.000049885446,0.0000057628536,0.0011348305,0.9970818,0.000021176338,0.0011745676,0.0000015521681],"about_ca_topic_score_codex":0.0008042162,"about_ca_topic_score_gemma":0.0010035675,"teacher_disagreement_score":0.0008042162,"about_ca_system_score_codex":0.00031780254,"about_ca_system_score_gemma":0.00016120389,"threshold_uncertainty_score":0.0023058057},"labels":[],"label_agreement":null},{"id":"W1991958842","doi":"10.1016/j.leukres.2004.11.012","title":"Engineering 3-alkyltriazenes to block bcr-abl kinase: a novel strategy for the therapy of advanced bcr-abl expressing leukemias","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Autophosphorylation; Tyrosine kinase; K562 cells; Cancer research; ABL; Chronic myelogenous leukemia; Leukemia; breakpoint cluster region; Philadelphia chromosome; Molecular biology; Biology; Chemistry; Kinase; Cell biology; Biochemistry; Immunology; Signal transduction; Protein kinase A; Receptor","score_opus":0.10583180042391337,"score_gpt":0.3902554435472102,"score_spread":0.2844236431232968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991958842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92892385,0.0074026613,0.04697542,0.0008834715,0.00021834923,0.00021001764,0.0005573117,0.0007069902,0.014121881],"genre_scores_gemma":[0.97690696,0.0054915957,0.01013397,0.00017199159,0.000024507384,0.00007233823,0.00030788337,0.00005458836,0.0068361782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993825,0.0000085322745,0.0000044189023,0.000012103238,0.000017664217,0.000019020412],"domain_scores_gemma":[0.9999707,0.0000050135986,0.000011017581,0.000004401263,0.0000041590124,0.0000047654585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001032002,0.0003715062,0.0002540038,0.00018560125,0.00014137225,0.00025950614,0.00024266858,0.00031722046,0.0014722554],"category_scores_gemma":[0.00007869247,0.00016627865,0.00028305285,0.00014783931,0.00016153502,0.00024951238,0.00019272981,0.0006606879,0.00044870574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001223668,0.000046106485,0.00004606104,0.000055862212,0.000007784848,0.000084737316,0.000026703197,0.0009145955,0.9888232,0.0012576234,0.00016478631,0.008450298],"study_design_scores_gemma":[0.000067660134,0.00029071732,0.00023913594,0.000005249316,0.000018124438,0.00021765997,0.000011505924,0.0014482234,0.988472,0.0002961048,0.0089262845,0.000007468193],"about_ca_topic_score_codex":0.00055067986,"about_ca_topic_score_gemma":0.001030731,"teacher_disagreement_score":0.0014722554,"about_ca_system_score_codex":0.0002578028,"about_ca_system_score_gemma":0.00023916866,"threshold_uncertainty_score":0.0049251914},"labels":[],"label_agreement":null},{"id":"W1993701888","doi":"10.1016/j.leukres.2009.06.019","title":"CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; Myeloid leukemia; CpG site; Myelodysplastic syndromes; MEG3; DNA methylation; Internal medicine; Biology; Cancer research; Oncology; Medicine; Bone marrow; Gene; Genetics; Gene expression","score_opus":0.026018310621875942,"score_gpt":0.33296416264056117,"score_spread":0.30694585201868524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993701888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979017,0.00041790202,0.0007339757,0.000026388501,0.0000039320457,0.0000049012165,0.00021252557,0.000011556683,0.0006870915],"genre_scores_gemma":[0.99882144,0.00013196429,0.00037946514,0.000017035829,0.000001898487,0.000004338512,0.00018773551,0.0000032749053,0.00045287274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999275,0.000015731026,0.000007862945,0.000012157294,0.000022197402,0.000014554442],"domain_scores_gemma":[0.99994516,0.000016015285,0.000011921269,0.0000054221055,0.000008285073,0.000013131793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012098386,0.00009141534,0.00013294251,0.0005660688,0.00014863865,0.00010397401,0.00012787302,0.00012266546,0.0011111293],"category_scores_gemma":[0.00025725822,0.00008542132,0.00013011628,0.00024028841,0.00015038575,0.000052222033,0.00014306165,0.0001331267,0.00012357025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000815968,0.000014847902,0.018751815,0.0000300844,0.00003764975,0.00018949663,0.00006139682,0.00016959982,0.97287184,0.00023667593,0.000060836177,0.0067597013],"study_design_scores_gemma":[0.000055613506,0.0003393313,0.557702,0.000009092095,0.00013866083,0.0024340712,0.0001765603,0.0019021797,0.434173,0.00047445003,0.0025831982,0.000011897304],"about_ca_topic_score_codex":0.0033895096,"about_ca_topic_score_gemma":0.005080724,"teacher_disagreement_score":0.0033895096,"about_ca_system_score_codex":0.00018851989,"about_ca_system_score_gemma":0.00012215991,"threshold_uncertainty_score":0.006739557},"labels":[],"label_agreement":null},{"id":"W1994072538","doi":"10.1016/s0145-2126(01)00181-3","title":"The kinase inhibitor STI571 reverses the Bcr–Abl induced point mutation frequencies observed in pre-leukemic P190Bcr–Abl transgenic mice","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Medical Research Council","keywords":"ABL; Chronic myelogenous leukemia; Point mutation; Cancer research; Biology; Leukemia; Philadelphia chromosome; breakpoint cluster region; Transgene; Genetically modified mouse; Tyrosine-kinase inhibitor; Tyrosine kinase; Molecular biology; Mutation; Immunology; Chromosomal translocation; Cancer; Genetics; Signal transduction; Receptor; Gene","score_opus":0.11712964894598563,"score_gpt":0.34268559322263736,"score_spread":0.22555594427665174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994072538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910754,0.0009229097,0.002675445,0.00040868347,0.00010193145,0.000050174403,0.0011234686,0.0007988154,0.0028430047],"genre_scores_gemma":[0.98979926,0.000927527,0.00242882,0.00010644768,0.000054944907,0.000078607954,0.0010697228,0.00018344233,0.005351227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961483,0.000048663183,0.000040480863,0.000059471753,0.00011272514,0.00012377306],"domain_scores_gemma":[0.99945074,0.00008266982,0.00020554503,0.000050076982,0.000029740962,0.00018114876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028160255,0.0007736075,0.0005912897,0.0012087857,0.00029758541,0.00047009703,0.00046176938,0.0005124359,0.0030612506],"category_scores_gemma":[0.0002434709,0.00038552465,0.00036676135,0.00043409702,0.0006734292,0.00035913798,0.00023456864,0.0024838783,0.00080608093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020988754,0.000066071196,0.00009640957,0.000020986183,0.0000065104914,0.0000579109,0.000011660547,0.000070600836,0.99763227,0.00027020866,0.00013559102,0.0014217598],"study_design_scores_gemma":[0.000056619003,0.0003689682,0.0013511627,0.000005762753,0.00001928791,0.00028644435,0.000014883734,0.0008149949,0.9953241,0.000082834566,0.0016694096,0.0000055447454],"about_ca_topic_score_codex":0.00089506834,"about_ca_topic_score_gemma":0.0014727778,"teacher_disagreement_score":0.0030612506,"about_ca_system_score_codex":0.0005684735,"about_ca_system_score_gemma":0.00046218772,"threshold_uncertainty_score":0.010240972},"labels":[],"label_agreement":null},{"id":"W1997733155","doi":"10.1016/j.leukres.2004.02.008","title":"Improved access to CD20 following B cell receptor cross-linking at Burkitt’s lymphoma cell surfaces","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Endocytosis; CD19; CD20; Lipid raft; breakpoint cluster region; B-cell receptor; Burkitt's lymphoma; B cell; Cell biology; Chemistry; Cell; Receptor; Cancer research; Antigen; Biology; Antibody; Lymphoma; Immunology; Biochemistry","score_opus":0.06860622073420451,"score_gpt":0.40398730831447704,"score_spread":0.3353810875802725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997733155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988191,0.002051436,0.005128826,0.00017531183,0.00005924846,0.000023465076,0.000125806,0.00013584294,0.004109073],"genre_scores_gemma":[0.9906414,0.00096527673,0.0021327217,0.00019190386,0.000029570416,0.000038758528,0.00053311203,0.000077896744,0.0053893556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943227,0.00010958989,0.000029250583,0.00007319047,0.00009656445,0.0002589782],"domain_scores_gemma":[0.99963856,0.00014311308,0.000037311067,0.000080287275,0.000049040358,0.00005165147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005300238,0.00041838508,0.00030946275,0.0004374797,0.00038163774,0.0007091917,0.0005368574,0.0005877132,0.008166169],"category_scores_gemma":[0.00059897586,0.00033250407,0.00041297034,0.00025277,0.00019611606,0.0009781086,0.00090410514,0.0009969732,0.0014196903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032070963,0.000055159646,0.00014837361,0.000048195965,0.000010670407,0.00008304825,0.000040085168,0.00011662873,0.996088,0.00049811567,0.00014060573,0.0024503337],"study_design_scores_gemma":[0.000030911295,0.0001866385,0.0027778745,0.000008570833,0.000018830575,0.00034293192,0.000051472347,0.0009896263,0.9909122,0.00014831482,0.0045259353,0.000006740611],"about_ca_topic_score_codex":0.0007876307,"about_ca_topic_score_gemma":0.0012690605,"teacher_disagreement_score":0.008166169,"about_ca_system_score_codex":0.0006515386,"about_ca_system_score_gemma":0.00016685328,"threshold_uncertainty_score":0.027318537},"labels":[],"label_agreement":null},{"id":"W1999705499","doi":"10.1016/j.leukres.2012.07.006","title":"Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Cytarabine; Pharmacokinetics; Medicine; Pharmacology; Leukemia; Liposome; Internal medicine; Drug; Chemotherapy; Gastroenterology; Chemistry","score_opus":0.023859024702157484,"score_gpt":0.3293869841911375,"score_spread":0.30552795948898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999705499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739,0.0012763881,0.00035805584,0.00012708796,0.000021776592,0.00005492478,0.00012424559,0.000036446432,0.00061111484],"genre_scores_gemma":[0.9990305,0.00020937769,0.00021090759,0.000059504986,0.000016088556,0.000018123315,0.0000835845,0.00000619731,0.00036579446],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998276,0.000076301454,0.000007001097,0.000038931368,0.000022793345,0.000027287973],"domain_scores_gemma":[0.9997764,0.00007348612,0.000044330587,0.00001631981,0.000012434818,0.00007708892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003932911,0.00023443092,0.00057899475,0.0001699484,0.00018602239,0.00051761424,0.00016358819,0.00037696766,0.0007667124],"category_scores_gemma":[0.00083978154,0.00020466627,0.00023438108,0.00017537897,0.00028781922,0.0004454933,0.000098271485,0.0010329743,0.00021750126],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33581072,0.010447408,0.028884148,0.00037379417,0.00058945495,0.00086390134,0.0011695029,0.01052429,0.4305861,0.0009615583,0.0031953182,0.17659375],"study_design_scores_gemma":[0.05117794,0.3952361,0.31930768,0.000085095184,0.0019017603,0.003147851,0.00070076104,0.034711774,0.1732407,0.0006828099,0.019572454,0.00023507458],"about_ca_topic_score_codex":0.0013508834,"about_ca_topic_score_gemma":0.0011042478,"teacher_disagreement_score":0.0013508834,"about_ca_system_score_codex":0.0006172242,"about_ca_system_score_gemma":0.00039914137,"threshold_uncertainty_score":0.004478276},"labels":[],"label_agreement":null},{"id":"W1999935620","doi":"10.1016/j.leukres.2009.12.008","title":"A diphtheria toxin interleukin-3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Terry Fox Research Institute","keywords":"Dasatinib; Diphtheria toxin; Tyrosine kinase; Imatinib; Cancer research; Leukemia; Imatinib mesylate; Fusion protein; Progenitor cell; Biology; Immunology; Stem cell; Signal transduction; Microbiology; Cell biology; Toxin; Myeloid leukemia; Recombinant DNA; Biochemistry","score_opus":0.020862546613417465,"score_gpt":0.3207704883987825,"score_spread":0.29990794178536506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999935620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950493,0.0013060708,0.00089837087,0.00013367241,0.0000591653,0.00008347242,0.00038968597,0.000087514476,0.0019926385],"genre_scores_gemma":[0.99549097,0.0012584752,0.0008771237,0.000070677626,0.000035197532,0.000077744946,0.000923285,0.000023701734,0.0012428976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996438,0.00007971754,0.000035917943,0.00002602618,0.00007548246,0.00013912482],"domain_scores_gemma":[0.99978346,0.000090617104,0.00002809648,0.000026064841,0.000011947486,0.000059829905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043648086,0.000509843,0.0007345284,0.00056745816,0.000316284,0.0007490755,0.00043280516,0.0004060113,0.0014718896],"category_scores_gemma":[0.00027930332,0.00028849143,0.00047624568,0.00051422796,0.00032881994,0.00031625052,0.00046197846,0.001112254,0.0005116694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029946472,0.0007010774,0.0011336121,0.00011010563,0.00004818464,0.00038611417,0.0000793543,0.0008758325,0.98319936,0.00052176224,0.0005861627,0.009363772],"study_design_scores_gemma":[0.00096444384,0.0046119946,0.014064361,0.000015009925,0.00016102615,0.0014861479,0.00008704896,0.0031621899,0.9700473,0.00021003053,0.005174655,0.000015874899],"about_ca_topic_score_codex":0.0007134203,"about_ca_topic_score_gemma":0.0015221077,"teacher_disagreement_score":0.0014718896,"about_ca_system_score_codex":0.00049357157,"about_ca_system_score_gemma":0.0005509828,"threshold_uncertainty_score":0.0049239397},"labels":[],"label_agreement":null},{"id":"W2001137834","doi":"10.1016/j.leukres.2011.07.023","title":"Promotional etiology for common childhood acute lymphoblastic leukemia: The infective lymphoid recovery hypothesis","year":2011,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atomic Energy (Canada)","funders":"","keywords":"Lymphoblastic Leukemia; Etiology; Medicine; Immunology; Leukemia; Pathology","score_opus":0.10463915337931044,"score_gpt":0.38564800040704783,"score_spread":0.2810088470277374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001137834","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006698755,0.9991013,0.000057149544,0.00027716887,0.00008363404,0.000001466996,0.000006353965,0.000002861161,0.0004031309],"genre_scores_gemma":[0.0006264661,0.9989029,0.000063266125,0.00012301463,0.00009614896,0.0000025847248,0.000010425077,5.4929296e-7,0.00017454084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999838,0.00003661077,0.00002647142,0.000034115983,0.000049530878,0.000015180772],"domain_scores_gemma":[0.99965847,0.00019286016,0.00005529901,0.000009298873,0.000058509413,0.000025516858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005174118,0.0007499769,0.0014604261,0.0029489277,0.00028943917,0.00072653353,0.00089602324,0.0012040919,0.0028052814],"category_scores_gemma":[0.00077052735,0.00021945252,0.0005167841,0.002469459,0.0009840567,0.0015954222,0.0005706874,0.0015771915,0.0013159058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000903082,0.000075897944,0.0010687435,0.024497852,0.00016229854,0.00094446976,0.00013639656,0.00041035796,0.00088226266,0.010420122,0.034182064,0.92712927],"study_design_scores_gemma":[0.000027057333,0.000092935064,0.0033388159,0.008440593,0.0002507135,0.0079645235,0.00023977103,0.00010390372,0.00043401364,0.0065080784,0.97257113,0.000028520137],"about_ca_topic_score_codex":0.0015455451,"about_ca_topic_score_gemma":0.0019329739,"teacher_disagreement_score":0.0029489277,"about_ca_system_score_codex":0.0008073982,"about_ca_system_score_gemma":0.0012624803,"threshold_uncertainty_score":0.009384632},"labels":[],"label_agreement":null},{"id":"W2002979416","doi":"10.1016/j.leukres.2005.04.022","title":"Acute monocytic leukemia and multiple abnormalities in a child with duplication of 1q detected by GTG-banding and SKY","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"dup; Karyotype; Trisomy; Gene duplication; Acute monocytic leukemia; Trisomy 8; Biology; Chromosome; Leukemia; Pathology; Bone marrow; Cancer research; Medicine; Genetics; Gene","score_opus":0.012180110885225363,"score_gpt":0.2642647038802693,"score_spread":0.25208459299504393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002979416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885943,0.0011194928,0.0015596608,0.0024558352,0.00014910848,0.00016333986,0.00088057783,0.00014430963,0.004933408],"genre_scores_gemma":[0.9955083,0.00083784515,0.0013337216,0.0003693828,0.00032462456,0.00004035114,0.00030692772,0.0000393951,0.0012394522],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99903893,0.000119611475,0.00012366791,0.0002355311,0.0001663556,0.00031598413],"domain_scores_gemma":[0.9982315,0.0006426126,0.0003249716,0.00008746442,0.00011084791,0.0006025803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049204915,0.002385258,0.0015852079,0.0041418634,0.0027696392,0.0010852995,0.0019436374,0.003176582,0.0035948236],"category_scores_gemma":[0.0026379644,0.001728245,0.001204447,0.0025732329,0.0023785096,0.0013709931,0.001590321,0.002689301,0.00082996365],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032596948,0.00008199574,0.014023732,0.000047502766,0.000017471824,0.97876054,0.0004714229,0.00013874448,0.004410483,0.00034446188,0.00027763576,0.0011000778],"study_design_scores_gemma":[0.00006506205,0.0004105338,0.046947625,0.000023736206,0.0001106327,0.94753534,0.0005431446,0.00041631632,0.002629675,0.00031734805,0.00096848246,0.00003214659],"about_ca_topic_score_codex":0.0074135405,"about_ca_topic_score_gemma":0.007884562,"teacher_disagreement_score":0.0074135405,"about_ca_system_score_codex":0.0012722368,"about_ca_system_score_gemma":0.0013303574,"threshold_uncertainty_score":0.014740765},"labels":[],"label_agreement":null},{"id":"W2003202645","doi":"10.1016/j.leukres.2014.02.009","title":"Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Ministry of Science and Technology of the People's Republic of China","keywords":"Multiple myeloma; Polyclonal antibodies; Medicine; Monoclonal; Internal medicine; Gastroenterology; Bone marrow; Monoclonal gammopathy of undetermined significance; Clinical significance; Bortezomib; Thalidomide; Immunology; Pathology; Oncology; Antibody; Monoclonal antibody","score_opus":0.04705372373716442,"score_gpt":0.3359393037555853,"score_spread":0.28888558001842085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003202645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896455,0.0001551464,0.00008906954,0.00006159949,0.0000070074257,0.0000041464123,0.00007668849,0.0000086903965,0.00063303794],"genre_scores_gemma":[0.9996051,0.000039289083,0.00006601676,0.000023362567,0.000024433913,0.0000030010817,0.00014117111,0.000003108053,0.00009453641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978703,0.000035437122,0.000024544564,0.000045262525,0.00003937163,0.000068395886],"domain_scores_gemma":[0.99937016,0.00012823528,0.00025939167,0.00004325112,0.00006863095,0.00013041304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026350978,0.00044819212,0.0006576217,0.0013500726,0.00064150046,0.00088327145,0.00039293378,0.00053589395,0.0023003707],"category_scores_gemma":[0.0014248515,0.00019047815,0.0004121796,0.00085238105,0.00033601883,0.00049829215,0.0004056447,0.00045988223,0.00034310482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003665726,0.00004100123,0.9922645,0.0000073068436,0.00003724673,0.00040463053,0.0000373335,0.000062982355,0.003980152,0.000052094038,0.00011920852,0.002626862],"study_design_scores_gemma":[0.000014621786,0.00017764971,0.99460125,0.000005130714,0.00007194481,0.003301448,0.00019839797,0.00045733587,0.00069428683,0.00022161301,0.000250586,0.000005818131],"about_ca_topic_score_codex":0.00077862974,"about_ca_topic_score_gemma":0.0007306176,"teacher_disagreement_score":0.0023003707,"about_ca_system_score_codex":0.00023411462,"about_ca_system_score_gemma":0.0002788236,"threshold_uncertainty_score":0.0076955557},"labels":[],"label_agreement":null},{"id":"W2003340156","doi":"10.1016/j.leukres.2013.12.024","title":"Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia: Do we have enough information to warrant this association?","year":2014,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Electromagnetic Fields and Biological Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Confusion; DNA damage; Ionizing radiation; Cancer; Leukemia; Cancer research; Neuroscience; Toxicology; Biology; Bioinformatics; Risk analysis (engineering); Immunology; Genetics; DNA; Psychology; Physics; Internal medicine","score_opus":0.011986858331141314,"score_gpt":0.25824767363350143,"score_spread":0.2462608153023601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003340156","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012471845,0.003822438,0.00013587798,0.9853297,0.007850568,0.0000059523127,0.00003381171,0.000014561482,0.0015598929],"genre_scores_gemma":[0.023972765,0.007988655,0.0005910297,0.84903556,0.11339084,0.00004304754,0.000054001124,0.000018150839,0.0049059857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979686,0.0009437629,0.00016757066,0.0002201125,0.0005266505,0.00017322332],"domain_scores_gemma":[0.9904214,0.0074004456,0.0005279192,0.00031652793,0.00070404226,0.000629716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00302261,0.00060997927,0.0015789324,0.0005846265,0.0017032357,0.0020895537,0.0018550343,0.031237474,0.004096551],"category_scores_gemma":[0.018224234,0.0005401634,0.0009987458,0.00055054994,0.0028483628,0.0028929214,0.0010795534,0.024677832,0.003168118],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088365213,0.0004428288,0.011811674,0.00023445344,0.00023667388,0.0057877237,0.0003036412,0.00029440862,0.0012755652,0.012336991,0.8842838,0.082108654],"study_design_scores_gemma":[0.0011782451,0.00065485283,0.01333428,0.0006975538,0.00038852848,0.0067650313,0.0010362843,0.0022328245,0.0014550689,0.0855661,0.8864974,0.00019374368],"about_ca_topic_score_codex":0.0028264055,"about_ca_topic_score_gemma":0.0035243698,"teacher_disagreement_score":0.031237474,"about_ca_system_score_codex":0.0024726314,"about_ca_system_score_gemma":0.0018034831,"threshold_uncertainty_score":0.017940223},"labels":[],"label_agreement":null},{"id":"W2005428520","doi":"10.1016/j.leukres.2004.02.003","title":"Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Acute promyelocytic leukemia; Leukemia; Myeloid leukemia; Acute leukemia; Medicine; Transplantation; Stem cell; Promyelocytic leukemia protein; Bone marrow; Immunology; Cancer research; Internal medicine; Biology; Cell culture; Genetics","score_opus":0.02319983555635367,"score_gpt":0.3273943232991777,"score_spread":0.30419448774282404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005428520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838457,0.0030908794,0.0047105877,0.00020832698,0.00011777795,0.00023040525,0.0002428251,0.00009846208,0.0074549853],"genre_scores_gemma":[0.99610645,0.0009413144,0.0009381781,0.000098387056,0.000067555324,0.000038377762,0.00023778046,0.000010887437,0.0015609968],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9997187,0.00007156532,0.000040757095,0.00003052967,0.00006008625,0.0000783582],"domain_scores_gemma":[0.99939644,0.00022008736,0.0001080436,0.00010845695,0.000045167755,0.00012175272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004640407,0.00029247833,0.0007185737,0.0007172768,0.0005615071,0.0005292804,0.0003426508,0.00047481668,0.0017597215],"category_scores_gemma":[0.00060006033,0.00014629312,0.00038207657,0.00053826673,0.000444847,0.0003612932,0.00047672875,0.00089453807,0.00050939195],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01861931,0.0027073864,0.05717249,0.001228305,0.00023935648,0.11936335,0.000796589,0.00087419385,0.70396125,0.016115876,0.0013627161,0.07755925],"study_design_scores_gemma":[0.0017809707,0.0119142495,0.1113521,0.00013506092,0.0009485547,0.251455,0.000708071,0.0033227077,0.57820106,0.010515617,0.029607655,0.000058934576],"about_ca_topic_score_codex":0.00020651992,"about_ca_topic_score_gemma":0.00027728762,"teacher_disagreement_score":0.0017597215,"about_ca_system_score_codex":0.00042034176,"about_ca_system_score_gemma":0.00036327186,"threshold_uncertainty_score":0.005886793},"labels":[],"label_agreement":null},{"id":"W2005871463","doi":"10.1016/s0145-2126(00)00060-6","title":"Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease","year":2000,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Escherichia coli research studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"H2020 European Research Council","keywords":"Lymphoma; Malignancy; Medicine; Transplantation; Pathology; Germinal center; Immunology; Cancer research; B cell; Internal medicine; Antibody","score_opus":0.010888764197983404,"score_gpt":0.276892260326297,"score_spread":0.2660034961283136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005871463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985049,0.0003889227,0.00020475444,0.000043108957,0.0000057281113,0.000008339975,0.000022586735,0.000012157759,0.00080957747],"genre_scores_gemma":[0.9995407,0.00012226612,0.00005607374,0.00001544963,0.000008507144,0.0000033762362,0.000044804947,0.000001671578,0.00020719554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998859,0.000044864126,0.000005652305,0.000014288533,0.000012006405,0.00003728501],"domain_scores_gemma":[0.99986136,0.000054549506,0.000021847256,0.000011316969,0.000014290089,0.00003668132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016087513,0.0001441966,0.00021340762,0.00023686732,0.00015739108,0.00031811054,0.00006551629,0.00023169238,0.0013845921],"category_scores_gemma":[0.00035318753,0.00009480092,0.00005973,0.00011462013,0.00010818338,0.00024620185,0.00012696952,0.00025899027,0.00020737432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067602736,0.0005874926,0.11828157,0.00008656744,0.000035071298,0.0014865242,0.00031549548,0.00026732145,0.84176475,0.00023931255,0.0003868607,0.029788723],"study_design_scores_gemma":[0.0005896159,0.009513396,0.7034126,0.000036527097,0.00018411445,0.013321273,0.0011697899,0.0038066376,0.26068717,0.00040798477,0.0068557225,0.000015123154],"about_ca_topic_score_codex":0.00023404522,"about_ca_topic_score_gemma":0.00031231763,"teacher_disagreement_score":0.0013845921,"about_ca_system_score_codex":0.00012439972,"about_ca_system_score_gemma":0.00006708111,"threshold_uncertainty_score":0.004631877},"labels":[],"label_agreement":null},{"id":"W2007253664","doi":"10.1016/j.leukres.2014.11.028","title":"One day at a time: Improving the patient experience during and after intensive chemotherapy for younger and older AML patients","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Chemotherapy; Pediatrics; Oncology; Internal medicine","score_opus":0.017615000180275193,"score_gpt":0.3000844991968336,"score_spread":0.28246949901655843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007253664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918928,0.0019150956,0.0001790874,0.002521892,0.00008997465,0.000027594528,0.00012261399,0.000022830702,0.0032279936],"genre_scores_gemma":[0.9962974,0.0015675264,0.00059548585,0.000715273,0.000100911275,0.00002672501,0.00014112728,0.0000064430487,0.0005490473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996947,0.00012802405,0.000028405153,0.000024166573,0.000044040306,0.00008067426],"domain_scores_gemma":[0.99832803,0.00024178931,0.00040523845,0.000028908946,0.000117860276,0.0008782056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047007776,0.00014027947,0.00034343865,0.0001504156,0.0006755969,0.0006691317,0.00028108672,0.00032932375,0.002272883],"category_scores_gemma":[0.005164433,0.000071297756,0.00029477046,0.00021257579,0.00016566715,0.0006099795,0.0007547598,0.0007427085,0.00024097327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049021654,0.0018107968,0.52618206,0.0004683634,0.0002473835,0.0011985855,0.007573173,0.0006212918,0.0016430583,0.00024231852,0.016784301,0.43832648],"study_design_scores_gemma":[0.00016951546,0.0042740875,0.96625715,0.00030934584,0.00026878843,0.0012251498,0.013417786,0.00050501036,0.0005246136,0.0004923422,0.012490725,0.00006546407],"about_ca_topic_score_codex":0.0026498062,"about_ca_topic_score_gemma":0.010158404,"teacher_disagreement_score":0.0026498062,"about_ca_system_score_codex":0.0004864279,"about_ca_system_score_gemma":0.00088902906,"threshold_uncertainty_score":0.007603526},"labels":[],"label_agreement":null},{"id":"W2009359182","doi":"10.1016/j.leukres.2013.04.006","title":"CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Cytogenetics; Medicine; Internal medicine; Oncology; Philadelphia chromosome; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Hematology; Overall survival; Leukemia; Chromosome; Biology; Chromosomal translocation; Genetics","score_opus":0.027676318770357946,"score_gpt":0.307048745033744,"score_spread":0.2793724262633861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009359182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980102,0.0007485386,0.00007567621,0.00011441084,0.000014309003,0.0000040155987,0.00018469262,0.00000553683,0.0008426474],"genre_scores_gemma":[0.9990895,0.00027557396,0.00007104495,0.00004539429,0.00003371725,0.0000048252455,0.00025059155,0.000002087476,0.0002272736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997453,0.000057810947,0.00003323871,0.00003842374,0.00006208031,0.00006312076],"domain_scores_gemma":[0.9989525,0.00027920926,0.00046102976,0.000042869615,0.00010707856,0.0001574019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026533424,0.00025815627,0.00033114347,0.00066012936,0.0003323941,0.0007078461,0.0003134099,0.0004830343,0.0014034524],"category_scores_gemma":[0.0021434706,0.00022586643,0.00016315638,0.001091817,0.00034740375,0.00049566873,0.00034048792,0.00056217116,0.00034185709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017898838,0.000014144388,0.99683267,0.000007358328,0.000013203233,0.00029981777,0.000019599296,0.000025127216,0.0006281373,0.000019480109,0.00018832028,0.0017731498],"study_design_scores_gemma":[0.000010918257,0.00007787973,0.9961551,0.000007729036,0.000034744244,0.0024322316,0.0001574326,0.00023820222,0.00032562326,0.000058188376,0.00049799436,0.000003805952],"about_ca_topic_score_codex":0.0012457768,"about_ca_topic_score_gemma":0.0019312146,"teacher_disagreement_score":0.0014034524,"about_ca_system_score_codex":0.00021237847,"about_ca_system_score_gemma":0.00024642263,"threshold_uncertainty_score":0.0046949983},"labels":[],"label_agreement":null},{"id":"W2011872467","doi":"10.1016/j.leukres.2005.05.010","title":"5-Aza-2′-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"National Cancer Institute; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Decitabine; Trichostatin A; Cancer research; Chromatin remodeling; Myeloid leukemia; Histone; Chromatin; Acetylation; DNA methylation; Chromatin immunoprecipitation; Epigenetics; Chemistry; Methylation; Histone deacetylase inhibitor; Biology; Histone deacetylase; Molecular biology; Promoter; Gene; Gene expression; Biochemistry","score_opus":0.03042550730184956,"score_gpt":0.36768447666998955,"score_spread":0.33725896936814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011872467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895812,0.0053395554,0.0012018898,0.00024048574,0.00015658693,0.00005570849,0.00059139344,0.00019312443,0.0026400206],"genre_scores_gemma":[0.9934722,0.0017096444,0.0010046777,0.0000759367,0.000022894461,0.000043068012,0.0008267351,0.000025186815,0.0028196734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999136,0.000013912183,0.000010720789,0.000011685863,0.000016679533,0.000033363467],"domain_scores_gemma":[0.99993396,0.000015101839,0.00000964319,0.000013929221,0.000006157532,0.000021158132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116398725,0.00026196343,0.00048324664,0.00021673327,0.00023538772,0.0002529631,0.00035001006,0.00018855855,0.0018320794],"category_scores_gemma":[0.00014160592,0.00021040165,0.00016156475,0.00018396761,0.00016380985,0.00008864495,0.00018222131,0.00057041115,0.00044395568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008934516,0.00009992613,0.00020412049,0.00008236995,0.000018396597,0.00008447888,0.00002123415,0.00012964805,0.9924615,0.00017890644,0.0002853208,0.005540789],"study_design_scores_gemma":[0.00016681159,0.00044757134,0.004729318,0.0000055680966,0.000030538555,0.00019905817,0.00001689645,0.00037969096,0.988478,0.000046014055,0.00549639,0.000004123527],"about_ca_topic_score_codex":0.0020943168,"about_ca_topic_score_gemma":0.0054351105,"teacher_disagreement_score":0.0020943168,"about_ca_system_score_codex":0.00039577283,"about_ca_system_score_gemma":0.00037305002,"threshold_uncertainty_score":0.006128907},"labels":[],"label_agreement":null},{"id":"W2012049957","doi":"10.1016/j.leukres.2010.02.023","title":"Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Myeloid leukemia; Mutation; Valine; Leukemia; Biology; Myeloid; Cancer research; Medicine; Amino acid; Gene; Immunology; Genetics","score_opus":0.030270332726815365,"score_gpt":0.3350075359139783,"score_spread":0.30473720318716296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012049957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989642,0.00019523245,0.0000938668,0.00002920938,0.0000052725327,0.000007828498,0.00023442376,0.000009318044,0.00046058453],"genre_scores_gemma":[0.99905246,0.00008937086,0.00016241801,0.000035229026,0.0000075046128,0.000008224311,0.0003644424,0.0000047011376,0.00027562393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972194,0.000045454268,0.000052774005,0.00006208894,0.000060567065,0.00005711648],"domain_scores_gemma":[0.9995921,0.0001586015,0.00007200834,0.000023997252,0.00008310311,0.00007030419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017360572,0.00031992138,0.0003464677,0.0017465359,0.0006208754,0.0005331526,0.00023634777,0.00048271005,0.0015442042],"category_scores_gemma":[0.0014048651,0.00022845047,0.0001590735,0.0008840507,0.00025475005,0.00021012337,0.00018253535,0.0003110426,0.00043015138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022623437,0.00016441691,0.85806936,0.00008128756,0.000052034702,0.0059418213,0.0008587896,0.00015082149,0.12133121,0.00011672958,0.00048823006,0.010482889],"study_design_scores_gemma":[0.000056378532,0.00076116255,0.94907403,0.00001798001,0.000097330354,0.021389496,0.0008521044,0.0005943405,0.025193263,0.000093139366,0.0018585516,0.0000122022175],"about_ca_topic_score_codex":0.0016787044,"about_ca_topic_score_gemma":0.0014671576,"teacher_disagreement_score":0.0017465359,"about_ca_system_score_codex":0.00022564793,"about_ca_system_score_gemma":0.00019603735,"threshold_uncertainty_score":0.005165875},"labels":[],"label_agreement":null},{"id":"W2014246201","doi":"10.1016/j.leukres.2008.08.021","title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"José Carreras Leukämie-Stiftung","keywords":"Blockade; Chronic lymphocytic leukemia; Cancer research; Leukemia; T cell; Immunology; Medicine; Internal medicine; Receptor; Immune system","score_opus":0.04986831443506784,"score_gpt":0.35710647795066497,"score_spread":0.30723816351559713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014246201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945728,0.0009189429,0.0010717666,0.00021098318,0.000042894342,0.000028537788,0.00022143428,0.000118094686,0.0028145541],"genre_scores_gemma":[0.9973127,0.00032441126,0.000730003,0.00005972965,0.0000172977,0.000026749642,0.00019006044,0.000012577554,0.001326491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981004,0.00004665093,0.000017232867,0.00002158439,0.0000297191,0.000074733754],"domain_scores_gemma":[0.9998951,0.000022101101,0.000022711298,0.000015316902,0.0000072679163,0.000037452635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021989025,0.00031339767,0.00023445081,0.0003662668,0.00027660534,0.00049913663,0.0003209243,0.0003444438,0.0018909681],"category_scores_gemma":[0.00015653977,0.00012731383,0.00020648567,0.00022613964,0.0003110384,0.00027528097,0.00020728773,0.0010886146,0.00046991644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010592261,0.00042876997,0.0005851929,0.000045440345,0.000013364114,0.00014693258,0.00003760364,0.00027872616,0.98815,0.0013518481,0.00038724262,0.007515713],"study_design_scores_gemma":[0.0003884068,0.0019971544,0.004516045,0.000011519015,0.00003556939,0.0009594563,0.00010549894,0.0023862654,0.98049015,0.0004407146,0.008660922,0.000008390963],"about_ca_topic_score_codex":0.0006308952,"about_ca_topic_score_gemma":0.0010436276,"teacher_disagreement_score":0.0018909681,"about_ca_system_score_codex":0.00041977514,"about_ca_system_score_gemma":0.00032231415,"threshold_uncertainty_score":0.0063259006},"labels":[],"label_agreement":null},{"id":"W2016677672","doi":"10.1016/j.leukres.2010.06.003","title":"Cytotoxic responses to BLV tax oncoprotein do not prevent leukemogenesis in sheep","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Science Centre for Human and Animal Health; University of Saskatchewan","funders":"Canadian Institutes of Health Research; Fondation Medic; Amis de l'Institut Bordet; University of Saskatchewan","keywords":"Cytotoxic T cell; Provirus; Immunology; Leukemia; Immune system; Retrovirus; Biology; Bovine leukemia virus; Cancer; Medicine; Virology; Cancer research; Virus; Genetics; Genome","score_opus":0.040355313039611276,"score_gpt":0.3365119209058765,"score_spread":0.29615660786626524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016677672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746037,0.0006028445,0.0004498884,0.00005193542,0.000023035898,0.000016281645,0.000118079806,0.0000427205,0.0012347314],"genre_scores_gemma":[0.99697363,0.00028733775,0.0001480104,0.000045260327,0.000014355958,0.000019690107,0.00023479776,0.000018880037,0.0022580484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999813,0.00004265847,0.000019844163,0.000039950828,0.00002737061,0.000057239202],"domain_scores_gemma":[0.99943715,0.00024508854,0.00008964348,0.000114268674,0.000033232332,0.00008066471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023625065,0.0002715116,0.0004349938,0.00032093038,0.0001588813,0.00035263386,0.00031495793,0.0005323381,0.0016812444],"category_scores_gemma":[0.0005835685,0.00020102756,0.00020587113,0.000098165096,0.00043704288,0.0003196787,0.00018801313,0.0009306707,0.00079054787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002144286,0.00019504126,0.0016659893,0.00007405947,0.000014578696,0.00043877968,0.00012181056,0.000093846815,0.9908874,0.00027152317,0.00016068493,0.0039320798],"study_design_scores_gemma":[0.00026454974,0.0060203313,0.021134537,0.000036499627,0.00007277325,0.0028209193,0.0002679644,0.0010373762,0.9628376,0.0005223005,0.004966369,0.000018694102],"about_ca_topic_score_codex":0.0005376237,"about_ca_topic_score_gemma":0.0004935008,"teacher_disagreement_score":0.0016812444,"about_ca_system_score_codex":0.00021990598,"about_ca_system_score_gemma":0.000153028,"threshold_uncertainty_score":0.0056242943},"labels":[],"label_agreement":null},{"id":"W2016908144","doi":"10.1016/j.leukres.2014.01.004","title":"Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; SickKids Foundation; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Leukapheresis; Myeloid leukemia; Meta-analysis; Chemotherapy; Leukocytosis; Oncology; Leukostasis; Leukemia; Internal medicine; Intensive care medicine; Biology","score_opus":0.13781208528964473,"score_gpt":0.4313074187190795,"score_spread":0.2934953334294348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016908144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071362634,0.99133927,0.00034540633,0.00017073972,0.00019130585,0.00013928673,0.00040278514,0.000023043202,0.00025175113],"genre_scores_gemma":[0.27807632,0.7162273,0.0019502718,0.0018031647,0.00032659923,0.00037685706,0.0006762964,0.000037503378,0.0005257206],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955414,0.0018291319,0.0013837528,0.0006008856,0.0004430824,0.00020172836],"domain_scores_gemma":[0.9921772,0.0052507366,0.0016451217,0.00027756425,0.00048514202,0.00016427645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065006902,0.0023381473,0.016134022,0.0026967572,0.00052261894,0.002253977,0.0020228096,0.0024392481,0.0047386284],"category_scores_gemma":[0.017764391,0.0015266582,0.030177874,0.0040272665,0.000717352,0.0015616459,0.0012682388,0.0023333824,0.00040656806],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041371607,0.000042299664,0.0035379436,0.29501358,0.6846926,0.000120964076,0.00009325369,0.00033536946,0.00028367672,0.00011084685,0.0007133594,0.010918923],"study_design_scores_gemma":[0.0013228996,0.00019854824,0.0026381738,0.009276122,0.98506886,0.000056474,0.000034836015,0.00007936414,0.000058442976,0.000120742865,0.0011271713,0.00001846906],"about_ca_topic_score_codex":0.007459069,"about_ca_topic_score_gemma":0.02383713,"teacher_disagreement_score":0.016134022,"about_ca_system_score_codex":0.0020969892,"about_ca_system_score_gemma":0.0023457655,"threshold_uncertainty_score":0.034379363},"labels":[],"label_agreement":null},{"id":"W2017649143","doi":"10.1016/j.leukres.2012.05.016","title":"A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University Health Network; University of Toronto; Toronto Rehabilitation Institute","funders":"National Institute on Aging; Toronto Rehabilitation Institute","keywords":"Medicine; Myeloid leukemia; Induction chemotherapy; Randomized controlled trial; Physical therapy; Quality of life (healthcare); Clinical trial; Internal medicine; Physical fitness; Population; Oncology; Chemotherapy; Intensive care medicine","score_opus":0.09383302063113753,"score_gpt":0.40952396712996575,"score_spread":0.31569094649882823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017649143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557674,0.0011372005,0.00013915205,0.00064325274,0.00033007393,0.0010168971,0.0002442921,0.00003141858,0.00088093866],"genre_scores_gemma":[0.9929549,0.001652718,0.0007803069,0.0007840066,0.0003852983,0.0018533295,0.00054218783,0.0000064229152,0.0010407689],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99963737,0.0001639859,0.000028428532,0.00007798096,0.000013337383,0.0000788573],"domain_scores_gemma":[0.9987411,0.00025015607,0.00011604395,0.00006115063,0.000047122187,0.00078442064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065827544,0.0010061216,0.0024811612,0.00029743026,0.00078442367,0.0006797195,0.00082635914,0.001594899,0.0061624697],"category_scores_gemma":[0.0017172325,0.0004071609,0.0013345355,0.00035124514,0.0010300095,0.00076249446,0.0007162839,0.0036696244,0.00064367056],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9309267,0.036809046,0.0018090386,0.00060860044,0.00065903785,0.00007288928,0.00012264686,0.00034610022,0.0013788446,0.0001097676,0.0007545623,0.026402703],"study_design_scores_gemma":[0.7605993,0.22866383,0.008562501,0.000101880505,0.00040993033,0.000039944607,0.00013261303,0.00045954436,0.00025897662,0.000104678176,0.000647169,0.00001964704],"about_ca_topic_score_codex":0.0017544384,"about_ca_topic_score_gemma":0.0044372603,"teacher_disagreement_score":0.0061624697,"about_ca_system_score_codex":0.0006120148,"about_ca_system_score_gemma":0.0014731663,"threshold_uncertainty_score":0.020615518},"labels":[],"label_agreement":null},{"id":"W2017848739","doi":"10.1016/j.leukres.2009.06.013","title":"High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Manitoba; CancerCare Manitoba","funders":"Microsoft","keywords":"Cancer registry; Chronic lymphocytic leukemia; Medicine; Immunophenotyping; Incidence (geometry); Population; Epidemiology; Cohort; Relative survival; Internal medicine; Lymphoma; Leukemia; Oncology; Immunology; Flow cytometry; Environmental health","score_opus":0.02041312935278395,"score_gpt":0.32311435822261675,"score_spread":0.3027012288698328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017848739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932902,0.00048464845,0.0001800052,0.0003741273,0.0000172145,0.00005496035,0.0033519818,0.000019821175,0.002226992],"genre_scores_gemma":[0.99737585,0.00045187416,0.00021324903,0.0001288259,0.0000088362285,0.000020389263,0.0010622032,0.000008500693,0.000730435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870086,0.0000863221,0.000061640814,0.00032731492,0.00035709326,0.0004668053],"domain_scores_gemma":[0.9977481,0.00009880799,0.00028897566,0.0001175937,0.0011103064,0.00063618383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094904477,0.00081276154,0.0007490805,0.0022814872,0.0067737503,0.0020652686,0.0020148684,0.0011400811,0.003756641],"category_scores_gemma":[0.0022513352,0.0010596617,0.0011299568,0.004520936,0.0013347453,0.00095999835,0.0012281587,0.0014374261,0.00041078846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015810387,0.00005566963,0.9945011,0.000021090127,0.000075412936,0.00021760711,0.0012601415,0.000094879826,0.0005957234,0.00018474486,0.0010531109,0.0017824419],"study_design_scores_gemma":[0.000028793747,0.00006426466,0.9953157,0.00002503914,0.00006417384,0.0004462424,0.002318952,0.00032732825,0.00008148333,0.000075359414,0.0012153997,0.00003737523],"about_ca_topic_score_codex":0.9926231,"about_ca_topic_score_gemma":0.9919584,"teacher_disagreement_score":0.023512682,"about_ca_system_score_codex":0.023512682,"about_ca_system_score_gemma":0.026657835,"threshold_uncertainty_score":0.17059726},"labels":[],"label_agreement":null},{"id":"W2019059796","doi":"10.1016/j.leukres.2007.06.019","title":"The morphological subcategories of acute monocytic leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features and clinical outcomes","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Immunophenotyping; Medicine; Internal medicine; Leukemia; Oncology; Immunology; Flow cytometry","score_opus":0.06637282434756417,"score_gpt":0.41099995334369255,"score_spread":0.34462712899612835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019059796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937868,0.00062939996,0.0007466298,0.000055927052,0.000007873064,0.000077774486,0.000743329,0.00002108515,0.003931314],"genre_scores_gemma":[0.9964508,0.00019058926,0.00087928365,0.00005595565,0.000015831738,0.00006421628,0.0017787776,0.0000076950655,0.00055686204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995834,0.00007394049,0.00006456688,0.00006302453,0.00009055854,0.00012446586],"domain_scores_gemma":[0.9991948,0.00013246296,0.00029373367,0.000068774505,0.00014268549,0.00016757411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003545413,0.00031470967,0.00045258732,0.0015381441,0.0004878471,0.00069544284,0.00036107493,0.0003318166,0.0030432814],"category_scores_gemma":[0.0012405602,0.000121012126,0.0003473571,0.0008875203,0.00035532258,0.00035198467,0.00079091283,0.00031461188,0.0007542867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022124979,0.00011535494,0.9198443,0.00011301497,0.00013123738,0.0014285818,0.0005298822,0.0002547728,0.047874026,0.0014194538,0.0007957491,0.02528108],"study_design_scores_gemma":[0.00003610706,0.00033031273,0.98568106,0.000026027385,0.00006125055,0.0061484617,0.00084430724,0.00029512827,0.0038400886,0.0008124333,0.0019143344,0.000010496567],"about_ca_topic_score_codex":0.0013229417,"about_ca_topic_score_gemma":0.0015255364,"teacher_disagreement_score":0.0030432814,"about_ca_system_score_codex":0.0003919734,"about_ca_system_score_gemma":0.00023931648,"threshold_uncertainty_score":0.010180831},"labels":[],"label_agreement":null},{"id":"W2020921982","doi":"10.1016/j.leukres.2012.06.012","title":"Nilotinib and imatinib inhibit cytarabine cellular uptake: Implications for combination therapy","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Nilotinib; Cytarabine; Imatinib; Myeloid leukemia; Medicine; Pharmacology; Tyrosine-kinase inhibitor; Nucleoside analogue; Tyrosine kinase; Oncology; Internal medicine; Nucleoside; Chemistry; Receptor","score_opus":0.13274411959298354,"score_gpt":0.4060545935447574,"score_spread":0.2733104739517739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020921982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8440546,0.10974695,0.0059895217,0.0070933895,0.0004886343,0.00019858193,0.0006119018,0.00025749116,0.03155896],"genre_scores_gemma":[0.98003584,0.014616081,0.0018099056,0.00027422834,0.00010321785,0.00006827308,0.00023167561,0.000028559012,0.0028322837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953806,0.00017985282,0.000031794872,0.00004436979,0.000119803575,0.000086157735],"domain_scores_gemma":[0.9997657,0.00008205452,0.000062870015,0.00002500663,0.000033167376,0.000031174754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000836594,0.00046071855,0.0009985879,0.00041017876,0.00031745856,0.0016216749,0.00056278554,0.0005907994,0.0036348053],"category_scores_gemma":[0.00068345614,0.0002856116,0.0003275587,0.0004702792,0.00043587963,0.0015465616,0.0005672624,0.0010341278,0.00073224684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012031332,0.0014995161,0.01240287,0.0011705334,0.00048824042,0.0006414825,0.0003424821,0.004761453,0.64186174,0.013517646,0.010398689,0.30088395],"study_design_scores_gemma":[0.003491425,0.013408722,0.06384935,0.00026628826,0.0009595777,0.006577976,0.0011721378,0.025559004,0.70436215,0.009126177,0.17102122,0.00020602925],"about_ca_topic_score_codex":0.00061672344,"about_ca_topic_score_gemma":0.0023889644,"teacher_disagreement_score":0.0036348053,"about_ca_system_score_codex":0.0011768321,"about_ca_system_score_gemma":0.0005889601,"threshold_uncertainty_score":0.012159646},"labels":[],"label_agreement":null},{"id":"W2022892254","doi":"10.1016/j.leukres.2012.08.001","title":"Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Queen's University; University of British Columbia","funders":"Celgene","keywords":"Medicine; Internal medicine; Red blood cell; Blood transfusion; Chelation therapy; Gastroenterology; Surgery; Thalassemia","score_opus":0.018809772660162583,"score_gpt":0.2856014937392905,"score_spread":0.2667917210791279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022892254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98491675,0.00445972,0.0010008012,0.0017727881,0.0001340478,0.000033759457,0.00039907065,0.00006511912,0.0072178533],"genre_scores_gemma":[0.9963897,0.0009621807,0.0005961985,0.0003195466,0.00015383362,0.000014894568,0.00046155832,0.0000050159238,0.0010971684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999026,0.000037354464,0.000008860278,0.000016050733,0.000015243382,0.000019849953],"domain_scores_gemma":[0.99949324,0.00014583954,0.00021212526,0.000029179202,0.000040675062,0.000079063386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034599687,0.00018320998,0.0003669182,0.00020195683,0.00020380071,0.00029097172,0.00018137382,0.00020740654,0.0038756817],"category_scores_gemma":[0.0011353316,0.000040980933,0.0003971154,0.00019514759,0.0001266399,0.00028779285,0.0001576858,0.00042861805,0.00026334776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070558134,0.0010005248,0.66347975,0.00028116236,0.0005595862,0.00096201967,0.000107691725,0.0011502991,0.012015765,0.0011840902,0.0046067378,0.30759647],"study_design_scores_gemma":[0.00036770044,0.0036439341,0.98239315,0.000104934436,0.00050698454,0.001959326,0.000105451676,0.0011208174,0.002175131,0.0014998438,0.0061084647,0.000014289473],"about_ca_topic_score_codex":0.00062671216,"about_ca_topic_score_gemma":0.0014442008,"teacher_disagreement_score":0.0038756817,"about_ca_system_score_codex":0.0002345277,"about_ca_system_score_gemma":0.00031948736,"threshold_uncertainty_score":0.012965441},"labels":[],"label_agreement":null},{"id":"W2023637084","doi":"10.1016/j.leukres.2012.08.019","title":"Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Regimen; Lymphoblastic Leukemia; Salvage therapy; Acute lymphocytic leukemia; Internal medicine; Induction chemotherapy; Oncology; Surgery; Leukemia","score_opus":0.020238150766954708,"score_gpt":0.3091990927972103,"score_spread":0.2889609420302556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023637084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822694,0.00040142483,0.000050622126,0.00009896181,0.0000074476475,0.000008842444,0.00036450019,0.0000034080422,0.0008378289],"genre_scores_gemma":[0.998552,0.00027832494,0.000040644434,0.00006430991,0.000017283195,0.0000062463196,0.00088033185,0.0000014682885,0.00015943685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998192,0.000037990852,0.00002026086,0.000021500706,0.00003326977,0.00006777383],"domain_scores_gemma":[0.9992729,0.00011270517,0.00034836022,0.000023875582,0.000063236585,0.00017897606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026154268,0.0001209278,0.00035929587,0.00021398402,0.00023301985,0.0004971166,0.00018070836,0.0002309139,0.0011038844],"category_scores_gemma":[0.0013154009,0.000070664406,0.00038258432,0.0005332586,0.00016677566,0.00041644345,0.0003278183,0.00042791077,0.0001360942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013536887,0.00012898313,0.98767763,0.000018880128,0.00006003675,0.00070445944,0.00014659396,0.00020732373,0.00027426064,0.000075097414,0.00043967957,0.008913375],"study_design_scores_gemma":[0.000055671706,0.0015491989,0.99466914,0.00001865893,0.00011333246,0.0018729575,0.0004535491,0.000325337,0.00015389288,0.0001034885,0.00067759765,0.000007118968],"about_ca_topic_score_codex":0.0026897588,"about_ca_topic_score_gemma":0.0039028341,"teacher_disagreement_score":0.0026897588,"about_ca_system_score_codex":0.0004700569,"about_ca_system_score_gemma":0.000318261,"threshold_uncertainty_score":0.005348265},"labels":[],"label_agreement":null},{"id":"W2024519140","doi":"10.1016/j.leukres.2013.10.010","title":"The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Scheme for Promotion of Academic and Research Collaboration","keywords":"Aryl hydrocarbon receptor nuclear translocator; Aryl hydrocarbon receptor; Apoptosis; Reactive oxygen species; Cell biology; Chemistry; Intracellular; Molecular biology; Biology; Transcription factor; Biochemistry; Gene","score_opus":0.013652361485429138,"score_gpt":0.2719087306249588,"score_spread":0.25825636913952965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024519140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994642,0.0015271085,0.0014703927,0.00034174466,0.000038047932,0.000013728917,0.00032159343,0.00007715946,0.0015682625],"genre_scores_gemma":[0.99599326,0.00062803284,0.00035618985,0.000059515787,0.000012674204,0.000009888959,0.00026020157,0.000011905019,0.0026683265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998317,0.00003713335,0.0000107466285,0.000022964761,0.00004311802,0.00005432351],"domain_scores_gemma":[0.9999262,0.00001339307,0.000014708512,0.000011475907,0.000014201537,0.000020058456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014370165,0.00016214272,0.00024082212,0.00023891612,0.00020764598,0.00042677176,0.00013030451,0.0001969385,0.0017236943],"category_scores_gemma":[0.00015605331,0.00010506245,0.00016037827,0.00025474373,0.00021912614,0.00026023234,0.00017225246,0.00044867964,0.00044741863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042204562,0.000024233981,0.0004906118,0.000015628606,0.000004347198,0.00004501006,0.000029729752,0.000046684032,0.99716836,0.00019701947,0.00007942191,0.0014769079],"study_design_scores_gemma":[0.000057936413,0.00024236874,0.010535587,0.000003864393,0.000023607168,0.00020174429,0.0001368318,0.00088456296,0.9828315,0.0002538712,0.0048226253,0.0000056653853],"about_ca_topic_score_codex":0.0010776417,"about_ca_topic_score_gemma":0.0012345121,"teacher_disagreement_score":0.0017236943,"about_ca_system_score_codex":0.0003398805,"about_ca_system_score_gemma":0.00019151875,"threshold_uncertainty_score":0.0057663918},"labels":[],"label_agreement":null},{"id":"W2026003064","doi":"10.1016/j.leukres.2009.08.007","title":"Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL)","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation Charles-Bruneau; Canadian Institutes of Health Research; Centre de recherche du CHU Sainte-Justine; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Haplotype; Lymphoblast; Single-nucleotide polymorphism; Intron; Allele; Biology; Glucocorticoid receptor; Gene; Gene isoform; Acute lymphocytic leukemia; Genetics; Internal medicine; Molecular biology; Cancer research; Lymphoblastic Leukemia; Leukemia; Medicine; Genotype; Cell culture","score_opus":0.029972575818002556,"score_gpt":0.33503767398288353,"score_spread":0.305065098164881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026003064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875665,0.0004374627,0.00004655207,0.00008605624,0.000008520324,0.000001595903,0.00023410788,0.0000042061324,0.00042475777],"genre_scores_gemma":[0.9994246,0.00017521968,0.000023108463,0.000014399734,0.000007876487,0.0000013380525,0.00020133496,0.0000019047943,0.00015020717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968183,0.0001210111,0.000025499477,0.000041620504,0.00005139103,0.00007871414],"domain_scores_gemma":[0.99888045,0.00030107785,0.0004369921,0.00007058798,0.00007242952,0.00023847085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035544403,0.00025967098,0.0003228567,0.00045551886,0.00037542806,0.000532682,0.00024753666,0.00037250074,0.0011838784],"category_scores_gemma":[0.0015474808,0.00015494572,0.0003012714,0.00087934016,0.00027345432,0.00020557357,0.00019215328,0.00062199926,0.00015423744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008857761,0.000057548117,0.9938002,0.0000119298475,0.000116179566,0.00036728638,0.00007789297,0.00013395736,0.0025179293,0.00008413183,0.00013351225,0.001813752],"study_design_scores_gemma":[0.000029559053,0.00015998671,0.99729013,0.000006409925,0.0001247478,0.0010373171,0.00014329918,0.00016896772,0.0005305679,0.00011001243,0.00039410006,0.0000049641917],"about_ca_topic_score_codex":0.0084020775,"about_ca_topic_score_gemma":0.0051679006,"teacher_disagreement_score":0.0084020775,"about_ca_system_score_codex":0.00048216784,"about_ca_system_score_gemma":0.00045034906,"threshold_uncertainty_score":0.016706347},"labels":[],"label_agreement":null},{"id":"W2026601287","doi":"10.1016/j.leukres.2005.04.020","title":"Treatment of elderly patients with acute lymphoblastic leukemia—Evidence for a benefit of imatinib in BCR-ABL positive patients","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Imatinib; Imatinib mesylate; Internal medicine; Regimen; Induction chemotherapy; Induction therapy; Chemotherapy; Oncology; Gastroenterology; Surgery; Myeloid leukemia","score_opus":0.04490805009228664,"score_gpt":0.357904061476144,"score_spread":0.31299601138385735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026601287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9347658,0.058774114,0.00013713916,0.0018160583,0.00013644644,0.000022996614,0.00023550709,0.000010631401,0.0041013537],"genre_scores_gemma":[0.9805131,0.017554197,0.00021324233,0.0008485887,0.00022542775,0.000020012983,0.00026075466,0.0000024135236,0.00036228553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99986064,0.00007104245,0.000016864407,0.000011235456,0.000021912383,0.000018302058],"domain_scores_gemma":[0.9996489,0.00013176953,0.00012406694,0.000013260829,0.000016559748,0.0000654789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035427487,0.00014161106,0.0004275018,0.00014301145,0.00011379953,0.0001964876,0.000106220716,0.00019539092,0.0009709594],"category_scores_gemma":[0.001141973,0.000054047618,0.00036337366,0.00024714143,0.00013245801,0.00021848004,0.00010602188,0.00031499245,0.000105029605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098326474,0.0013639064,0.32335803,0.0022393204,0.0031345894,0.0014139228,0.00024076777,0.0013873542,0.016146304,0.00073731446,0.0063659726,0.5452862],"study_design_scores_gemma":[0.009282281,0.020773845,0.93540496,0.00049937755,0.0032129437,0.0037172788,0.00029394476,0.00065377704,0.0022002864,0.0008953219,0.023036186,0.000029786168],"about_ca_topic_score_codex":0.00040696358,"about_ca_topic_score_gemma":0.0013836174,"teacher_disagreement_score":0.0009709594,"about_ca_system_score_codex":0.00017659522,"about_ca_system_score_gemma":0.0001953669,"threshold_uncertainty_score":0.0032481551},"labels":[],"label_agreement":null},{"id":"W2027611958","doi":"10.1016/j.leukres.2014.03.022","title":"Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Melphalan; Oncology; Angiogenesis; Internal medicine; Pazopanib; Pharmacology; Multiple myeloma; Cancer; Sunitinib","score_opus":0.09011501660460082,"score_gpt":0.44628126325013334,"score_spread":0.35616624664553254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027611958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958264,0.0010966491,0.00032146674,0.00026558127,0.000031347106,0.0016115055,0.00031869963,0.000030317795,0.0004980397],"genre_scores_gemma":[0.9915543,0.0009892047,0.0025405604,0.000487038,0.000118751836,0.0021929373,0.0011380443,0.000016367314,0.00096279936],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931824,0.00042665776,0.000034706736,0.000061490384,0.000059867405,0.00009899954],"domain_scores_gemma":[0.99929917,0.0001291721,0.00015401482,0.000055019944,0.00003394442,0.00032867715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002151642,0.001143395,0.001549697,0.00047359488,0.0003078314,0.0007441094,0.0007538379,0.0009244957,0.0019119249],"category_scores_gemma":[0.0008732,0.00047340713,0.0007939413,0.00044951422,0.00081167603,0.0007340837,0.00038146877,0.002339056,0.0003045613],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52034533,0.1762705,0.023965044,0.00082055794,0.0010577823,0.0005091174,0.0004726846,0.0032841652,0.121633574,0.0006005732,0.0028029138,0.14823772],"study_design_scores_gemma":[0.31109238,0.65198374,0.022417763,0.000038461934,0.00032732045,0.0004477671,0.00006990022,0.0014214913,0.009220909,0.00023582642,0.002706503,0.000037924616],"about_ca_topic_score_codex":0.00059965043,"about_ca_topic_score_gemma":0.0020762535,"teacher_disagreement_score":0.002151642,"about_ca_system_score_codex":0.0008258278,"about_ca_system_score_gemma":0.0014353174,"threshold_uncertainty_score":0.011379063},"labels":[],"label_agreement":null},{"id":"W2028619564","doi":"10.1016/j.leukres.2010.01.006","title":"Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute","funders":"Cancer Research Society; Leukemia and Lymphoma Society","keywords":"Haematopoiesis; Myeloid leukemia; Cancer research; Progenitor cell; Fms-Like Tyrosine Kinase 3; Stem cell; Leukemia; Myeloid; Cytotoxic T cell; Bone marrow; Integrin-linked kinase; CD135; Tyrosine-kinase inhibitor; Tyrosine kinase; Medicine; Biology; Immunology; Kinase; Signal transduction; Cell biology; Internal medicine; Cancer; Protein kinase A","score_opus":0.03293949577269067,"score_gpt":0.32414813245436985,"score_spread":0.2912086366816792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028619564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454874,0.0010661831,0.002079575,0.00021099982,0.000041004634,0.000024129413,0.00014685416,0.00011724257,0.0017652523],"genre_scores_gemma":[0.9970335,0.00030954607,0.00071072904,0.00006190525,0.000010866736,0.000017440509,0.00022197409,0.000019119558,0.0016150007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999736,0.00003183054,0.00002116361,0.00004151042,0.00008893937,0.00008051541],"domain_scores_gemma":[0.9997856,0.000053905576,0.00005666204,0.000034967343,0.000011564728,0.000057407426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022171217,0.0003361465,0.000505806,0.0002975423,0.00024587673,0.0008105004,0.00035488387,0.0005360906,0.0014087209],"category_scores_gemma":[0.00018780638,0.000263507,0.0002929631,0.0002464043,0.0004385332,0.0003600281,0.00028639252,0.0010877583,0.00034573622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036524195,0.00008323578,0.00039252327,0.000031548476,0.000018525889,0.00011391888,0.000033909157,0.00037505303,0.9940316,0.00094799727,0.00015152789,0.0034549923],"study_design_scores_gemma":[0.00009795075,0.0008776038,0.0040751873,0.0000072876005,0.000051544353,0.00083545194,0.0000829744,0.0024914006,0.9867317,0.00043072982,0.004310711,0.0000074895347],"about_ca_topic_score_codex":0.00038681735,"about_ca_topic_score_gemma":0.00074141973,"teacher_disagreement_score":0.0014087209,"about_ca_system_score_codex":0.000381037,"about_ca_system_score_gemma":0.00033873893,"threshold_uncertainty_score":0.0047126412},"labels":[],"label_agreement":null},{"id":"W2029200519","doi":"10.1016/j.leukres.2010.04.014","title":"3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Medical Research Council Canada","keywords":"Deoxycytidine kinase; Deoxycytidine; Cytarabine; Prodrug; Pharmacology; Drug; Cancer research; Leukemia; Drug resistance; In vitro; Chemistry; Chemotherapy; Medicine; Biology; Immunology; Gemcitabine; Biochemistry; Internal medicine; Genetics","score_opus":0.02942375182383521,"score_gpt":0.3517070445500963,"score_spread":0.3222832927262611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029200519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885721,0.0042683915,0.0018032866,0.00017336398,0.00010952558,0.000038875005,0.00024665074,0.00019781085,0.0045900736],"genre_scores_gemma":[0.99615544,0.0009254216,0.0010536889,0.000044331657,0.000027979231,0.000010258058,0.0002501646,0.00002406545,0.0015086202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998062,0.000059882306,0.000017009308,0.000030492854,0.000038938895,0.00004743893],"domain_scores_gemma":[0.99981207,0.000066353496,0.000036784317,0.000031467436,0.00001983824,0.00003347558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022649417,0.00027224544,0.00047335704,0.0002703871,0.00013749932,0.00046354512,0.0002956562,0.00036229362,0.0022579385],"category_scores_gemma":[0.00030116024,0.00017335774,0.00022124377,0.0001557554,0.00018867347,0.00023994524,0.0001462701,0.00061395974,0.0005639948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006169423,0.000084325766,0.00025908652,0.000037756323,0.000012309497,0.00006281146,0.000019222807,0.0001557626,0.9927879,0.00025298947,0.00011144672,0.0055994834],"study_design_scores_gemma":[0.00007236356,0.0011390843,0.0029238919,0.0000052850623,0.000029737057,0.0003862201,0.000013569869,0.0007317789,0.9900517,0.00004734959,0.004594268,0.0000047006633],"about_ca_topic_score_codex":0.0006748118,"about_ca_topic_score_gemma":0.0014356956,"teacher_disagreement_score":0.0022579385,"about_ca_system_score_codex":0.0003547986,"about_ca_system_score_gemma":0.0002294776,"threshold_uncertainty_score":0.0075535774},"labels":[],"label_agreement":null},{"id":"W2031245996","doi":"10.1016/j.leukres.2003.11.015","title":"Cytokines and retinoic acid therapy for APL: new tricks from an old combination","year":2004,"lang":"en","type":"editorial","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Retinoic acid; Combination therapy; Cancer research; Retinoic acid-inducible orphan G protein-coupled receptor; Retinoic acid receptor; Tretinoin; Medicine; Computational biology; Biology; Internal medicine; Biochemistry","score_opus":0.027928041562333774,"score_gpt":0.3558299878990524,"score_spread":0.32790194633671865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031245996","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009959192,0.06593659,0.00039989437,0.062427163,0.86939555,0.000024461717,0.000034285626,0.00006339787,0.0016191339],"genre_scores_gemma":[0.0011572066,0.04067941,0.00044109303,0.049522426,0.9001766,0.000030882304,0.00002849801,0.00003621867,0.00792767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976265,0.00053675694,0.00046068616,0.0002888049,0.0009181554,0.00016910967],"domain_scores_gemma":[0.9909287,0.0045415936,0.00037574928,0.00020024448,0.0028914637,0.0010622016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005891954,0.0032062693,0.0035829796,0.00224721,0.0017087237,0.005010049,0.0033538693,0.015350378,0.0038128165],"category_scores_gemma":[0.0097205825,0.00095932867,0.0021796455,0.0010454765,0.0024784105,0.0043928265,0.0011715156,0.027248366,0.0031787434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013233567,0.000023557715,0.00003285712,0.00050895027,0.00006271516,0.00036407652,0.00002275269,0.00004185706,0.00023591293,0.0009351088,0.98091197,0.01672779],"study_design_scores_gemma":[0.000141084,0.00007854485,0.00020723692,0.00039512388,0.00013542657,0.0006928823,0.000044175707,0.00014933282,0.00022772833,0.0010903261,0.99680907,0.00002909601],"about_ca_topic_score_codex":0.0013842685,"about_ca_topic_score_gemma":0.0043473346,"teacher_disagreement_score":0.015350378,"about_ca_system_score_codex":0.0024819109,"about_ca_system_score_gemma":0.0017392434,"threshold_uncertainty_score":0.031159997},"labels":[],"label_agreement":null},{"id":"W2032403766","doi":"10.1016/j.leukres.2013.03.003","title":"Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Myeloid leukemia; Progenitor cell; MAPK/ERK pathway; Cancer research; Medicine; Protein kinase A; Leukemia; PI3K/AKT/mTOR pathway; Protein kinase B; Kinase; Myeloid; MEK inhibitor; Pharmacology; Chemistry; Immunology; Stem cell; Biology; Cell biology; Phosphorylation; Signal transduction; Biochemistry","score_opus":0.02154962473545705,"score_gpt":0.2819466830449602,"score_spread":0.2603970583095031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032403766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265844,0.0020474263,0.0013253468,0.00010866904,0.000066678374,0.00006307452,0.00038008322,0.0001094183,0.0032409865],"genre_scores_gemma":[0.9955178,0.001079297,0.0009036873,0.000030028603,0.000017420589,0.000049937702,0.00047761152,0.000012931225,0.0019113992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979526,0.00003328662,0.000025579926,0.000027438546,0.000061080005,0.000057435744],"domain_scores_gemma":[0.9998919,0.00002303691,0.000014208961,0.000020462447,0.000006853825,0.00004357003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024536293,0.000533975,0.00045945702,0.00041885077,0.00018622293,0.00042867401,0.00036918675,0.00026439206,0.0014746358],"category_scores_gemma":[0.00014206143,0.00023656938,0.00034495708,0.0003863948,0.00023275227,0.00021069232,0.0003312695,0.00073551224,0.00043648414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002430136,0.0006243305,0.0007139601,0.00012843146,0.000069293485,0.00019351447,0.000050826176,0.0011741652,0.9825533,0.0008203755,0.00048005913,0.010761534],"study_design_scores_gemma":[0.00024202178,0.0019120547,0.0025903073,0.0000071434297,0.00006977483,0.00043123864,0.000024423482,0.0010948053,0.99041045,0.000099724566,0.0031120984,0.000006016966],"about_ca_topic_score_codex":0.0007202245,"about_ca_topic_score_gemma":0.0012299066,"teacher_disagreement_score":0.0014746358,"about_ca_system_score_codex":0.0002934545,"about_ca_system_score_gemma":0.00051995914,"threshold_uncertainty_score":0.0049331784},"labels":[],"label_agreement":null},{"id":"W2033332996","doi":"10.1016/s0145-2126(01)00162-x","title":"Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Canada Research Chairs","funders":"National Cancer Institute; Medical Research Council Canada","keywords":"Etoposide; Vincristine; Apoptosis; Cell culture; Cancer research; Dexamethasone; Methotrexate; Medicine; Immunology; Chemistry; Internal medicine; Biology; Chemotherapy; Biochemistry; Cyclophosphamide","score_opus":0.08887992542065368,"score_gpt":0.38207603295175174,"score_spread":0.29319610753109804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033332996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916855,0.0017441233,0.0020462244,0.00009310834,0.000023945493,0.00002539236,0.0009877931,0.000066300636,0.003327475],"genre_scores_gemma":[0.98842746,0.0012267572,0.002310181,0.0000808982,0.000012928673,0.000067882116,0.0032335804,0.000022021291,0.004618219],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995072,0.000107336935,0.00007853656,0.000066457564,0.00015147663,0.000089046225],"domain_scores_gemma":[0.9996107,0.00014418269,0.000042020223,0.000056476973,0.00009943668,0.000047192418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002984927,0.0002732935,0.00033021727,0.0006069876,0.000303794,0.00061979884,0.00018800201,0.00028809538,0.0028883144],"category_scores_gemma":[0.00033734814,0.00015925108,0.0002977401,0.0006274063,0.00021456856,0.00035082203,0.00022378881,0.0006534001,0.0006143352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019890034,0.00004329904,0.00081764563,0.00004751489,0.000018116016,0.000024447187,0.000096780175,0.000101662394,0.99678975,0.00030569872,0.00008351952,0.0014727009],"study_design_scores_gemma":[0.000012466367,0.00036169201,0.011040193,0.000005781194,0.00003580485,0.00018910243,0.00017789111,0.00055542885,0.98492986,0.00004878318,0.0026380015,0.0000050066915],"about_ca_topic_score_codex":0.0017819614,"about_ca_topic_score_gemma":0.0014947085,"teacher_disagreement_score":0.0028883144,"about_ca_system_score_codex":0.00048468434,"about_ca_system_score_gemma":0.00022442002,"threshold_uncertainty_score":0.00966239},"labels":[],"label_agreement":null},{"id":"W2033495545","doi":"10.1016/j.leukres.2009.08.030","title":"Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Dasatinib; Proto-oncogene tyrosine-protein kinase Src; Src family kinase; Cancer research; Kinase; Phosphorylation; Imatinib; Lymphoma; Biology; Medicine; Internal medicine; Cell biology","score_opus":0.0668813852658236,"score_gpt":0.3853924470342055,"score_spread":0.3185110617683819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033495545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81364787,0.1230422,0.0032219712,0.016533228,0.0016432423,0.00019178716,0.00036443362,0.00020231122,0.04115293],"genre_scores_gemma":[0.98122656,0.013675412,0.000955886,0.00077973434,0.0005753386,0.00007155429,0.00014349431,0.000016501821,0.0025554744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998087,0.000070363436,0.000013299529,0.000015575439,0.000035096178,0.000057013458],"domain_scores_gemma":[0.9998442,0.000063243424,0.000025056983,0.000018448713,0.000017033786,0.000032041284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059364876,0.00026560127,0.00051285344,0.0003007832,0.00036031223,0.0006916714,0.000436377,0.0006680268,0.0021182923],"category_scores_gemma":[0.0006088556,0.00010365693,0.00029646797,0.00026199291,0.00045360168,0.00047957673,0.00037673736,0.0013559742,0.0004867653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03649133,0.0031494466,0.009742942,0.0019160854,0.00031422163,0.0053771087,0.00033917316,0.0021336523,0.4620577,0.02889806,0.023243288,0.426337],"study_design_scores_gemma":[0.029422697,0.039619602,0.06836741,0.00066206005,0.001713435,0.03205548,0.0011214393,0.0083855605,0.39766482,0.03304902,0.387798,0.00014057451],"about_ca_topic_score_codex":0.00020590685,"about_ca_topic_score_gemma":0.00056081417,"teacher_disagreement_score":0.0021182923,"about_ca_system_score_codex":0.0004994003,"about_ca_system_score_gemma":0.00048433428,"threshold_uncertainty_score":0.007086396},"labels":[],"label_agreement":null},{"id":"W2034409643","doi":"10.1016/s0145-2126(03)00180-2","title":"Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunophenotyping; CD33; Medicine; Internal medicine; Gastroenterology; CD34; Acute promyelocytic leukemia; Myeloid leukemia; Daunorubicin; Leukemia; Oncology; Immunology; Flow cytometry; Biology; Stem cell","score_opus":0.025738497860918738,"score_gpt":0.31812977727637065,"score_spread":0.2923912794154519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034409643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869835,0.00033951478,0.00005342124,0.00007251832,0.000008819093,0.000003473325,0.00026892123,0.0000024743956,0.00055238936],"genre_scores_gemma":[0.9994597,0.00009940554,0.000037407524,0.000028196318,0.000013711967,0.000003986195,0.00027374105,0.000001771215,0.00008211378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994931,0.0001252174,0.00004452395,0.00007738678,0.00009712218,0.00016258795],"domain_scores_gemma":[0.9984451,0.0005897298,0.00043674916,0.00008145014,0.00014546448,0.00030165323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031787468,0.00023799056,0.00037426365,0.0007707264,0.000591989,0.0005658349,0.00037425113,0.0004168613,0.0015627295],"category_scores_gemma":[0.002501937,0.0001907326,0.00021256707,0.0013923177,0.00045801877,0.0003884766,0.0003557013,0.0004821805,0.0003012056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022406172,0.000009735118,0.9979511,0.0000034389057,0.000010153047,0.00014969392,0.000025025574,0.00004417999,0.00035232515,0.000020003989,0.00008467464,0.0011256539],"study_design_scores_gemma":[0.000019074363,0.00010287793,0.9972813,0.0000056648464,0.00003923672,0.0011050766,0.0002158707,0.00020799538,0.00033501926,0.00009866612,0.00058420177,0.0000049679647],"about_ca_topic_score_codex":0.0029833366,"about_ca_topic_score_gemma":0.003425921,"teacher_disagreement_score":0.0029833366,"about_ca_system_score_codex":0.0004539882,"about_ca_system_score_gemma":0.0005121876,"threshold_uncertainty_score":0.005931914},"labels":[],"label_agreement":null},{"id":"W2035278640","doi":"10.1016/j.leukres.2014.10.005","title":"Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Bosutinib; Ponatinib; Nilotinib; Dasatinib; Medicine; Tyrosine kinase; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Internal medicine; Imatinib; Pharmacology; Oncology; Leukemia; Myeloid leukemia","score_opus":0.08836413084802916,"score_gpt":0.4135965523823236,"score_spread":0.32523242153429444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035278640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032570623,0.9993019,0.00002874338,0.00004131849,0.000036588946,0.0000062325275,0.000029285118,0.0000014444183,0.00022883975],"genre_scores_gemma":[0.002757725,0.9967585,0.00013728674,0.00011663814,0.00004303274,0.0000084546145,0.000053859967,8.921455e-7,0.00012365336],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997706,0.000054789478,0.000056993347,0.000036721212,0.00006463725,0.000016373528],"domain_scores_gemma":[0.9994491,0.00035324323,0.000112134585,0.000008026735,0.0000620766,0.00001543203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009334032,0.00056039204,0.0024212913,0.0012346096,0.00012187683,0.0007922231,0.0008689471,0.00060167216,0.0025752198],"category_scores_gemma":[0.0012181214,0.00019547182,0.0015829222,0.001423157,0.00022627164,0.0005844677,0.00029090486,0.0009970721,0.00036673757],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014917463,0.0001564201,0.00036030612,0.10038494,0.001773571,0.00011714407,0.00005257767,0.0004798548,0.0015584609,0.0013058456,0.008268052,0.8840511],"study_design_scores_gemma":[0.0030928645,0.004075853,0.013281494,0.07798505,0.020026207,0.002955189,0.00033698822,0.0005955535,0.0029847191,0.002677638,0.8718508,0.00013768728],"about_ca_topic_score_codex":0.001125177,"about_ca_topic_score_gemma":0.0033252952,"teacher_disagreement_score":0.0025752198,"about_ca_system_score_codex":0.00050971564,"about_ca_system_score_gemma":0.0008624192,"threshold_uncertainty_score":0.008614957},"labels":[],"label_agreement":null},{"id":"W2035901454","doi":"10.1016/j.leukres.2013.09.025","title":"Genomic aberrations in anaplastic multiple myeloma: High frequency of 1q21(CKS1B) amplifications","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Fluorescence in situ hybridization; Multiple myeloma; Biology; Hematology; Gene duplication; Chromosome instability; Cytogenetics; Cancer research; Molecular biology; Pathology; Medicine; Internal medicine; Genetics; Gene; Chromosome","score_opus":0.06511811730914109,"score_gpt":0.3531914296015694,"score_spread":0.28807331229242833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035901454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951426,0.0016421989,0.00044190013,0.00013409482,0.000012530967,0.000014592763,0.00036854664,0.00005489098,0.0021886672],"genre_scores_gemma":[0.9989502,0.00030307984,0.00018852911,0.00002074739,0.000021584121,0.000005802444,0.00015160692,0.0000059723143,0.0003525642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995437,0.00005485494,0.0000435038,0.00011116355,0.00015527499,0.00009153303],"domain_scores_gemma":[0.9991628,0.0002270628,0.0002735345,0.00006907453,0.00013538692,0.00013222407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003113716,0.00041025892,0.00029819008,0.0054157902,0.0006319173,0.0007393499,0.0004011612,0.00077224744,0.004717505],"category_scores_gemma":[0.0015485206,0.00023520578,0.00020341319,0.0021302851,0.0004058064,0.00034597085,0.00046687186,0.00027014234,0.00065502676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019223146,0.00010873208,0.7232779,0.00017197017,0.00015346671,0.013514288,0.000539726,0.00045255112,0.21644895,0.00040096353,0.0012060897,0.04180298],"study_design_scores_gemma":[0.000023872877,0.00017264766,0.93694854,0.000017037763,0.00017762156,0.043632213,0.0003146432,0.0006239148,0.014740542,0.00037678264,0.0029581597,0.000014000694],"about_ca_topic_score_codex":0.0014772408,"about_ca_topic_score_gemma":0.001357784,"teacher_disagreement_score":0.0054157902,"about_ca_system_score_codex":0.00026496415,"about_ca_system_score_gemma":0.00017678525,"threshold_uncertainty_score":0.015781581},"labels":[],"label_agreement":null},{"id":"W2036563645","doi":"10.1016/j.leukres.2007.09.015","title":"Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Efflux; Western blot; Multiple drug resistance; Transporter; Cell culture; Pharmacology; Cell biology; Biology; Chemistry; Drug resistance; Biochemistry; Gene; Genetics","score_opus":0.026076508364292508,"score_gpt":0.33030586412090385,"score_spread":0.30422935575661136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036563645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980952,0.00049405143,0.0004306032,0.00009458312,0.000017814997,0.000010572727,0.00022906443,0.000046264147,0.0005818693],"genre_scores_gemma":[0.9975049,0.000253749,0.00035437994,0.000022358861,0.000010059424,0.000021609905,0.0005135537,0.000010720994,0.0013085955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998381,0.000037361748,0.00001862158,0.000020061241,0.00003785862,0.000047920526],"domain_scores_gemma":[0.99989367,0.00002874447,0.000020332887,0.00002004916,0.000016429478,0.000020729785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011639329,0.00023367016,0.00038423564,0.00029814005,0.00023664699,0.00045630135,0.00017536059,0.00035043745,0.003056789],"category_scores_gemma":[0.00027250175,0.00024356587,0.00031029823,0.00032100198,0.0002400963,0.00027599445,0.00018046093,0.00048481973,0.00057007355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004965173,0.00004945566,0.0006100978,0.00002624029,0.000013877161,0.00028533605,0.000034035205,0.00006581268,0.9972053,0.00017721954,0.00009071832,0.0009451948],"study_design_scores_gemma":[0.00011450594,0.00069773145,0.031377025,0.000004758485,0.000056682013,0.002449845,0.00015691116,0.0015612743,0.9594972,0.00012336588,0.003948692,0.000011970692],"about_ca_topic_score_codex":0.00071669323,"about_ca_topic_score_gemma":0.0004477309,"teacher_disagreement_score":0.003056789,"about_ca_system_score_codex":0.0002689535,"about_ca_system_score_gemma":0.000202205,"threshold_uncertainty_score":0.010226011},"labels":[],"label_agreement":null},{"id":"W2036608644","doi":"10.1016/s0145-2126(07)70460-5","title":"Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy","year":2007,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Internal medicine; Chelation therapy; Overall survival; Bone marrow; Thalassemia","score_opus":0.14516294574171884,"score_gpt":0.447201765059812,"score_spread":0.3020388193180932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036608644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007185094,0.9986125,0.000074821924,0.000121169396,0.00006401763,0.0000057836296,0.000015124632,0.0000041088138,0.00038389376],"genre_scores_gemma":[0.0045860843,0.99444723,0.00027289236,0.00024513618,0.00014271065,0.000012561035,0.00005978521,8.2119647e-7,0.00023267978],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988174,0.00002721273,0.000027768989,0.000017591521,0.00003430694,0.000011390514],"domain_scores_gemma":[0.99979883,0.000109108056,0.000045562407,0.000003613157,0.000031671323,0.000011268659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038332908,0.00052208995,0.0020188938,0.0008478905,0.00012231925,0.00030497363,0.0006229277,0.0005047844,0.0012509765],"category_scores_gemma":[0.000640169,0.00012350605,0.0005873641,0.0008417283,0.00016415304,0.00027696052,0.00021835176,0.0006323532,0.00030738945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034442852,0.00014430357,0.0013904357,0.014892444,0.0005805199,0.00034079683,0.000029895731,0.0001727903,0.00095589826,0.00032349033,0.010318657,0.9705063],"study_design_scores_gemma":[0.0023074048,0.0025631157,0.061216824,0.031333473,0.010069271,0.01670999,0.00037124203,0.00083775853,0.002800361,0.0027592222,0.86890674,0.00012470131],"about_ca_topic_score_codex":0.00078568317,"about_ca_topic_score_gemma":0.0016348882,"teacher_disagreement_score":0.0020188938,"about_ca_system_score_codex":0.00019488095,"about_ca_system_score_gemma":0.0005215085,"threshold_uncertainty_score":0.0041849613},"labels":[],"label_agreement":null},{"id":"W2038378803","doi":"10.1016/j.leukres.2007.05.004","title":"The expression of cytoplasmic CD79a correlates with surface CD3 expression in childhood T-ALL lymphoblasts","year":2007,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Lymphoblast; Expression (computer science); Cytoplasm; CD3; Biology; Cell biology; Immunology; Genetics; Cell culture; Antigen; Computer science","score_opus":0.029157580527006767,"score_gpt":0.32278567813704384,"score_spread":0.29362809761003705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038378803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91028774,0.0030777017,0.001435326,0.04822885,0.0011292151,0.00004045784,0.000318456,0.00017332357,0.035308953],"genre_scores_gemma":[0.99128133,0.00089072395,0.0004381045,0.0035534638,0.0010318457,0.000017491495,0.00012183424,0.000031665393,0.0026336606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996289,0.0000756924,0.000035482575,0.00004522805,0.00009817704,0.0001163996],"domain_scores_gemma":[0.9987562,0.000700956,0.00012853151,0.00010305218,0.00018203822,0.00012918848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030431637,0.0002576689,0.00044207263,0.00045489008,0.0006470865,0.0008514188,0.00038064254,0.0019836163,0.0018227762],"category_scores_gemma":[0.0027863123,0.0002520615,0.00021155954,0.0005553439,0.00058945763,0.00049726584,0.00026646262,0.001677236,0.0007406429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022361465,0.00019816839,0.4377115,0.00028007585,0.00008218305,0.29967237,0.0013687446,0.0009786914,0.092769645,0.0073289936,0.0799052,0.07746825],"study_design_scores_gemma":[0.00019375341,0.00071533606,0.35034245,0.00013764354,0.00015032983,0.50917685,0.0019138594,0.0046490533,0.036727782,0.0044277087,0.09149657,0.0000686883],"about_ca_topic_score_codex":0.0025361704,"about_ca_topic_score_gemma":0.004092887,"teacher_disagreement_score":0.0025361704,"about_ca_system_score_codex":0.0011133739,"about_ca_system_score_gemma":0.00041512577,"threshold_uncertainty_score":0.008078098},"labels":[],"label_agreement":null},{"id":"W2039249445","doi":"10.1016/j.leukres.2006.06.001","title":"CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Myeloid leukemia; Internal medicine; Karyotype; Medicine; Gastroenterology; Leukemia; Multivariate analysis; CD34; Myeloid; Complete remission; Oncology; Chemotherapy; Biology; Chromosome; Stem cell","score_opus":0.015210120782076229,"score_gpt":0.2828162813017182,"score_spread":0.267606160519642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039249445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993319,0.0001632473,0.000024215376,0.000061390565,0.0000060249304,0.000001698214,0.000055079814,0.0000017248469,0.00035458995],"genre_scores_gemma":[0.9994869,0.00007733584,0.00003322283,0.000025699755,0.000016682245,0.0000032561684,0.00019081443,0.0000012174108,0.00016495149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985206,0.000031754098,0.000013099714,0.000021487145,0.000027590042,0.00005400431],"domain_scores_gemma":[0.9992748,0.00026915033,0.00020242733,0.000030408159,0.000063060375,0.00016026427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019927944,0.00024074133,0.00037752272,0.00041031698,0.0003798038,0.0006410781,0.00031134783,0.0006437181,0.0016497265],"category_scores_gemma":[0.0014667775,0.00018431913,0.00023311339,0.000538791,0.00035690053,0.00039005576,0.00029959262,0.0005089709,0.00029273887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005495111,0.000035774177,0.9958896,0.000005659439,0.00002547016,0.00019491001,0.000029929924,0.000079387864,0.0012537176,0.00003080074,0.00016869373,0.001736462],"study_design_scores_gemma":[0.000031389463,0.00018254001,0.9968297,0.000005092878,0.000057959693,0.001183099,0.0002086536,0.0006559753,0.00035291316,0.00012044683,0.00036704316,0.0000051120887],"about_ca_topic_score_codex":0.0012704555,"about_ca_topic_score_gemma":0.0019554761,"teacher_disagreement_score":0.0016497265,"about_ca_system_score_codex":0.00028609918,"about_ca_system_score_gemma":0.00020124446,"threshold_uncertainty_score":0.0055189133},"labels":[],"label_agreement":null},{"id":"W2039577073","doi":"10.1016/j.leukres.2013.11.014","title":"Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: A population-based study","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; University of Toronto; SickKids Foundation; St. Michael's Hospital","funders":"National Cancer Institute; Pediatric Oncology Group of Ontario; McMaster University; Amgen","keywords":"Medicine; Lymphoblastic Leukemia; Pediatrics; Overall survival; Population; Internal medicine; Leukemia","score_opus":0.038217547418533296,"score_gpt":0.33992017999049995,"score_spread":0.30170263257196667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039577073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935645,0.0002386011,0.000021259551,0.00004252269,0.0000034268955,0.0000026345,0.00018385111,0.0000012132859,0.0001499449],"genre_scores_gemma":[0.9995511,0.0001215779,0.000019848258,0.000018259228,0.000006588642,0.0000046070677,0.00021121057,0.0000014777519,0.00006529746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892044,0.00043113614,0.00010407176,0.00017147195,0.00015416318,0.00021872172],"domain_scores_gemma":[0.9965359,0.0009214739,0.0014919189,0.00019929277,0.00019120013,0.0006602381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010463239,0.00029450806,0.00048731448,0.0008510415,0.0005492972,0.0009117941,0.0005092346,0.00076689763,0.0011823964],"category_scores_gemma":[0.004259964,0.00038016005,0.0011144244,0.0016574031,0.0005057761,0.00073570217,0.0005997848,0.0011137468,0.00015943583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025283606,0.00006300343,0.9989963,0.000004472653,0.000098844655,0.000042567364,0.00006639617,0.000027091572,0.00007058082,0.0000098244545,0.000025275252,0.00034268407],"study_design_scores_gemma":[0.000010874579,0.00019831429,0.99926525,0.000002764867,0.000054622,0.00011032454,0.00020327154,0.00005510682,0.000019082132,0.000010003705,0.00006695026,0.0000035285773],"about_ca_topic_score_codex":0.013040722,"about_ca_topic_score_gemma":0.010497449,"teacher_disagreement_score":0.013040722,"about_ca_system_score_codex":0.0007575236,"about_ca_system_score_gemma":0.00064312486,"threshold_uncertainty_score":0.02592963},"labels":[],"label_agreement":null},{"id":"W2041743288","doi":"10.1016/j.leukres.2010.12.009","title":"Correlation among nuclear localization of NuMA-RARα, deregulation of gene expression and leukemic phenotype of hCG-NuMA-RARα transgenic mice","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Transgene; Fusion gene; Genetically modified mouse; Biology; Phenotype; Gene; Cancer research; Gene expression; Molecular biology; Genetics","score_opus":0.02869935577656829,"score_gpt":0.2714664752402198,"score_spread":0.24276711946365148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041743288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940333,0.00083159236,0.002505141,0.00014071206,0.00001777437,0.000020620517,0.00078296225,0.00017933101,0.0014885726],"genre_scores_gemma":[0.99253356,0.000528317,0.001298692,0.000038618615,0.000012482807,0.00004441145,0.00082396594,0.00007753129,0.004642413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997038,0.000044421908,0.00003758583,0.00008021836,0.00006292317,0.000071078335],"domain_scores_gemma":[0.9992168,0.00014801626,0.00027240746,0.00007587248,0.000037059086,0.00024979262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022431648,0.00038797123,0.00036116407,0.001552994,0.00019478082,0.0004864559,0.00031246117,0.00039766968,0.0025059648],"category_scores_gemma":[0.0002866444,0.00040132646,0.00022795307,0.00037549852,0.00061960856,0.0003166388,0.00027078003,0.0009880969,0.00062770175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020197366,0.000016543803,0.00062206533,0.000005806313,0.0000033383576,0.00010854746,0.000016022175,0.000026559153,0.99853396,0.00015525101,0.000013983816,0.00029595254],"study_design_scores_gemma":[0.000038508406,0.00018816056,0.013563106,0.0000046458126,0.000028989849,0.0011961866,0.00006317134,0.00071897666,0.9828236,0.00020859497,0.0011583323,0.000007650452],"about_ca_topic_score_codex":0.0005305232,"about_ca_topic_score_gemma":0.0006646512,"teacher_disagreement_score":0.0025059648,"about_ca_system_score_codex":0.00041863424,"about_ca_system_score_gemma":0.0002402497,"threshold_uncertainty_score":0.008383274},"labels":[],"label_agreement":null},{"id":"W2041790656","doi":"10.1016/j.leukres.2005.07.008","title":"Analysis of PTEN deletions and mutations in multiple myeloma","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PTEN; Plasma cell leukemia; Cancer research; Multiple myeloma; Biology; Tumor suppressor gene; Pathogenesis; Plasma cell; Molecular biology; Mutation; Gene; Genetics; Immunology; Carcinogenesis; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.04689792716890501,"score_gpt":0.3650777894425504,"score_spread":0.3181798622736454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041790656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957059,0.000691344,0.0010350557,0.00007451832,0.000010834305,0.000040321873,0.00078876776,0.00005538914,0.0015979557],"genre_scores_gemma":[0.9982242,0.00026644705,0.00061387644,0.000015576848,0.0000053587205,0.000013466966,0.00037183877,0.000012249003,0.0004770995],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99964166,0.000041508873,0.000043221964,0.000062251616,0.00012239876,0.00008894837],"domain_scores_gemma":[0.999652,0.000136532,0.00008325428,0.000026712005,0.00003219727,0.000069209724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035278418,0.00046396727,0.00036862039,0.0030879504,0.0004743058,0.00041055022,0.0005289718,0.0004249966,0.002098812],"category_scores_gemma":[0.00083036907,0.00036445018,0.0004001876,0.0013349303,0.00048129744,0.00024803728,0.0006056542,0.00030905617,0.0003335019],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004118795,0.00023422741,0.06198775,0.00014497175,0.00015494751,0.020427179,0.00033743365,0.0011200386,0.8947088,0.0012818003,0.00037400157,0.015110029],"study_design_scores_gemma":[0.00014228298,0.0009946913,0.2809511,0.000024895813,0.00036256821,0.05380674,0.00035285132,0.0030557143,0.65235287,0.00076767884,0.007155697,0.000032878866],"about_ca_topic_score_codex":0.0021903587,"about_ca_topic_score_gemma":0.0019564051,"teacher_disagreement_score":0.0030879504,"about_ca_system_score_codex":0.00047360524,"about_ca_system_score_gemma":0.00036013487,"threshold_uncertainty_score":0.0070211887},"labels":[],"label_agreement":null},{"id":"W2043169671","doi":"10.1016/j.leukres.2011.03.007","title":"Mouse models of myelodysplastic syndromes","year":2011,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Genome British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia; Michael Smith Health Research BC; European Molecular Biology Organization","keywords":"Myelodysplastic syndromes; Phenotype; Bone marrow; Haematopoiesis; Progenitor cell; Biology; Xenotransplantation; Cancer research; Disease; Leukemia; clone (Java method); Hematopoietic stem cell; Stem cell; Immunology; Computational biology; Medicine; Pathology; Genetics; Transplantation; Gene; Internal medicine","score_opus":0.2860556436850702,"score_gpt":0.4401797091625552,"score_spread":0.15412406547748503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043169671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037527006,0.997223,0.00048438416,0.00033374492,0.00019738254,0.00001369013,0.000098749966,0.000026975586,0.0012468603],"genre_scores_gemma":[0.0011461542,0.9969146,0.00049177953,0.00026486957,0.00007244245,0.000017879607,0.00020120449,0.0000030733197,0.0008879658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997793,0.00003809462,0.000031862317,0.000028113813,0.00010162635,0.000021008635],"domain_scores_gemma":[0.99972194,0.00011160256,0.000063688385,0.000012508212,0.000063292224,0.0000270122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000849382,0.0014104379,0.0016816236,0.0022550314,0.00020493087,0.00085690396,0.0013296315,0.0010043288,0.0020770896],"category_scores_gemma":[0.0005687561,0.00027588633,0.0005778926,0.0013083752,0.00045681163,0.00084670645,0.0005147426,0.0017865252,0.0010770228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033691459,0.00020064208,0.0004488141,0.018073708,0.00021261544,0.00048108085,0.0000381951,0.00063969765,0.01927967,0.005941964,0.049274307,0.90507245],"study_design_scores_gemma":[0.00008989494,0.00015168781,0.0007891348,0.0028498564,0.00042031697,0.0014880986,0.000032395586,0.0001007714,0.004068563,0.0019797448,0.9880028,0.000026710728],"about_ca_topic_score_codex":0.00095949037,"about_ca_topic_score_gemma":0.0022545431,"teacher_disagreement_score":0.0022550314,"about_ca_system_score_codex":0.0006579737,"about_ca_system_score_gemma":0.0009276024,"threshold_uncertainty_score":0.0069485903},"labels":[],"label_agreement":null},{"id":"W2043192919","doi":"10.1016/j.leukres.2014.09.005","title":"MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+/CD131− epitope expressed by leukemia stem cells","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; CSL Limited; University Health Network","keywords":"Radioimmunotherapy; Nod; Bone marrow; Cancer research; Leukemia; Spleen; Epitope; Monoclonal antibody; Medicine; Myeloid leukemia; Immunology; Pathology; Antigen; Antibody","score_opus":0.04371917395543981,"score_gpt":0.338180696160755,"score_spread":0.2944615222053152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043192919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679461,0.0022838896,0.020106776,0.0003686865,0.000038038932,0.00014367753,0.0017800967,0.00034038958,0.0069924253],"genre_scores_gemma":[0.9670889,0.0013480629,0.022100484,0.00017460251,0.000021372018,0.00011958031,0.0018531819,0.00010679652,0.0071871975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992776,0.000011308032,0.0000053022327,0.000015310712,0.000016483698,0.000023894763],"domain_scores_gemma":[0.9999329,0.000019599354,0.000012245619,0.0000057594248,0.000007814552,0.000021651576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029131758,0.0004051493,0.00020113646,0.0005388162,0.00016570128,0.0002151633,0.00022967657,0.00051765324,0.0025103241],"category_scores_gemma":[0.00008305911,0.00021612718,0.00022204894,0.0002357718,0.00026818478,0.00027426583,0.00018895035,0.0006653122,0.0003930467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034543488,0.00003861777,0.0002441901,0.000047348072,0.000007283248,0.00014603844,0.000025522477,0.00035941662,0.9969297,0.00023151757,0.00013502922,0.0014898491],"study_design_scores_gemma":[0.00009022106,0.00041750947,0.012061525,0.000011254022,0.00005562712,0.0017106781,0.000058227044,0.0072461166,0.9758872,0.00012408449,0.0023272166,0.000010436229],"about_ca_topic_score_codex":0.0035155467,"about_ca_topic_score_gemma":0.0024120237,"teacher_disagreement_score":0.0035155467,"about_ca_system_score_codex":0.00033563958,"about_ca_system_score_gemma":0.00035700793,"threshold_uncertainty_score":0.008397937},"labels":[],"label_agreement":null},{"id":"W2043263033","doi":"10.1016/j.leukres.2011.07.030","title":"Analysis of chromosome 12p deletion in plasma cell dyscrasias","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Plasma cell leukemia; Plasma cell; Immunofluorescence; Biology; Pathology; Monoclonal; Molecular biology; Medicine; Internal medicine; Monoclonal antibody; Antibody; Immunology","score_opus":0.11919883259301393,"score_gpt":0.3748475671737794,"score_spread":0.2556487345807654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043263033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140984,0.00072278176,0.002840905,0.00020613705,0.000028038336,0.00007280064,0.0012787974,0.00008856176,0.003352169],"genre_scores_gemma":[0.99530315,0.00027931962,0.0019630375,0.00006894117,0.000014071719,0.00004059078,0.00089362334,0.000027277412,0.001410028],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995191,0.000091079295,0.000060416398,0.00013447778,0.00011246878,0.00008247474],"domain_scores_gemma":[0.9994469,0.0002827406,0.00009246703,0.00004202199,0.0000650634,0.000070760354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002848681,0.0005442265,0.0004921927,0.0032349913,0.0005637159,0.00042192568,0.0006700759,0.0008039752,0.006241679],"category_scores_gemma":[0.0010165297,0.00028166297,0.0005053995,0.0011505055,0.00044973538,0.00019947601,0.0006099775,0.000603186,0.00090979383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032382705,0.00021617323,0.047422037,0.00017560301,0.0001993231,0.02015136,0.0003875183,0.0007423698,0.901697,0.00085578766,0.0005567184,0.024357857],"study_design_scores_gemma":[0.00035646,0.0015273452,0.38031423,0.000060389262,0.0007662865,0.0855307,0.0007600992,0.0037438055,0.5120022,0.00088949257,0.013990146,0.00005883904],"about_ca_topic_score_codex":0.0025466646,"about_ca_topic_score_gemma":0.002093373,"teacher_disagreement_score":0.006241679,"about_ca_system_score_codex":0.00030468998,"about_ca_system_score_gemma":0.00023489425,"threshold_uncertainty_score":0.02088052},"labels":[],"label_agreement":null},{"id":"W2046150302","doi":"10.1016/j.leukres.2005.08.016","title":"Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Cyclin D1; Mantle cell lymphoma; Cyclin; Cell culture; Chromosomal translocation; Biology; Molecular biology; Messenger RNA; Lymphoma; Cell; Cell cycle; Gene; Genetics; Immunology","score_opus":0.051532910390858944,"score_gpt":0.3407128781114639,"score_spread":0.28917996772060495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046150302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920913,0.00046569225,0.0031130824,0.00018733324,0.00006376459,0.00017594,0.0014307122,0.00007739998,0.0023947973],"genre_scores_gemma":[0.9910458,0.00043458212,0.003734612,0.000114425144,0.00001658856,0.00010749289,0.003227725,0.000040450817,0.0012784132],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99930775,0.00019092782,0.00012683662,0.00008936267,0.00013591917,0.00014920613],"domain_scores_gemma":[0.99906904,0.0004392048,0.000046005818,0.0002208256,0.00012600997,0.000099035475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046301738,0.0003749568,0.0004967426,0.0009861303,0.0006710079,0.00089552137,0.00096986745,0.0007426745,0.0027529513],"category_scores_gemma":[0.0012858724,0.00025048916,0.00046053567,0.00084802666,0.0004911454,0.00031052137,0.0006136798,0.0007786608,0.000580003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021604924,0.0004912894,0.019748632,0.00015180674,0.00015712304,0.0039570937,0.00088101526,0.0011296569,0.9577082,0.0018970867,0.0012763797,0.010441269],"study_design_scores_gemma":[0.00080872915,0.003404932,0.17590638,0.00006843761,0.0006477717,0.038386766,0.003146784,0.009358537,0.7383623,0.0013045999,0.028473547,0.00013126175],"about_ca_topic_score_codex":0.0032339122,"about_ca_topic_score_gemma":0.0032451937,"teacher_disagreement_score":0.0032339122,"about_ca_system_score_codex":0.0005417536,"about_ca_system_score_gemma":0.00021145266,"threshold_uncertainty_score":0.009209573},"labels":[],"label_agreement":null},{"id":"W2046610014","doi":"10.1016/j.leukres.2012.01.023","title":"RBC-transfusion guidelines update","year":2012,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Myelofibrosis; Medicine; Randomized controlled trial; Erythropoiesis; Thalidomide; Disease; Clinical trial; Anemia; Intensive care medicine; Ruxolitinib; Pediatrics; Internal medicine; Bone marrow; Multiple myeloma","score_opus":0.19294292271923746,"score_gpt":0.4371403201345239,"score_spread":0.24419739741528645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046610014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046873884,0.028246088,0.000570433,0.85721505,0.058087002,0.00010133128,0.0008225238,0.00016575647,0.05432308],"genre_scores_gemma":[0.003428573,0.031846344,0.0025899387,0.8104262,0.077853896,0.00035066024,0.0020251244,0.00012165808,0.07135763],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940263,0.0017522277,0.0010731878,0.00030526987,0.0022097367,0.0006332313],"domain_scores_gemma":[0.9853601,0.0046686702,0.0019262969,0.00032200367,0.0056148428,0.0021080445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046214084,0.0009876277,0.0018644452,0.002800437,0.0023859923,0.0048242267,0.002353355,0.023541734,0.020453043],"category_scores_gemma":[0.021780241,0.0008107863,0.00193454,0.002504485,0.0010901645,0.0022862193,0.0024177353,0.016967675,0.016586535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013120445,0.000019480749,0.00011551152,0.00007418423,0.0000059627723,0.00015657335,0.000016779608,0.0000319485,0.000031259202,0.00067527767,0.98484856,0.014011368],"study_design_scores_gemma":[0.000034053355,0.000011840415,0.000656031,0.000729947,0.000022833578,0.00042325878,0.00003853521,0.00008608825,0.000046633922,0.0010372715,0.99690104,0.00001253947],"about_ca_topic_score_codex":0.012409255,"about_ca_topic_score_gemma":0.040497232,"teacher_disagreement_score":0.023541734,"about_ca_system_score_codex":0.006151922,"about_ca_system_score_gemma":0.010267022,"threshold_uncertainty_score":0.0684222},"labels":[],"label_agreement":null},{"id":"W2047332763","doi":"10.1016/j.leukres.2009.03.002","title":"Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Reductive amination; Chemistry; Alkylation; Sodium cyanoborohydride; Iminosugar; Piperidine; Myeloid leukemia; Stereochemistry; Intramolecular force; Docking (animal); Combinatorial chemistry; Enzyme; Medicinal chemistry; Biochemistry; Cancer research; Medicine; Catalysis","score_opus":0.07239733739088638,"score_gpt":0.4088779336070712,"score_spread":0.3364805962161848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047332763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799466,0.00088467804,0.00016092158,0.00012217216,0.000011955866,0.000007957642,0.00014278416,0.00001565545,0.00065920927],"genre_scores_gemma":[0.9994043,0.000099434634,0.00010705295,0.00004342532,0.000015002482,0.0000056772897,0.00017468524,0.0000022376719,0.00014803669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939823,0.00027560073,0.00008078443,0.00007138753,0.000111241105,0.0000627405],"domain_scores_gemma":[0.9950128,0.0029361695,0.001268312,0.00015792702,0.000227674,0.00039708035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011165427,0.00016143432,0.0004317928,0.00044087306,0.00017555982,0.00046550072,0.00019934044,0.0004866767,0.0012719374],"category_scores_gemma":[0.0060530882,0.00015307966,0.00019735958,0.00050940114,0.00030161912,0.00035767542,0.00023476106,0.0008273973,0.00028449378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013463948,0.00022488864,0.9537928,0.000046796966,0.0001817106,0.0001953259,0.00006410609,0.0010904555,0.008334339,0.000105631014,0.0005108148,0.021989034],"study_design_scores_gemma":[0.00013809984,0.0021120543,0.99220806,0.000007164221,0.00008566967,0.0006738165,0.000049403385,0.0023918436,0.0016068802,0.00011871119,0.00059885345,0.000009458341],"about_ca_topic_score_codex":0.00045523586,"about_ca_topic_score_gemma":0.00055671437,"teacher_disagreement_score":0.0012719374,"about_ca_system_score_codex":0.00032456114,"about_ca_system_score_gemma":0.00022872901,"threshold_uncertainty_score":0.005904913},"labels":[],"label_agreement":null},{"id":"W2048159897","doi":"10.1016/j.leukres.2009.07.006","title":"Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Karyotype; International Prognostic Scoring System; Cytogenetics; Myelodysplastic syndromes; Medicine; Internal medicine; Biology; Chromosome; Genetics; Bone marrow","score_opus":0.12957703736855045,"score_gpt":0.47788043306124756,"score_spread":0.3483033956926971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048159897","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7358596,0.0073361164,0.15142882,0.028161801,0.00237391,0.017020313,0.008575202,0.0018749442,0.047369324],"genre_scores_gemma":[0.7356156,0.0036102512,0.22812809,0.005377435,0.00045499046,0.00982689,0.013691957,0.00047302837,0.002821749],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9808667,0.0087421425,0.006279204,0.0008146378,0.0026875562,0.0006097798],"domain_scores_gemma":[0.929835,0.014492256,0.0067418325,0.010073905,0.037212856,0.0016441355],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.040242605,0.0005875802,0.0014225744,0.0029848632,0.001280218,0.0021819677,0.0015995251,0.0009823565,0.00212786],"category_scores_gemma":[0.049791187,0.0003178977,0.00096375996,0.0034701626,0.00100388,0.002367146,0.001733481,0.0011468945,0.0007686459],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044231318,0.0009688439,0.6489941,0.00047559204,0.00017846338,0.00025466317,0.0015016169,0.0017978534,0.0041567986,0.0026655039,0.0206805,0.31788376],"study_design_scores_gemma":[0.00042709775,0.0013565536,0.9114614,0.0014280576,0.0003370259,0.001135758,0.009304533,0.005536291,0.008805084,0.0041150576,0.05588627,0.00020674737],"about_ca_topic_score_codex":0.009873542,"about_ca_topic_score_gemma":0.012991971,"teacher_disagreement_score":0.9597574,"about_ca_system_score_codex":0.0016699289,"about_ca_system_score_gemma":0.010362272,"threshold_uncertainty_score":0.21282572},"labels":[],"label_agreement":null},{"id":"W2049295282","doi":"10.1016/j.leukres.2010.07.021","title":"Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"NPM1; Internal medicine; Myeloid leukemia; Oncology; Medicine; Karyotype; Leukemia; Clinical significance; Gastroenterology; CD34; Stage (stratigraphy); Biology; Stem cell; Gene; Genetics; Chromosome","score_opus":0.03491698175438952,"score_gpt":0.34600353556413654,"score_spread":0.31108655380974704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049295282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989434,0.00031264333,0.00008324566,0.000101810365,0.000016471791,0.0000027111344,0.00012873106,0.000005991447,0.00040509147],"genre_scores_gemma":[0.99954695,0.000063574334,0.000046508292,0.000012839974,0.000036317233,0.000002076587,0.0001687188,0.0000023432754,0.00012074002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972314,0.00007951869,0.00002944578,0.000037019712,0.00005311919,0.0000777555],"domain_scores_gemma":[0.99791247,0.000735242,0.0006053556,0.00010250591,0.00012566596,0.00051880704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045482244,0.00037354464,0.00042533322,0.00093918253,0.0003807554,0.00064630155,0.00046749736,0.00070479943,0.0017185899],"category_scores_gemma":[0.0036016414,0.00020042773,0.00027885498,0.0011777893,0.00054200203,0.00047103493,0.00034168197,0.0007019781,0.0003212901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013087114,0.000029725274,0.9933651,0.000006946683,0.000027109938,0.000839474,0.000031979464,0.000156154,0.001300643,0.00005824568,0.00019521557,0.0026806612],"study_design_scores_gemma":[0.00004224904,0.0002039844,0.9954965,0.000004412366,0.000071698945,0.0023936385,0.00013379396,0.0007493114,0.00036632115,0.00022610776,0.00030209884,0.000009933213],"about_ca_topic_score_codex":0.0015391815,"about_ca_topic_score_gemma":0.0017130467,"teacher_disagreement_score":0.0017185899,"about_ca_system_score_codex":0.0002941276,"about_ca_system_score_gemma":0.0004355959,"threshold_uncertainty_score":0.0057492256},"labels":[],"label_agreement":null},{"id":"W2050306927","doi":"10.1016/j.leukres.2006.10.023","title":"Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes","year":2006,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Celgene","keywords":"Myelodysplastic syndromes; Lenalidomide; Chromosomal Abnormality; Abnormality; Medicine; Cytogenetics; Disease; Chromosome abnormality; Oncology; Internal medicine; Karyotype; Chromosome; Bone marrow; Biology; Multiple myeloma; Genetics","score_opus":0.3313275746400015,"score_gpt":0.49310803610809817,"score_spread":0.16178046146809666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050306927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001374948,0.99934834,0.00006164649,0.00011952558,0.000055384964,0.0000034898942,0.0000073317087,0.0000024412323,0.0002643423],"genre_scores_gemma":[0.0009479153,0.9984289,0.00020842368,0.00015971986,0.00008917396,0.0000042677875,0.000021036358,8.110744e-7,0.00013965626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999516,0.00012231687,0.00009171189,0.00006486846,0.00018273664,0.000022259288],"domain_scores_gemma":[0.99872285,0.0007316926,0.0001973953,0.000025200756,0.0002760048,0.00004684027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013700501,0.00073070044,0.0026659642,0.0029478706,0.00020988389,0.0008812198,0.0014026867,0.0009835721,0.0018019893],"category_scores_gemma":[0.002151884,0.00026302657,0.0006892104,0.0030047714,0.0005053267,0.00080183253,0.00045098594,0.0011013389,0.0007420205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101528334,0.00004162441,0.0005742,0.0144022545,0.00016570592,0.0004953323,0.000044099394,0.00022670774,0.00089027267,0.0005966691,0.009708736,0.9727528],"study_design_scores_gemma":[0.00019094234,0.00045172306,0.0071626194,0.015474682,0.0015630707,0.009624946,0.00024984835,0.00023844656,0.0016467457,0.0016882772,0.9616507,0.000058084366],"about_ca_topic_score_codex":0.0016150714,"about_ca_topic_score_gemma":0.00342576,"teacher_disagreement_score":0.0029478706,"about_ca_system_score_codex":0.0006496381,"about_ca_system_score_gemma":0.0013279149,"threshold_uncertainty_score":0.00724566},"labels":[],"label_agreement":null},{"id":"W2051711544","doi":"10.1016/j.leukres.2007.03.002","title":"Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chronic myelogenous leukemia; Biology; Tyrosine kinase; ABL; Nilotinib; Cancer research; Imatinib mesylate; Molecular biology; Signal transduction; breakpoint cluster region; Kinase; Gene; Leukemia; Imatinib; Immunology; Cell biology; Genetics; Myeloid leukemia","score_opus":0.051629105179668136,"score_gpt":0.36487851310431596,"score_spread":0.31324940792464784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051711544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98067653,0.0012424547,0.007821479,0.00019336933,0.000078992474,0.00008508019,0.0058777295,0.00017118653,0.0038531318],"genre_scores_gemma":[0.9505159,0.0020532883,0.020277288,0.0003145433,0.00004974728,0.00039376575,0.014813207,0.00009119026,0.01149098],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997534,0.000020802307,0.000018604844,0.000073677395,0.00007480561,0.000058616173],"domain_scores_gemma":[0.9998772,0.000043636923,0.000017767497,0.00001749284,0.000030891377,0.000013024591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001427639,0.00027154657,0.00045756667,0.00050569826,0.0003606944,0.00038098946,0.00019897622,0.000315393,0.0019273398],"category_scores_gemma":[0.00014430251,0.00019545578,0.0002914423,0.0006171297,0.00021411812,0.00016218756,0.00013099906,0.00043314815,0.0004668087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000617703,0.000014839581,0.00016412837,0.000008512184,0.000003820319,0.000010008477,0.000011998941,0.000024443176,0.99912804,0.000026107566,0.00003836634,0.0005079657],"study_design_scores_gemma":[0.000024415092,0.00032962926,0.033787344,0.000004122963,0.000049819042,0.00020507509,0.00009566693,0.0013345777,0.95993763,0.000049731225,0.0041728215,0.000009221205],"about_ca_topic_score_codex":0.0023960366,"about_ca_topic_score_gemma":0.004607912,"teacher_disagreement_score":0.0023960366,"about_ca_system_score_codex":0.0002841842,"about_ca_system_score_gemma":0.00025568274,"threshold_uncertainty_score":0.0064476132},"labels":[],"label_agreement":null},{"id":"W2053491031","doi":"10.1016/j.leukres.2008.12.008","title":"Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Perception; Intensive care medicine; Internal medicine; Pediatrics; Family medicine; Psychology","score_opus":0.11091300153310268,"score_gpt":0.4241619655654159,"score_spread":0.3132489640323132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053491031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967771,0.00029966698,0.000019065448,0.00085866346,0.0000099463605,0.000024996945,0.00033888218,0.0000024957678,0.0016690858],"genre_scores_gemma":[0.99799144,0.0004527848,0.000087042026,0.0007682677,0.000024959894,0.00002295557,0.00021462722,0.0000012883165,0.00043662483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949205,0.00015148618,0.000101612655,0.000042512565,0.00007443825,0.00013780023],"domain_scores_gemma":[0.9968436,0.0013059484,0.0009507942,0.00003117519,0.0002540499,0.00061450445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052888226,0.00013585252,0.00037867596,0.0006517025,0.00090787705,0.0006879351,0.00013289422,0.0006526784,0.0034513103],"category_scores_gemma":[0.0064792633,0.00014123926,0.0003497284,0.0007557282,0.00017795389,0.0008889997,0.00059705507,0.00063715904,0.0002742305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026965165,0.0005011991,0.9667808,0.00016405155,0.0000530972,0.001165803,0.00977029,0.00010612662,0.0002751219,0.000115193645,0.0025010975,0.018297574],"study_design_scores_gemma":[0.00006189876,0.00093935354,0.95921,0.00013440035,0.00011789822,0.0025149183,0.032190032,0.00042587108,0.0001334136,0.00015925757,0.004084837,0.000028221511],"about_ca_topic_score_codex":0.010680771,"about_ca_topic_score_gemma":0.013966773,"teacher_disagreement_score":0.010680771,"about_ca_system_score_codex":0.00053932564,"about_ca_system_score_gemma":0.0007580547,"threshold_uncertainty_score":0.021237195},"labels":[],"label_agreement":null},{"id":"W2054701803","doi":"10.1016/j.leukres.2010.08.003","title":"Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Biology; Copy-number variation; Myelodysplastic syndromes; Genetics; Somatic cell; clone (Java method); Genome; Gene; Immunology","score_opus":0.03185149492784102,"score_gpt":0.3371596112225978,"score_spread":0.3053081162947568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054701803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867356,0.00019683741,0.00018316618,0.000060366263,0.000005846372,0.0000046481723,0.00012444002,0.00000948721,0.000741723],"genre_scores_gemma":[0.9995498,0.000047690777,0.00013397077,0.000018855566,0.000011493433,0.0000025065797,0.00007622636,0.0000024489118,0.00015699964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970967,0.000052311512,0.00004237079,0.000052841347,0.000094388284,0.000048332924],"domain_scores_gemma":[0.99914026,0.00035215492,0.00032995766,0.000041655756,0.00006275961,0.00007316267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019639543,0.0002706316,0.00023130412,0.0011224722,0.00024081088,0.00044825516,0.0003099742,0.00043259087,0.0025409781],"category_scores_gemma":[0.0019428171,0.0001511647,0.00017297914,0.0008246063,0.00028587284,0.0003044362,0.0002268017,0.0003746302,0.00027935285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014117691,0.000106896005,0.8999025,0.00004941702,0.00010919329,0.008318348,0.00018284656,0.0005142796,0.07024495,0.00041130825,0.00027252114,0.01847605],"study_design_scores_gemma":[0.000050115454,0.00035606977,0.9574126,0.000008730281,0.00012910437,0.028760063,0.00015561144,0.00137406,0.01062511,0.00048796722,0.00062975474,0.000010828587],"about_ca_topic_score_codex":0.00041288292,"about_ca_topic_score_gemma":0.0006095245,"teacher_disagreement_score":0.0025409781,"about_ca_system_score_codex":0.00018679466,"about_ca_system_score_gemma":0.00013481601,"threshold_uncertainty_score":0.008500397},"labels":[],"label_agreement":null},{"id":"W2055730957","doi":"10.1016/j.leukres.2010.10.006","title":"Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Hox gene; Biology; Cancer research; Computational biology; Evolutionary biology; Genetics; Gene; Transcription factor","score_opus":0.031152478463214565,"score_gpt":0.35880705011389596,"score_spread":0.3276545716506814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055730957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363166,0.00047170446,0.0046106693,0.000055224493,0.000004266728,0.00000844465,0.000105096726,0.000024328167,0.0010887273],"genre_scores_gemma":[0.9963445,0.0001886887,0.0023369554,0.000014050297,0.0000029481148,0.000008754991,0.00025548867,0.00001268921,0.00083587214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999236,0.0000131551,0.000006865949,0.000015666079,0.000023080653,0.000017593886],"domain_scores_gemma":[0.9998367,0.00007144091,0.000027557218,0.000025804991,0.000009836123,0.000028573053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020824674,0.00018998806,0.0001133944,0.00023507552,0.00028227805,0.00037680092,0.00025864827,0.00028366558,0.0010805941],"category_scores_gemma":[0.00025089335,0.0001430105,0.00015553027,0.0001770447,0.0003071214,0.00034098656,0.00024168263,0.0004946688,0.00042307316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015201654,0.000011637857,0.00025983126,0.000008495791,0.0000013765033,0.00005911962,0.000018951494,0.0001586258,0.99758434,0.00050506,0.000016541802,0.0012239825],"study_design_scores_gemma":[0.000013799764,0.00004472531,0.0038854543,0.000002792923,0.0000049081686,0.0004415236,0.000039253016,0.0018243315,0.99093175,0.00023367905,0.0025745619,0.0000031489726],"about_ca_topic_score_codex":0.0003600339,"about_ca_topic_score_gemma":0.0004676083,"teacher_disagreement_score":0.0010805941,"about_ca_system_score_codex":0.00020727923,"about_ca_system_score_gemma":0.000118037206,"threshold_uncertainty_score":0.003614962},"labels":[],"label_agreement":null},{"id":"W2055946535","doi":"10.1016/j.leukres.2013.03.012","title":"CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavourable acute myeloid leukemia","year":2013,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Lipid droplet; Biosynthesis; Biochemistry; Biogenesis; Retinoic acid; Mitochondrion; Chemistry; Organelle; Retinol binding protein; Biology; Cell biology; Retinol; Enzyme; Gene","score_opus":0.04582927067193436,"score_gpt":0.31709003017872234,"score_spread":0.27126075950678796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055946535","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33382773,0.0074113817,0.0012211644,0.60472757,0.011203472,0.00008469117,0.0005389831,0.0001411997,0.04084381],"genre_scores_gemma":[0.8765497,0.0038029617,0.0012854877,0.085750565,0.022321394,0.000086441454,0.00032663724,0.00003736376,0.009839469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995395,0.00013146555,0.000062569794,0.000043954384,0.0000992832,0.00012325749],"domain_scores_gemma":[0.9987035,0.0006067551,0.00013008463,0.000071971845,0.00023724846,0.00025035883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004681888,0.0002930262,0.0005120946,0.00045445925,0.0007942788,0.0009669713,0.000408472,0.003754208,0.0021955715],"category_scores_gemma":[0.0051261117,0.00023824556,0.00021965703,0.0004374814,0.00068884634,0.0005893113,0.00037042878,0.0028475716,0.0013548027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001633259,0.00021652546,0.41161975,0.0001631861,0.000088520916,0.13945271,0.00043964424,0.00050250476,0.0065623065,0.0035139772,0.3418929,0.09391469],"study_design_scores_gemma":[0.0006181693,0.0008112558,0.32134345,0.00044542502,0.0002312459,0.42950997,0.002369813,0.006494201,0.0040668403,0.013984631,0.21998474,0.00014020104],"about_ca_topic_score_codex":0.0013300558,"about_ca_topic_score_gemma":0.0023616068,"teacher_disagreement_score":0.003754208,"about_ca_system_score_codex":0.0008609343,"about_ca_system_score_gemma":0.00048765418,"threshold_uncertainty_score":0.0073449016},"labels":[],"label_agreement":null},{"id":"W2056534555","doi":"10.1016/j.leukres.2010.06.031","title":"Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Foothills Medical Centre; University of Calgary","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; National Cancer Research Institute","keywords":"CD20; Chronic lymphocytic leukemia; Flow cytometry; Leukemia; Messenger RNA; Population; Molecular biology; B cell; Biology; Real-time polymerase chain reaction; Antibody; Cancer research; Immunology; Gene; Medicine; Biochemistry","score_opus":0.057326997000381054,"score_gpt":0.36791973138580897,"score_spread":0.3105927343854279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056534555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873104,0.0020604725,0.0056915428,0.00020331529,0.000056399902,0.000035166184,0.00079874415,0.00020879462,0.0036352095],"genre_scores_gemma":[0.98742896,0.00067476515,0.004609286,0.00012165566,0.000044531866,0.00008607448,0.0017366337,0.0000678824,0.0052302177],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996754,0.000039690072,0.000025715586,0.00007455144,0.000091557835,0.000093170725],"domain_scores_gemma":[0.9995053,0.00013011783,0.000071957606,0.000066415865,0.00012389921,0.00010231998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003102926,0.00036983847,0.0002240995,0.00089653,0.0004917247,0.00070541835,0.00022635752,0.00043028092,0.0037619988],"category_scores_gemma":[0.0004711254,0.00025954252,0.00024507908,0.00042372214,0.00052329164,0.00044841965,0.0002997792,0.0007329499,0.0010014976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012394172,0.000024547939,0.0016735818,0.000017075736,0.000004167261,0.000043582593,0.000024458974,0.000015040654,0.99662954,0.00014932115,0.00004880325,0.0012459252],"study_design_scores_gemma":[0.000028322253,0.00038914313,0.0798945,0.000011315291,0.000030827247,0.00080441084,0.00020910155,0.0008422037,0.91197395,0.00027941147,0.0055276616,0.0000090484955],"about_ca_topic_score_codex":0.0007703981,"about_ca_topic_score_gemma":0.0014524838,"teacher_disagreement_score":0.0037619988,"about_ca_system_score_codex":0.00044003184,"about_ca_system_score_gemma":0.0002621266,"threshold_uncertainty_score":0.012585163},"labels":[],"label_agreement":null},{"id":"W2058169114","doi":"10.1016/j.leukres.2013.08.021","title":"Income and outcome in myelodysplastic syndrome: The prognostic impact of SES in a single-payer system","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Quartile; Medicine; Internal medicine; Demography; Overall survival; Pediatrics; Confidence interval","score_opus":0.05507466281810802,"score_gpt":0.36357585916393176,"score_spread":0.30850119634582374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058169114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986015,0.00025959194,0.000060011374,0.0003854376,0.00001360211,0.0000024372125,0.00022380249,0.0000018047359,0.0004519368],"genre_scores_gemma":[0.99965966,0.00006473662,0.00001290957,0.000022369324,0.000016483067,0.000001186465,0.00014067657,0.0000010213814,0.00008103568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925524,0.00029856837,0.000053304273,0.00006871245,0.00007689135,0.00024739397],"domain_scores_gemma":[0.9965328,0.00061288563,0.0013244492,0.00018665609,0.00019300371,0.0011501386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012195198,0.00023249301,0.00033627136,0.0008903362,0.0005739847,0.001090897,0.00059375796,0.0004703563,0.0025850588],"category_scores_gemma":[0.005205828,0.000174733,0.0006692156,0.0013503555,0.00064700353,0.00086312334,0.0011452754,0.0010561383,0.00021991857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014535297,0.00003243591,0.99852127,0.0000024377955,0.00006252937,0.00010342339,0.00003802151,0.0001272252,0.0000305247,0.00010116459,0.00009623641,0.0007394999],"study_design_scores_gemma":[0.000010936611,0.00008113889,0.9980599,0.000007860251,0.000050800754,0.00014353718,0.00035531388,0.0008018148,0.00002390674,0.00034206602,0.00011701128,0.000005733881],"about_ca_topic_score_codex":0.013174585,"about_ca_topic_score_gemma":0.012872354,"teacher_disagreement_score":0.013174585,"about_ca_system_score_codex":0.0005204716,"about_ca_system_score_gemma":0.0006655523,"threshold_uncertainty_score":0.026195824},"labels":[],"label_agreement":null},{"id":"W2062483137","doi":"10.1016/j.leukres.2004.01.006","title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD34; Pathology; Chemotherapy; Myeloid; Internal medicine; Biology","score_opus":0.11430635881337432,"score_gpt":0.41852287938176536,"score_spread":0.30421652056839105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062483137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983569,0.00029605476,0.00011152289,0.000035970672,0.000005950948,0.000004489104,0.000059603568,0.0000057537322,0.0011237181],"genre_scores_gemma":[0.99935776,0.00008846322,0.000103118284,0.000018088253,0.000025131645,0.0000041985136,0.00011773412,0.0000027975252,0.0002826628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969006,0.00007066156,0.0000433155,0.000052021845,0.000058235255,0.000085728214],"domain_scores_gemma":[0.9980028,0.0004717282,0.000845024,0.00016933747,0.00011740441,0.0003936174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004475321,0.00027204462,0.0004692182,0.000780211,0.00040728803,0.00077955285,0.00030557578,0.00049813424,0.0032763334],"category_scores_gemma":[0.0020433753,0.00017716172,0.00017374482,0.0005885134,0.0003687819,0.00051451626,0.00052192796,0.00041409995,0.00047099544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017589187,0.00007701322,0.969118,0.000029507753,0.000059451857,0.005102805,0.00007833917,0.00011544901,0.014816244,0.00012469961,0.00012536437,0.0085941935],"study_design_scores_gemma":[0.000018836061,0.00019500307,0.97831047,0.000009330718,0.00006488945,0.018957395,0.00016566925,0.00019472766,0.0012575843,0.00022111562,0.0005973872,0.000007615379],"about_ca_topic_score_codex":0.00029654065,"about_ca_topic_score_gemma":0.0006445269,"teacher_disagreement_score":0.0032763334,"about_ca_system_score_codex":0.00020770043,"about_ca_system_score_gemma":0.00017234003,"threshold_uncertainty_score":0.01096046},"labels":[],"label_agreement":null},{"id":"W2062572127","doi":"10.1016/j.leukres.2015.01.013","title":"Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa; Atomic Energy (Canada); Ottawa Hospital","funders":"Canadian Institutes of Health Research; Canadian Nuclear Laboratories","keywords":"Mesenchymal stem cell; Haematopoiesis; CD34; Bone marrow; Myeloid leukemia; Progenitor cell; Cancer research; Stromal cell; Leukemia; Immunology; Medicine; Myeloid; Biology; Stem cell; Pathology; Cell biology","score_opus":0.07850938879730575,"score_gpt":0.3334496553550783,"score_spread":0.2549402665577726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062572127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983286,0.00026602752,0.00024340967,0.00004772577,0.000009993148,0.000009668147,0.0003455437,0.000015255484,0.00073374383],"genre_scores_gemma":[0.9985417,0.00009751769,0.00011808816,0.000040766296,0.000013085142,0.00000957124,0.0006642867,0.000006037306,0.00050885294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998611,0.000021497957,0.000021686537,0.00002241159,0.000043144257,0.00003015556],"domain_scores_gemma":[0.9997727,0.000065284905,0.00004227945,0.000020669364,0.00003729199,0.000061672195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114015675,0.0001822378,0.00026995823,0.00066539855,0.00019517049,0.0005282092,0.00015076222,0.00022084461,0.0039848867],"category_scores_gemma":[0.0006081359,0.00010666255,0.00013169694,0.0004619472,0.00019335028,0.00016694701,0.00024986733,0.00028833802,0.00084468984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003481715,0.00019658683,0.21243896,0.00011395609,0.000097353455,0.004838455,0.00071664713,0.0003340526,0.7480413,0.0006084786,0.00096123136,0.028171368],"study_design_scores_gemma":[0.00025591045,0.0019031094,0.80025744,0.00002067192,0.00022597137,0.03499672,0.0013887488,0.0014931901,0.14672922,0.00063715456,0.012062743,0.000029178867],"about_ca_topic_score_codex":0.000485209,"about_ca_topic_score_gemma":0.00031916707,"teacher_disagreement_score":0.0039848867,"about_ca_system_score_codex":0.00010562882,"about_ca_system_score_gemma":0.00011065738,"threshold_uncertainty_score":0.013330817},"labels":[],"label_agreement":null},{"id":"W2062857204","doi":"10.1016/j.leukres.2015.04.016","title":"Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Canada Research Chairs; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Chronic lymphocytic leukemia; Stromal cell; Cancer research; Biology; Ectopic expression; Leukemia; Immunology; Signal transduction; Cell biology; Cell culture","score_opus":0.07459560821292835,"score_gpt":0.3570972380758317,"score_spread":0.2825016298629034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062857204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970215,0.00082874374,0.0003162875,0.000021689224,0.000006581118,0.000005754212,0.00015114158,0.000016047201,0.0016321874],"genre_scores_gemma":[0.9980586,0.0003231354,0.00015372522,0.000016146434,0.0000056673152,0.000009857466,0.00028037888,0.0000069278913,0.0011454086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997594,0.000023353517,0.000012238217,0.00003063591,0.00003731419,0.00013699928],"domain_scores_gemma":[0.99988985,0.00002323544,0.000012839565,0.000016818321,0.000021352482,0.00003584612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001099297,0.00018120649,0.00016745782,0.00065548456,0.0003793381,0.0007963732,0.00022403988,0.00025324232,0.002296373],"category_scores_gemma":[0.00018272309,0.00013654772,0.00023528092,0.00046400752,0.00024454552,0.00037161884,0.0004377217,0.00045513603,0.00061963167],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000561444,0.00003855338,0.004096678,0.000032980915,0.000013686158,0.0001482128,0.00010962786,0.00006423275,0.99190265,0.00049511046,0.00008059612,0.0024561964],"study_design_scores_gemma":[0.00012652001,0.0008262527,0.18496536,0.000028490347,0.00014354546,0.0030272857,0.0020201951,0.0023884713,0.79366845,0.00058808917,0.012186276,0.000031152103],"about_ca_topic_score_codex":0.0012054616,"about_ca_topic_score_gemma":0.0010673479,"teacher_disagreement_score":0.002296373,"about_ca_system_score_codex":0.00048351224,"about_ca_system_score_gemma":0.00023226722,"threshold_uncertainty_score":0.007682085},"labels":[],"label_agreement":null},{"id":"W2065022509","doi":"10.1016/s0145-2126(03)00106-1","title":"Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"CD86; CD80; Immune system; Cytokine; Immunology; T cell; Hematopoietic stem cell transplantation; Biology; Priming (agriculture); B cell; Stem cell; Cancer research; CD40; Antibody; Cell biology; Cytotoxic T cell; In vitro; Genetics","score_opus":0.040129378897188005,"score_gpt":0.30625840562663126,"score_spread":0.2661290267294433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065022509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982027,0.00062112726,0.00017416615,0.000024940144,0.00001916452,0.000016622052,0.00026056648,0.000028820508,0.0006519821],"genre_scores_gemma":[0.99872595,0.00019666499,0.00014115903,0.000027426926,0.000015403992,0.000021492358,0.00039662438,0.0000071156146,0.00046810159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964094,0.000077073026,0.00003565648,0.000043771513,0.00006059347,0.00014199199],"domain_scores_gemma":[0.9998424,0.000038120394,0.000028897544,0.000030317857,0.00001934639,0.000041021234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017267937,0.0003106484,0.00047097765,0.0004627674,0.00016887016,0.00048565434,0.00019333647,0.00027624902,0.0021280483],"category_scores_gemma":[0.0002504118,0.0001266637,0.00025643123,0.00039376642,0.00023696353,0.00021539337,0.0002150394,0.0007961615,0.0006225404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015279405,0.00007152102,0.0019373662,0.000044778953,0.00001225207,0.00024559637,0.000066775894,0.000056633442,0.9935586,0.00008322545,0.00007354686,0.0023219166],"study_design_scores_gemma":[0.00018401835,0.004250929,0.1501233,0.000023990116,0.00013973036,0.0028186066,0.0006131843,0.0009222195,0.8359269,0.000291576,0.0046835802,0.000021966878],"about_ca_topic_score_codex":0.000274052,"about_ca_topic_score_gemma":0.000353687,"teacher_disagreement_score":0.0021280483,"about_ca_system_score_codex":0.000235902,"about_ca_system_score_gemma":0.000114451286,"threshold_uncertainty_score":0.007119},"labels":[],"label_agreement":null},{"id":"W2065183816","doi":"10.1016/j.leukres.2012.06.011","title":"FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Leukemia and Lymphoma Research; Leukemia and Lymphoma Society","keywords":"Medicine; Chemotherapy; Myeloid leukemia; Induction chemotherapy; Gene knockdown; Bone marrow; Internal medicine; Oncology; Small hairpin RNA; Leukemia; Myeloid; Puma; Cytarabine; Cancer research; Clinical significance; Immunology; Gastroenterology; Biology; Apoptosis","score_opus":0.03905140989411161,"score_gpt":0.36528964764357685,"score_spread":0.32623823774946525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065183816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848396,0.00038342836,0.000039202074,0.00016487761,0.000015169658,0.000004851659,0.00024131723,0.0000031586428,0.0006640631],"genre_scores_gemma":[0.99877256,0.000115671275,0.00005677346,0.00008894014,0.000029308207,0.000005286968,0.0005575533,0.0000014839784,0.00037246762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978584,0.000057186953,0.0000222929,0.00003850336,0.000041163512,0.00005511319],"domain_scores_gemma":[0.99941826,0.00017208308,0.0002038039,0.00003240748,0.000049060654,0.00012434852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031423147,0.00023563471,0.00032600688,0.00043440933,0.00030323665,0.00055039045,0.00027216732,0.00050767843,0.0017996082],"category_scores_gemma":[0.0015380929,0.00011842041,0.000300058,0.0005308768,0.00022453666,0.00027505244,0.0002598924,0.0005249655,0.00022835594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008097874,0.000060016297,0.99377716,0.000008553532,0.00005590907,0.000076133925,0.000020262116,0.00013883284,0.0009282196,0.000035036886,0.000393262,0.0036967036],"study_design_scores_gemma":[0.00005383393,0.00020745279,0.9963108,0.0000088630895,0.00009079975,0.00044616233,0.00011268089,0.00090842246,0.0007618833,0.000100918885,0.0009929087,0.0000052639975],"about_ca_topic_score_codex":0.0018250907,"about_ca_topic_score_gemma":0.0024820121,"teacher_disagreement_score":0.0018250907,"about_ca_system_score_codex":0.0004355967,"about_ca_system_score_gemma":0.00019385183,"threshold_uncertainty_score":0.0060203075},"labels":[],"label_agreement":null},{"id":"W2066443904","doi":"10.1016/j.leukres.2009.02.010","title":"Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: A retrospective study of 322 bone marrows","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Internal medicine; Anemia; Pediatrics; Bone marrow","score_opus":0.027599261148578996,"score_gpt":0.32929654646346235,"score_spread":0.3016972853148834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066443904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996234,0.00011107205,0.00003592187,0.00000603138,8.589484e-7,0.000005971947,0.00008519707,0.0000012276475,0.00013037122],"genre_scores_gemma":[0.9996044,0.00010211508,0.00005095658,0.0000148029985,0.0000038028593,0.000008490277,0.00015723702,0.0000013170975,0.00005695008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991967,0.0002349112,0.0001324041,0.00017890507,0.00015683987,0.00010015892],"domain_scores_gemma":[0.9976578,0.0007016402,0.0008606109,0.00027053172,0.00027055157,0.00023884588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009623083,0.00041447332,0.0004648035,0.0013989733,0.0006456108,0.00082300726,0.0005086763,0.0007564429,0.00097653875],"category_scores_gemma":[0.00410571,0.00070957944,0.0003640224,0.0011190077,0.00058476557,0.00077493745,0.00062029815,0.00054377434,0.00036268219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035190402,0.00001302046,0.99944955,0.0000022797756,0.000007946687,0.00007786154,0.000060457893,0.00000918006,0.00016574842,0.0000039033375,0.000007926116,0.00016698166],"study_design_scores_gemma":[0.0000046980535,0.00018089394,0.9981219,0.0000035578926,0.000020455756,0.0009783586,0.00037546884,0.00008226816,0.00010742446,0.0000071421814,0.00011409708,0.000003667788],"about_ca_topic_score_codex":0.003538456,"about_ca_topic_score_gemma":0.0027042313,"teacher_disagreement_score":0.003538456,"about_ca_system_score_codex":0.00031180322,"about_ca_system_score_gemma":0.00030153777,"threshold_uncertainty_score":0.0070357323},"labels":[],"label_agreement":null},{"id":"W2068835878","doi":"10.1016/j.leukres.2006.09.010","title":"Nucleoside transporter expression and activity is regulated during granulocytic differentiation of NB4 cells in response to all-trans-retinoic acid","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Guanosine; Retinoic acid; Intracellular; Nucleoside transporter; Nucleoside; Transporter; Cell biology; Cellular differentiation; Biochemistry; Chemistry; Biology; Gene","score_opus":0.013672177237651472,"score_gpt":0.28047803128854365,"score_spread":0.2668058540508922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068835878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943374,0.0012901243,0.00094513973,0.00013294704,0.000018418454,0.000011678221,0.00089992036,0.00004721626,0.002317269],"genre_scores_gemma":[0.9912101,0.00051165593,0.0009348949,0.000064680535,0.000010142906,0.000030209845,0.00147851,0.000034872675,0.0057249162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997545,0.000038867754,0.000025672825,0.0000452522,0.00005018195,0.000085643194],"domain_scores_gemma":[0.999772,0.000050097187,0.000041047067,0.000025833235,0.00004818287,0.00006294337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014673332,0.00019529613,0.00060660363,0.0004293785,0.00035551251,0.0009303307,0.0002933544,0.00036569877,0.0015168649],"category_scores_gemma":[0.00027343395,0.000292189,0.00034688713,0.00043898114,0.00046437173,0.00051915366,0.00030124496,0.0006091787,0.0006269556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007471077,0.000014596771,0.00058041984,0.0000139725325,0.0000055737705,0.00006205559,0.00005239812,0.00003161152,0.9978034,0.0001936603,0.000027795173,0.0004673286],"study_design_scores_gemma":[0.000048094782,0.00018150124,0.054261323,0.000011749323,0.000039852966,0.00023812856,0.00031646198,0.0015852038,0.93915534,0.00020771171,0.0039355704,0.000019000976],"about_ca_topic_score_codex":0.005395875,"about_ca_topic_score_gemma":0.0061450074,"teacher_disagreement_score":0.005395875,"about_ca_system_score_codex":0.00084548345,"about_ca_system_score_gemma":0.00046220643,"threshold_uncertainty_score":0.010728955},"labels":[],"label_agreement":null},{"id":"W2069327083","doi":"10.1016/j.leukres.2013.04.014","title":"Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Ectodomain; Disintegrin; Transfection; Molecular biology; Biology; ADAM10; Metalloproteinase; Cell culture; Glycoprotein; Cell biology; Enzyme; Receptor; Genetics; Biochemistry","score_opus":0.033153868947830935,"score_gpt":0.3298452281077127,"score_spread":0.29669135915988176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069327083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682236,0.0008452416,0.00067978073,0.00013587988,0.00001753527,0.0000072476687,0.0001358287,0.000032966607,0.0013230721],"genre_scores_gemma":[0.99641967,0.00036260122,0.00044793083,0.00003153876,0.000011643242,0.000011038423,0.00036395894,0.000015761541,0.0023358962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974614,0.00004473763,0.000017251696,0.000034376826,0.00005336689,0.000104026454],"domain_scores_gemma":[0.99982196,0.000027993228,0.000040041854,0.000018220475,0.000028567185,0.000063147636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014579111,0.00018983812,0.0002361162,0.00024553188,0.00029245074,0.00065599295,0.00015634287,0.00024297833,0.0026674364],"category_scores_gemma":[0.00026165516,0.00014974513,0.0002879468,0.00009778633,0.000252186,0.0003548916,0.0003984707,0.0007309341,0.00091002486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041106174,0.000037506652,0.0011268507,0.000021880523,0.0000070674555,0.00026754753,0.00004690411,0.000057373494,0.99605787,0.00018758926,0.0001978873,0.0015803244],"study_design_scores_gemma":[0.00007989625,0.00029791804,0.08445894,0.000014481663,0.000027925558,0.0020859514,0.0004480468,0.0029373933,0.9037819,0.00039945648,0.005450577,0.000017541306],"about_ca_topic_score_codex":0.00058777013,"about_ca_topic_score_gemma":0.000828093,"teacher_disagreement_score":0.0026674364,"about_ca_system_score_codex":0.00048654285,"about_ca_system_score_gemma":0.00023516653,"threshold_uncertainty_score":0.008923411},"labels":[],"label_agreement":null},{"id":"W2069409895","doi":"10.1016/j.leukres.2005.01.002","title":"Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation—a case study","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Transplantation; Immunology; Immune system; Leukemia; Lymphoblastic Leukemia; Bone marrow; Acute lymphocytic leukemia; Co-stimulation; T cell; Internal medicine; CD28","score_opus":0.036769347658729606,"score_gpt":0.3442511086549102,"score_spread":0.30748176099618063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069409895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878098,0.0019531462,0.0011051368,0.000703012,0.000048471196,0.000091042166,0.00006286677,0.00004170011,0.0081847245],"genre_scores_gemma":[0.99736387,0.0011121324,0.00046709777,0.00016645214,0.00016308001,0.000019063358,0.00004782866,0.000011950815,0.00064842403],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994622,0.000119937155,0.000040287057,0.00006303468,0.00007247902,0.00024210647],"domain_scores_gemma":[0.9990445,0.00036207752,0.00023400816,0.00010211882,0.00005218545,0.00020508892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059580815,0.0012924678,0.0010732332,0.0016069586,0.0027970022,0.0012977151,0.0011420338,0.0032097676,0.002084339],"category_scores_gemma":[0.002557936,0.0006552188,0.0008800409,0.0011445682,0.0019460485,0.0011674183,0.001176511,0.0021887023,0.0005795548],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070367256,0.000059811395,0.010972197,0.000021421358,0.000006678036,0.9863708,0.00019293457,0.00006783126,0.00035795677,0.0004372848,0.00007389688,0.0013688295],"study_design_scores_gemma":[0.000011334921,0.0000911343,0.0042307726,0.000005288721,0.000015845559,0.9944239,0.00022676891,0.00015258136,0.00034473458,0.00014951805,0.00034415856,0.000003926969],"about_ca_topic_score_codex":0.0019455336,"about_ca_topic_score_gemma":0.0014725549,"teacher_disagreement_score":0.0032097676,"about_ca_system_score_codex":0.0013585661,"about_ca_system_score_gemma":0.00084815675,"threshold_uncertainty_score":0.009857178},"labels":[],"label_agreement":null},{"id":"W2072432392","doi":"10.1016/j.leukres.2004.11.011","title":"Cytokinetics and mechanism of action of AKO4: a novel nitrogen mustard targeted to bcr-abl","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Chlorambucil; Nitrogen mustard; breakpoint cluster region; ABL; K562 cells; Cancer research; Apoptosis; Philadelphia chromosome; Biology; Tyrosine kinase; DNA damage; Flow cytometry; Chemistry; Molecular biology; Cell biology; DNA; Biochemistry; Receptor; Signal transduction; Chemotherapy; Chromosomal translocation; Genetics","score_opus":0.08074433413515884,"score_gpt":0.37642908915909085,"score_spread":0.295684755023932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072432392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98461807,0.0078117317,0.0024324053,0.00050659454,0.00014102252,0.00013685574,0.00013957029,0.00009245783,0.0041214195],"genre_scores_gemma":[0.99210984,0.0030275518,0.0013629104,0.00011105973,0.000036284793,0.000045088902,0.00016706674,0.0000085247475,0.00313178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999238,0.000013449496,0.000004508769,0.000010735162,0.000016486323,0.000030970812],"domain_scores_gemma":[0.99997103,0.0000059729355,0.000008205443,0.0000026961154,0.000003503751,0.000008618573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020638155,0.0002861619,0.0003155822,0.00021247166,0.00022787896,0.00029844916,0.00036273096,0.0003963418,0.0013782025],"category_scores_gemma":[0.00010682785,0.00010624392,0.00025480907,0.00011474787,0.00029744502,0.0003003631,0.0001983863,0.0005369797,0.00019971428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017363462,0.0002322997,0.00046930395,0.00012491681,0.000024115378,0.00028875913,0.000035240384,0.000622031,0.981025,0.001537422,0.00029145245,0.013613291],"study_design_scores_gemma":[0.00041600288,0.0021801577,0.0017680434,0.000010244264,0.000046593264,0.00066624413,0.000043144897,0.0013279087,0.9853821,0.00042423955,0.0077245245,0.000010814033],"about_ca_topic_score_codex":0.00055683806,"about_ca_topic_score_gemma":0.0007201909,"teacher_disagreement_score":0.0013782025,"about_ca_system_score_codex":0.00039580322,"about_ca_system_score_gemma":0.00034290864,"threshold_uncertainty_score":0.0046105385},"labels":[],"label_agreement":null},{"id":"W2072804684","doi":"10.1016/j.leukres.2013.10.021","title":"The role of hematopoietic cell transplantation in adult ALL: Clinical equipoise persists","year":2013,"lang":"es","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Manitoba Health; University of Manitoba","funders":"","keywords":"Medicine; Transplantation; Hematopoietic cell; Clinical equipoise; Hematopoietic stem cell transplantation; Sibling; Clinical trial; Blinatumomab; Induction chemotherapy; Chemotherapy; Oncology; Internal medicine; Intensive care medicine; Surgery; Leukemia; Haematopoiesis; Stem cell; Lymphoblastic Leukemia; Psychology","score_opus":0.03696496635478481,"score_gpt":0.3732737135994941,"score_spread":0.33630874724470927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072804684","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021025417,0.70696604,0.0032065432,0.24400319,0.004875635,0.00004637404,0.00026798545,0.000060046586,0.019548757],"genre_scores_gemma":[0.37265512,0.5154092,0.00489683,0.05763673,0.043942373,0.00008505604,0.00034726155,0.00010320364,0.004924284],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956239,0.002515987,0.00046430604,0.00038420438,0.0007149388,0.00029671408],"domain_scores_gemma":[0.9594485,0.028646514,0.0021444375,0.0026864868,0.004549448,0.002524602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027015913,0.00048641674,0.0012338797,0.00093925715,0.00087275374,0.0044723377,0.0013919479,0.002690497,0.005541996],"category_scores_gemma":[0.01957841,0.00018195254,0.0006425223,0.0010701902,0.0055781025,0.004483108,0.0016677545,0.0060101897,0.0011700027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013318206,0.00024275268,0.020554047,0.0013295148,0.00020765244,0.00044404186,0.00039184742,0.00075119245,0.0017458203,0.04570002,0.03336756,0.89393383],"study_design_scores_gemma":[0.00074764853,0.0034894666,0.059410755,0.0070974105,0.00062076893,0.0046075704,0.0029069048,0.0017500701,0.0034220067,0.0831359,0.8326672,0.00014431555],"about_ca_topic_score_codex":0.0009497446,"about_ca_topic_score_gemma":0.002610834,"teacher_disagreement_score":0.027015913,"about_ca_system_score_codex":0.0015697455,"about_ca_system_score_gemma":0.003241343,"threshold_uncertainty_score":0.1428755},"labels":[],"label_agreement":null},{"id":"W2073489459","doi":"10.1016/j.leukres.2013.09.018","title":"Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Regimen; Pediatrics; Vincristine; Lymphoblastic Leukemia; Normative; Population; Protocol (science); Physical therapy; Internal medicine; Leukemia; Chemotherapy; Alternative medicine; Pathology","score_opus":0.09730389761392953,"score_gpt":0.42129860007737513,"score_spread":0.3239947024634456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073489459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86073375,0.00051888486,0.0021957709,0.0025279205,0.0001230036,0.10038937,0.01492818,0.0001417619,0.018441372],"genre_scores_gemma":[0.809293,0.000859312,0.014338131,0.0010825064,0.00009794955,0.15428282,0.017824983,0.000025649842,0.0021957955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948171,0.0029204933,0.0009080464,0.0002662771,0.0005159519,0.0005721425],"domain_scores_gemma":[0.99009484,0.0019195171,0.00339342,0.00080271164,0.0014546477,0.0023348469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008704123,0.0003888547,0.00081506645,0.0009900437,0.0013809247,0.0010869871,0.0014349233,0.0005826448,0.00478469],"category_scores_gemma":[0.014398846,0.00031802774,0.0015660103,0.0019449486,0.0004366546,0.00087733613,0.0014475418,0.0013755575,0.00048564604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05534671,0.035410237,0.61968136,0.0025096647,0.0020878462,0.0004928753,0.003005515,0.0067205876,0.0016366404,0.002745003,0.04156565,0.2287979],"study_design_scores_gemma":[0.016802322,0.023601804,0.9341642,0.00070303224,0.0006099426,0.00023759787,0.0010561865,0.0023286424,0.0013120562,0.0008301756,0.018274445,0.00007957735],"about_ca_topic_score_codex":0.008630271,"about_ca_topic_score_gemma":0.01707179,"teacher_disagreement_score":0.008704123,"about_ca_system_score_codex":0.0057491753,"about_ca_system_score_gemma":0.018218515,"threshold_uncertainty_score":0.04603237},"labels":[],"label_agreement":null},{"id":"W2074908346","doi":"10.1016/j.leukres.2012.12.007","title":"Abducted by the illness: A qualitative study of traumatic stress in individuals with acute leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; University Health Network","keywords":"Traumatic stress; Qualitative research; Psychological intervention; Grounded theory; Medicine; Clinical psychology; Preference; Population; Psychiatry; Leukemia; Acute leukemia; Psychology; Internal medicine","score_opus":0.07244435580026112,"score_gpt":0.4215284975666684,"score_spread":0.34908414176640723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074908346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920036,0.0010186306,0.00067618024,0.0032356824,0.00013063588,0.00017094737,0.00014698756,0.000009265656,0.002608005],"genre_scores_gemma":[0.99566203,0.0009260736,0.00050139724,0.0013303246,0.00002785855,0.00020494657,0.0000676263,0.000015504627,0.0012641927],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99017006,0.0071592047,0.00034576328,0.00038769378,0.00047195042,0.0014654006],"domain_scores_gemma":[0.9814408,0.012070706,0.002220258,0.0004696645,0.001298742,0.0024997932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010681723,0.0009006719,0.0011798504,0.0016834129,0.017946139,0.005837088,0.0026132553,0.0024511945,0.0028085741],"category_scores_gemma":[0.019958893,0.0009921385,0.00067613536,0.0021108314,0.012643211,0.0055860193,0.009131412,0.0069701523,0.0002863988],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021307238,0.000042653814,0.0027366604,0.00008201048,0.0000050079125,0.00029531814,0.99496716,0.000014067532,0.00017800156,0.00033644502,0.00024900484,0.0010723573],"study_design_scores_gemma":[0.000001802661,0.000015553454,0.00072655804,0.000045152483,0.0000018023154,0.00007690694,0.9980767,0.000007874782,0.000034107918,0.00006215564,0.000946221,0.0000052096552],"about_ca_topic_score_codex":0.020535916,"about_ca_topic_score_gemma":0.06284986,"teacher_disagreement_score":0.020535916,"about_ca_system_score_codex":0.007284159,"about_ca_system_score_gemma":0.009386341,"threshold_uncertainty_score":0.056491017},"labels":[],"label_agreement":null},{"id":"W2075549873","doi":"10.1016/j.leukres.2004.09.006","title":"Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Nova Scotia Health Research Foundation; University of Manitoba; Cancer Research Society; Philipps-Universität Marburg","keywords":"Fibroblast growth factor; Antisense RNA; Sense (electronics); Haematopoiesis; Biology; Cell biology; Messenger RNA; Gene expression; K562 cells; RNA; Molecular biology; Gene; Stem cell; Chemistry; Genetics","score_opus":0.02260809386565673,"score_gpt":0.30874492795088265,"score_spread":0.28613683408522594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075549873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927872,0.0009976184,0.0039435336,0.000080412596,0.000044775563,0.00002082988,0.0003880024,0.000105165454,0.0016325692],"genre_scores_gemma":[0.99225396,0.00039811156,0.0024936753,0.000032598495,0.000016042335,0.000034461787,0.0007147447,0.00005461808,0.0040018884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99969673,0.000047246056,0.000035242767,0.000063478794,0.00009180068,0.0000655395],"domain_scores_gemma":[0.99966145,0.00012290369,0.000057251757,0.00006026794,0.00004777354,0.000050420236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024769295,0.0003776597,0.00038083203,0.0004567796,0.0002999353,0.0006857792,0.00026915202,0.00026676868,0.0014300123],"category_scores_gemma":[0.00027970437,0.00025659436,0.00035078722,0.00031711403,0.00033990887,0.00031288894,0.00031327398,0.0005695115,0.00047405262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057215777,0.000010035004,0.00012263181,0.000005842496,0.0000021497074,0.000018710523,0.00001395737,0.00004466908,0.9991171,0.00023982566,0.000015873042,0.00035201077],"study_design_scores_gemma":[0.000009994908,0.00007554967,0.0017452872,0.0000011852626,0.00000870933,0.0001038609,0.000029125635,0.0006511569,0.99586177,0.00004885461,0.0014620129,0.0000025479203],"about_ca_topic_score_codex":0.0020506587,"about_ca_topic_score_gemma":0.0025694415,"teacher_disagreement_score":0.0020506587,"about_ca_system_score_codex":0.0005011387,"about_ca_system_score_gemma":0.0003045439,"threshold_uncertainty_score":0.004783869},"labels":[],"label_agreement":null},{"id":"W2076061288","doi":"10.1016/s0145-2126(01)00052-2","title":"Regression of engineered myeloma cells secreting interferon-γ-inducing factor is mediated by both CD4+/CD8+ T and natural killer cells","year":2001,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Medical Research Council","keywords":"CD8; Immune system; Cytotoxic T cell; Interleukin 21; Cytokine; Biology; Interleukin 12; Interferon gamma; In vivo; Immunology; In vitro; T cell; Molecular biology; Cancer research; Biochemistry","score_opus":0.022898225258847826,"score_gpt":0.2891107219130749,"score_spread":0.2662124966542271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076061288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887959,0.00056312187,0.0076984065,0.00007575837,0.000057555495,0.000053340253,0.00043970766,0.00036356392,0.0019527315],"genre_scores_gemma":[0.9916888,0.00026804107,0.003367957,0.00002897459,0.000015129342,0.000029026445,0.00060038717,0.0000792479,0.0039224457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996722,0.000048090194,0.00003425555,0.000054957294,0.00009711957,0.00009340931],"domain_scores_gemma":[0.9996213,0.000100000056,0.00009652185,0.00007499593,0.000031559273,0.000075665055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002242491,0.0007320431,0.0004173351,0.0005160541,0.00021214229,0.00048977515,0.0003271143,0.00037785724,0.0017671738],"category_scores_gemma":[0.00016499101,0.00022037237,0.00045395855,0.00023823987,0.00023008602,0.00020314573,0.00035646954,0.0010253505,0.00082619424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012021093,0.000035716526,0.00012816748,0.000008018086,0.0000049632595,0.000022177846,0.000008077213,0.00008759638,0.9988722,0.00009604299,0.00002100219,0.0005956519],"study_design_scores_gemma":[0.000010712881,0.00010207023,0.00050191715,0.0000010211579,0.000007209202,0.00005547912,0.0000047418807,0.00062314235,0.9982187,0.000015839814,0.00045786583,0.0000012505059],"about_ca_topic_score_codex":0.0009913808,"about_ca_topic_score_gemma":0.000897743,"teacher_disagreement_score":0.0017671738,"about_ca_system_score_codex":0.0004215773,"about_ca_system_score_gemma":0.00024883385,"threshold_uncertainty_score":0.005911827},"labels":[],"label_agreement":null},{"id":"W2077489715","doi":"10.1016/j.leukres.2012.02.013","title":"Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Notch signaling pathway; Insulin-like growth factor 1 receptor; microRNA; Biology; Cell biology; Signal transduction; Context (archaeology); Cancer research; Receptor; Growth factor; Gene; Genetics","score_opus":0.05331835162137881,"score_gpt":0.374634736131901,"score_spread":0.3213163845105222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077489715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809079,0.0042256713,0.0052652434,0.00042852378,0.00009058703,0.000028560635,0.0005043868,0.00021446051,0.008334698],"genre_scores_gemma":[0.99535453,0.0006004327,0.0010441266,0.00008420798,0.000014559294,0.000011664832,0.00026485938,0.000033109078,0.0025925508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998202,0.000024442408,0.00001930797,0.00003642367,0.0000509306,0.00004882786],"domain_scores_gemma":[0.9998876,0.000016512662,0.000033383672,0.000012579483,0.000020521198,0.00002949084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002498347,0.00022368663,0.00020614771,0.00034229885,0.00030997713,0.0009331209,0.0002732255,0.00021362852,0.0014148612],"category_scores_gemma":[0.00023231308,0.00019306436,0.00026880222,0.00013706915,0.00029169107,0.00022073787,0.00033597814,0.00064042804,0.0005910416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025317626,0.000024861427,0.0022354256,0.000037040165,0.000012816045,0.00023595088,0.000035178662,0.00022657635,0.98909163,0.0010749339,0.00028641554,0.0064859586],"study_design_scores_gemma":[0.000046555902,0.00017349243,0.043968562,0.000017554226,0.000089178335,0.0015710169,0.0002127428,0.0058681043,0.9326828,0.000984841,0.014361345,0.000023752364],"about_ca_topic_score_codex":0.0010779097,"about_ca_topic_score_gemma":0.0019141055,"teacher_disagreement_score":0.0014148612,"about_ca_system_score_codex":0.00068961416,"about_ca_system_score_gemma":0.00034824287,"threshold_uncertainty_score":0.005003512},"labels":[],"label_agreement":null},{"id":"W2078892073","doi":"10.1016/j.leukres.2013.04.019","title":"Epigenetic action of decitabine (5-aza-2′-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C)","year":2013,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Cancer Society","keywords":"Decitabine; Cytarabine; Myeloid leukemia; Deoxycytidine; Medicine; Azacitidine; Oncology; Chemotherapy; Leukopenia; Leukemia; Clinical trial; Pharmacology; Acute leukemia; Internal medicine; DNA methylation; Gemcitabine; Biology","score_opus":0.06026619633971207,"score_gpt":0.370613817139751,"score_spread":0.3103476208000389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078892073","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03622416,0.0104249725,0.00069670763,0.9017869,0.012718057,0.000063374486,0.00012650654,0.00015391226,0.037805356],"genre_scores_gemma":[0.29612452,0.014196324,0.001863524,0.5968478,0.034256604,0.00011421239,0.0001665944,0.000056208755,0.056374352],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997087,0.00008538639,0.000030409123,0.00003763235,0.00007832715,0.00005958083],"domain_scores_gemma":[0.9995697,0.00024416452,0.00004513713,0.000020563586,0.000057001405,0.0000633797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037266916,0.00025823578,0.0005816588,0.00013920561,0.0007327285,0.00062667124,0.00035233027,0.0059508467,0.0037457568],"category_scores_gemma":[0.0020199048,0.00013283607,0.0003396217,0.00018393043,0.00066296745,0.00045968234,0.00023392006,0.005116199,0.0018771851],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017587658,0.00059597206,0.0076119998,0.0005355254,0.0001053234,0.06349725,0.00034889844,0.0004984274,0.022502197,0.014280598,0.64508295,0.2431822],"study_design_scores_gemma":[0.0008594994,0.0009065812,0.009135574,0.00017255408,0.00009354872,0.046290092,0.00030689884,0.0011833557,0.01046591,0.008221723,0.92231995,0.00004428349],"about_ca_topic_score_codex":0.0011743781,"about_ca_topic_score_gemma":0.0027522082,"teacher_disagreement_score":0.0059508467,"about_ca_system_score_codex":0.0015027798,"about_ca_system_score_gemma":0.00061407353,"threshold_uncertainty_score":0.012530804},"labels":[],"label_agreement":null},{"id":"W2080820574","doi":"10.1016/j.leukres.2005.08.013","title":"HLA-DM expression is elevated in ETV6–AML1 translocation-positive pediatric acute lymphoblastic leukemia","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"ETV6; Chromosomal translocation; Human leukocyte antigen; CD19; Immunology; Leukemia; Major histocompatibility complex; MHC class I; Cancer research; Medicine; Biology; Antigen; Gene; Genetics","score_opus":0.02856127762690191,"score_gpt":0.34426415436863905,"score_spread":0.31570287674173714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080820574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887437,0.00022470554,0.00010559434,0.000029288225,0.0000032903408,0.0000021567246,0.00009208723,0.000009351051,0.000659059],"genre_scores_gemma":[0.9993999,0.00013995136,0.0001260892,0.00001497937,0.000009410592,0.000003343736,0.000143994,0.0000033759443,0.00015898787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983704,0.00002895463,0.000016661308,0.000025040394,0.00004218092,0.000050095572],"domain_scores_gemma":[0.9997031,0.00008732213,0.00011586321,0.000012108148,0.000031539115,0.00004997111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114662434,0.00016125232,0.00021099306,0.0007742071,0.0002302967,0.00051161356,0.00016362798,0.00025370147,0.0016977862],"category_scores_gemma":[0.0008201669,0.00015293027,0.00008674067,0.00077583856,0.00022188324,0.00026572868,0.0002041019,0.00024823318,0.00026363012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081583404,0.000057927922,0.8657816,0.000056013032,0.000036761052,0.0062415916,0.00025953422,0.00014994168,0.11407891,0.00020597116,0.0005435124,0.011772371],"study_design_scores_gemma":[0.000019189165,0.0001244644,0.96126646,0.0000099997305,0.000044045748,0.02221391,0.0005845647,0.00063163333,0.012640911,0.00020073351,0.002258376,0.0000057629845],"about_ca_topic_score_codex":0.0005793836,"about_ca_topic_score_gemma":0.00056129013,"teacher_disagreement_score":0.0016977862,"about_ca_system_score_codex":0.00017079312,"about_ca_system_score_gemma":0.00009714096,"threshold_uncertainty_score":0.0056796074},"labels":[],"label_agreement":null},{"id":"W2081434852","doi":"10.1016/j.leukres.2013.06.020","title":"t(11;14) multiple myeloma: A subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Multiple myeloma; Bortezomib; Cohort; Internal medicine; CD20; Incidence (geometry); Medicine; Plasma cell leukemia; Population; Oncology; Immunology; Gastroenterology; Lymphoma","score_opus":0.06183816214560683,"score_gpt":0.32980931248744055,"score_spread":0.2679711503418337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081434852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742043,0.00016759094,0.00028877333,0.000080260994,0.000009350592,0.000018134877,0.00020396407,0.000008507626,0.0018029144],"genre_scores_gemma":[0.99849033,0.000093096416,0.00042301096,0.00005128481,0.00002898128,0.000011063598,0.00043166912,0.0000120127215,0.00045864275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994516,0.00007152149,0.00006565554,0.00013204616,0.000096328826,0.0001828115],"domain_scores_gemma":[0.99900836,0.00015230702,0.00037730605,0.000108129025,0.00012258724,0.00023137653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044259574,0.0005154059,0.0007562073,0.0008884646,0.0009638274,0.00107981,0.00064990076,0.0006819184,0.0019615141],"category_scores_gemma":[0.0012698524,0.00020335056,0.0003140952,0.0012918985,0.00056577026,0.00037651276,0.000862286,0.00058191305,0.0006258994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002166382,0.0002755645,0.8966198,0.000063899344,0.00013028306,0.019016333,0.00069568143,0.000492133,0.060874414,0.0011928433,0.00088916416,0.017583456],"study_design_scores_gemma":[0.0001210858,0.00072839414,0.8501661,0.00003212459,0.00020770698,0.1339165,0.0019801336,0.0012631902,0.005220593,0.0023933675,0.003930946,0.000039914135],"about_ca_topic_score_codex":0.0022454346,"about_ca_topic_score_gemma":0.00272934,"teacher_disagreement_score":0.0022454346,"about_ca_system_score_codex":0.0005504657,"about_ca_system_score_gemma":0.0006051305,"threshold_uncertainty_score":0.0065618753},"labels":[],"label_agreement":null},{"id":"W2082440968","doi":"10.1016/j.leukres.2010.01.015","title":"Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; Leukemia; Bone marrow; Pharmacology; Medicine; Cancer research; Immunology","score_opus":0.031563724515059406,"score_gpt":0.33557359054153746,"score_spread":0.30400986602647806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082440968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627435,0.001372838,0.00092039915,0.00005663265,0.0000116564415,0.000018303737,0.00023964902,0.000039136587,0.0010670287],"genre_scores_gemma":[0.99816626,0.00034296454,0.00064407766,0.000008537632,0.000002394791,0.000010271572,0.00018326704,0.000012719009,0.0006296246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984777,0.00003515718,0.000009577072,0.00003277072,0.00003437494,0.00004042925],"domain_scores_gemma":[0.9999398,0.000020998827,0.000011330621,0.0000066442108,0.000007946689,0.000013208276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002153977,0.00028230067,0.00033808575,0.00022785485,0.0001910717,0.00034150627,0.00023749078,0.0002466753,0.0008647137],"category_scores_gemma":[0.000120545796,0.00016327496,0.00014381912,0.00020707873,0.0002219848,0.0002698136,0.000093616996,0.00053118885,0.0001919235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045437188,0.00007459551,0.00010966126,0.000038192244,0.0000060858206,0.000029239336,0.00003929989,0.0004811462,0.9967392,0.00021806854,0.00009905011,0.0017111418],"study_design_scores_gemma":[0.000051651372,0.00080498616,0.0017406093,0.0000029163898,0.000021629667,0.0001549545,0.000030015959,0.0023293705,0.994079,0.00002638109,0.0007534664,0.0000049493497],"about_ca_topic_score_codex":0.003873983,"about_ca_topic_score_gemma":0.0028878958,"teacher_disagreement_score":0.003873983,"about_ca_system_score_codex":0.00054271804,"about_ca_system_score_gemma":0.00037077698,"threshold_uncertainty_score":0.0077028275},"labels":[],"label_agreement":null},{"id":"W2083042132","doi":"10.1016/j.leukres.2011.01.004","title":"Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Jewish General Hospital; Leukemia and Lymphoma Society","keywords":"Chlorambucil; RAD51; Chronic lymphocytic leukemia; DNA repair; Homologous recombination; Non-homologous end joining; Cancer research; DNA; DNA damage; Biology; Leukemia; Homologous chromosome; Genetics; Chemotherapy; Gene","score_opus":0.07937477045542254,"score_gpt":0.3175927071213793,"score_spread":0.23821793666595678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083042132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9061854,0.060796976,0.014167674,0.0020378467,0.0006816781,0.00030263004,0.00041588725,0.00031194577,0.015099983],"genre_scores_gemma":[0.97622025,0.009697596,0.0044671516,0.00022066949,0.00012578466,0.00016170181,0.00029548167,0.000025881865,0.00878542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995683,0.000113793394,0.000035210258,0.000046413625,0.000113324786,0.00012302792],"domain_scores_gemma":[0.999833,0.000037076854,0.000037127167,0.000037056525,0.000019785279,0.00003594205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085458823,0.0005020287,0.00064943294,0.00057767454,0.00026578037,0.00078049354,0.0005819347,0.000562143,0.002335089],"category_scores_gemma":[0.00026677072,0.00019043202,0.00044791447,0.0003447886,0.00036587327,0.0006027843,0.0005267732,0.0016796123,0.00046431922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029119784,0.001542877,0.0013978869,0.000554546,0.00011445505,0.00022625238,0.00010425058,0.001012668,0.8214875,0.010567514,0.0018897526,0.15819027],"study_design_scores_gemma":[0.0012686669,0.0066799275,0.0064031235,0.00009466777,0.0002758753,0.0020476019,0.000109981396,0.003120858,0.9065229,0.0023794563,0.071062714,0.000034210618],"about_ca_topic_score_codex":0.00015092129,"about_ca_topic_score_gemma":0.00049235736,"teacher_disagreement_score":0.002335089,"about_ca_system_score_codex":0.00043122272,"about_ca_system_score_gemma":0.0003633477,"threshold_uncertainty_score":0.0078116655},"labels":[],"label_agreement":null},{"id":"W2084532520","doi":"10.1016/s0145-2126(11)70040-6","title":"38 Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Institut de Veille Sanitaire; Leukemia and Lymphoma Society; National Institute for Health and Care Research; University College Dublin; National Institutes of Health; Cancer Research UK; Leukemia and Lymphoma Research","keywords":"Chemistry; GTP'; Hydrolysis; Pharmacology; Food science; Biochemistry; Biology; Enzyme","score_opus":0.06756490857831893,"score_gpt":0.30104212818858905,"score_spread":0.23347721961027013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084532520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915507,0.0009217097,0.0029966116,0.00075882295,0.00013948248,0.000023536973,0.00050033594,0.00019004363,0.0029189128],"genre_scores_gemma":[0.99713373,0.0003327781,0.0009986557,0.00010240863,0.000033749824,0.0000087988965,0.00013934361,0.000030110608,0.0012204181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997098,0.00005532347,0.00004400755,0.00006758982,0.000080231,0.000043142536],"domain_scores_gemma":[0.99940646,0.00026151392,0.00013768612,0.00004348592,0.00003266984,0.00011821815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021363136,0.0010511215,0.00036879594,0.0010397657,0.00049455184,0.0002702374,0.0005661575,0.0012738603,0.0035132957],"category_scores_gemma":[0.00091190095,0.00028763348,0.00038409137,0.00044275308,0.0009958455,0.00031413473,0.000649118,0.0008104,0.00062602945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002642679,0.0002464942,0.026758099,0.00029450867,0.00026499561,0.28056592,0.00062416226,0.0019451601,0.64293253,0.00939028,0.004730083,0.029605072],"study_design_scores_gemma":[0.00071400416,0.001305245,0.07803156,0.00008792319,0.0005039157,0.32995194,0.0005740988,0.006915523,0.5369776,0.0074744048,0.03732613,0.00013770831],"about_ca_topic_score_codex":0.0022502558,"about_ca_topic_score_gemma":0.0012893007,"teacher_disagreement_score":0.0035132957,"about_ca_system_score_codex":0.0005504117,"about_ca_system_score_gemma":0.00043658656,"threshold_uncertainty_score":0.0117532015},"labels":[],"label_agreement":null},{"id":"W2086512786","doi":"10.1016/j.leukres.2004.02.006","title":"Growth and apoptosis of human natural killer cell neoplasms: role of interleukin-2/15 signaling","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Shionogi; Cell Science Research Foundation; World Health Organization","keywords":"Interleukin 15; STAT5; Apoptosis; Lymphokine-activated killer cell; Natural killer cell; Cell biology; Cancer research; Biology; Cell culture; Cell; Cell growth; Interleukin; Interleukin 21; Immunology; Signal transduction; In vitro; Cytokine; Cytotoxicity; T cell; Immune system; Biochemistry","score_opus":0.017384462507242075,"score_gpt":0.2822947841443441,"score_spread":0.26491032163710204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086512786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892089,0.006888911,0.0008601425,0.00016232685,0.000023605457,0.00001694643,0.00018543242,0.000035178236,0.0026186127],"genre_scores_gemma":[0.99631906,0.0013996245,0.00024871784,0.000030071837,0.000008098837,0.000012919781,0.00026728175,0.0000040818536,0.0017100389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982077,0.00004230976,0.000014996929,0.00001959783,0.000041393003,0.000060948372],"domain_scores_gemma":[0.9999175,0.00002100589,0.000015620111,0.000014707037,0.000012720005,0.000018394758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023588062,0.00026197243,0.00017586107,0.0003301433,0.00019525312,0.00051241,0.00015066579,0.00018264643,0.0014400664],"category_scores_gemma":[0.00018790957,0.000112696,0.00023784472,0.00019904927,0.00020044301,0.00029808376,0.00023625314,0.00038153952,0.00024493987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00229224,0.00018654192,0.009242085,0.000110676636,0.000038259182,0.0003771335,0.0001927661,0.00041581888,0.9622598,0.0016653165,0.00050862576,0.022710683],"study_design_scores_gemma":[0.00020137148,0.0013434435,0.08232347,0.000024404684,0.00006561573,0.0019459059,0.0003707013,0.002424484,0.89969987,0.0007933975,0.010796906,0.0000102947],"about_ca_topic_score_codex":0.0012825027,"about_ca_topic_score_gemma":0.0014922098,"teacher_disagreement_score":0.0014400664,"about_ca_system_score_codex":0.0005902031,"about_ca_system_score_gemma":0.0003541766,"threshold_uncertainty_score":0.0048175454},"labels":[],"label_agreement":null},{"id":"W2087111933","doi":"10.1016/j.leukres.2009.09.012","title":"Genetic inactivation of Ikaros is a rare event in human T-ALL","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Biology; Genetics; Allele; Gene; Molecular biology","score_opus":0.05855812171636873,"score_gpt":0.4050134406573147,"score_spread":0.34645531894094594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087111933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171585,0.00071906677,0.0027280806,0.00016676373,0.00003763611,0.000059682556,0.0005532153,0.00020120498,0.003818604],"genre_scores_gemma":[0.99899,0.000119008044,0.00032771457,0.000032558393,0.000015952191,0.00000874877,0.0002303975,0.000017386747,0.00025813733],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996251,0.00008537501,0.000055370936,0.00006161371,0.00009826772,0.00007423121],"domain_scores_gemma":[0.9991278,0.0002596522,0.00028409372,0.00019138398,0.000048359736,0.00008877506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024153934,0.0002943551,0.00032654504,0.0010188305,0.00040300525,0.0005919653,0.00037961666,0.0008111858,0.0021840378],"category_scores_gemma":[0.0011799341,0.00018148591,0.00036908948,0.00066176744,0.00054767967,0.00030659395,0.00045518874,0.0005666545,0.00067442347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020126798,0.00020469824,0.11607919,0.00022083716,0.000217487,0.055298157,0.00039224105,0.000977333,0.79198617,0.002770987,0.0011479405,0.028692283],"study_design_scores_gemma":[0.00025903483,0.0014660549,0.35568672,0.00004822667,0.00062882854,0.33074602,0.0009491669,0.0021980237,0.28661275,0.0034971437,0.017833918,0.00007406934],"about_ca_topic_score_codex":0.00033681357,"about_ca_topic_score_gemma":0.00044144076,"teacher_disagreement_score":0.0021840378,"about_ca_system_score_codex":0.0001934316,"about_ca_system_score_gemma":0.00018931211,"threshold_uncertainty_score":0.0073063374},"labels":[],"label_agreement":null},{"id":"W2089243465","doi":"10.1016/j.leukres.2011.07.033","title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review","year":2011,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"Medical Center, University of Rochester; University of Toronto; European Hematology Association","keywords":"Presentation (obstetrics); Context (archaeology); Lineage (genetic); Neoplasm; Expression (computer science); Pathology; Medicine; Biology; Gene; Computer science; Genetics; Radiology","score_opus":0.07700582834842269,"score_gpt":0.3829620155647267,"score_spread":0.305956187216304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089243465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007348432,0.98848337,0.0005093079,0.00040616817,0.00021324579,0.00002703832,0.00013161909,0.00003091432,0.0028499337],"genre_scores_gemma":[0.024209484,0.97282165,0.0009344062,0.0004986708,0.0004725406,0.000012904485,0.00023287706,0.0000066886514,0.00081083336],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997242,0.000032295113,0.00009759174,0.00006271226,0.000055103326,0.00002807208],"domain_scores_gemma":[0.9995315,0.00020420524,0.00013472694,0.000018281173,0.000063560015,0.000047769514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000272165,0.00090065994,0.0014746,0.0034871805,0.00040517535,0.001266392,0.0010045201,0.0010603125,0.0021564818],"category_scores_gemma":[0.0008768147,0.00038829425,0.00053894636,0.0032853838,0.000660455,0.0022916433,0.00068201235,0.0007177274,0.0009208653],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002155935,0.00021278164,0.016198438,0.03255784,0.0004998224,0.2002395,0.0006843397,0.00066847494,0.007521965,0.0013659836,0.037491675,0.70234364],"study_design_scores_gemma":[0.000038834187,0.000101599886,0.013372226,0.005793361,0.0011065141,0.72452605,0.0011021876,0.00023824557,0.0012963341,0.000999757,0.25133547,0.000089399626],"about_ca_topic_score_codex":0.0008717065,"about_ca_topic_score_gemma":0.0016255071,"teacher_disagreement_score":0.0034871805,"about_ca_system_score_codex":0.00031765774,"about_ca_system_score_gemma":0.0010098456,"threshold_uncertainty_score":0.0072141886},"labels":[],"label_agreement":null},{"id":"W2089483976","doi":"10.1016/j.leukres.2011.09.020","title":"Identification of a novel non-immunoglobulin/MYC translocation t(8;12)(q24;p12) involving the LRMP gene in a primary B-cell lymphoma. A case report","year":2011,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Vascular endothelial growth factor A; Flow cytometry; Cell growth; Angiogenesis; Apoptosis; Biology; Molecular biology; MALAT1; Cancer research; microRNA; Cell; Chemistry; Downregulation and upregulation; Vascular endothelial growth factor; Gene; Genetics; VEGF receptors","score_opus":0.06736260677681681,"score_gpt":0.3178418013336248,"score_spread":0.25047919455680795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089483976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8712738,0.009709782,0.004986496,0.070987366,0.003159733,0.00026516768,0.00055967504,0.0005629592,0.03849494],"genre_scores_gemma":[0.98201823,0.0020226357,0.0018016598,0.004880341,0.005586623,0.0000570439,0.00015395893,0.000041860094,0.003437582],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990557,0.00016520314,0.00010963126,0.00023115877,0.0001527591,0.00028546448],"domain_scores_gemma":[0.9969897,0.0015351381,0.00031931454,0.00027305415,0.00021589157,0.00066681614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055094605,0.001442326,0.001384595,0.0020554927,0.0027948841,0.0024471716,0.0018063094,0.012284454,0.003801983],"category_scores_gemma":[0.0055261035,0.0013996337,0.0012471159,0.0013917569,0.0024341238,0.0030533818,0.0013914416,0.0058684703,0.0016142926],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044301978,0.000018895995,0.0014744382,0.000021531308,0.0000046159894,0.99565095,0.00007402266,0.000038126793,0.00065678835,0.00017678828,0.00096923375,0.0008703069],"study_design_scores_gemma":[0.00004513202,0.00005129671,0.0017588814,0.000011998011,0.000016791182,0.9952781,0.00010605758,0.00036845784,0.00052682497,0.00038015394,0.001446441,0.000009935685],"about_ca_topic_score_codex":0.002530359,"about_ca_topic_score_gemma":0.002194667,"teacher_disagreement_score":0.012284454,"about_ca_system_score_codex":0.0022116883,"about_ca_system_score_gemma":0.0010079119,"threshold_uncertainty_score":0.016047},"labels":[],"label_agreement":null},{"id":"W2090923510","doi":"10.1016/j.leukres.2014.08.017","title":"Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: A population-based cohort study","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Institute for Clinical Evaluative Sciences; University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Ontario Ministry of Health and Long-Term Care; Canadian Child Health Clinician Scientist Program","keywords":"Lymphoblastic Leukemia; Medicine; Cohort; Socioeconomic status; Cohort study; Event (particle physics); Oncology; Population; Pediatrics; Demography; Internal medicine; Leukemia; Environmental health","score_opus":0.0198843650246531,"score_gpt":0.3273311305163556,"score_spread":0.30744676549170247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090923510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939156,0.00009512534,0.000028515835,0.000028557502,0.0000032546593,0.000003250853,0.00032729926,0.0000014223517,0.00012102893],"genre_scores_gemma":[0.9993699,0.00012897541,0.00003147591,0.000013120547,0.0000043696864,0.000005499569,0.0003581518,0.0000014611637,0.00008708531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994875,0.00012816058,0.000046944893,0.00011052412,0.00007761925,0.00014926186],"domain_scores_gemma":[0.9990464,0.00011771573,0.0004033808,0.000112279624,0.00008026229,0.00023992216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059983024,0.0003682923,0.00040527427,0.0007451639,0.00062958995,0.0008035861,0.00053383125,0.0005979585,0.0010659472],"category_scores_gemma":[0.0016136634,0.0005057134,0.00081775006,0.0017682214,0.00033676252,0.00081447297,0.00067900924,0.00097618153,0.0001822093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008941071,0.000048006077,0.99913484,0.0000026513078,0.00008336387,0.00009302848,0.000043907472,0.000029669984,0.0000991278,0.000016048705,0.00004928399,0.00031055603],"study_design_scores_gemma":[0.0000066590396,0.000056804187,0.99937314,0.0000021238068,0.00003827429,0.00018160116,0.0001599847,0.000083259554,0.000017535483,0.000015065787,0.0000627513,0.0000028132088],"about_ca_topic_score_codex":0.0152768595,"about_ca_topic_score_gemma":0.016794588,"teacher_disagreement_score":0.0152768595,"about_ca_system_score_codex":0.0005848851,"about_ca_system_score_gemma":0.0006027415,"threshold_uncertainty_score":0.030375838},"labels":[],"label_agreement":null},{"id":"W2091231814","doi":"10.1016/j.leukres.2012.02.022","title":"Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Clofarabine; Gemtuzumab ozogamicin; Decitabine; Cytarabine; Myeloid leukemia; Daunorubicin; Azacitidine; In vitro; Leukemia; Cancer research; Medicine; Pharmacology; Biology; Immunology; Stem cell; CD33; Biochemistry; DNA methylation; Cell biology; CD34","score_opus":0.1375267582072328,"score_gpt":0.40075598130245965,"score_spread":0.26322922309522684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091231814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242204,0.0019683356,0.0018534879,0.00010011311,0.00002574548,0.000072822935,0.0011505154,0.00005432088,0.0023524868],"genre_scores_gemma":[0.9919626,0.0016523565,0.0017220159,0.00006473224,0.00001582148,0.0001260793,0.0022053628,0.000011696074,0.0022393276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995472,0.00013583664,0.00004214457,0.000050613915,0.00013659867,0.00008763342],"domain_scores_gemma":[0.9997607,0.000085073414,0.00004902054,0.000029343944,0.000046598518,0.000029311586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043567872,0.00032415887,0.00033596277,0.0008120768,0.00030206345,0.0006354071,0.00021327479,0.00030461387,0.002882032],"category_scores_gemma":[0.0005052102,0.00019394002,0.00037966442,0.0006576185,0.00019696461,0.00030299477,0.00017668532,0.0007174573,0.0005368745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010858766,0.00032374274,0.007636628,0.000095905474,0.00006122901,0.00008191043,0.00006934994,0.0007691878,0.98295814,0.00022965623,0.00025316715,0.0064351643],"study_design_scores_gemma":[0.000052108655,0.001516813,0.048368264,0.000013545098,0.00012166409,0.00047734327,0.00022243321,0.002999889,0.94246346,0.00016042915,0.0035932607,0.000010749875],"about_ca_topic_score_codex":0.00062916946,"about_ca_topic_score_gemma":0.0009100188,"teacher_disagreement_score":0.002882032,"about_ca_system_score_codex":0.00044437763,"about_ca_system_score_gemma":0.00025197788,"threshold_uncertainty_score":0.009641349},"labels":[],"label_agreement":null},{"id":"W2092340195","doi":"10.1016/j.leukres.2012.03.001","title":"Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institutes of Health","keywords":"EZH2; PRC2; Biology; DNA methylation; Epigenetics; Histone methyltransferase; Cancer research; Histone methylation; Cancer epigenetics; Gene silencing; Molecular biology; Methylation; Carcinogenesis; Histone H3; Epigenetic therapy; Histone; Gene expression; Gene; Genetics","score_opus":0.05787510951991737,"score_gpt":0.3848753231151511,"score_spread":0.32700021359523374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092340195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97692204,0.012876935,0.003024525,0.00018026665,0.00014996542,0.00022598302,0.0006054995,0.00021191113,0.0058028996],"genre_scores_gemma":[0.9895734,0.0051104864,0.0023116532,0.00010722413,0.00004473788,0.00012619255,0.00068961474,0.000013555297,0.0020231062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998479,0.000032126587,0.000016308139,0.00002910644,0.000038140457,0.000036403566],"domain_scores_gemma":[0.999928,0.000016550379,0.000012025751,0.000007482684,0.000008490903,0.000027470363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155065,0.0004813424,0.0007268341,0.00039113202,0.00010151012,0.00028117304,0.00026697887,0.00024040803,0.0013850697],"category_scores_gemma":[0.00015517623,0.00014090298,0.00030308895,0.00027081073,0.000121332174,0.00017475849,0.0002653684,0.00052264734,0.00027396265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015860613,0.00046178015,0.00051473704,0.00025955623,0.00010692664,0.00015582072,0.000028683944,0.00073817774,0.9682025,0.00021613105,0.00038464818,0.027344981],"study_design_scores_gemma":[0.00075536204,0.009746966,0.008703231,0.000030030227,0.00024868848,0.0011672468,0.00004120459,0.0022388068,0.95894235,0.00014197164,0.017950904,0.000033256852],"about_ca_topic_score_codex":0.00027594867,"about_ca_topic_score_gemma":0.0009973975,"teacher_disagreement_score":0.0013850697,"about_ca_system_score_codex":0.00017676402,"about_ca_system_score_gemma":0.00026397422,"threshold_uncertainty_score":0.0046334863},"labels":[],"label_agreement":null},{"id":"W2092925479","doi":"10.1016/j.leukres.2004.03.015","title":"The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Diphtheria toxin; Cytarabine; Cytosine; Myeloid leukemia; Bone marrow; Granulocyte macrophage colony-stimulating factor; Leukemia; Immunology; Cancer research; Molecular biology; Biology; Virology; Medicine; Toxin; Cytokine; Microbiology; Gene; Biochemistry","score_opus":0.033625179882540567,"score_gpt":0.3283182852802339,"score_spread":0.29469310539769333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092925479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461657,0.00144768,0.0018060666,0.00019802069,0.00006589272,0.000054526892,0.0005097829,0.0001666136,0.0011348173],"genre_scores_gemma":[0.9953843,0.00060093665,0.0017462323,0.000039085782,0.000022548013,0.00005548136,0.00035819356,0.000033009528,0.0017601388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994481,0.0001438464,0.000063844236,0.00006812647,0.000111854104,0.00016419176],"domain_scores_gemma":[0.99932206,0.00018826702,0.00017869033,0.000096394455,0.000036838803,0.000177775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053587527,0.00087408035,0.0007485746,0.0008571632,0.00029171945,0.00058506714,0.00047226792,0.00081903604,0.0010321455],"category_scores_gemma":[0.00031293815,0.0003663609,0.0004637343,0.0003772687,0.00070201454,0.000523465,0.00033900546,0.0018539847,0.00033766154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075402827,0.00011525096,0.00011116552,0.000027988204,0.000008054347,0.000071725204,0.000017578843,0.00012216353,0.9978461,0.00020351009,0.00004526677,0.00067703205],"study_design_scores_gemma":[0.000052512878,0.0005957674,0.0006970673,0.0000040932555,0.000018620867,0.00013881159,0.000010215876,0.00063163973,0.99727243,0.000039017483,0.0005357217,0.000003972896],"about_ca_topic_score_codex":0.00085626444,"about_ca_topic_score_gemma":0.0009824589,"teacher_disagreement_score":0.0010321455,"about_ca_system_score_codex":0.0005839507,"about_ca_system_score_gemma":0.000353911,"threshold_uncertainty_score":0.004236877},"labels":[],"label_agreement":null},{"id":"W2093592416","doi":"10.1016/j.leukres.2005.06.011","title":"Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biology","year":2005,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; World Health Organization","keywords":"Myelodysplastic syndromes; Haematopoiesis; Leukemia; Bone marrow; Stem cell; Preleukemia; Disease; Immunology; Hematology; Pathogenesis; Cancer research; Acute leukemia; Medicine; Biology; Pathology; Genetics","score_opus":0.14402969213854586,"score_gpt":0.5130137743359242,"score_spread":0.3689840821973783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093592416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005557695,0.9988619,0.000073677365,0.00032760785,0.00022676638,0.000002649532,0.000010849518,0.0000036538058,0.0004374095],"genre_scores_gemma":[0.00026736542,0.99897456,0.00012198415,0.00022129886,0.00016664942,0.0000031089407,0.00001567586,4.5426222e-7,0.00022897562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997123,0.000058752277,0.000048777583,0.00005646461,0.00010095035,0.0000227395],"domain_scores_gemma":[0.99932635,0.0003160907,0.0001003513,0.000016521788,0.00018393835,0.000056814584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010585609,0.0008970748,0.0020335848,0.002617101,0.0003350076,0.0015456518,0.0010986044,0.0015389366,0.0031380428],"category_scores_gemma":[0.0013304455,0.0003075568,0.000530065,0.0034248207,0.0008491554,0.0016706159,0.00066959485,0.0019008116,0.0018576345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114349445,0.000062769264,0.000394502,0.014697216,0.000113458584,0.00042844174,0.00006728523,0.0004794351,0.0015435232,0.0048849876,0.05192094,0.9252931],"study_design_scores_gemma":[0.000037440313,0.000093822826,0.0008895318,0.0035624444,0.00013314656,0.0016541653,0.000091060734,0.000057664423,0.00028136233,0.0025184816,0.9906634,0.000017493032],"about_ca_topic_score_codex":0.0018675812,"about_ca_topic_score_gemma":0.0042062267,"teacher_disagreement_score":0.0031380428,"about_ca_system_score_codex":0.0011832239,"about_ca_system_score_gemma":0.0020614178,"threshold_uncertainty_score":0.010497749},"labels":[],"label_agreement":null},{"id":"W2094949617","doi":"10.1016/j.leukres.2013.07.020","title":"Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Medicine; Myeloid leukemia; Abortion; Tyrosine-kinase inhibitor; Tyrosine kinase; Pregnancy; Leukemia; Myeloid; Obstetrics; Internal medicine; Cancer","score_opus":0.02018674346074954,"score_gpt":0.2786858571405371,"score_spread":0.25849911367978756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094949617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97861415,0.010917229,0.00024288679,0.0021837102,0.0001376468,0.000031542284,0.0006543472,0.000011685871,0.007206755],"genre_scores_gemma":[0.9927094,0.005300552,0.00018462742,0.0005533675,0.000089466135,0.000023984967,0.00027397036,0.0000029352416,0.000861698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963236,0.00014911602,0.000028197102,0.00004174517,0.000059110567,0.00008943169],"domain_scores_gemma":[0.9990994,0.00043877432,0.00026584443,0.000020994046,0.000023450166,0.00015160209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036911253,0.00009329813,0.00029368486,0.00042364543,0.00045792077,0.0004000133,0.0001361708,0.0005030471,0.0026253287],"category_scores_gemma":[0.004184759,0.00010646693,0.00021962877,0.00062644127,0.00023974538,0.00026500027,0.00025923262,0.0010069036,0.000119181896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011805644,0.000264056,0.9543178,0.00007219922,0.000082917926,0.003149029,0.00031210194,0.0001559719,0.00074228615,0.00081076706,0.0013649478,0.037547417],"study_design_scores_gemma":[0.00021406963,0.0012479934,0.96578616,0.0003304473,0.00032854464,0.017729174,0.0026185238,0.0010495428,0.0010456792,0.002273938,0.0073468466,0.000029072029],"about_ca_topic_score_codex":0.0033098278,"about_ca_topic_score_gemma":0.004009019,"teacher_disagreement_score":0.0033098278,"about_ca_system_score_codex":0.0005411856,"about_ca_system_score_gemma":0.00083883264,"threshold_uncertainty_score":0.008782566},"labels":[],"label_agreement":null},{"id":"W2095086994","doi":"10.1016/s0145-2126(02)00002-4","title":"Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"CTL*; Dendritic cell; CD86; Immune system; Priming (agriculture); CD40; Biology; Cell fusion; Immunology; CD80; Immunotherapy; Immunity; Cytotoxic T cell; T cell; In vitro; Cell culture; CD8","score_opus":0.02628098346899559,"score_gpt":0.2836075055417486,"score_spread":0.257326522072753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095086994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918109,0.0007278466,0.0053096744,0.000114594,0.00011075913,0.00005332466,0.00014999251,0.00014948254,0.0015733815],"genre_scores_gemma":[0.99590045,0.00024066256,0.0019770185,0.000045106135,0.000027998438,0.000025646152,0.00018884525,0.000016297892,0.0015780636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978596,0.00003206307,0.00001447084,0.000039370458,0.000047599573,0.000080601865],"domain_scores_gemma":[0.9998646,0.000036194662,0.000027227372,0.00002118089,0.000018217794,0.0000325969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021436509,0.000483731,0.00048290126,0.00035143225,0.00017214048,0.00047411566,0.0003048925,0.00042940592,0.001628045],"category_scores_gemma":[0.00014748843,0.00019780174,0.00026730972,0.00021892607,0.00025350225,0.00033997142,0.00034679903,0.0012408881,0.00043003392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003129318,0.00014479725,0.00018016667,0.000030535834,0.000011917167,0.000036185575,0.000012830215,0.00036313836,0.99622643,0.00043257693,0.00007380541,0.0021746513],"study_design_scores_gemma":[0.00007909621,0.0005709321,0.00046797458,0.0000034695854,0.000038627903,0.0001467236,0.000013128691,0.0017938385,0.99512875,0.00012784894,0.0016250606,0.000004470916],"about_ca_topic_score_codex":0.00026184059,"about_ca_topic_score_gemma":0.00024054883,"teacher_disagreement_score":0.001628045,"about_ca_system_score_codex":0.0004374812,"about_ca_system_score_gemma":0.00034886374,"threshold_uncertainty_score":0.005446315},"labels":[],"label_agreement":null},{"id":"W2096848137","doi":"10.1016/j.leukres.2014.04.008","title":"Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Facilities Council; Natural Sciences and Engineering Research Council of Canada; Science and Technology Development Fund","keywords":"Telomerase; Telomerase reverse transcriptase; Telomere; Telomerase RNA component; Biology; Cancer research; Reverse transcriptase; Molecular biology; Genetics; DNA; RNA; Gene","score_opus":0.023649398371706636,"score_gpt":0.2954190187352776,"score_spread":0.27176962036357094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096848137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983912,0.0008085549,0.00004980008,0.00006522267,0.000007082836,0.000001957551,0.00009711943,0.000004037068,0.0005750151],"genre_scores_gemma":[0.9994011,0.00022296087,0.00004298066,0.000021497044,0.000014784386,0.0000017317819,0.00010488464,0.0000015251736,0.00018857967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997813,0.00004778282,0.000045299228,0.000044340653,0.000052144314,0.000029096398],"domain_scores_gemma":[0.9993162,0.00019325249,0.00026602088,0.000034156663,0.00007467434,0.00011573346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031345355,0.0002656319,0.00031362392,0.0010264853,0.00042066825,0.00053603516,0.00027389318,0.00058508804,0.0012781846],"category_scores_gemma":[0.0019368017,0.00017446447,0.00021312578,0.0010567874,0.00030265324,0.000454283,0.00020541779,0.00044962222,0.00015079342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049227127,0.000031351497,0.99072427,0.000010108498,0.000039582595,0.0017826793,0.0001300325,0.00010968,0.0021600907,0.00011989419,0.000091770155,0.004308324],"study_design_scores_gemma":[0.000026914162,0.00027530052,0.9849546,0.000014474695,0.000099837685,0.012305017,0.00041477047,0.0003586116,0.0006481219,0.00032116746,0.000570948,0.000010357648],"about_ca_topic_score_codex":0.0013395827,"about_ca_topic_score_gemma":0.0013021512,"teacher_disagreement_score":0.0013395827,"about_ca_system_score_codex":0.00023434129,"about_ca_system_score_gemma":0.00019602595,"threshold_uncertainty_score":0.0042759776},"labels":[],"label_agreement":null},{"id":"W2099334882","doi":"10.1016/j.leukres.2006.08.002","title":"Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Cancer Research Society","keywords":"Bortezomib; Multiple myeloma; Internal medicine; Fluorescence in situ hybridization; Refractory (planetary science); Medicine; Gastroenterology; Salvage therapy; Oncology; Cytogenetics; Chemotherapy; Biology; Chromosome","score_opus":0.06428577554715627,"score_gpt":0.36019112052934144,"score_spread":0.2959053449821852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099334882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797994,0.0010648092,0.00007087813,0.0000963539,0.000008829742,0.000008583942,0.00014648536,0.000020626652,0.0006035656],"genre_scores_gemma":[0.99929094,0.00015813058,0.00007104383,0.00005087583,0.00001803936,0.0000054443226,0.00019327931,0.000007608509,0.00020460476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940836,0.00019385121,0.000062123814,0.00007148356,0.00017317155,0.00009100765],"domain_scores_gemma":[0.99697,0.0011796949,0.0010777476,0.00024247413,0.00013600956,0.00039421517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010147237,0.00021831656,0.00083756197,0.0008307117,0.0002854292,0.000784725,0.00037321096,0.0004238472,0.0017329934],"category_scores_gemma":[0.0030963907,0.00025556915,0.00030729803,0.00066347,0.00044023764,0.0004379443,0.00023932265,0.00078053813,0.00033871504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037340257,0.00085281755,0.6769064,0.00020251557,0.0006241084,0.0013424895,0.0003737583,0.0013288474,0.20768559,0.00043264215,0.0015825093,0.071328126],"study_design_scores_gemma":[0.00029762,0.0013369605,0.990141,0.000010172677,0.00013479545,0.0015882227,0.00006687321,0.00071594556,0.0047347,0.0002297514,0.0007304392,0.000013480748],"about_ca_topic_score_codex":0.001332888,"about_ca_topic_score_gemma":0.0015481978,"teacher_disagreement_score":0.0017329934,"about_ca_system_score_codex":0.0005736631,"about_ca_system_score_gemma":0.00037435105,"threshold_uncertainty_score":0.0057975054},"labels":[],"label_agreement":null},{"id":"W2102107035","doi":"10.1016/j.leukres.2006.10.001","title":"Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Myeloid leukemia; Cancer research; Matrix metalloproteinase; Angiogenesis; Leukemia; Catechin; Secretion; Myeloid; Epicatechin gallate; Epigallocatechin gallate; Chemistry; Biology; Molecular biology; Immunology; Biochemistry; Polyphenol","score_opus":0.01868978015668817,"score_gpt":0.29305602553917054,"score_spread":0.2743662453824824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102107035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574286,0.0017250113,0.00075961184,0.00016845284,0.000055082404,0.00001947959,0.00038563946,0.00007353091,0.0010702853],"genre_scores_gemma":[0.9927631,0.0011374981,0.0009513892,0.00008158943,0.000026171623,0.000046257584,0.00090448227,0.000015583855,0.0040738774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998,0.000029901772,0.00002224036,0.000021503329,0.000029967176,0.00009633163],"domain_scores_gemma":[0.9999387,0.00001405512,0.000009811905,0.000012772715,0.000007628093,0.000017096738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014630247,0.00040932215,0.00044910389,0.0003010899,0.00028855333,0.00030788512,0.00019648441,0.00024731422,0.0012680226],"category_scores_gemma":[0.00008819781,0.0002308571,0.0005493543,0.00027836196,0.00028856986,0.0002057269,0.000189265,0.0007878866,0.00043069053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066732924,0.00006764277,0.00015244524,0.000040347306,0.000011251809,0.000057414632,0.00003254593,0.000035508914,0.9978269,0.00006387528,0.00006584554,0.0009788905],"study_design_scores_gemma":[0.00006113299,0.0003923828,0.004471404,0.0000034660034,0.000028477132,0.00007906415,0.000049093498,0.00031020117,0.9932192,0.00003495602,0.0013461969,0.0000044884314],"about_ca_topic_score_codex":0.0022117621,"about_ca_topic_score_gemma":0.0034166086,"teacher_disagreement_score":0.0022117621,"about_ca_system_score_codex":0.00032605446,"about_ca_system_score_gemma":0.00033422283,"threshold_uncertainty_score":0.00439775},"labels":[],"label_agreement":null},{"id":"W2102640163","doi":"10.1016/s0145-2126(01)00010-8","title":"CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis","year":2001,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Apoptosis; Programmed cell death; CD28; CD8; Cell biology; Fas ligand; Biology; CD3; Lymphocyte; Cytotoxic T cell; Chemistry; Molecular biology; Immunology; In vitro; Antigen; Biochemistry","score_opus":0.043982405355010995,"score_gpt":0.3521894276525018,"score_spread":0.30820702229749075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102640163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979037,0.0003083583,0.00049295306,0.00006231389,0.000024365656,0.00001653656,0.00026097253,0.00006952312,0.0008612378],"genre_scores_gemma":[0.99771655,0.00009680782,0.0003144873,0.00003178012,0.000011390883,0.000028324379,0.0004819734,0.000027608097,0.0012911379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996075,0.000067110974,0.000042996755,0.00006465556,0.000068393645,0.00014932292],"domain_scores_gemma":[0.9993216,0.00014266631,0.00014345217,0.00014930271,0.000061811734,0.00018124233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022099414,0.00043956732,0.00064074126,0.00080958963,0.00042979003,0.0007294832,0.00061596656,0.0009589265,0.0043619266],"category_scores_gemma":[0.00041700221,0.00037816336,0.00030381454,0.0003646987,0.0008239983,0.0006296068,0.0003658161,0.0013374903,0.0012255616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011869867,0.00019693837,0.0022155875,0.00004893496,0.000021030552,0.0005861539,0.00007242928,0.0001495021,0.9926456,0.000450368,0.00019455823,0.0022317555],"study_design_scores_gemma":[0.000912471,0.0026791135,0.0458886,0.000028880615,0.00014678233,0.011808883,0.00068166706,0.0024415823,0.9288239,0.0014596146,0.0050873505,0.00004107637],"about_ca_topic_score_codex":0.00039461325,"about_ca_topic_score_gemma":0.00046463957,"teacher_disagreement_score":0.0043619266,"about_ca_system_score_codex":0.00035829606,"about_ca_system_score_gemma":0.00017155714,"threshold_uncertainty_score":0.014592111},"labels":[],"label_agreement":null},{"id":"W2103243005","doi":"10.1016/j.leukres.2007.10.003","title":"The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancerfonden; Swedish Cancer Foundation; Cancer Research Society","keywords":"IGHV@; Chronic lymphocytic leukemia; GNAS complex locus; Single-nucleotide polymorphism; SNP; Oncology; Internal medicine; Genotype; CD38; Cohort; Medicine; Leukemia; Immunology; Biology; Genetics; Gene","score_opus":0.16642233714392834,"score_gpt":0.4781560145288114,"score_spread":0.31173367738488306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103243005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803466,0.00072115683,0.000053750497,0.0003967078,0.000027655353,0.0000026903508,0.00016855786,0.0000053561293,0.00058951316],"genre_scores_gemma":[0.9995685,0.00010411267,0.000047761492,0.000046528905,0.000044906512,0.0000017170695,0.00009254119,0.000002537427,0.000091402966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992926,0.00026940962,0.00010218628,0.0001150477,0.00011999653,0.000100734025],"domain_scores_gemma":[0.9942801,0.0020757106,0.0015967705,0.00040444123,0.0004476353,0.0011952177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011929447,0.00043004475,0.0006987892,0.0012617152,0.00066354364,0.00085307774,0.0007415988,0.0009846855,0.0018123188],"category_scores_gemma":[0.006932858,0.00019470061,0.00034662962,0.0023261008,0.0008150102,0.0006381387,0.00039630345,0.00087204017,0.00032661538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003277993,0.000061726205,0.9862345,0.00002280244,0.00015687477,0.00072057755,0.00007444956,0.00015881466,0.0036795465,0.000097058866,0.000254153,0.0052614966],"study_design_scores_gemma":[0.00021507696,0.00048216782,0.9911641,0.000021725917,0.00025946426,0.0038779904,0.0002165822,0.00096230936,0.0009312735,0.00084880955,0.0010009713,0.000019572886],"about_ca_topic_score_codex":0.0027401182,"about_ca_topic_score_gemma":0.0025066577,"teacher_disagreement_score":0.0027401182,"about_ca_system_score_codex":0.00056988804,"about_ca_system_score_gemma":0.00065223756,"threshold_uncertainty_score":0.006308973},"labels":[],"label_agreement":null},{"id":"W2103291845","doi":"10.1016/s0145-2126(02)00040-1","title":"The novel helicase homologue DDX32 is down-regulated in acute lymphoblastic leukemia","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Helicase; Gene; Biology; Genetics; RNA Helicase A; Exon; Homology (biology); Coding region; Conserved sequence; Peptide sequence","score_opus":0.05516609748878513,"score_gpt":0.3378502918039867,"score_spread":0.28268419431520153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103291845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391514,0.004014422,0.00046155398,0.00014045041,0.000038849583,0.0000078418725,0.0005077808,0.00006110055,0.0008528239],"genre_scores_gemma":[0.996086,0.0010883197,0.00030270292,0.000039677027,0.000018094974,0.000008710776,0.000861291,0.000013533214,0.0015817087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985886,0.000016054439,0.000010830424,0.000027982462,0.0000446303,0.00004166425],"domain_scores_gemma":[0.99980944,0.00002894505,0.00007557558,0.000018062876,0.000019732184,0.00004826156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009296252,0.00021200541,0.0003445034,0.00044723338,0.00028887318,0.00055841554,0.00011963314,0.00023737464,0.0017966306],"category_scores_gemma":[0.0002715406,0.00020365832,0.000118003336,0.0003656306,0.0002321209,0.0001705443,0.00026142152,0.00039158855,0.0005639612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004631465,0.000017382717,0.004758368,0.000050134968,0.000012856105,0.0006037169,0.00004130945,0.000060102033,0.9904929,0.00014090177,0.00037141773,0.002987752],"study_design_scores_gemma":[0.00015134574,0.00050671154,0.35340255,0.000032865122,0.00011164442,0.011003352,0.0004176009,0.0013572375,0.6109338,0.0005748122,0.021487877,0.000020163521],"about_ca_topic_score_codex":0.00042119127,"about_ca_topic_score_gemma":0.00056017045,"teacher_disagreement_score":0.0017966306,"about_ca_system_score_codex":0.00028700999,"about_ca_system_score_gemma":0.0001785084,"threshold_uncertainty_score":0.0060103536},"labels":[],"label_agreement":null},{"id":"W2106234158","doi":"10.1016/s0145-2126(03)00076-6","title":"Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia","year":2003,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Abnormality; Trisomy; Cytogenetics; Chromosomal Abnormality; Clinical significance; Myeloid leukemia; Acute myeloblastic leukemia; Trisomy 8; Chromosome abnormality; Internal medicine; Medicine; Aneuploidy; Leukemia; Oncology; Karyotype; Pathology; Biology; Chromosome; Genetics","score_opus":0.10789559779961926,"score_gpt":0.42323121666036095,"score_spread":0.3153356188607417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106234158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002114075,0.9990682,0.000039462968,0.00021756071,0.00008555903,0.0000016772232,0.000023604585,0.0000024051592,0.00035010418],"genre_scores_gemma":[0.0013311129,0.9981674,0.000091116824,0.0001277367,0.00010053035,0.0000016461655,0.000035712055,5.5596115e-7,0.00014414886],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996952,0.00005424363,0.00006954983,0.000055754972,0.00010878599,0.000016474474],"domain_scores_gemma":[0.9990464,0.00047257895,0.0001688023,0.00001450003,0.00025779,0.000039956678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084928604,0.00054896827,0.0017750214,0.0029508236,0.00017000818,0.0008309282,0.0008955968,0.0006134792,0.0014147459],"category_scores_gemma":[0.0022238195,0.00020569611,0.00041766223,0.004232586,0.0004372575,0.00076024124,0.00038352463,0.0006683991,0.00052851415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017516325,0.00001711068,0.0033314247,0.017210709,0.00023736322,0.00055028097,0.000050688188,0.00021733118,0.00081635907,0.00077772303,0.025325358,0.9512906],"study_design_scores_gemma":[0.00011198163,0.00018195108,0.020103479,0.018286934,0.002674897,0.008639146,0.00031397698,0.0001805143,0.001041074,0.002283014,0.94611484,0.000068137895],"about_ca_topic_score_codex":0.0033184858,"about_ca_topic_score_gemma":0.005592568,"teacher_disagreement_score":0.0033184858,"about_ca_system_score_codex":0.00067293044,"about_ca_system_score_gemma":0.0018859997,"threshold_uncertainty_score":0.0065983534},"labels":[],"label_agreement":null},{"id":"W2108145697","doi":"10.1016/j.leukres.2010.05.029","title":"p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; CancerCare Manitoba; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Dasatinib; Autophagy; Chronic lymphocytic leukemia; Cancer research; Endoplasmic reticulum; Medicine; Leukemia; Cytotoxic T cell; Immunology; In vitro; Apoptosis; Biology; Imatinib; Cell biology; Myeloid leukemia","score_opus":0.030326447120379046,"score_gpt":0.36152442372722693,"score_spread":0.3311979766068479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108145697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930576,0.0028621512,0.0004645513,0.00035486795,0.000036249072,0.000024787681,0.0004780068,0.00008567272,0.002636139],"genre_scores_gemma":[0.99801373,0.0003662148,0.00011256939,0.00004900236,0.0000122958045,0.000016868096,0.00027727013,0.0000072187554,0.0011448908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957925,0.000075941556,0.000039416,0.00005699358,0.00010329065,0.00014502293],"domain_scores_gemma":[0.99972194,0.00008002664,0.000042667485,0.00005274447,0.00004547205,0.00005705191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029636538,0.00023937375,0.0005639505,0.000504574,0.00049363344,0.001280176,0.00025360403,0.0005948523,0.0050828503],"category_scores_gemma":[0.0004957419,0.00030421163,0.00040380785,0.00034025626,0.00031079122,0.0005009023,0.00037986878,0.001128718,0.0011036578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033834688,0.00058533956,0.016696716,0.00022011549,0.00010707805,0.001089335,0.00020747865,0.00041676377,0.9547201,0.0009528079,0.002480626,0.01914008],"study_design_scores_gemma":[0.00064452324,0.0027901176,0.17413343,0.000051647392,0.00022750635,0.010904809,0.0010887253,0.0037463324,0.78681415,0.0012322405,0.018325925,0.00004054055],"about_ca_topic_score_codex":0.0005458793,"about_ca_topic_score_gemma":0.001041636,"teacher_disagreement_score":0.0050828503,"about_ca_system_score_codex":0.0006795025,"about_ca_system_score_gemma":0.00035435596,"threshold_uncertainty_score":0.017003834},"labels":[],"label_agreement":null},{"id":"W2116177153","doi":"10.1016/j.leukres.2009.05.020","title":"Susceptibility of mantle cell lymphomas to reovirus oncolysis","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Cytopathic effect; Lymphoma; Cancer research; Cell culture; In vivo; Virology; In vitro; Oncolytic virus; Cell; Biology; Medicine; Virus; Immunology; Tumor cells; Biochemistry; Genetics","score_opus":0.038046361106444916,"score_gpt":0.370724057029703,"score_spread":0.3326776959232581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116177153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974185,0.00035135067,0.00072288787,0.00005072378,0.000015217075,0.000020910014,0.00011460021,0.000051815106,0.0012538856],"genre_scores_gemma":[0.99939966,0.00007596442,0.000055443827,0.000011154886,0.0000071463473,0.000007658815,0.00008591313,0.0000072314965,0.0003497694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995752,0.00016013948,0.00003093033,0.00006833751,0.0000649573,0.00010036116],"domain_scores_gemma":[0.99888915,0.00041594522,0.0001314493,0.0003115133,0.00007726246,0.00017464565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047423615,0.00024338062,0.0003036049,0.0009577628,0.00023504818,0.00046272395,0.00021203836,0.00035763197,0.0040693763],"category_scores_gemma":[0.0011235799,0.00019216463,0.0003068694,0.00021789732,0.0002627053,0.0003143001,0.00035351224,0.0007460531,0.00047613517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021286022,0.00039974524,0.01448135,0.000038508457,0.0000571617,0.00034105577,0.000183367,0.0003634405,0.97567517,0.000828956,0.0002176827,0.0052850307],"study_design_scores_gemma":[0.00023538606,0.0078000473,0.18981951,0.00002835546,0.00022652882,0.00938218,0.0008476158,0.004681075,0.77871084,0.001819694,0.0063997507,0.000049004222],"about_ca_topic_score_codex":0.0006156388,"about_ca_topic_score_gemma":0.00025188876,"teacher_disagreement_score":0.0040693763,"about_ca_system_score_codex":0.00024232453,"about_ca_system_score_gemma":0.0001311508,"threshold_uncertainty_score":0.013613462},"labels":[],"label_agreement":null},{"id":"W2116251489","doi":"10.1016/j.leukres.2007.03.011","title":"Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changjiang Scholar Program of Chinese Ministry of Education; Institute of Genetics; National Natural Science Foundation of China","keywords":"Camptothecin; Acute promyelocytic leukemia; Medicine; Apoptosis; Myeloid leukemia; Pharmacology; In vitro; Cytarabine; Cancer research; Leukemia; Myeloid; Immunology; Biology; Cell culture; Retinoic acid","score_opus":0.04523862598922479,"score_gpt":0.34851472211330575,"score_spread":0.30327609612408096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116251489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952974,0.0012611684,0.00078425475,0.00022354584,0.00008050098,0.00006935478,0.00043789798,0.00014270576,0.001703222],"genre_scores_gemma":[0.99639136,0.0010043985,0.0007179376,0.000051438146,0.000020419784,0.000055566998,0.0003254608,0.000012536573,0.0014209694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982387,0.000028946242,0.000016520966,0.000024828216,0.000048603593,0.000057168247],"domain_scores_gemma":[0.99986875,0.000022304317,0.000035219462,0.000016078977,0.00000847284,0.000049188293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020074597,0.00049209764,0.0007535898,0.0006964158,0.00027361835,0.00032852255,0.00038372522,0.0006374561,0.00084332266],"category_scores_gemma":[0.00011052525,0.00013798305,0.0003084292,0.00036923148,0.00056407147,0.00031549917,0.00015205855,0.001284255,0.00018701958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003685707,0.0012965816,0.00028216044,0.00013107159,0.00003593609,0.00019061421,0.000047911337,0.00097193604,0.9815725,0.00062983704,0.0003903016,0.010765545],"study_design_scores_gemma":[0.000765529,0.008615283,0.0020068628,0.000017381626,0.00012712942,0.00037003527,0.000044739547,0.0021260944,0.9832744,0.00017221208,0.0024638432,0.000016356347],"about_ca_topic_score_codex":0.0013129452,"about_ca_topic_score_gemma":0.0017022768,"teacher_disagreement_score":0.0013129452,"about_ca_system_score_codex":0.0003523489,"about_ca_system_score_gemma":0.00046128719,"threshold_uncertainty_score":0.0028211474},"labels":[],"label_agreement":null},{"id":"W2117111164","doi":"10.1016/j.leukres.2014.01.003","title":"Standardizing dysgranulopoiesis in MDS and AML: Refining diagnostics and laying the foundation for novel morphological-genetic correlations","year":2014,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research Council; European Hematology Association","keywords":"Myeloid leukemia; Imatinib mesylate; Medicine; Mutation; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Point mutation; Drug resistance; Imatinib; Protein kinase domain; Cancer research; Genetics; Biology; Cancer; Gene","score_opus":0.11842634867562067,"score_gpt":0.3782195400815864,"score_spread":0.25979319140596574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117111164","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001002511,0.0030697172,0.0008270491,0.98653245,0.0069510313,0.000017192839,0.000041992163,0.00003649414,0.0015216621],"genre_scores_gemma":[0.029823858,0.0060992558,0.00487967,0.87639284,0.07886138,0.00008257039,0.00009877012,0.00004075997,0.003720856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965693,0.0014581692,0.00061670505,0.00028877304,0.00085251435,0.00021458541],"domain_scores_gemma":[0.9879104,0.008132487,0.00047730978,0.0005259689,0.0022084564,0.0007452953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041948915,0.00051759573,0.001694142,0.00071726413,0.0016737283,0.0022327108,0.0015243718,0.019658403,0.0022702182],"category_scores_gemma":[0.027757771,0.00045184637,0.000843066,0.0005277784,0.003189189,0.003675354,0.0016480662,0.023829881,0.0019705484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030173958,0.00019292263,0.007779388,0.00021949428,0.000071220835,0.008193517,0.00024550143,0.0007265699,0.0015608994,0.016087012,0.8225944,0.14202732],"study_design_scores_gemma":[0.00051916233,0.00041185456,0.0062237936,0.00075408764,0.00015960785,0.02355138,0.00085883227,0.004115893,0.002659147,0.15349248,0.80708736,0.00016648698],"about_ca_topic_score_codex":0.0016810114,"about_ca_topic_score_gemma":0.0033019437,"teacher_disagreement_score":0.019658403,"about_ca_system_score_codex":0.0031941722,"about_ca_system_score_gemma":0.002698779,"threshold_uncertainty_score":0.023175418},"labels":[],"label_agreement":null},{"id":"W2119733997","doi":"10.1016/j.leukres.2013.03.001","title":"All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Acute promyelocytic leukemia; Medicine; Chemotherapy; Retinoic acid; Randomized controlled trial; Induction chemotherapy; Internal medicine; Surgery; Pediatrics; Gastroenterology","score_opus":0.019261250513052133,"score_gpt":0.299783781594682,"score_spread":0.2805225310816299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119733997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737024,0.0008969622,0.000079399964,0.00008364957,0.000018958886,0.000014369876,0.0010520859,0.000007855935,0.0004763694],"genre_scores_gemma":[0.9970004,0.00034245092,0.000033237287,0.000051274892,0.00003001078,0.000016266828,0.0019003954,0.000004259459,0.0006217305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994118,0.00015948954,0.000052782747,0.00010700914,0.00009026435,0.00017864963],"domain_scores_gemma":[0.9985707,0.00016325025,0.00048529255,0.00016701678,0.00018807362,0.000425637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010780097,0.00052527635,0.0008131562,0.0011823147,0.001148406,0.0013802444,0.0008367738,0.00092065777,0.0009466503],"category_scores_gemma":[0.0015206394,0.00040271683,0.00079553586,0.0019891188,0.0004986338,0.0009669173,0.000760733,0.0012827849,0.0003909192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002057736,0.00021344515,0.99236625,0.000014974415,0.00018757326,0.00034816045,0.00022704505,0.000083054656,0.0006654671,0.00003164206,0.00030939083,0.0034952832],"study_design_scores_gemma":[0.000041102692,0.00033815863,0.99829525,0.0000078006315,0.00011670773,0.00023482734,0.00036889958,0.000064815555,0.000090621594,0.000030274408,0.00040084726,0.000010665453],"about_ca_topic_score_codex":0.014831161,"about_ca_topic_score_gemma":0.012869349,"teacher_disagreement_score":0.014831161,"about_ca_system_score_codex":0.00062333216,"about_ca_system_score_gemma":0.00068659405,"threshold_uncertainty_score":0.029489636},"labels":[],"label_agreement":null},{"id":"W2121112512","doi":"10.1016/j.leukres.2007.06.013","title":"Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Sciences Centre Foundation; Amgen","keywords":"Apoptosis; Bone marrow; Stromal cell; Progenitor cell; Biology; In vitro; Myeloid leukemia; In vivo; Myeloid; Cell growth; Cancer research; Peripheral blood mononuclear cell; Immunology; Leukemia; Cell biology; Stem cell; Genetics","score_opus":0.022879054072160572,"score_gpt":0.3158942908060971,"score_spread":0.29301523673393653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121112512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943901,0.001822007,0.000942418,0.00005412806,0.000017586104,0.00003204099,0.0009311783,0.000042016425,0.0017685293],"genre_scores_gemma":[0.9949626,0.000772974,0.0008931719,0.000053282052,0.000028944563,0.00007507111,0.0016129385,0.00001240898,0.0015886071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997998,0.000055778146,0.000022868915,0.00002886351,0.00006191212,0.00003081925],"domain_scores_gemma":[0.99980503,0.000045827474,0.0000492489,0.000026930073,0.00003098994,0.000042055373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013989555,0.00024364391,0.00030605015,0.0005401447,0.00023238087,0.00034125423,0.00011836779,0.00021567328,0.003327638],"category_scores_gemma":[0.00028838447,0.00014791165,0.00013147485,0.0003245828,0.00011283643,0.00012669487,0.0002288396,0.00028144877,0.0009491398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012552765,0.00007370166,0.021356039,0.000098920056,0.000027705153,0.0008147787,0.00020259639,0.00009009601,0.96806985,0.00019292855,0.00023972616,0.007578424],"study_design_scores_gemma":[0.00027767528,0.0019941311,0.3961647,0.000048451475,0.00021920368,0.019132493,0.00080489664,0.0008700145,0.5565415,0.00040512983,0.023517268,0.000024605115],"about_ca_topic_score_codex":0.0003703857,"about_ca_topic_score_gemma":0.0005170659,"teacher_disagreement_score":0.003327638,"about_ca_system_score_codex":0.00011219771,"about_ca_system_score_gemma":0.000082154096,"threshold_uncertainty_score":0.0111320615},"labels":[],"label_agreement":null},{"id":"W2125735390","doi":"10.1016/j.leukres.2009.07.043","title":"Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; McGill University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Daunorubicin; Etoposide; Leukemia; Cytotoxic T cell; Cytarabine; Cancer research; Chemistry; Pharmacology; Biology; In vitro; Biochemistry; Immunology; Chemotherapy","score_opus":0.03392273483800691,"score_gpt":0.34130229196626527,"score_spread":0.3073795571282584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125735390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98366874,0.0068561663,0.0011504029,0.00046591298,0.00047631588,0.00023341316,0.0009865919,0.00022090663,0.0059416285],"genre_scores_gemma":[0.9916638,0.0029485642,0.0018764338,0.00011189466,0.00014570827,0.000145955,0.00079989585,0.000030248935,0.0022775214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958116,0.00010243027,0.000057101464,0.000059766764,0.000099332705,0.00010024181],"domain_scores_gemma":[0.999681,0.000084072606,0.000035658486,0.000050994466,0.000030447456,0.00011798815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039198593,0.0010013955,0.0015321319,0.0009788405,0.0005764749,0.0007830566,0.00055514567,0.0005447278,0.0026628303],"category_scores_gemma":[0.00039148045,0.0003751597,0.0007245699,0.001063632,0.00040554997,0.0003534957,0.0005778347,0.0012554253,0.00068482757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014568768,0.0034577122,0.0021189651,0.00061290024,0.00029756856,0.00062940584,0.00021791809,0.0033339623,0.9293629,0.000995111,0.0027067494,0.041698005],"study_design_scores_gemma":[0.0009751233,0.010936634,0.007652645,0.000036068628,0.00032821682,0.00070123025,0.00011406448,0.0019762442,0.9652191,0.00019066424,0.01182381,0.000046293026],"about_ca_topic_score_codex":0.0013377228,"about_ca_topic_score_gemma":0.004215722,"teacher_disagreement_score":0.0026628303,"about_ca_system_score_codex":0.0005998774,"about_ca_system_score_gemma":0.0010242981,"threshold_uncertainty_score":0.008908093},"labels":[],"label_agreement":null},{"id":"W2127147516","doi":"10.1016/j.leukres.2008.02.021","title":"Iron overload in myelodysplastic syndromes: A Canadian consensus guideline","year":2008,"lang":"en","type":"editorial","venue":"Leukemia Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; BC Cancer Agency; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; McMaster University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Diamond Blackfan Anemia Foundation","keywords":"Guideline; Medicine; Myelodysplastic syndromes; Clinical Practice; Intensive care medicine; Expert opinion; Mandate; Family medicine; Internal medicine; Pathology","score_opus":0.039923936664683496,"score_gpt":0.36495552449591284,"score_spread":0.3250315878312293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127147516","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012159447,0.1173003,0.000682816,0.304486,0.5701161,0.00019587789,0.00048409347,0.00008003158,0.006533181],"genre_scores_gemma":[0.0021073392,0.16514625,0.0025865636,0.26610276,0.5459347,0.0003660917,0.0006520222,0.00008378348,0.017020594],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98962516,0.0018708931,0.002641116,0.0005722326,0.0045965975,0.00069402583],"domain_scores_gemma":[0.94578093,0.014303654,0.0033324328,0.0005100886,0.031931635,0.004141215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01302757,0.002850644,0.0055452846,0.007476447,0.0036746524,0.006383344,0.0055158143,0.022027537,0.004624153],"category_scores_gemma":[0.040588535,0.0014328893,0.0040663104,0.005007806,0.0036363427,0.0031041987,0.001905216,0.02744641,0.00336062],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021389977,0.000009758802,0.000044590273,0.00051585224,0.000037338203,0.00010022322,0.000021157475,0.00002859493,0.000021816515,0.0001603332,0.9916893,0.007349626],"study_design_scores_gemma":[0.00023029686,0.000018625753,0.0007581995,0.005144693,0.0003065029,0.0004011577,0.00008148897,0.00013272038,0.0000651844,0.0006061534,0.99220204,0.000053007032],"about_ca_topic_score_codex":0.18270564,"about_ca_topic_score_gemma":0.36263025,"teacher_disagreement_score":0.81729436,"about_ca_system_score_codex":0.01593155,"about_ca_system_score_gemma":0.046260566,"threshold_uncertainty_score":0.36328435},"labels":[],"label_agreement":null},{"id":"W2131671733","doi":"10.1016/j.leukres.2008.01.008","title":"Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Lymphoma; Angiogenesis; Medicine; Immunohistochemistry; Carcinogenesis; Epstein–Barr virus; Pathology; Immunology; Virus; Cancer research; Internal medicine; Cancer","score_opus":0.05021236526045336,"score_gpt":0.3500590489006126,"score_spread":0.29984668364015926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131671733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979494,0.0010933623,0.00010012953,0.00004897949,0.000012605476,0.0000030892372,0.0000952515,0.0000070724072,0.0006901256],"genre_scores_gemma":[0.9994332,0.00016962933,0.00006052717,0.0000074250765,0.000030864827,0.000004033681,0.00008429935,0.0000015188301,0.00020838038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997814,0.00006759338,0.00002252366,0.000030935527,0.000038942864,0.00005855033],"domain_scores_gemma":[0.99893457,0.0004635207,0.00023167251,0.000049585284,0.00011022284,0.00021039216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055578497,0.00017696858,0.00023655924,0.00080915156,0.00036078176,0.0006247054,0.0002559037,0.00040027112,0.0017067954],"category_scores_gemma":[0.001837381,0.00016647125,0.0001428072,0.00063367357,0.0003661423,0.0006418472,0.00026176893,0.00037226736,0.00024941674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017568838,0.00004827628,0.9771937,0.00004202825,0.000072382805,0.0006139852,0.00012155827,0.00017791444,0.009516442,0.00011834861,0.00025172162,0.010086679],"study_design_scores_gemma":[0.000034823923,0.00018772029,0.9923982,0.000009494399,0.00010631698,0.0020621056,0.0003426208,0.00091726775,0.0027366646,0.00020247968,0.0009940095,0.000008268229],"about_ca_topic_score_codex":0.0008077206,"about_ca_topic_score_gemma":0.0009683246,"teacher_disagreement_score":0.0017067954,"about_ca_system_score_codex":0.00034056927,"about_ca_system_score_gemma":0.00021357779,"threshold_uncertainty_score":0.005709827},"labels":[],"label_agreement":null},{"id":"W2134390751","doi":"10.1016/j.leukres.2014.07.008","title":"CLL—Clear sailing ahead for many, while rough waters remain for some","year":2014,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Environmental science","score_opus":0.1405077939171797,"score_gpt":0.4000109766601689,"score_spread":0.25950318274298917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134390751","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002320827,0.001328479,0.000051599538,0.98799825,0.008470886,0.0000051048137,0.000017281456,0.000017185475,0.0018790526],"genre_scores_gemma":[0.004014722,0.0018688522,0.0002685631,0.94421107,0.04061479,0.000019651034,0.000026975425,0.000019804158,0.00895557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694484,0.0011175115,0.0003316889,0.00031805897,0.00087564834,0.00041224808],"domain_scores_gemma":[0.99545515,0.0015797577,0.00026584047,0.00016798134,0.0007134031,0.0018178858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027227886,0.00075191807,0.0011963431,0.00062225957,0.004593218,0.00423073,0.0013588022,0.042168427,0.010350743],"category_scores_gemma":[0.016380107,0.0005508292,0.000928112,0.00047153042,0.0034601418,0.00468706,0.0020484973,0.03585067,0.006638754],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007133667,0.000046364043,0.0010956561,0.00003577256,0.000017069233,0.0016735694,0.000073224895,0.000049275117,0.00019661909,0.0033978338,0.9804951,0.012848159],"study_design_scores_gemma":[0.000225808,0.00012442896,0.0014772643,0.00035091682,0.0000320346,0.0039688507,0.0006091777,0.0003571454,0.00022219421,0.021004004,0.97156537,0.00006268387],"about_ca_topic_score_codex":0.0042015375,"about_ca_topic_score_gemma":0.00842286,"teacher_disagreement_score":0.042168427,"about_ca_system_score_codex":0.004207243,"about_ca_system_score_gemma":0.004131268,"threshold_uncertainty_score":0.034626663},"labels":[],"label_agreement":null},{"id":"W2135893584","doi":"10.1016/j.leukres.2011.07.016","title":"Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"Alberta Heritage Foundation for Medical Research; Alberta Cancer Foundation","keywords":"Multiple myeloma; PLK1; Cancer research; Bone marrow; Centrosome; Medicine; Plasma Cell Myeloma; Internal medicine; Cell cycle; Cancer","score_opus":0.10407348632317467,"score_gpt":0.3334838629593509,"score_spread":0.22941037663617622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135893584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918779,0.0056964345,0.00022520403,0.00054525194,0.000038446236,0.0000094180805,0.00019897665,0.000015453952,0.0013930016],"genre_scores_gemma":[0.99795073,0.0009289488,0.00009854525,0.00005957364,0.000041429295,0.0000065155705,0.00018646392,0.0000026097662,0.000725238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998252,0.000047068315,0.00001394852,0.000024206935,0.000046676203,0.000042888245],"domain_scores_gemma":[0.9996581,0.00012122642,0.00010989391,0.000027146463,0.000030098501,0.000053504053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005052321,0.00017567453,0.0003069332,0.00038987008,0.0002268603,0.0006819876,0.00024447395,0.00035366762,0.0012496844],"category_scores_gemma":[0.00090920663,0.00018021606,0.00017060642,0.0004175639,0.00031464247,0.00036680387,0.00015475703,0.00064614165,0.00020285965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027623571,0.0009359826,0.40203172,0.00032724274,0.00037797395,0.0014304543,0.00024107863,0.0025597312,0.4372468,0.002050685,0.0024783493,0.122696355],"study_design_scores_gemma":[0.00075762195,0.005979864,0.8057665,0.000041734453,0.00065354584,0.0043550264,0.00045905952,0.0062173186,0.15790963,0.0023592317,0.015460675,0.00003978924],"about_ca_topic_score_codex":0.00047861264,"about_ca_topic_score_gemma":0.0005948186,"teacher_disagreement_score":0.0012496844,"about_ca_system_score_codex":0.0004824879,"about_ca_system_score_gemma":0.00028873855,"threshold_uncertainty_score":0.0041805506},"labels":[],"label_agreement":null},{"id":"W2136112505","doi":"10.1016/j.leukres.2008.06.028","title":"In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":354,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; In vivo; Pharmacology; Drug; Therapeutic index; Medicine; Chemistry; Leukemia; Immunology; Biology","score_opus":0.052816271630835215,"score_gpt":0.32778969499979,"score_spread":0.2749734233689548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136112505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918343,0.0013757251,0.0046824166,0.0001339057,0.000056860343,0.00005716416,0.00020360878,0.00020710706,0.0014489572],"genre_scores_gemma":[0.99664634,0.0002539662,0.0018293284,0.000019313682,0.000014156952,0.000030601277,0.00010653387,0.000032235443,0.001067537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997942,0.000040025352,0.000015604472,0.000047300844,0.00004089918,0.00006203648],"domain_scores_gemma":[0.99986315,0.00003299406,0.000032827153,0.00002041942,0.000014094244,0.000036618745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029035012,0.0004636353,0.00040177238,0.0002654547,0.00018965086,0.00034985028,0.00024801906,0.00032651826,0.0015441234],"category_scores_gemma":[0.00019943512,0.00017367309,0.00018249011,0.00017631323,0.0002685727,0.0003839122,0.00016076457,0.0007489563,0.00029183296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005523254,0.000108839115,0.000061410225,0.000015866222,0.0000065222675,0.000015125455,0.00001316429,0.00012525513,0.996935,0.00011677645,0.000080799255,0.001968965],"study_design_scores_gemma":[0.000026214382,0.0004640479,0.00023246293,0.0000010174564,0.0000138652185,0.000060259594,0.000004530456,0.0005193815,0.99811506,0.000022855847,0.0005383103,0.0000020028438],"about_ca_topic_score_codex":0.000477137,"about_ca_topic_score_gemma":0.00058941916,"teacher_disagreement_score":0.0015441234,"about_ca_system_score_codex":0.00036241644,"about_ca_system_score_gemma":0.0003509205,"threshold_uncertainty_score":0.005165577},"labels":[],"label_agreement":null},{"id":"W2136752052","doi":"10.1016/j.leukres.2012.08.022","title":"Corrigendum to ‘Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia’ [Leuk. Res. 36 (10) (2012) 1241–1248]","year":2012,"lang":"en","type":"erratum","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Gerontology; Oncology; Quality of life (healthcare); Chemotherapy; Internal medicine","score_opus":0.09005882696424405,"score_gpt":0.3805983479039067,"score_spread":0.2905395209396626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136752052","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008887215,0.00162188,0.000142245,0.09357533,0.9016708,0.00002350034,0.0005258488,0.00011820168,0.0022333327],"genre_scores_gemma":[0.0060902955,0.01122388,0.0016509142,0.42132154,0.41078246,0.00025278202,0.0021251282,0.00042222027,0.14613074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996816,0.00053895364,0.00077779224,0.0004316591,0.0010973653,0.0003382849],"domain_scores_gemma":[0.9816176,0.0054204534,0.0010642606,0.00088897545,0.010302996,0.00070564053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034918499,0.00202886,0.002933261,0.0031874126,0.0024461823,0.0025426452,0.0030696606,0.008447165,0.033706393],"category_scores_gemma":[0.03984941,0.0013032269,0.00276346,0.0023998008,0.0020689406,0.001568734,0.0018581508,0.010232055,0.02938633],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014067135,0.000005584687,0.00006852346,0.000057304078,0.000006928522,0.00012322784,0.000010079632,0.000014418869,0.0000118169555,0.00010696331,0.9971334,0.0024477292],"study_design_scores_gemma":[0.00008873932,0.00005457361,0.004498001,0.00058184844,0.00009526179,0.00074388686,0.00011632492,0.00021860715,0.00018410622,0.0008582577,0.9924885,0.00007188043],"about_ca_topic_score_codex":0.054709885,"about_ca_topic_score_gemma":0.06971934,"teacher_disagreement_score":0.054709885,"about_ca_system_score_codex":0.0035585403,"about_ca_system_score_gemma":0.004753392,"threshold_uncertainty_score":0.11275911},"labels":[],"label_agreement":null},{"id":"W2137302850","doi":"10.1016/j.leukres.2012.05.022","title":"An emerging role for retinoid X receptor α in malignant hematopoiesis","year":2012,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Retinoid X receptor; Haematopoiesis; Retinoid X receptor alpha; Nuclear receptor; Receptor; Biology; Acute promyelocytic leukemia; Retinoid; Extramedullary hematopoiesis; Cancer research; Cell biology; Immunology; Genetics; Stem cell; Retinoic acid; Transcription factor; Gene","score_opus":0.0974717512306307,"score_gpt":0.4227176889337155,"score_spread":0.32524593770308474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137302850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012526277,0.99846965,0.00022522884,0.00032047945,0.0001866157,0.000002174604,0.000011159395,0.0000074901063,0.0006520079],"genre_scores_gemma":[0.0007982442,0.99809724,0.00026647924,0.00017602151,0.00020661081,0.0000034687127,0.000018689785,0.0000014556542,0.00043173647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998474,0.00002524993,0.000024581559,0.000031130003,0.00005144687,0.000020183943],"domain_scores_gemma":[0.9997576,0.0001137251,0.00003058355,0.000009994689,0.00006067728,0.00002734269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007369488,0.0008264939,0.0013956924,0.0014124769,0.00027999387,0.0011419082,0.00088357786,0.0012695186,0.0017693419],"category_scores_gemma":[0.0006165107,0.00024698055,0.00035221726,0.0016884699,0.00084791303,0.0012977183,0.00073393155,0.0021303897,0.0012367954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015129376,0.000057951012,0.00023911669,0.008450787,0.0000731696,0.00056442793,0.00006595179,0.00046946233,0.0066887215,0.0075717866,0.03401329,0.941654],"study_design_scores_gemma":[0.000029031904,0.000059458638,0.0004970484,0.0009288358,0.00009845111,0.0015335375,0.00007707659,0.000099235294,0.0012329797,0.0030439687,0.99238247,0.00001775958],"about_ca_topic_score_codex":0.0011424441,"about_ca_topic_score_gemma":0.001963221,"teacher_disagreement_score":0.0017693419,"about_ca_system_score_codex":0.0007029612,"about_ca_system_score_gemma":0.0010401753,"threshold_uncertainty_score":0.0059190392},"labels":[],"label_agreement":null},{"id":"W2142535539","doi":"10.1016/j.leukres.2008.10.013","title":"Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"","keywords":"CHOP; Lymphoma; CD20; Rituximab; Diffuse large B-cell lymphoma; Oncology; Cancer research; Internal medicine; Immunology; Medicine; Mutation; Biology; Gene; Gastroenterology; Genetics","score_opus":0.04413447653465624,"score_gpt":0.3095650200788036,"score_spread":0.26543054354414736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142535539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953866,0.00012942121,0.000028563638,0.000029968773,0.00000490468,0.0000016145807,0.000024640356,0.0000022354195,0.00023996782],"genre_scores_gemma":[0.99979144,0.00003034055,0.00001612723,0.000016782542,0.000009174859,0.0000014295325,0.000044632314,0.0000015143662,0.000088551846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971956,0.000081962986,0.000040048788,0.000054244323,0.000038248803,0.000065896296],"domain_scores_gemma":[0.9990748,0.0004005175,0.00025332297,0.00005219689,0.000051958796,0.00016721924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002751684,0.0003005109,0.00047853804,0.0006449214,0.00034222426,0.00044371543,0.00030951586,0.0006160379,0.002145591],"category_scores_gemma":[0.0019182321,0.00022211968,0.00040383943,0.00058294804,0.00033387824,0.0003457875,0.00017018206,0.0004515032,0.0003573067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025002488,0.00018583382,0.9752364,0.00002393758,0.00017628876,0.0032592886,0.0001410875,0.00015850326,0.013306345,0.00007845119,0.00017447102,0.004759052],"study_design_scores_gemma":[0.000100540354,0.00065477943,0.9862114,0.000009206866,0.00018195543,0.010218472,0.00017722708,0.0006048623,0.001269682,0.00012993393,0.00043067452,0.0000112271255],"about_ca_topic_score_codex":0.0006329332,"about_ca_topic_score_gemma":0.0005322372,"teacher_disagreement_score":0.002145591,"about_ca_system_score_codex":0.00016549253,"about_ca_system_score_gemma":0.00019884839,"threshold_uncertainty_score":0.0071777105},"labels":[],"label_agreement":null},{"id":"W2144153160","doi":"10.1016/j.leukres.2009.05.014","title":"Valproic acid exerts differential effects on CXCR4 expression in leukemic cells","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"CD34; CXCR4; Haematopoiesis; Progenitor cell; Cancer research; Stem cell; Histone deacetylase inhibitor; Cell culture; Chemistry; Biology; Histone deacetylase; Molecular biology; Receptor; Cell biology; Histone; Biochemistry; Chemokine; Genetics","score_opus":0.01772282883425628,"score_gpt":0.3261410201651962,"score_spread":0.3084181913309399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144153160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949157,0.0027121059,0.0002926412,0.00012584061,0.00004472323,0.00001038187,0.0004730574,0.0000453503,0.0013801552],"genre_scores_gemma":[0.99624974,0.0010973497,0.00032309897,0.00005153188,0.000016607848,0.000013634002,0.0006837782,0.000009897997,0.0015543178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997956,0.0000480876,0.000025403611,0.000026796959,0.000033133972,0.000071046576],"domain_scores_gemma":[0.9999131,0.000019951358,0.000013936677,0.000015142076,0.000010357224,0.000027476974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011790154,0.00030193015,0.0004466925,0.0003143801,0.00025099693,0.0005018593,0.00021005746,0.00026720727,0.0016853245],"category_scores_gemma":[0.00018688713,0.00016665708,0.00033719206,0.00037371903,0.0002580758,0.0002488896,0.00019147382,0.00061979314,0.00037750814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029659509,0.00011149609,0.00074038404,0.00006511795,0.000024157558,0.0001484227,0.000049852155,0.00017861665,0.99092394,0.00020886467,0.00016517278,0.0044179857],"study_design_scores_gemma":[0.00015988185,0.0015512996,0.008604362,0.00000917442,0.00005184083,0.00038681575,0.00013049101,0.0004843643,0.98564076,0.000073750205,0.0028991767,0.000008049894],"about_ca_topic_score_codex":0.001668934,"about_ca_topic_score_gemma":0.0022853916,"teacher_disagreement_score":0.0016853245,"about_ca_system_score_codex":0.0003893282,"about_ca_system_score_gemma":0.00040628505,"threshold_uncertainty_score":0.0056379437},"labels":[],"label_agreement":null},{"id":"W2150386152","doi":"10.1016/j.leukres.2004.03.019","title":"Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of Texas MD Anderson Cancer Center; University of Saskatchewan","keywords":"Methylation; Molecular biology; Biology; DNA methylation; Cancer research; Epigenetics; Gene silencing; CpG site; Gene expression; Gene; Genetics","score_opus":0.02305254884950352,"score_gpt":0.2981897047031424,"score_spread":0.27513715585363885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150386152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979888,0.0007628885,0.00026340532,0.000026212516,0.00000350094,0.0000033161946,0.00015218873,0.000010516175,0.0007892489],"genre_scores_gemma":[0.9991167,0.00024183452,0.00007939827,0.0000084007,0.0000022791771,0.000003442574,0.000112396585,0.000003563987,0.00043195538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995637,0.000009138522,0.0000027393323,0.000008385779,0.000010407438,0.000012939968],"domain_scores_gemma":[0.9999305,0.000020806288,0.000015584112,0.0000048104384,0.000011631247,0.00001660172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080432335,0.00007253006,0.00013540415,0.00046947744,0.00016301518,0.00016261618,0.00007195984,0.00009440598,0.0012084242],"category_scores_gemma":[0.00020418444,0.00008963993,0.00006308814,0.00025342565,0.00010447452,0.00007501486,0.00008468651,0.00011297154,0.00014397939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014974205,0.00003170725,0.043159425,0.000044475546,0.00003530493,0.00037113644,0.0002296259,0.00022203191,0.94459647,0.00028599382,0.00016375368,0.009362618],"study_design_scores_gemma":[0.000084250474,0.0003293821,0.7316481,0.000016659124,0.00016632922,0.0033189347,0.00038300015,0.0016364726,0.25710627,0.0006037788,0.004695009,0.000011779057],"about_ca_topic_score_codex":0.0031840678,"about_ca_topic_score_gemma":0.0027075629,"teacher_disagreement_score":0.0031840678,"about_ca_system_score_codex":0.00024790512,"about_ca_system_score_gemma":0.00013368094,"threshold_uncertainty_score":0.006331086},"labels":[],"label_agreement":null},{"id":"W2156134411","doi":"10.1016/s0145-2126(02)00222-9","title":"Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trichostatin A; Histone deacetylase; DNA methylation; Cancer research; Azacitidine; Acetylation; Histone deacetylase inhibitor; Histone; Decitabine; Myeloid leukemia; Epigenetics; CpG site; Deoxycytidine; Chromatin; Biology; Chemistry; DNA; Biochemistry; Gene expression; Chemotherapy; Genetics; Gene","score_opus":0.06027886334873608,"score_gpt":0.3861331952723275,"score_spread":0.3258543319235914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156134411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203265,0.003064294,0.0010398042,0.000255264,0.000113042195,0.00047820705,0.00066252693,0.00012227274,0.0022318785],"genre_scores_gemma":[0.99285674,0.0031488978,0.00088947883,0.00006085241,0.000069071706,0.00029589084,0.0009089419,0.000020472386,0.0017496004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959177,0.00014766991,0.000026594822,0.00004500681,0.000058404665,0.00013059606],"domain_scores_gemma":[0.9995395,0.00011070012,0.00008289784,0.00004815062,0.000042451058,0.00017637677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009801058,0.0010324356,0.0012414586,0.00094239635,0.0004492917,0.00050375913,0.0011207194,0.0006428408,0.0027132444],"category_scores_gemma":[0.0005038389,0.00051597145,0.000748845,0.00068452256,0.0006663164,0.0006194111,0.00027771463,0.002022829,0.00051887933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05642078,0.03767428,0.0018651305,0.00056571275,0.0005344244,0.00048295446,0.00033871122,0.006073392,0.83980644,0.0012348745,0.002294387,0.05270893],"study_design_scores_gemma":[0.0156094795,0.38860917,0.006705332,0.000047166894,0.00077831734,0.0006940958,0.00017063465,0.0032851049,0.5753231,0.0002573206,0.008481161,0.000039122948],"about_ca_topic_score_codex":0.0021387332,"about_ca_topic_score_gemma":0.004289053,"teacher_disagreement_score":0.0027132444,"about_ca_system_score_codex":0.00059655675,"about_ca_system_score_gemma":0.0011653529,"threshold_uncertainty_score":0.009076655},"labels":[],"label_agreement":null},{"id":"W2157051030","doi":"10.1016/j.leukres.2013.10.025","title":"Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Dana-Farber Cancer Institute","keywords":"Medicine; Lymphoblastic Leukemia; Internal medicine; Regimen; Philadelphia chromosome; Overall survival; Acute lymphocytic leukemia; Oncology; Leukemia; Gastroenterology; Chromosomal translocation; Biology","score_opus":0.02066863335111047,"score_gpt":0.2998187167356622,"score_spread":0.2791500833845517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157051030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981712,0.0005660055,0.00004581266,0.00018157781,0.000011116912,0.0000050885965,0.00020252877,0.0000034206678,0.00081326754],"genre_scores_gemma":[0.9992136,0.00029191453,0.000038111644,0.000051391853,0.000018126326,0.000003956713,0.00028944234,0.0000019603892,0.00009150743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984574,0.000041244024,0.000019005634,0.000017446506,0.00002920776,0.000047444923],"domain_scores_gemma":[0.99890566,0.00028535628,0.0004195442,0.000029709949,0.00007922154,0.00028061363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024453315,0.0001499789,0.00026995334,0.0002574113,0.00023223643,0.000447156,0.00015315719,0.00031522586,0.001022169],"category_scores_gemma":[0.0021733874,0.000091276925,0.0002120056,0.00061230303,0.00017835037,0.0003014613,0.00023493032,0.0007169788,0.0001501124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025132066,0.000028119064,0.9980501,0.0000033802476,0.000011666944,0.00010274027,0.000023641847,0.000048250065,0.00009599324,0.00001630097,0.00011830905,0.0012502113],"study_design_scores_gemma":[0.000020640542,0.00040876385,0.9975764,0.000013365917,0.00004977586,0.0008026326,0.00025496216,0.00028165436,0.0001344334,0.000049946473,0.00040416638,0.000003141341],"about_ca_topic_score_codex":0.002439703,"about_ca_topic_score_gemma":0.0027712663,"teacher_disagreement_score":0.002439703,"about_ca_system_score_codex":0.0002911124,"about_ca_system_score_gemma":0.00045584375,"threshold_uncertainty_score":0.0048509836},"labels":[],"label_agreement":null},{"id":"W2158429148","doi":"10.1016/j.leukres.2015.03.017","title":"Whole genome and transcriptome analysis of a novel AML cell line with a normal karyotype","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Louisiana State University","keywords":"Biology; Karyotype; Cancer research; Transcriptome; Cell culture; Myeloid leukemia; Myeloid; Progenitor cell; Haematopoiesis; Gene; Cell growth; CD34; Genetics; Stem cell; Gene expression; Chromosome","score_opus":0.081088432951783,"score_gpt":0.3520627893634922,"score_spread":0.2709743564117092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158429148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753219,0.0006427247,0.0062297154,0.00027178574,0.000065361026,0.000047116093,0.015083888,0.00022540211,0.002112219],"genre_scores_gemma":[0.9348452,0.0008485491,0.010376054,0.00030771655,0.000027933855,0.00011263249,0.047871713,0.00015648991,0.0054537766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998784,0.000005821399,0.000008336271,0.000035829748,0.00005054043,0.000021027536],"domain_scores_gemma":[0.99992704,0.00002150241,0.000012475976,0.000012087541,0.000014374406,0.000012409595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007123672,0.00021465367,0.0003185196,0.0003524865,0.00036905622,0.000379779,0.00020499478,0.00030978836,0.0016621772],"category_scores_gemma":[0.0001331968,0.00011575576,0.00032828742,0.0005409925,0.0001396992,0.00013961384,0.00022630855,0.00053653226,0.0006372067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009567526,0.000015178907,0.0010862576,0.000019090996,0.000012616621,0.00015740025,0.00003014966,0.000081286315,0.9966299,0.0000624292,0.00022223068,0.001587841],"study_design_scores_gemma":[0.00009014346,0.0005056628,0.23598057,0.00001885677,0.00033013744,0.0038817981,0.0005972372,0.007511994,0.71210206,0.00053138705,0.03839928,0.000050866685],"about_ca_topic_score_codex":0.0014562551,"about_ca_topic_score_gemma":0.002914346,"teacher_disagreement_score":0.0016621772,"about_ca_system_score_codex":0.00016733812,"about_ca_system_score_gemma":0.00020941834,"threshold_uncertainty_score":0.0055605173},"labels":[],"label_agreement":null},{"id":"W2158505514","doi":"10.1016/j.leukres.2013.05.001","title":"Differential survival improvement for patients 20–29 years of age with acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; Public Health Ontario; University of Toronto; University Health Network; Pediatric Oncology Group","funders":"Canadian Institutes of Health Research; Pediatric Oncology Group of Ontario","keywords":"Medicine; Lymphoblastic Leukemia; Epidemiology; Surveillance, Epidemiology, and End Results; Cancer registry; Overall survival; Survival analysis; Pediatrics; Leukemia; Internal medicine; Oncology","score_opus":0.02425534564726084,"score_gpt":0.30988027109674005,"score_spread":0.2856249254494792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158505514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674135,0.0009289196,0.00005067223,0.00019039155,0.000024970794,0.0000028813756,0.00044414905,0.0000047487188,0.0016120451],"genre_scores_gemma":[0.99904233,0.00023201105,0.000020311874,0.000041148207,0.000017248529,0.0000014106834,0.00043905276,0.0000013204673,0.0002050355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998171,0.00003258684,0.000013103917,0.000025751604,0.00002011074,0.000091343696],"domain_scores_gemma":[0.9995253,0.000121128964,0.00015686035,0.000017845492,0.00005023206,0.0001286667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027616974,0.00014332081,0.00030233225,0.00041884696,0.00028676796,0.00035544473,0.00014624179,0.0003170439,0.0016757566],"category_scores_gemma":[0.0018155314,0.00006061538,0.00043327594,0.00047622912,0.00014999222,0.00039938855,0.00037290086,0.00045279707,0.00023950617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011181359,0.000035112414,0.9866811,0.000013401817,0.000043051285,0.00026497553,0.00008758239,0.0001434709,0.0004072905,0.00005235782,0.00033640023,0.0108170705],"study_design_scores_gemma":[0.000014273206,0.00028470423,0.9980526,0.0000061431274,0.000067146604,0.0005324431,0.00015336115,0.00014737576,0.000118104064,0.00008345524,0.0005371885,0.00000319977],"about_ca_topic_score_codex":0.0031607451,"about_ca_topic_score_gemma":0.006292066,"teacher_disagreement_score":0.0031607451,"about_ca_system_score_codex":0.0003399064,"about_ca_system_score_gemma":0.000351964,"threshold_uncertainty_score":0.0062847137},"labels":[],"label_agreement":null},{"id":"W2158751744","doi":"10.1016/j.leukres.2007.11.012","title":"Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110–FGFR1 fusion: Report of a new case and review of the literature","year":2007,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Fibroblast growth factor receptor 1; Myeloproliferative Disorders; Cancer research; Fibroblast growth factor receptor; Chronic myelomonocytic leukemia; Medicine; Acute leukemia; Chromosomal translocation; Fusion gene; Haematopoiesis; Leukemia; Myelofibrosis; Tyrosine kinase; Bone marrow; Internal medicine; Stem cell; Fibroblast growth factor; Biology; Gene; Myelodysplastic syndromes; Receptor; Genetics","score_opus":0.06378112172896884,"score_gpt":0.41930828561375,"score_spread":0.35552716388478117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158751744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066153547,0.9894052,0.00053080235,0.00034784584,0.00019222197,0.000016377617,0.00010385006,0.000041157466,0.0027471893],"genre_scores_gemma":[0.022265788,0.9747108,0.000987767,0.00042204853,0.00036406805,0.000012156985,0.0002060446,0.000006113615,0.0010250983],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9996718,0.00003719003,0.00009206499,0.00006923915,0.00008892247,0.000040766376],"domain_scores_gemma":[0.9994294,0.00027848475,0.00015419377,0.00002109094,0.000069605114,0.000047253743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032373142,0.0010225308,0.0020005933,0.0038302613,0.00027290528,0.0008376912,0.0013087454,0.0011509921,0.002413042],"category_scores_gemma":[0.00082307786,0.00031442058,0.0005696863,0.0029173489,0.00052270916,0.0014120593,0.0005566433,0.000584265,0.0011335204],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016986392,0.0001025017,0.0067390427,0.017939003,0.00031048324,0.1856451,0.00033579822,0.00033790368,0.009413227,0.00075842,0.02157142,0.7566772],"study_design_scores_gemma":[0.000043769276,0.00010707873,0.016344097,0.0035139013,0.00074103783,0.70911485,0.00061945774,0.00015924496,0.0018243523,0.000676844,0.2667792,0.0000761158],"about_ca_topic_score_codex":0.00096558477,"about_ca_topic_score_gemma":0.0017008464,"teacher_disagreement_score":0.0038302613,"about_ca_system_score_codex":0.00032484566,"about_ca_system_score_gemma":0.00070323783,"threshold_uncertainty_score":0.008072376},"labels":[],"label_agreement":null},{"id":"W2165275170","doi":"10.1016/j.leukres.2012.03.013","title":"Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Bone marrow; Fluorescence in situ hybridization; Concomitant; Myelodysplastic syndromes; Peripheral blood; clone (Java method); Fish <Actinopterygii>; Pathology; Abnormality; Karyotype; Biology; Cytogenetics; Medicine; Chromosome; Internal medicine; DNA; Genetics","score_opus":0.08444588771323226,"score_gpt":0.3568744699875528,"score_spread":0.27242858227432054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165275170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82977164,0.03601629,0.023705523,0.08189142,0.0037153233,0.00025141545,0.0011052177,0.000200162,0.023343045],"genre_scores_gemma":[0.9589096,0.009478264,0.012860355,0.011043976,0.004597645,0.00009886891,0.0005090838,0.000054954366,0.002447217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980317,0.0010530658,0.00017890656,0.00019121011,0.00036287622,0.00018226267],"domain_scores_gemma":[0.9918749,0.005161567,0.0006475411,0.00042530964,0.0013027418,0.0005880004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063752974,0.00044497,0.0009188267,0.00073994795,0.00035679404,0.0015465984,0.0006094048,0.002901247,0.0016616937],"category_scores_gemma":[0.02457187,0.0003700582,0.00041995585,0.0006627887,0.001323195,0.0016273475,0.00034028673,0.0013836498,0.0018595542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006071839,0.000496593,0.59889513,0.0005064135,0.00021604678,0.0098413285,0.00030244986,0.0009541686,0.019611288,0.005322968,0.019411169,0.33837065],"study_design_scores_gemma":[0.0012725489,0.00808427,0.56806934,0.0014145871,0.0014807417,0.107990116,0.004789292,0.018342193,0.100686885,0.050881438,0.13675703,0.0002315004],"about_ca_topic_score_codex":0.0006793267,"about_ca_topic_score_gemma":0.0009948654,"teacher_disagreement_score":0.0063752974,"about_ca_system_score_codex":0.000414786,"about_ca_system_score_gemma":0.0008455713,"threshold_uncertainty_score":0.0337162},"labels":[],"label_agreement":null},{"id":"W2185835112","doi":"10.1016/j.leukres.2015.11.011","title":"Deletion of the putative tumor suppressor gene, G0s2, does not affect progression of Eμ-Myc driven lymphomas in mice","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Cancer Research Society","keywords":"Suppressor; Cancer research; Leukemia; Lymphoma; Gene; Latency (audio); Affect (linguistics); Tumor suppressor gene; Biology; Cancer; Carcinogenesis; Immunology; Genetics; Psychology","score_opus":0.03688109432518323,"score_gpt":0.36289647678563736,"score_spread":0.32601538246045414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185835112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526936,0.0002436988,0.0017379369,0.00010264805,0.000022977254,0.000023406967,0.00072780804,0.00025028415,0.0016218992],"genre_scores_gemma":[0.99067324,0.00023736652,0.001091469,0.00007291006,0.000013970523,0.000032906133,0.0010433123,0.00017076272,0.006664084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99967396,0.000056851914,0.000028102917,0.0000835799,0.00006790391,0.00008956763],"domain_scores_gemma":[0.99933773,0.00010184064,0.00018986859,0.000072933144,0.00003150931,0.00026607479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026111785,0.0008301333,0.00030255946,0.0012989077,0.00025381253,0.000642114,0.0005631359,0.0007626107,0.0023619854],"category_scores_gemma":[0.00019526262,0.00039780408,0.0004447904,0.00029002255,0.00080325844,0.00039438947,0.00033822068,0.0011735477,0.00088112406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002613666,0.00004832459,0.00028284144,0.000008053215,0.0000054128486,0.00007315916,0.00001689936,0.00007950937,0.9985274,0.00017321933,0.0000357711,0.00048803783],"study_design_scores_gemma":[0.00007033099,0.00034405396,0.0029939646,0.0000071774425,0.000017023382,0.00030328202,0.00004268737,0.00085865805,0.9939681,0.0001443218,0.0012440048,0.000006258361],"about_ca_topic_score_codex":0.0010770592,"about_ca_topic_score_gemma":0.0012196323,"teacher_disagreement_score":0.0023619854,"about_ca_system_score_codex":0.00045228074,"about_ca_system_score_gemma":0.0003244077,"threshold_uncertainty_score":0.007901609},"labels":[],"label_agreement":null},{"id":"W2314043688","doi":"10.1016/j.leukres.2016.03.013","title":"Zfp521 promotes B-cell viability and cyclin D1 gene expression in a B cell culture system","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; University of Westminster; University of Manchester; Lunds Universitet; Biotechnology and Biological Sciences Research Council; Thomas Jefferson University","keywords":"Cyclin D1; Biology; Progenitor cell; Cell growth; B cell; Haematopoiesis; Cancer research; Cyclin D2; Leukemia; Cell culture; Cell biology; Gene knockdown; Cyclin B; Cell; Molecular biology; Stem cell; Cell cycle; Immunology; Genetics; Antibody","score_opus":0.012790216540334071,"score_gpt":0.2725568820615396,"score_spread":0.25976666552120553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314043688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033046,0.001445528,0.0045712036,0.00015079377,0.000042216183,0.000028332093,0.00089563004,0.00023897855,0.0022967728],"genre_scores_gemma":[0.98706055,0.00062555115,0.005348551,0.00007124244,0.000019807247,0.000045371424,0.0019041988,0.000102337974,0.004822512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996636,0.00007625096,0.00004443058,0.0000721547,0.00007609304,0.00006738179],"domain_scores_gemma":[0.99965847,0.00010876,0.000054030887,0.000052857944,0.000031927302,0.00009394091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041482828,0.0003635608,0.00031038196,0.0005577801,0.0003663293,0.0005382662,0.0004415479,0.00028673734,0.0021189023],"category_scores_gemma":[0.00022186653,0.00020795566,0.00023773771,0.00034588692,0.0002563293,0.00027220495,0.00040663822,0.0007896646,0.00072770985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000991142,0.000021641585,0.00009341531,0.000009024161,0.0000024797212,0.000013528835,0.0000095027335,0.000022865806,0.9992912,0.000045028173,0.000043350276,0.00034883455],"study_design_scores_gemma":[0.000013851093,0.00007792113,0.0009879032,0.0000018958569,0.000006396974,0.000043766275,0.0000090451285,0.00038188044,0.9975986,0.000012102484,0.0008648992,0.0000017803288],"about_ca_topic_score_codex":0.0021147372,"about_ca_topic_score_gemma":0.004352737,"teacher_disagreement_score":0.0021189023,"about_ca_system_score_codex":0.0005531755,"about_ca_system_score_gemma":0.00026422727,"threshold_uncertainty_score":0.0070884824},"labels":[],"label_agreement":null},{"id":"W2326073198","doi":"10.1016/j.leukres.2016.04.005","title":"Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Myeloid leukemia; Concordance; Minimal residual disease; Leukemia; Internal medicine; Bone marrow; Biopsy; Oncology; Pathology","score_opus":0.057582608312993236,"score_gpt":0.37202350533225254,"score_spread":0.3144408970192593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326073198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830772,0.0077235163,0.0030139117,0.00094623724,0.00034537909,0.000059801125,0.00081336,0.0000952057,0.003925375],"genre_scores_gemma":[0.99662507,0.0007930948,0.0013914906,0.00014834013,0.0002544534,0.000012551119,0.00045217396,0.000009713943,0.00031316455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978668,0.00093357847,0.00017529012,0.00025161405,0.00058432936,0.00018837296],"domain_scores_gemma":[0.98172194,0.013707353,0.0010180277,0.00087748136,0.001782448,0.0008926151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004270318,0.00089164695,0.0010708974,0.0011367823,0.0002555682,0.0014405155,0.0013202067,0.001378459,0.0013747677],"category_scores_gemma":[0.028116368,0.00033453395,0.0010179606,0.00062550616,0.000517486,0.0013819272,0.00059692306,0.0015840364,0.00042959306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056816917,0.00018173663,0.93623203,0.000124096,0.0005077613,0.0006932997,0.000054159937,0.0038080607,0.002620194,0.00024153118,0.00064437435,0.049211077],"study_design_scores_gemma":[0.00019431811,0.0034964941,0.9278799,0.00014401726,0.0038434924,0.0035661042,0.0004568064,0.049421884,0.0065341736,0.001710816,0.0026744162,0.00007761003],"about_ca_topic_score_codex":0.0036200099,"about_ca_topic_score_gemma":0.004805637,"teacher_disagreement_score":0.004270318,"about_ca_system_score_codex":0.00063087535,"about_ca_system_score_gemma":0.0009860144,"threshold_uncertainty_score":0.022583842},"labels":[],"label_agreement":null},{"id":"W2411195875","doi":"10.1016/j.leukres.2016.06.001","title":"Do quality of life, physical function, or the Wheatley index at diagnosis predict 1-year mortality with intensive chemotherapy in older acute myeloid leukemia patients?","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Public Health Ontario; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Quality of life (healthcare); Confidence interval; Myeloid leukemia; Prospective cohort study; Logistic regression; Univariate analysis; Intensive care medicine; Multivariate analysis","score_opus":0.056334667987655206,"score_gpt":0.37537310767456816,"score_spread":0.319038439686913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411195875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970482,0.001269437,0.000107723965,0.00041933559,0.000037232025,0.0000073811043,0.00034287325,0.0000036549466,0.0007642424],"genre_scores_gemma":[0.9990884,0.00024486968,0.00006437023,0.00011110729,0.000058385835,0.0000041541225,0.0003160329,0.0000010629965,0.000111602705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994758,0.00015229401,0.00007040416,0.00008382736,0.00008791905,0.00012974128],"domain_scores_gemma":[0.9974535,0.0005684061,0.0012131702,0.00012730496,0.00013510171,0.0005024747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010828639,0.00046000938,0.0006390355,0.00063435425,0.00030948457,0.0009447924,0.0005454526,0.0012572806,0.0013155406],"category_scores_gemma":[0.0053436416,0.0002781187,0.0012159206,0.0008209465,0.00041267023,0.0010909037,0.000550621,0.0011099032,0.00023197288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011337178,0.000029569832,0.99847335,0.000005454039,0.00008585438,0.000014104563,0.000013278068,0.00005030564,0.000029474979,0.0000089970545,0.00007115569,0.0011050451],"study_design_scores_gemma":[0.000008637414,0.00008289833,0.9992329,0.000009168639,0.000060000206,0.00004913592,0.00006640195,0.00034167495,0.000019143323,0.000048285507,0.000077854165,0.0000039589786],"about_ca_topic_score_codex":0.0044155726,"about_ca_topic_score_gemma":0.008033256,"teacher_disagreement_score":0.0044155726,"about_ca_system_score_codex":0.00037075437,"about_ca_system_score_gemma":0.0003396065,"threshold_uncertainty_score":0.008779764},"labels":[],"label_agreement":null},{"id":"W2488647697","doi":"10.1016/j.leukres.2016.07.004","title":"A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Merck","keywords":"Medicine; Regimen; Tolerability; Internal medicine; Refractory (planetary science); Gastroenterology; Phases of clinical research; Adverse effect; Surgery; Clinical trial; Biology","score_opus":0.05038255470315886,"score_gpt":0.36697083761968635,"score_spread":0.3165882829165275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488647697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037045,0.0036413453,0.00053912576,0.0007236371,0.00020457462,0.0010634129,0.0008418805,0.00018476331,0.0024308579],"genre_scores_gemma":[0.98956513,0.0029919003,0.0012075292,0.0007444606,0.00018219049,0.0010141487,0.0017372434,0.000033913162,0.002523464],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998235,0.000074785465,0.0000071817212,0.000030992047,0.000012600673,0.00005094782],"domain_scores_gemma":[0.99967265,0.000052935775,0.00004758006,0.000027312119,0.000012982693,0.00018651865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008199946,0.0012362254,0.0017793222,0.0003102234,0.0003008856,0.0008499969,0.00069975515,0.0008598706,0.0035203327],"category_scores_gemma":[0.0005502722,0.0004384266,0.0008102803,0.00032627088,0.00068198075,0.0006321438,0.00031001377,0.0026490476,0.00082371297],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7601201,0.027531048,0.0043690642,0.0010581998,0.0014311532,0.0003589166,0.00031006415,0.0035070346,0.052007746,0.00075797905,0.0084793875,0.14006934],"study_design_scores_gemma":[0.7327569,0.24486183,0.009401518,0.000040304025,0.00058877567,0.00041904303,0.00008007535,0.0016013834,0.004421686,0.0003194098,0.0054729846,0.00003604807],"about_ca_topic_score_codex":0.0008603783,"about_ca_topic_score_gemma":0.0023765324,"teacher_disagreement_score":0.0035203327,"about_ca_system_score_codex":0.00056625064,"about_ca_system_score_gemma":0.0009938456,"threshold_uncertainty_score":0.011776686},"labels":[],"label_agreement":null},{"id":"W2505615084","doi":"10.1016/j.leukres.2016.07.012","title":"Palliative care for patients with hematological malignancies: Time for a new model","year":2016,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hematologic Neoplasms; Palliative care; Oncology; Intensive care medicine; Internal medicine; Nursing; Cancer","score_opus":0.21951116096228762,"score_gpt":0.4541278630218535,"score_spread":0.23461670205956586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505615084","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110523375,0.0023605688,0.00008964294,0.99183136,0.00493928,0.000003049143,0.0000043459363,0.0000044634126,0.00065673084],"genre_scores_gemma":[0.0040706266,0.006306237,0.00059361424,0.94213194,0.045111474,0.000029537912,0.000015258386,0.000014867902,0.001726442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898189,0.004414283,0.0011556107,0.0008907935,0.0024805944,0.0012397951],"domain_scores_gemma":[0.9505429,0.025424298,0.0027179641,0.0012381912,0.0062790145,0.013797625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013391243,0.00095751975,0.0023911041,0.0008881815,0.009246981,0.009185978,0.0032923738,0.06043795,0.012557366],"category_scores_gemma":[0.03940947,0.00086997106,0.0019875122,0.00084209937,0.012224791,0.026366938,0.009487025,0.09882014,0.0035817404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105299514,0.00016313478,0.0006772772,0.00036629796,0.000043201893,0.0030807236,0.0011054565,0.00023479537,0.00030905506,0.028671281,0.93587667,0.02936671],"study_design_scores_gemma":[0.00032021926,0.00026471692,0.00069264846,0.0022697712,0.000053665128,0.0044166096,0.0039800336,0.0005811863,0.00013173456,0.075540386,0.9116098,0.00013914963],"about_ca_topic_score_codex":0.003623269,"about_ca_topic_score_gemma":0.012829068,"teacher_disagreement_score":0.06043795,"about_ca_system_score_codex":0.010374068,"about_ca_system_score_gemma":0.017236985,"threshold_uncertainty_score":0.07526952},"labels":[],"label_agreement":null},{"id":"W2523424222","doi":"10.1016/j.leukres.2016.09.016","title":"Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Manitoba Beekeepers' Association; University of Winnipeg; George & Fay Yee Centre for Healthcare Innovation; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Canadian Institutes of Health Research","keywords":"Bendamustine; Chronic lymphocytic leukemia; Chlorambucil; Pentostatin; Fludarabine; Cladribine; Nucleoside analogue; Nucleoside; Deoxyadenosine; Cytotoxicity; Cytotoxic T cell; Medicine; Cancer research; Leukemia; Cross-resistance; Pharmacology; Biology; In vitro; Immunology; Chemotherapy; Virology; Lymphoma; Biochemistry; Internal medicine; Adenosine","score_opus":0.035868452944270934,"score_gpt":0.3611571789687671,"score_spread":0.32528872602449616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523424222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97471255,0.016400108,0.0006252355,0.0005339445,0.00010129704,0.00005872538,0.00024186238,0.000054368433,0.007271988],"genre_scores_gemma":[0.9946668,0.003189042,0.00035084912,0.00015133017,0.000041151714,0.0000249713,0.0003428526,0.000011112399,0.0012218419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999587,0.00017096486,0.00003800076,0.000032576358,0.000057733036,0.000113769915],"domain_scores_gemma":[0.99969053,0.00010094603,0.000055737273,0.000053695538,0.000027689406,0.000071441784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008515534,0.00028149653,0.00054041145,0.00040230263,0.00018711321,0.00047462303,0.00037957993,0.00033182956,0.0027398565],"category_scores_gemma":[0.0005285119,0.00015545999,0.00044050717,0.0003777868,0.000231352,0.0003934953,0.00045052788,0.0008602996,0.00042746394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0144118145,0.0026161154,0.023921868,0.000656681,0.00057445525,0.0009665975,0.00036098072,0.0046153977,0.676158,0.0058382703,0.005071542,0.26480833],"study_design_scores_gemma":[0.007731082,0.071536966,0.19358602,0.0003286595,0.0013130285,0.015576641,0.0006118504,0.0068459013,0.55733514,0.003611197,0.14143097,0.00009247556],"about_ca_topic_score_codex":0.00072751637,"about_ca_topic_score_gemma":0.0020798154,"teacher_disagreement_score":0.0027398565,"about_ca_system_score_codex":0.0006584228,"about_ca_system_score_gemma":0.00039471537,"threshold_uncertainty_score":0.009165704},"labels":[],"label_agreement":null},{"id":"W2552329590","doi":"10.1016/j.leukres.2016.11.007","title":"Conserved hierarchical gain of chromosome 4 is an independent prognostic factor in high hyperdiploid pediatric acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Trisomy; Fluorescence in situ hybridization; Lymphoblastic Leukemia; Chromosome; Biology; Aneuploidy; Internal medicine; Oncology; Leukemia; Genetics; Medicine; Gene","score_opus":0.04352849427960141,"score_gpt":0.3317221267253496,"score_spread":0.2881936324457482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552329590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779296,0.00028527778,0.0005022193,0.000045848086,0.0000051193424,0.00000849367,0.00025295114,0.000025594321,0.0010816285],"genre_scores_gemma":[0.9990408,0.00011379561,0.00032122625,0.000015072716,0.0000073245683,0.000005025003,0.0002907769,0.000007336964,0.00019857875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997936,0.00004314163,0.000018178996,0.0000372139,0.000059293332,0.000048616264],"domain_scores_gemma":[0.99923646,0.00019502771,0.00033245195,0.000077268174,0.00006037138,0.00009836264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019953477,0.00020472523,0.00022072712,0.0012457597,0.0003283964,0.0004912925,0.0003523162,0.00024727883,0.0029765053],"category_scores_gemma":[0.001183791,0.00014326055,0.00019252722,0.00087718235,0.00037826342,0.0002740183,0.000514698,0.00038812292,0.00034888487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001267842,0.00004654284,0.84694284,0.000075480304,0.00014747886,0.0025187433,0.00015184506,0.0009417082,0.12683229,0.00047136066,0.00045339306,0.02015042],"study_design_scores_gemma":[0.000023339882,0.000106451174,0.9868401,0.000007729196,0.00007774925,0.0032209686,0.00015276899,0.0011993691,0.0066824565,0.0006088773,0.0010721249,0.000007933509],"about_ca_topic_score_codex":0.001336935,"about_ca_topic_score_gemma":0.0016511235,"teacher_disagreement_score":0.0029765053,"about_ca_system_score_codex":0.00027533766,"about_ca_system_score_gemma":0.00026771193,"threshold_uncertainty_score":0.009957433},"labels":[],"label_agreement":null},{"id":"W2574014792","doi":"10.1016/j.leukres.2017.01.023","title":"Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada); St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; Royal Columbian Hospital; University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Fludarabine; Medicine; Rituximab; Hazard ratio; Internal medicine; Chemoimmunotherapy; Population; Chronic lymphocytic leukemia; Confidence interval; Regimen; Proportional hazards model; Oncology; Cohort; Alemtuzumab; Vincristine; Surgery; Cyclophosphamide; Chemotherapy; Leukemia; Transplantation; Lymphoma","score_opus":0.03724798008251208,"score_gpt":0.3164581650059118,"score_spread":0.2792101849233997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574014792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526924,0.0004001442,0.000089287256,0.0003105238,0.0000104024,0.000023739207,0.002428595,0.000008663386,0.0014593556],"genre_scores_gemma":[0.9978624,0.00023864962,0.000057398993,0.00013239284,0.000005460129,0.0000125610695,0.001233378,0.0000065756167,0.00045119118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984478,0.00014476266,0.00011168728,0.00031651536,0.00035615603,0.00062315585],"domain_scores_gemma":[0.99724907,0.00019959085,0.00046309843,0.00013570256,0.0011544467,0.000798148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005014753,0.00042010003,0.0006541656,0.0017247489,0.0031600974,0.0019683086,0.0019305972,0.00087477977,0.002123918],"category_scores_gemma":[0.0027579686,0.0005207158,0.00053324463,0.005215574,0.0010858715,0.0004980296,0.0011201954,0.001317171,0.00035855352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057093337,0.000021289467,0.99781126,0.0000060648536,0.000032616786,0.00010293083,0.00028533957,0.00006151012,0.00015963263,0.00004108645,0.00048496324,0.0009362333],"study_design_scores_gemma":[0.000007107167,0.000017961964,0.9978523,0.000014002726,0.00002176092,0.00013601457,0.0013434043,0.00016555078,0.00003076746,0.000024103063,0.0003780781,0.000008963179],"about_ca_topic_score_codex":0.9833777,"about_ca_topic_score_gemma":0.98640627,"teacher_disagreement_score":0.019868653,"about_ca_system_score_codex":0.019868653,"about_ca_system_score_gemma":0.019224443,"threshold_uncertainty_score":0.14415789},"labels":[],"label_agreement":null},{"id":"W2576905928","doi":"10.1016/j.leukres.2017.01.005","title":"Current approach to the treatment of chronic myeloid leukaemia","year":2017,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Ponatinib; Hematologist; Imatinib; Intensive care medicine; Imatinib mesylate; Chronic myeloid leukaemia; Oncology; Myeloid leukemia; Immunology; Internal medicine; Disease","score_opus":0.31006381007860545,"score_gpt":0.4895030462241493,"score_spread":0.17943923614554386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576905928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040308914,0.99886936,0.000056835743,0.00023648316,0.00014541321,0.000004924321,0.000017671404,0.000004088401,0.0006249769],"genre_scores_gemma":[0.00036787812,0.9988695,0.00010550082,0.0002687081,0.00011717222,0.0000044917556,0.000023896713,6.620552e-7,0.00024221225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973994,0.000059054495,0.000046373716,0.000038852144,0.00009308402,0.00002273692],"domain_scores_gemma":[0.99951863,0.00027622128,0.000076258955,0.000011170928,0.00008861054,0.000029089973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006500986,0.0007123947,0.001539224,0.0019400489,0.0002926387,0.001083486,0.0008953759,0.0009729155,0.0063131857],"category_scores_gemma":[0.0012503618,0.0002435301,0.00074844295,0.0017914438,0.00041471756,0.0010600362,0.0007182156,0.0020160903,0.0017184174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001276127,0.000072505245,0.00010599977,0.035029873,0.00015305248,0.000077109704,0.000038280526,0.0002723591,0.0006728409,0.0033142024,0.02770714,0.932429],"study_design_scores_gemma":[0.00007697194,0.00013312386,0.0005468099,0.013541726,0.00042304982,0.0004860549,0.00005532223,0.00007907551,0.00021369699,0.0020387697,0.9823882,0.000017340177],"about_ca_topic_score_codex":0.0016382594,"about_ca_topic_score_gemma":0.0038516258,"teacher_disagreement_score":0.0063131857,"about_ca_system_score_codex":0.0006013996,"about_ca_system_score_gemma":0.0015251457,"threshold_uncertainty_score":0.021119654},"labels":[],"label_agreement":null},{"id":"W2610988607","doi":"10.1016/j.leukres.2017.11.005","title":"Iron chelation therapy in lower IPSS risk myelodysplastic syndromes; which subtypes benefit?","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Chelation therapy; Medicine; Internal medicine; Chelation; International Prognostic Scoring System; Oncology; Chemistry","score_opus":0.06300820510607573,"score_gpt":0.3745029270335802,"score_spread":0.31149472192750444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610988607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8231724,0.12908337,0.00064256875,0.02666197,0.0011607243,0.0001657763,0.000971184,0.000044498334,0.018097635],"genre_scores_gemma":[0.96274,0.024820464,0.0011077829,0.0054724272,0.0021006954,0.0001202249,0.0009905585,0.000012832209,0.0026350562],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998103,0.00006948027,0.000024170222,0.00003037372,0.000026706504,0.000039057355],"domain_scores_gemma":[0.999443,0.00021784999,0.00013119148,0.00002374822,0.000046153666,0.00013810027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005140533,0.00022369347,0.0012310452,0.00028975777,0.0002782402,0.0006903168,0.00032272036,0.00062216143,0.003766716],"category_scores_gemma":[0.0019324907,0.00012311063,0.00072179595,0.00031974574,0.0003169674,0.0006333713,0.00021454216,0.00090205425,0.00047925932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04979616,0.0018511078,0.13656269,0.0012031291,0.0014046987,0.0005851198,0.0002115539,0.0012540879,0.0039681247,0.003153599,0.02237909,0.7776306],"study_design_scores_gemma":[0.039633337,0.02621783,0.75848114,0.004724924,0.009566024,0.004422582,0.0020060674,0.0027224089,0.0033259864,0.030144135,0.11859764,0.00015786452],"about_ca_topic_score_codex":0.0012611138,"about_ca_topic_score_gemma":0.0045819017,"teacher_disagreement_score":0.003766716,"about_ca_system_score_codex":0.0005748223,"about_ca_system_score_gemma":0.00070544187,"threshold_uncertainty_score":0.012600899},"labels":[],"label_agreement":null},{"id":"W2619736384","doi":"10.1016/j.leukres.2017.05.017","title":"A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Chronic lymphocytic leukemia; Biology; Shelterin; Exon; RNA splicing; Alternative splicing; Molecular biology; Leukemia; Promyelocytic leukemia protein; Telomere; Gene; Cancer research; RNA; Genetics; Nuclear protein; DNA-binding protein","score_opus":0.09683330156801429,"score_gpt":0.40200515823104815,"score_spread":0.30517185666303387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619736384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817383,0.00032049633,0.0005330774,0.00007843838,0.000034057804,0.0000059475597,0.00017786563,0.000015984078,0.0006602973],"genre_scores_gemma":[0.99890375,0.000060895894,0.0003495148,0.000055391694,0.000016486632,0.000003418725,0.00026827585,0.0000079361325,0.00033431666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99980956,0.000028901666,0.000024966455,0.000055500008,0.000045918456,0.00003527526],"domain_scores_gemma":[0.99963665,0.000087903936,0.00012691031,0.00003144371,0.000035075383,0.00008204792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016145187,0.0003464775,0.00024817494,0.00056418515,0.00032442535,0.0004914761,0.00035375563,0.0005490679,0.0018595443],"category_scores_gemma":[0.00052049867,0.00011421906,0.00025600105,0.0004369329,0.00050250697,0.00014808084,0.0002992338,0.00039367692,0.00041641828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028094405,0.00011627816,0.12400616,0.0001064118,0.00020642832,0.037580505,0.00027729888,0.00056606985,0.81776667,0.0012971341,0.0011314192,0.014136168],"study_design_scores_gemma":[0.00065543456,0.001204468,0.5623553,0.00009627284,0.0004678967,0.18181933,0.0011695093,0.008832142,0.21731898,0.0027676898,0.023219777,0.000093150535],"about_ca_topic_score_codex":0.000598001,"about_ca_topic_score_gemma":0.00074579235,"teacher_disagreement_score":0.0018595443,"about_ca_system_score_codex":0.0002840244,"about_ca_system_score_gemma":0.000128289,"threshold_uncertainty_score":0.0062208176},"labels":[],"label_agreement":null},{"id":"W2620862566","doi":"10.1016/j.leukres.2017.05.023","title":"Sharing post-AML consolidation supportive therapy with local centers reduces patient travel burden without compromising outcomes","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Consolidation (business); Myeloid leukemia; Chemotherapy; Internal medicine; Business","score_opus":0.07686276982342112,"score_gpt":0.38999897339934586,"score_spread":0.31313620357592475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620862566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9255619,0.0018793853,0.018523358,0.01244173,0.0006571987,0.000811327,0.0019105877,0.00077672093,0.037437905],"genre_scores_gemma":[0.9893727,0.00025211583,0.0052023893,0.0007315264,0.00020223581,0.00018749511,0.00071876886,0.000050681476,0.0032820667],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997468,0.0013810899,0.0001733535,0.00019794761,0.00026848388,0.00051113346],"domain_scores_gemma":[0.99281704,0.0007599095,0.001915936,0.00088927103,0.0008161157,0.0028017324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018521537,0.0003796521,0.00048819836,0.00039635182,0.0013426201,0.0015297397,0.0017408486,0.00042507905,0.040578946],"category_scores_gemma":[0.011183925,0.00018551845,0.0009538729,0.00054449734,0.00037902629,0.0018728613,0.0048041046,0.0006534131,0.003030564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034379761,0.003702145,0.24266969,0.0004061064,0.0008737254,0.00041871838,0.0010416037,0.011436654,0.0014892677,0.0037485599,0.05486383,0.6759117],"study_design_scores_gemma":[0.0033413747,0.016222866,0.74966866,0.0012838815,0.0031042641,0.004147433,0.019863851,0.042193115,0.0054216986,0.02690052,0.12756449,0.00028773875],"about_ca_topic_score_codex":0.0070702294,"about_ca_topic_score_gemma":0.016517267,"teacher_disagreement_score":0.040578946,"about_ca_system_score_codex":0.0017997657,"about_ca_system_score_gemma":0.005879873,"threshold_uncertainty_score":0.13575006},"labels":[],"label_agreement":null},{"id":"W2625541339","doi":"10.1016/j.leukres.2017.06.009","title":"Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Ministry of Education, Science and Technology; National Research Foundation of Korea; Ministry of Education","keywords":"Myeloid leukemia; Tyrosine-kinase inhibitor; Exome sequencing; Tyrosine kinase; Cancer research; Exome; CD135; Medicine; Mutation; Biology; Receptor; Genetics; Internal medicine; Gene; Cancer","score_opus":0.054807777901119875,"score_gpt":0.36418839409618997,"score_spread":0.30938061619507007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625541339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645555,0.0009321337,0.00024641346,0.00019667204,0.000009433758,0.000007669811,0.0010903334,0.00001589378,0.0010460136],"genre_scores_gemma":[0.9974401,0.000277299,0.00026542268,0.00010457696,0.000010368523,0.0000066519237,0.0010932478,0.000008421467,0.0007939133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977714,0.00002266245,0.000018270412,0.0000769679,0.000067660614,0.000037342765],"domain_scores_gemma":[0.9995969,0.00010091328,0.00018332574,0.000028267288,0.000047196983,0.00004343514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023133193,0.00016850502,0.00029224416,0.00038229118,0.00022764444,0.00051289523,0.00021754422,0.00041861765,0.0018127166],"category_scores_gemma":[0.00087811024,0.00009557545,0.00027666046,0.0006545952,0.00016658432,0.00028260957,0.00019106951,0.00040212108,0.00023804686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047993744,0.00017397811,0.72078353,0.00011364836,0.0006631748,0.0028047266,0.00025764536,0.001122179,0.1971529,0.0007191527,0.0028809556,0.068528645],"study_design_scores_gemma":[0.00007020878,0.00029635945,0.97763765,0.000018845722,0.00024473533,0.0037217455,0.00012137654,0.0012792044,0.011445114,0.00056784006,0.0045822365,0.000014688825],"about_ca_topic_score_codex":0.0018429058,"about_ca_topic_score_gemma":0.0036399344,"teacher_disagreement_score":0.0018429058,"about_ca_system_score_codex":0.00037685697,"about_ca_system_score_gemma":0.00018027931,"threshold_uncertainty_score":0.0060641766},"labels":[],"label_agreement":null},{"id":"W2747596230","doi":"10.1016/j.leukres.2017.08.011","title":"Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Medical Research Council; World Health Organization","keywords":"Myeloid leukemia; Medicine; Myeloid; Myelodysplastic syndromes; Leukemia; Internal medicine; Oncology; Immunology; Bone marrow; Cancer research","score_opus":0.19457947418994617,"score_gpt":0.4626872585099872,"score_spread":0.268107784320041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747596230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7000814,0.041283995,0.024050843,0.014085355,0.0037612428,0.0021691706,0.047950312,0.0009105064,0.16570714],"genre_scores_gemma":[0.93754774,0.008538622,0.014344628,0.0016395841,0.00045489395,0.0004699891,0.02845562,0.00026065527,0.00828819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99548006,0.00096270826,0.0010099532,0.00037995778,0.0014892996,0.0006779955],"domain_scores_gemma":[0.990324,0.0007397456,0.0020388756,0.0008347491,0.005553264,0.00050944043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003728102,0.0005854183,0.0008536393,0.0047637424,0.00062892574,0.0014278507,0.0011667385,0.0005486557,0.0025147316],"category_scores_gemma":[0.010391098,0.00016073561,0.0011314992,0.003308859,0.00064035726,0.0011918633,0.0010024227,0.0010526838,0.0013469049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008179855,0.000050065653,0.85095066,0.000528241,0.000231666,0.0005834784,0.00055459683,0.0007189361,0.0022874002,0.0022602824,0.031595036,0.10942164],"study_design_scores_gemma":[0.000079091005,0.00023172678,0.8599475,0.0013994412,0.0007315525,0.0046406677,0.0028512601,0.0033663595,0.0049978266,0.002986098,0.11869311,0.00007554881],"about_ca_topic_score_codex":0.029429179,"about_ca_topic_score_gemma":0.031253923,"teacher_disagreement_score":0.029429179,"about_ca_system_score_codex":0.0031478282,"about_ca_system_score_gemma":0.004275597,"threshold_uncertainty_score":0.058515728},"labels":[],"label_agreement":null},{"id":"W2766904819","doi":"10.1016/j.leukres.2017.10.016","title":"JAK2V617F detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosis","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"DNA Genotek","keywords":"Saliva; Myelofibrosis; Medicine; Concordance; Internal medicine; Gastroenterology; Peripheral blood; Allele; Bone marrow; Biology; Genetics","score_opus":0.04390164215939978,"score_gpt":0.3152982846775243,"score_spread":0.2713966425181245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766904819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843127,0.0005493529,0.00009120317,0.00006266653,0.000018796174,0.0000048756892,0.00012054086,0.000010513396,0.0007108596],"genre_scores_gemma":[0.9993457,0.00015932058,0.00011310555,0.000050326358,0.000021746398,0.0000055179917,0.0001284777,0.0000030605702,0.0001725776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996319,0.000093672,0.000039891285,0.00007874249,0.000083608415,0.00007209834],"domain_scores_gemma":[0.9994696,0.00023336409,0.00012145499,0.000031109754,0.00006917341,0.000075293676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045711413,0.00038184464,0.00050616916,0.0009715432,0.00035887788,0.00096851646,0.00022621211,0.0007456846,0.0009285113],"category_scores_gemma":[0.0022310417,0.00026307625,0.00024413597,0.00051591586,0.0002946839,0.00057567545,0.00030569235,0.0005585675,0.00031862865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094680925,0.00009682824,0.98435473,0.000026549744,0.000034312994,0.00062645087,0.00021467355,0.000072518924,0.0063237,0.000037634163,0.00020605909,0.0070598363],"study_design_scores_gemma":[0.00002087893,0.000534362,0.9897934,0.000024157951,0.000094853734,0.0037276703,0.00082459097,0.0010097835,0.0031827716,0.00014744206,0.00062338944,0.000016778804],"about_ca_topic_score_codex":0.0007364324,"about_ca_topic_score_gemma":0.0006921112,"teacher_disagreement_score":0.0009715432,"about_ca_system_score_codex":0.00019236666,"about_ca_system_score_gemma":0.00018123482,"threshold_uncertainty_score":0.0031062365},"labels":[],"label_agreement":null},{"id":"W2775090033","doi":"10.1016/j.leukres.2017.12.003","title":"Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"European Hematology Association","keywords":"Chronic myelomonocytic leukemia; Arginase; Cancer research; Myelodysplastic syndromes; Bone marrow; Myeloid; Biology; Immune dysregulation; Immune system; Epigenetics; Immunology; Innate immune system; Inflammation; Genetics; Arginine; Gene","score_opus":0.06930819219866653,"score_gpt":0.39275013868571823,"score_spread":0.3234419464870517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775090033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999292,0.00010810837,0.00018274989,0.000027128708,0.0000035255268,0.0000053548843,0.00008690389,0.0000088956485,0.00028520462],"genre_scores_gemma":[0.9995396,0.000043001914,0.00014546681,0.000014729209,0.00000807821,0.0000026078533,0.000083387626,0.000005279068,0.00015771536],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997415,0.000054234864,0.00004939704,0.0000536737,0.000057450405,0.00004383984],"domain_scores_gemma":[0.9988612,0.0002459065,0.00064193126,0.000041324853,0.000036927027,0.00017276456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019644301,0.0005008837,0.0002763736,0.0014606564,0.0003100729,0.0004193174,0.00037352438,0.00065962184,0.0029711146],"category_scores_gemma":[0.00093746197,0.00024969157,0.00030467604,0.00066823186,0.0005319531,0.00019153062,0.00042770238,0.00044884838,0.00040427042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030125303,0.00028725405,0.3197843,0.00014785078,0.00018812226,0.034038644,0.00039889,0.0006794999,0.6308643,0.00080756703,0.0002811866,0.009509899],"study_design_scores_gemma":[0.00016649548,0.0004792644,0.8662173,0.000036093257,0.00024881892,0.07824406,0.00028395394,0.0024428235,0.049167532,0.0008817392,0.0017970316,0.00003490913],"about_ca_topic_score_codex":0.0006333007,"about_ca_topic_score_gemma":0.0006586717,"teacher_disagreement_score":0.0029711146,"about_ca_system_score_codex":0.00020746232,"about_ca_system_score_gemma":0.00013601377,"threshold_uncertainty_score":0.009939373},"labels":[],"label_agreement":null},{"id":"W2782967915","doi":"10.1016/j.leukres.2018.01.006","title":"Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Chronic lymphocytic leukemia; Fludarabine; Cancer research; Bone marrow; In vivo; Immunology; In vitro; Leukemia; Mesenchymal stem cell; Interleukin 4; Interleukin; Cytokine; Medicine; Biology; Chemotherapy; Pathology; Internal medicine; Cyclophosphamide","score_opus":0.033310886801141915,"score_gpt":0.33809158004007767,"score_spread":0.30478069323893575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782967915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428404,0.0034525988,0.0034527767,0.00062841485,0.00035924584,0.00007622744,0.0012365363,0.00023242683,0.006277662],"genre_scores_gemma":[0.98978335,0.0020939016,0.0020545598,0.00017341723,0.000058677728,0.00011578471,0.001093311,0.000046041965,0.004581045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996369,0.000077610785,0.000028308104,0.000040035546,0.000100884405,0.000116146046],"domain_scores_gemma":[0.99981064,0.00004384099,0.000041987285,0.000027063952,0.000017516262,0.00005903806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026362133,0.00048731008,0.0003016844,0.00038775103,0.00025511585,0.00059437036,0.00020015732,0.00032638226,0.0035208396],"category_scores_gemma":[0.0001692719,0.00015787943,0.00033226263,0.00024807136,0.00033903244,0.0003285047,0.0002124269,0.002013815,0.0010367517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010316303,0.00078435056,0.00054951303,0.0000974278,0.000018147597,0.00005865378,0.000056121706,0.0003672727,0.99094874,0.00038950666,0.00066257914,0.0050359713],"study_design_scores_gemma":[0.00018023774,0.0023655635,0.002553715,0.000014546036,0.000039504153,0.00012511807,0.00010642701,0.0012551725,0.98508924,0.0001612642,0.008103284,0.0000059121066],"about_ca_topic_score_codex":0.0007656862,"about_ca_topic_score_gemma":0.0014937174,"teacher_disagreement_score":0.0035208396,"about_ca_system_score_codex":0.0003919237,"about_ca_system_score_gemma":0.0004768844,"threshold_uncertainty_score":0.011778414},"labels":[],"label_agreement":null},{"id":"W2789431138","doi":"10.1016/j.leukres.2018.02.005","title":"Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Incidence (geometry); Internal medicine; Hazard ratio; International Prognostic Scoring System; Deferasirox; Blood transfusion; Anemia; Surgery; Thalassemia; Confidence interval; Bone marrow","score_opus":0.014959519650715038,"score_gpt":0.28039519484022407,"score_spread":0.26543567518950906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789431138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894446,0.00037772584,0.000043256783,0.000078189994,0.0000132535315,0.000004537755,0.00005625619,0.0000019102795,0.00048039973],"genre_scores_gemma":[0.9995895,0.000106528176,0.000050703893,0.000028346554,0.000038355116,0.000004269018,0.00008892091,9.697975e-7,0.000092298906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979156,0.000058755086,0.00002542321,0.000030272113,0.000033053144,0.00006098444],"domain_scores_gemma":[0.9990526,0.00026516736,0.00034763836,0.000030720417,0.000056547593,0.00024735555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029213974,0.00036869297,0.00051178376,0.0008028356,0.00040704972,0.00051207165,0.0002804427,0.0005832321,0.0018294757],"category_scores_gemma":[0.0020649217,0.0001910453,0.00042779575,0.0008830261,0.00027161546,0.00041223064,0.0002601646,0.0007655155,0.00019887096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007029541,0.00009854536,0.9968656,0.000010577462,0.000033780605,0.00041516413,0.000036788857,0.000061427156,0.00021677074,0.0000329352,0.00006922081,0.001456199],"study_design_scores_gemma":[0.00003635349,0.0003997414,0.99775773,0.000008489063,0.00007651378,0.0007940113,0.00016846371,0.00045279536,0.000058626894,0.00012613957,0.00011491471,0.000006273624],"about_ca_topic_score_codex":0.0014639205,"about_ca_topic_score_gemma":0.0012526012,"teacher_disagreement_score":0.0018294757,"about_ca_system_score_codex":0.00023884758,"about_ca_system_score_gemma":0.00033944822,"threshold_uncertainty_score":0.006120205},"labels":[],"label_agreement":null},{"id":"W2789525108","doi":"10.1016/j.leukres.2018.03.002","title":"An autologous tumor vaccine for CLL","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; Immunology; Chronic lymphocytic leukemia; Antigen; Cancer research; CD8; Ionomycin; Antigen-presenting cell; Biology; CD40; Medicine; Leukemia; T cell; Immune system; In vitro; Stimulation; Endocrinology","score_opus":0.08414939493496212,"score_gpt":0.4536357256324654,"score_spread":0.36948633069750325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789525108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9369549,0.015441911,0.017135741,0.0041053323,0.0023746782,0.0006366069,0.0008632294,0.00052953063,0.021957941],"genre_scores_gemma":[0.98032045,0.0037821468,0.005010944,0.00074204773,0.00041213277,0.00019328215,0.0009437034,0.00003955205,0.008555701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997004,0.0000980325,0.000013782718,0.000043341897,0.000057447276,0.00008699439],"domain_scores_gemma":[0.99981946,0.000055285185,0.000023313887,0.00002864033,0.000029068051,0.00004419471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045543423,0.00050451746,0.00037650234,0.0004192061,0.00028146055,0.0007533119,0.0003394186,0.0007410601,0.0059365844],"category_scores_gemma":[0.0005085044,0.00019248904,0.00033637925,0.00016921492,0.00027024487,0.00054904044,0.0007197737,0.0018008823,0.0013759958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041661537,0.004158223,0.0030777415,0.0007646155,0.00015914733,0.00059741974,0.0003167663,0.005389661,0.69416547,0.012454723,0.013851633,0.2608985],"study_design_scores_gemma":[0.0047898297,0.033430167,0.008747633,0.00048677763,0.00076681864,0.0047278544,0.00086965633,0.020601891,0.59088045,0.013170899,0.3214448,0.00008326559],"about_ca_topic_score_codex":0.00033592258,"about_ca_topic_score_gemma":0.00037173307,"teacher_disagreement_score":0.0059365844,"about_ca_system_score_codex":0.00036983177,"about_ca_system_score_gemma":0.000632711,"threshold_uncertainty_score":0.01985991},"labels":[],"label_agreement":null},{"id":"W2790326841","doi":"10.1016/j.leukres.2018.02.009","title":"The importance of meaningful activity in people living with acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Deconditioning; Quality of life (healthcare); Psychology; Psychological intervention; Qualitative research; Gerontology; Population; Observational study; Medicine; Disease; Incentive; Physical therapy; Psychiatry; Environmental health; Psychotherapist; Pathology","score_opus":0.03365902177792159,"score_gpt":0.3485649236618035,"score_spread":0.31490590188388196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790326841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688136,0.006628706,0.00016008854,0.0075718155,0.0002666544,0.000034588804,0.000520204,0.00000838078,0.015996],"genre_scores_gemma":[0.9964408,0.0021209673,0.00010772787,0.00058045704,0.00007714759,0.000011456734,0.00016640263,0.0000019439083,0.0004930693],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9992507,0.0003246346,0.0000658119,0.000047799887,0.00012469565,0.00018630005],"domain_scores_gemma":[0.9971102,0.00049324456,0.00085961295,0.000063955595,0.0003233722,0.0011496275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005468029,0.00017027766,0.00033534534,0.00066246284,0.0009222917,0.0013673889,0.00032874692,0.0005861013,0.002775572],"category_scores_gemma":[0.005998777,0.000107886175,0.00045339938,0.00082594075,0.0006369092,0.0007132255,0.0012378583,0.0013120589,0.00022145377],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026975333,0.0004183683,0.9191158,0.00037985123,0.00024490262,0.00034237464,0.0051545156,0.00008928795,0.00037121944,0.00094509503,0.0040387283,0.06863015],"study_design_scores_gemma":[0.000014638005,0.0001467819,0.9846468,0.00015232815,0.00009383662,0.000256863,0.009250472,0.00007756165,0.000049892944,0.0008494886,0.00444675,0.000014473139],"about_ca_topic_score_codex":0.008300319,"about_ca_topic_score_gemma":0.024167234,"teacher_disagreement_score":0.008300319,"about_ca_system_score_codex":0.00064795656,"about_ca_system_score_gemma":0.00072405464,"threshold_uncertainty_score":0.01650399},"labels":[],"label_agreement":null},{"id":"W2791883352","doi":"10.1016/j.leukres.2018.02.012","title":"AML refractory to primary induction with Ida-FLAG has a poor clinical outcome","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Princess Margaret Cancer Foundation","keywords":"Flag (linear algebra); Refractory (planetary science); Medicine; Complete remission; Internal medicine; Induction chemotherapy; Oncology; Chemotherapy; Salvage therapy; Transplantation; Surgery; Biology","score_opus":0.2133251517237102,"score_gpt":0.46321697722524635,"score_spread":0.24989182550153616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791883352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97473836,0.0042039515,0.0012345222,0.0018207702,0.00017200188,0.000119294345,0.0016496119,0.00020264591,0.01585892],"genre_scores_gemma":[0.9926817,0.0010006438,0.0004863648,0.00052675256,0.000110049295,0.000042559972,0.0030558917,0.000023178107,0.0020727525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977344,0.000033306536,0.00001972741,0.00002795644,0.000044077933,0.00010142098],"domain_scores_gemma":[0.9988483,0.00025378077,0.00026068403,0.00009673508,0.000083703024,0.0004568211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004067987,0.0001808678,0.0006393736,0.0003034368,0.000502914,0.00091206253,0.00018089541,0.00037860882,0.002667731],"category_scores_gemma":[0.00084487186,0.00006330504,0.00025648478,0.0004816247,0.00029179594,0.00031043967,0.00041585736,0.00053153525,0.0010344002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011456763,0.0013159285,0.51565796,0.00039954926,0.0003303378,0.0073663816,0.00035886653,0.0017117617,0.10788604,0.002443669,0.03050347,0.3205693],"study_design_scores_gemma":[0.0005117854,0.0062989043,0.8772726,0.000105799874,0.00032152823,0.034425374,0.00043503472,0.0012636523,0.022110442,0.0023319898,0.054863237,0.000059600294],"about_ca_topic_score_codex":0.0005449047,"about_ca_topic_score_gemma":0.0009757478,"teacher_disagreement_score":0.002667731,"about_ca_system_score_codex":0.000753611,"about_ca_system_score_gemma":0.00069135765,"threshold_uncertainty_score":0.008924425},"labels":[],"label_agreement":null},{"id":"W2793996297","doi":"10.1016/j.leukres.2018.02.016","title":"RETRACTED: Arsenic Trioxide Inhibits Proliferation and Induced apoptosis of Leukemia Stem Cells with Drug Resistance","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Department of Gansu Province; Lanzhou University; Ryerson University","keywords":"Arsenic trioxide; Apoptosis; Cancer research; Drug resistance; Leukemia; Stem cell; Drug; Pharmacology; Arsenic; Medicine; Chemistry; Biology; Cell biology; Immunology; Microbiology; Biochemistry","score_opus":0.024333322470176194,"score_gpt":0.28935695904442615,"score_spread":0.26502363657425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793996297","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027085477,0.007767005,0.0012149616,0.43658844,0.5440041,0.00007486442,0.0008054465,0.00092076603,0.005915809],"genre_scores_gemma":[0.029215956,0.01484473,0.0036373378,0.426235,0.28944433,0.00016244044,0.001972499,0.00044588535,0.23404184],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996671,0.00031506448,0.0005824854,0.000338552,0.0017331754,0.0003597686],"domain_scores_gemma":[0.9861216,0.0033873012,0.0007694415,0.0010363851,0.006810834,0.0018745679],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004332121,0.0010079695,0.0015893128,0.0019364855,0.0030549557,0.0038765601,0.005244528,0.016388744,0.014010988],"category_scores_gemma":[0.0183616,0.0008765207,0.0013729536,0.001470359,0.0019483828,0.0022238905,0.0020339806,0.01154598,0.011648826],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001483432,0.000057833775,0.00045587504,0.00022929789,0.000035626617,0.0011356733,0.00008193063,0.00011184127,0.0013738082,0.00064542796,0.965008,0.030716343],"study_design_scores_gemma":[0.00004064726,0.00008405682,0.0020403147,0.00009174006,0.00006349869,0.00078019744,0.00011004662,0.00035270926,0.0018223381,0.0007577992,0.9938198,0.000036890186],"about_ca_topic_score_codex":0.006955692,"about_ca_topic_score_gemma":0.008264772,"teacher_disagreement_score":0.9836112,"about_ca_system_score_codex":0.003774386,"about_ca_system_score_gemma":0.004981991,"threshold_uncertainty_score":0.046871424},"labels":[],"label_agreement":null},{"id":"W2799981331","doi":"10.1016/j.leukres.2018.04.007","title":"Cell membrane-bound CD200 signals both via an extracellular domain and following nuclear translocation of a cytoplasmic fragment","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Transfection; Cell biology; Biology; Chromatin immunoprecipitation; Transcription factor; Nuclear localization sequence; Cytoplasm; Immunoprecipitation; Molecular biology; Intracellular; HEK 293 cells; Cell; Cell culture; Gene; Gene expression; Genetics","score_opus":0.05781588580220475,"score_gpt":0.32169662980595093,"score_spread":0.26388074400374617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799981331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067116,0.00083004445,0.0039785122,0.00017946605,0.000027447963,0.0000168493,0.00030977975,0.000056235294,0.003930541],"genre_scores_gemma":[0.9916687,0.00037567035,0.0024308744,0.00009470213,0.000012646208,0.00002086742,0.0007543849,0.000014768288,0.004627499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981457,0.000024421302,0.000009857392,0.00003763637,0.000044326483,0.00006915169],"domain_scores_gemma":[0.9998683,0.000022298203,0.000029871237,0.000017818413,0.000023208806,0.000038454276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016033945,0.0003304607,0.00018478598,0.0002762717,0.00029246966,0.00054276665,0.00022045286,0.00039230107,0.002558441],"category_scores_gemma":[0.00016405103,0.000100476005,0.00034383504,0.00030916138,0.00026541116,0.0004703639,0.0003518199,0.000827835,0.00094984635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013052368,0.00001785798,0.0002533426,0.000026579906,0.0000057057996,0.0001412236,0.00002916944,0.000026936446,0.9977544,0.00047441348,0.00006608477,0.0010737937],"study_design_scores_gemma":[0.000031887208,0.00014924687,0.0071913367,0.000013237411,0.000016323713,0.00094184146,0.00013042273,0.0006353472,0.9869192,0.00024956206,0.003713988,0.0000075053454],"about_ca_topic_score_codex":0.0010008976,"about_ca_topic_score_gemma":0.0016794852,"teacher_disagreement_score":0.002558441,"about_ca_system_score_codex":0.0008556197,"about_ca_system_score_gemma":0.000330496,"threshold_uncertainty_score":0.00855881},"labels":[],"label_agreement":null},{"id":"W2806323598","doi":"10.1016/j.leukres.2018.06.001","title":"The real-world outcomes of treating Polycythemia Vera: Physician adherence to treatment guidelines","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Population Health Research Institute; McMaster University","funders":"Heart and Stroke Foundation of Canada; American Society of Hematology","keywords":"Medicine; Polycythemia vera; Internal medicine; Myeloproliferative neoplasm; Cohort; Retrospective cohort study; White blood cell; Myelofibrosis; Bone marrow","score_opus":0.1747975853204603,"score_gpt":0.477876164278517,"score_spread":0.3030785789580567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806323598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643275,0.00616867,0.0004284136,0.018119004,0.00014190694,0.00004608283,0.0020863507,0.000019373447,0.008662632],"genre_scores_gemma":[0.99804246,0.0006527471,0.00015164664,0.0005547374,0.000056616733,0.000007907216,0.00042004784,0.0000033828114,0.00011036779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99048775,0.005440527,0.0011882184,0.0005884417,0.0015780356,0.0007170389],"domain_scores_gemma":[0.95262724,0.017098617,0.023421366,0.0010402295,0.0031014641,0.0027110374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037438301,0.00009949493,0.00033024748,0.0006369146,0.0005684797,0.0014627819,0.00041735874,0.0011622942,0.0020307193],"category_scores_gemma":[0.052961636,0.00015394196,0.00042845405,0.0020252205,0.00047944486,0.0011423744,0.00057651417,0.0015699846,0.00015811325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018596521,0.00016755961,0.9784113,0.000058041078,0.00021866779,0.00009441873,0.00035387595,0.0003275628,0.00003419864,0.00028649578,0.0021723786,0.017689614],"study_design_scores_gemma":[0.000036089874,0.00011677106,0.9959416,0.000093236886,0.00008600548,0.000237928,0.00094003015,0.00093888654,0.000042891803,0.00031468258,0.0012378083,0.000013986966],"about_ca_topic_score_codex":0.027440988,"about_ca_topic_score_gemma":0.031259913,"teacher_disagreement_score":0.027440988,"about_ca_system_score_codex":0.0018661798,"about_ca_system_score_gemma":0.0021009813,"threshold_uncertainty_score":0.05456257},"labels":[],"label_agreement":null},{"id":"W2806968913","doi":"10.1016/j.leukres.2018.06.005","title":"Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Canadian Cancer Society Research Institute; CancerCare Manitoba Foundation; Research Manitoba","keywords":"Mefloquine; Lysosome; Programmed cell death; Chronic lymphocytic leukemia; Pharmacology; Leukemia; Primaquine; Myeloid leukemia; Apoptosis; Cancer research; Chemistry; Immunology; Medicine; Chloroquine; Biochemistry","score_opus":0.04492586500004525,"score_gpt":0.35592609796185143,"score_spread":0.3110002329618062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806968913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989527,0.003373897,0.0014753914,0.00026238823,0.0000592953,0.00005029688,0.00087881007,0.00009614156,0.0042768396],"genre_scores_gemma":[0.9959273,0.000921898,0.00053459464,0.00010141299,0.000014741655,0.00003828631,0.00061808183,0.000006499,0.0018372585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997311,0.00006743249,0.000028762746,0.000025388917,0.00006382043,0.000083424755],"domain_scores_gemma":[0.99988925,0.0000344011,0.000020526088,0.000016437854,0.000024597875,0.000014890227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018278249,0.0001958298,0.00028227616,0.00024428265,0.00025554578,0.00050548883,0.00013535883,0.00042546925,0.003773382],"category_scores_gemma":[0.0001811581,0.00014423291,0.00028165168,0.00024747365,0.00013124286,0.00032708657,0.00027286104,0.0005209563,0.0010659406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009819816,0.00013086465,0.0016608118,0.00012812011,0.000024251382,0.00017887623,0.00008170929,0.000098316224,0.99082434,0.00041333822,0.0004972605,0.004980087],"study_design_scores_gemma":[0.00016828977,0.0014267327,0.02861858,0.000021939757,0.000039575905,0.0009890797,0.0002599069,0.0011847414,0.9592239,0.00019763189,0.007859913,0.000009638054],"about_ca_topic_score_codex":0.00062041695,"about_ca_topic_score_gemma":0.0010436763,"teacher_disagreement_score":0.003773382,"about_ca_system_score_codex":0.00034948907,"about_ca_system_score_gemma":0.00020916987,"threshold_uncertainty_score":0.0126232505},"labels":[],"label_agreement":null},{"id":"W2807946057","doi":"10.1016/j.leukres.2018.06.008","title":"Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity","year":2018,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunosuppression; Internal medicine; Lymphoma; Gastroenterology; Inflammatory bowel disease; Ulcerative colitis; Chemotherapy; Gastrointestinal tract; Disease","score_opus":0.07467158238057321,"score_gpt":0.39730007063406203,"score_spread":0.32262848825348883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807946057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005171422,0.99773335,0.00010537087,0.0006192848,0.00011311449,0.000003011428,0.000012392094,0.0000043249584,0.0008920138],"genre_scores_gemma":[0.0057188836,0.9926069,0.0002819597,0.00062351394,0.0004478494,0.0000041637377,0.000030408004,0.0000012786605,0.00028508052],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997843,0.00004841247,0.000042013853,0.000038020695,0.000065866894,0.000021298369],"domain_scores_gemma":[0.99961686,0.00021770052,0.00007721979,0.000009592993,0.00005335042,0.00002520879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035419466,0.0004612793,0.000892984,0.0023276396,0.0002624532,0.0011451674,0.0006423199,0.0010193499,0.0012017981],"category_scores_gemma":[0.001085876,0.00020336083,0.0003022147,0.0018921366,0.0007217017,0.0017822608,0.000675471,0.001464306,0.0004196245],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010653045,0.00005283532,0.0047104903,0.01597397,0.00017870992,0.008831231,0.0005750568,0.00033524734,0.0029337467,0.005872263,0.03482585,0.92560405],"study_design_scores_gemma":[0.000043414562,0.00008380756,0.0120658595,0.017745279,0.00050715375,0.10947127,0.0011476245,0.00026178686,0.0006464496,0.0064787776,0.8514846,0.00006394266],"about_ca_topic_score_codex":0.000701168,"about_ca_topic_score_gemma":0.0016582537,"teacher_disagreement_score":0.0023276396,"about_ca_system_score_codex":0.0003562499,"about_ca_system_score_gemma":0.0005882016,"threshold_uncertainty_score":0.0040204525},"labels":[],"label_agreement":null},{"id":"W2888861919","doi":"10.1016/j.leukres.2018.08.004","title":"Acute promyelocytic leukemia in the intensive care unit: A retrospective analysis","year":2018,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Flow cytometry; Medicine; Acute promyelocytic leukemia; Acute leukemia; Leukemia; Immunophenotyping; Chronic myelomonocytic leukemia; Internal medicine; Immunology; Pathology; Bone marrow; Myelodysplastic syndromes; Biology","score_opus":0.037696488725430174,"score_gpt":0.3518346856172466,"score_spread":0.31413819689181643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888861919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980513,0.000640136,0.00028454073,0.00017837579,0.000012256041,0.000019142397,0.000332671,0.0000040565806,0.00047742578],"genre_scores_gemma":[0.99876475,0.00033700655,0.0001633401,0.00015887637,0.000032647833,0.000012175696,0.00040050852,0.0000027275332,0.00012796755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924976,0.00018119006,0.0001586871,0.0001673773,0.00013128275,0.00011167417],"domain_scores_gemma":[0.9986324,0.00029853138,0.0004814316,0.00022515749,0.00019722653,0.00016519804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000679096,0.00020831922,0.0004145243,0.00078324846,0.00054420804,0.0005827014,0.00030239855,0.0004565465,0.0011647969],"category_scores_gemma":[0.0018017277,0.00034261975,0.00033877575,0.0015213955,0.00035873285,0.00053202664,0.0004932511,0.00044734252,0.00023981852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011376783,0.000023356324,0.99606115,0.000009654462,0.00004408404,0.0019051001,0.00007371171,0.000021377382,0.00020604387,0.00004743901,0.00018240589,0.0013118052],"study_design_scores_gemma":[0.00003349035,0.00026828676,0.97823286,0.000030824434,0.00021414463,0.016815389,0.0010886114,0.0004054615,0.00037424144,0.00016464668,0.0023539462,0.000017993232],"about_ca_topic_score_codex":0.001603199,"about_ca_topic_score_gemma":0.0015176408,"teacher_disagreement_score":0.001603199,"about_ca_system_score_codex":0.00035022685,"about_ca_system_score_gemma":0.00043150975,"threshold_uncertainty_score":0.0038966537},"labels":[],"label_agreement":null},{"id":"W2889965434","doi":"10.1016/j.leukres.2018.09.005","title":"Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS","year":2018,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Foothills Medical Centre; Université Laval; CancerCare Manitoba; Health Sciences Centre; University of Alberta Hospital; University Health Network; Employment and Social Development Canada; Princess Margaret Cancer Centre; University of Saskatchewan; Leukemia & Lymphoma Society of Canada; Queen Elizabeth II Health Sciences Centre; University of Alberta; Jewish General Hospital; Sunnybrook Health Science Centre; McMaster University; St. Paul's Hospital","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Guideline; Intensive care medicine; Grading (engineering); Myeloid leukemia; Internal medicine; Pathology; Bone marrow","score_opus":0.3079888152962133,"score_gpt":0.4594524009597839,"score_spread":0.1514635856635706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889965434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081453276,0.9974043,0.000097620956,0.0012385615,0.00028127347,0.000057315767,0.00021531378,0.0000079357515,0.0006162328],"genre_scores_gemma":[0.0009361774,0.99628687,0.0008257975,0.0012229709,0.00015017178,0.00006695856,0.00025015566,0.000002625216,0.00025828998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979473,0.0003239682,0.00079365907,0.00015619266,0.00065287104,0.00012602487],"domain_scores_gemma":[0.9941553,0.0026618473,0.0012176154,0.00006942545,0.0016500374,0.00024576543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004625863,0.0015174493,0.0051321243,0.008472832,0.000922018,0.0027302047,0.0026761044,0.002850815,0.004094701],"category_scores_gemma":[0.00953152,0.00069987687,0.004291581,0.0071032154,0.00081512047,0.0015420091,0.0015986619,0.0027934294,0.00071950693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037828684,0.00010886813,0.0010892256,0.27148023,0.0024258154,0.00026604434,0.00023255877,0.000762892,0.0004660893,0.0027780244,0.10157711,0.6184349],"study_design_scores_gemma":[0.0006170461,0.00013244007,0.0058011995,0.4217079,0.011457908,0.00074546685,0.00025206918,0.00027240193,0.00026066974,0.002110651,0.5565303,0.00011194385],"about_ca_topic_score_codex":0.08685267,"about_ca_topic_score_gemma":0.16877401,"teacher_disagreement_score":0.99423444,"about_ca_system_score_codex":0.005765582,"about_ca_system_score_gemma":0.025236273,"threshold_uncertainty_score":0.17269427},"labels":[],"label_agreement":null},{"id":"W2890730652","doi":"10.1016/j.leukres.2018.08.021","title":"Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; Ottawa Hospital; University Health Network; Université Laval; University of Ottawa; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; Alberta Health Services; BC Cancer Agency; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Transplantation; Gastroenterology; Tyrosine-kinase inhibitor; Population; Oncology; Cancer","score_opus":0.03327361829229448,"score_gpt":0.3345510187944684,"score_spread":0.30127740050217394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890730652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7533431,0.0107983975,0.00045710104,0.032133065,0.0007417161,0.00014593061,0.12562014,0.00011173234,0.07664881],"genre_scores_gemma":[0.9495792,0.0065399124,0.00032481624,0.0024674912,0.00029479648,0.00007000601,0.029796483,0.00003786733,0.010889428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987431,0.000101110185,0.00005280531,0.0001126422,0.00040293313,0.0005873869],"domain_scores_gemma":[0.9963883,0.00014790545,0.0007547225,0.00005258334,0.0015608689,0.0010956832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007224046,0.00027482884,0.00045610496,0.0012220367,0.0018314508,0.0012160816,0.0008251451,0.00042085117,0.0111380145],"category_scores_gemma":[0.0034924073,0.00017269238,0.00069227145,0.004573293,0.00040112218,0.0006002005,0.0010200085,0.0014001897,0.00051407283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024060453,0.00026365652,0.7135118,0.00043135486,0.00047400236,0.0003873586,0.0011461109,0.0010174515,0.0005516623,0.007357851,0.19202462,0.080428004],"study_design_scores_gemma":[0.00027654163,0.0001301843,0.9511599,0.00021777411,0.00022456942,0.00022568238,0.001552847,0.0003606068,0.00020512199,0.000417206,0.045180142,0.000049449434],"about_ca_topic_score_codex":0.978227,"about_ca_topic_score_gemma":0.98901373,"teacher_disagreement_score":0.038387153,"about_ca_system_score_codex":0.038387153,"about_ca_system_score_gemma":0.04750932,"threshold_uncertainty_score":0.27851957},"labels":[],"label_agreement":null},{"id":"W2903979174","doi":"10.1016/j.leukres.2018.12.002","title":"The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Celgene","keywords":"Medicine; Observational study; Myelodysplastic syndromes; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.06938188478336435,"score_gpt":0.33238649535146897,"score_spread":0.26300461056810465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903979174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984074,0.00029726428,0.00009823614,0.00006188677,0.000007025901,0.000011179993,0.000906639,0.000003109547,0.00020721045],"genre_scores_gemma":[0.9983752,0.00016834273,0.00008298792,0.000047698646,0.000012547908,0.00001699632,0.0012334089,0.000003132161,0.0000597188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977943,0.00066108786,0.00041333126,0.0005381784,0.0002468966,0.00034624984],"domain_scores_gemma":[0.9940706,0.0007006566,0.003357249,0.00069002167,0.0005205527,0.00066089426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015816032,0.00035950076,0.0009356047,0.00091817824,0.0009528652,0.0017347075,0.0010687792,0.00089268875,0.0011115252],"category_scores_gemma":[0.0056377556,0.0006187809,0.0011556256,0.0030660275,0.00052992126,0.0017056178,0.001452331,0.0013000483,0.00023537267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016196417,0.000051383995,0.99879223,0.00001283936,0.00014076215,0.00013271856,0.00009724623,0.000032446475,0.00007970358,0.000034940866,0.00013894681,0.0003247717],"study_design_scores_gemma":[0.000037260652,0.00016858663,0.997769,0.000017386126,0.000117707474,0.00065512955,0.0006730715,0.00024359289,0.000036569767,0.00006500951,0.0002015652,0.00001512189],"about_ca_topic_score_codex":0.010563758,"about_ca_topic_score_gemma":0.009847932,"teacher_disagreement_score":0.010563758,"about_ca_system_score_codex":0.0008174053,"about_ca_system_score_gemma":0.0013413273,"threshold_uncertainty_score":0.021004558},"labels":[],"label_agreement":null},{"id":"W2907456071","doi":"10.1016/j.leukres.2019.01.002","title":"Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease","year":2019,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"Université de Montréal; Hoechst Marion Roussel","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Population; Context (archaeology); Lymphoma; Hematopoietic cell; Oncology; Surgery; Stem cell; Haematopoiesis","score_opus":0.018073278266295643,"score_gpt":0.2787530836565074,"score_spread":0.2606798053902118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907456071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988152,0.00031973756,0.000036070232,0.00008920089,0.00001625391,0.0000041078765,0.00009282983,0.0000015261674,0.00062497065],"genre_scores_gemma":[0.99946874,0.000097535456,0.00001089994,0.00004742047,0.0000254585,0.00000190782,0.00021291211,6.5392584e-7,0.00013450473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984014,0.000031520583,0.000014689192,0.000021913858,0.000018033672,0.00007377752],"domain_scores_gemma":[0.99940395,0.000092937,0.00016575445,0.000021003252,0.000033688648,0.00028265783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024269495,0.00019478324,0.00032682472,0.0003032786,0.00038722594,0.00053110655,0.00016117023,0.0003644415,0.0011037908],"category_scores_gemma":[0.0010930956,0.00006742686,0.0005690009,0.00030515774,0.0002894273,0.0004075364,0.0004710457,0.00045033576,0.00015418009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005612026,0.00030205888,0.97996956,0.000023988034,0.00012758399,0.0021962614,0.00016947782,0.0004643632,0.0007890806,0.00010664201,0.00030860686,0.009930275],"study_design_scores_gemma":[0.000087495035,0.0027980076,0.9934242,0.000016781592,0.00013959204,0.0020966672,0.00033713033,0.0004108841,0.00015211807,0.00016662887,0.00035873562,0.000011758512],"about_ca_topic_score_codex":0.0018817148,"about_ca_topic_score_gemma":0.0025690016,"teacher_disagreement_score":0.0018817148,"about_ca_system_score_codex":0.00041867152,"about_ca_system_score_gemma":0.0002234055,"threshold_uncertainty_score":0.0037415028},"labels":[],"label_agreement":null},{"id":"W2949586010","doi":"10.1016/j.leukres.2019.106170","title":"Delayed time from RBC transfusion dependence to first cardiac event in lower IPSS risk MDS patients receiving iron chelation therapy","year":2019,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Celgene","keywords":"Chelation therapy; Medicine; Internal medicine; Cardiovascular event; Cardiology; Thalassemia","score_opus":0.01229884529623126,"score_gpt":0.2871517802211221,"score_spread":0.2748529349248908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949586010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719256,0.0006276095,0.00009757325,0.00013744872,0.000029075189,0.000007997317,0.0002527288,0.0000061599944,0.0016488256],"genre_scores_gemma":[0.99900097,0.0001537784,0.00006167639,0.000062716936,0.0000349527,0.0000061375117,0.00029577204,0.0000023878933,0.0003818118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997919,0.000029125693,0.00002635883,0.000050156796,0.00003369398,0.0000687668],"domain_scores_gemma":[0.9986725,0.00031133316,0.0005838432,0.00003689971,0.00009927044,0.00029622432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022322027,0.00016831346,0.0003672015,0.00038956484,0.0003463911,0.00062347593,0.00020243997,0.0003401854,0.0040342533],"category_scores_gemma":[0.0024165912,0.000128731,0.0003063891,0.00042002072,0.00011385456,0.0003287425,0.00025837246,0.0008628988,0.0003289946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015376772,0.000097517724,0.9896769,0.00003091914,0.000049372655,0.00068617985,0.00012211136,0.00011698891,0.0006708399,0.000115215145,0.00046056844,0.006435738],"study_design_scores_gemma":[0.00004347344,0.00046077438,0.9945024,0.00004345164,0.00010882575,0.0019950876,0.0003975447,0.00052055967,0.00024957166,0.00024551875,0.001416405,0.000016462367],"about_ca_topic_score_codex":0.0015734462,"about_ca_topic_score_gemma":0.0022333486,"teacher_disagreement_score":0.0040342533,"about_ca_system_score_codex":0.00035158236,"about_ca_system_score_gemma":0.00044750908,"threshold_uncertainty_score":0.013495922},"labels":[],"label_agreement":null},{"id":"W2956956185","doi":"10.1016/j.leukres.2019.106193","title":"Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada","year":2019,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Immunology; Human leukocyte antigen; Stem cell; Leukemia; Chronic lymphocytic leukemia; Population; Internal medicine; Biology; Antigen; Genetics","score_opus":0.020211706848198577,"score_gpt":0.28614271253281076,"score_spread":0.2659310056846122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956956185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978162,0.00021684899,0.00005954488,0.00008466513,0.000007653933,0.000022706678,0.00065880606,0.000005513152,0.001128143],"genre_scores_gemma":[0.998755,0.00019912396,0.000060679533,0.00005332832,0.000006047084,0.000011685321,0.00057246204,0.0000073599845,0.0003342751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980598,0.00021675162,0.00013600523,0.0004273662,0.0004933091,0.000666795],"domain_scores_gemma":[0.99687886,0.00032965196,0.0007201304,0.00019351848,0.0012313524,0.00064644974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006594079,0.0006931052,0.00082254387,0.0021032458,0.003686746,0.0025639213,0.0019738344,0.0009879848,0.0028583982],"category_scores_gemma":[0.0035259742,0.00072862965,0.0006759037,0.0058323,0.0015486667,0.0007113232,0.0010967196,0.0010895432,0.00046753656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006269385,0.00003912225,0.9974968,0.000009974579,0.00004645488,0.00032541816,0.0006156585,0.000026684733,0.00015531963,0.000033616056,0.00030577378,0.00088257116],"study_design_scores_gemma":[0.000012261152,0.000036696158,0.99614394,0.000017333543,0.00005075732,0.00045628884,0.0028110524,0.00012447534,0.0000335608,0.000026134083,0.00027425622,0.000013225241],"about_ca_topic_score_codex":0.92936355,"about_ca_topic_score_gemma":0.95009905,"teacher_disagreement_score":0.07063645,"about_ca_system_score_codex":0.010016805,"about_ca_system_score_gemma":0.010678488,"threshold_uncertainty_score":0.14210486},"labels":[],"label_agreement":null},{"id":"W2970918745","doi":"10.1016/j.leukres.2019.106220","title":"Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia","year":2019,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"Research Manitoba","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Outbreak; Cluster (spacecraft); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Family medicine; Virology; Disease; Internal medicine; Infectious disease (medical specialty)","score_opus":0.09863748031594236,"score_gpt":0.37400464742956685,"score_spread":0.2753671671136245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970918745","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009494325,0.0038340206,0.00012954278,0.97262007,0.008783596,0.000009286979,0.00014781037,0.000025424455,0.0049559283],"genre_scores_gemma":[0.107819915,0.0062657055,0.00065896986,0.81808525,0.060310848,0.00004522637,0.00019511081,0.000035407094,0.0065835994],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99800915,0.00080419803,0.00042002622,0.00017394201,0.00035425878,0.0002384365],"domain_scores_gemma":[0.9886906,0.007605996,0.000659165,0.00033288507,0.0015977287,0.001113562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027121748,0.00033311042,0.0009789761,0.000870603,0.0017106362,0.0016067221,0.00082909846,0.01271936,0.0028469963],"category_scores_gemma":[0.024300935,0.0003673172,0.00044044064,0.00089612947,0.0013770708,0.0015015004,0.00066000636,0.010940263,0.002642722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052480085,0.00017374201,0.09557362,0.00021278388,0.0000839307,0.018592952,0.0006025798,0.00012283515,0.0010069662,0.0033185885,0.7883479,0.09143939],"study_design_scores_gemma":[0.00093168614,0.0011243548,0.11410585,0.002585391,0.0004106505,0.07540579,0.006315489,0.0022096438,0.0016895137,0.029541498,0.76541203,0.00026820137],"about_ca_topic_score_codex":0.006225598,"about_ca_topic_score_gemma":0.0086302515,"teacher_disagreement_score":0.01271936,"about_ca_system_score_codex":0.0020515048,"about_ca_system_score_gemma":0.0018109012,"threshold_uncertainty_score":0.01488477},"labels":[],"label_agreement":null},{"id":"W2971612352","doi":"10.1016/j.leukres.2019.106222","title":"Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature","year":2019,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Toxicity; Oncology; Internal medicine; Clinical trial; Leukemia; Cancer; Myeloid leukemia; Chemotherapy; Pharmacology","score_opus":0.08932005962414828,"score_gpt":0.40803120393072545,"score_spread":0.31871114430657715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971612352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046180445,0.99903584,0.000052236388,0.000091208014,0.000034859208,0.00003926019,0.00018053316,0.0000024839958,0.00010172583],"genre_scores_gemma":[0.0045831203,0.99470055,0.00020738751,0.00029471604,0.000034819997,0.00004065947,0.00010010745,0.0000015568302,0.000037071033],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978332,0.00055261113,0.00095520983,0.00024183799,0.00034826764,0.00006891186],"domain_scores_gemma":[0.992188,0.0055207824,0.0016790004,0.000082224666,0.00044304732,0.00008704273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032315042,0.0011191341,0.005922919,0.0044166357,0.00030381716,0.001519883,0.0013532147,0.0010846588,0.0029954966],"category_scores_gemma":[0.012717265,0.00060253614,0.006540365,0.005349745,0.000470609,0.0012841956,0.001139077,0.0009966836,0.00020158784],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043680676,0.000027139347,0.0012065079,0.88182014,0.013852074,0.000097472104,0.00008962706,0.00024159874,0.0003659287,0.00019636651,0.002186222,0.09948009],"study_design_scores_gemma":[0.00069479586,0.00060675165,0.009481179,0.7162618,0.2043083,0.0009805466,0.0003009548,0.00019485428,0.00050967786,0.0007308813,0.06584736,0.00008289896],"about_ca_topic_score_codex":0.0039155264,"about_ca_topic_score_gemma":0.014340716,"teacher_disagreement_score":0.005922919,"about_ca_system_score_codex":0.0015251915,"about_ca_system_score_gemma":0.0039838133,"threshold_uncertainty_score":0.017090082},"labels":[],"label_agreement":null},{"id":"W2976783757","doi":"10.1016/j.leukres.2019.106228","title":"Impact of DARC, GSDMA and CXCL2 polymorphisms on induction toxicity in children with acute lymphoblastic leukemia: A complementary study","year":2019,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Lymphoblastic Leukemia; Medicine; Leukemia; Oncology; Internal medicine","score_opus":0.040023689254644314,"score_gpt":0.35315997224226175,"score_spread":0.3131362829876174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976783757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93275654,0.008347084,0.00030686657,0.048303694,0.0010285901,0.0000354916,0.0021148548,0.00001760165,0.0070893876],"genre_scores_gemma":[0.97667193,0.002744588,0.0003539469,0.016612392,0.001427469,0.00003961215,0.000647346,0.000008833762,0.0014939159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953306,0.00018526186,0.00004942109,0.000070176786,0.00008503101,0.00007701453],"domain_scores_gemma":[0.99788326,0.0012458779,0.00024905085,0.00011546802,0.00027784135,0.00022842207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046342277,0.00016977168,0.0004684026,0.00019411354,0.00029233142,0.00045485602,0.00024912064,0.0009257336,0.0015494587],"category_scores_gemma":[0.0036923266,0.00010518184,0.0005738422,0.0006469264,0.0002185169,0.00023963979,0.00017114737,0.0010392027,0.00024904415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046476526,0.00020553806,0.9176003,0.00015607312,0.0005893379,0.006267044,0.00024232465,0.00028918666,0.0017332784,0.00048321285,0.021514056,0.046272207],"study_design_scores_gemma":[0.0012123786,0.001858206,0.94125855,0.00023921033,0.00158135,0.014530095,0.0007042775,0.0007049783,0.0013591232,0.0017478084,0.034760285,0.00004362796],"about_ca_topic_score_codex":0.004430689,"about_ca_topic_score_gemma":0.0057433504,"teacher_disagreement_score":0.004430689,"about_ca_system_score_codex":0.0007137399,"about_ca_system_score_gemma":0.00079456076,"threshold_uncertainty_score":0.008809805},"labels":[],"label_agreement":null},{"id":"W2991655819","doi":"10.1016/j.leukres.2019.106285","title":"The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia","year":2019,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network; Dalhousie University; Windsor Regional Hospital; Université de Montréal; Ottawa Hospital; Alberta Health Services; McMaster University","funders":"Novartis Pharmaceuticals Canada; Princess Margaret Cancer Foundation","keywords":"Imatinib; Myeloid leukemia; Medicine; Predictive value; Value (mathematics); Internal medicine; Oncology; Leukemia; Cancer research; Statistics; Mathematics","score_opus":0.04394516131639886,"score_gpt":0.33581562774929136,"score_spread":0.2918704664328925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991655819","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09127522,0.011765453,0.0004493439,0.86098725,0.008659332,0.000028065091,0.00044360495,0.000058072586,0.026333677],"genre_scores_gemma":[0.69353,0.0072034285,0.0011635454,0.24345434,0.045995414,0.00005335633,0.00034504724,0.00003012437,0.008224702],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99933857,0.00027092546,0.00010686495,0.000053834225,0.0001335152,0.000096291486],"domain_scores_gemma":[0.9956251,0.0030352874,0.00028970372,0.00011483443,0.00044711394,0.0004880028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080628064,0.00022848052,0.00056361547,0.00068734883,0.000715014,0.0010516739,0.0004757706,0.0049269274,0.0019082124],"category_scores_gemma":[0.009737585,0.00021458961,0.00033717213,0.00053029566,0.0006768178,0.0008539749,0.00030804277,0.004231841,0.0009906339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023913193,0.00034312656,0.34303382,0.00020355804,0.00014338414,0.06459002,0.000523923,0.0008033727,0.004308724,0.0052766423,0.41206127,0.16632088],"study_design_scores_gemma":[0.0013266834,0.0017704353,0.28356776,0.0018307342,0.0006323223,0.17410684,0.0030598824,0.01909258,0.0069545303,0.03598405,0.471401,0.00027323642],"about_ca_topic_score_codex":0.0028472615,"about_ca_topic_score_gemma":0.004220641,"teacher_disagreement_score":0.0049269274,"about_ca_system_score_codex":0.001275848,"about_ca_system_score_gemma":0.0007687209,"threshold_uncertainty_score":0.009257019},"labels":[],"label_agreement":null},{"id":"W3007551495","doi":"10.1016/j.leukres.2020.106335","title":"Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada","year":2020,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Richmond Hospital; St. Paul's Hospital; BC Cancer Agency; University of British Columbia, Okanagan Campus; Kelowna General Hospital; Abbotsford Veterinary Clinic; Kwantlen Polytechnic University; Surrey Memorial Hospital; University of British Columbia; Royal Columbian Hospital; Vernon Jubilee Hospital; University of British Columbia Hospital; Vancouver General Hospital; Columbia Bible College","funders":"","keywords":"Ibrutinib; Chemoimmunotherapy; Medicine; Chronic lymphocytic leukemia; Internal medicine; Population; Oncology; Leukemia","score_opus":0.03979922661886139,"score_gpt":0.34434966859959676,"score_spread":0.3045504419807354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007551495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769653,0.0025690051,0.00020872355,0.0018780443,0.000050797513,0.00007601519,0.014213864,0.000031470106,0.004006785],"genre_scores_gemma":[0.9941603,0.001069913,0.00016723602,0.00023641459,0.000010014304,0.000023820961,0.0031818934,0.000014904532,0.0011356361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977729,0.00022313853,0.00023742579,0.00035413608,0.0004946899,0.00091771316],"domain_scores_gemma":[0.9942508,0.00045509086,0.00117396,0.000144235,0.00267062,0.0013053925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008113806,0.00033211568,0.0006369957,0.0022830095,0.0023107708,0.0021127558,0.0023018443,0.0007934259,0.0029112452],"category_scores_gemma":[0.0044241524,0.0005002267,0.0007767529,0.0073661082,0.0010269828,0.0005327922,0.0010356179,0.0013387334,0.00028877077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033138625,0.000060626007,0.9849541,0.000114973365,0.00015076702,0.00019864328,0.0011572707,0.0006345507,0.00027872648,0.0002469575,0.004067252,0.0078047495],"study_design_scores_gemma":[0.000015709456,0.000024542796,0.99465007,0.00008335542,0.000036773803,0.00007471048,0.0031253695,0.0004135795,0.00006136246,0.000028328655,0.001463943,0.000022233507],"about_ca_topic_score_codex":0.9974179,"about_ca_topic_score_gemma":0.99853206,"teacher_disagreement_score":0.057643063,"about_ca_system_score_codex":0.057643063,"about_ca_system_score_gemma":0.056828313,"threshold_uncertainty_score":0.41823167},"labels":[],"label_agreement":null},{"id":"W3028535930","doi":"10.1016/j.leukres.2020.106370","title":"Anabolic steroids in myelodysplastic syndromes: A systematic review","year":2020,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Danazol; Medicine; Randomized controlled trial; Anabolism; Myelodysplastic syndromes; Systematic review; Internal medicine; MEDLINE; Chemistry","score_opus":0.153479901526021,"score_gpt":0.4567358407268689,"score_spread":0.3032559392008479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028535930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038270353,0.999065,0.000038579692,0.00009707613,0.00006713214,0.0000630689,0.00017375263,0.0000041704984,0.00010854037],"genre_scores_gemma":[0.0062027187,0.99293923,0.00018041913,0.00040033268,0.00005176978,0.00007716375,0.00007857162,0.0000021866867,0.00006754294],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976285,0.0006969914,0.0009176355,0.00023823217,0.0003810415,0.00013765604],"domain_scores_gemma":[0.992983,0.0046533425,0.00172236,0.0000793495,0.0004169314,0.00014513632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032201556,0.0015915465,0.009481928,0.005938096,0.0004665569,0.00218796,0.0015883542,0.001985269,0.007976214],"category_scores_gemma":[0.011413108,0.000996508,0.007746218,0.0079393685,0.0006807596,0.0018038152,0.0015010315,0.0015251145,0.00040629975],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004098633,0.000022395241,0.0007114838,0.9481202,0.019862438,0.00009815152,0.00009031429,0.000106681866,0.00014352985,0.00014260372,0.0021666482,0.028125726],"study_design_scores_gemma":[0.0017573948,0.0003610468,0.0061445776,0.6775129,0.28722876,0.00044375946,0.00030417473,0.00010634222,0.00015200746,0.00039401164,0.025526483,0.00006857972],"about_ca_topic_score_codex":0.01007122,"about_ca_topic_score_gemma":0.03586252,"teacher_disagreement_score":0.01007122,"about_ca_system_score_codex":0.0025683027,"about_ca_system_score_gemma":0.0060014054,"threshold_uncertainty_score":0.026683033},"labels":[],"label_agreement":null},{"id":"W3043664983","doi":"10.1016/j.leukres.2020.106423","title":"Antihistamines are synergistic with Bruton’s tyrosine kinase inhibiter ibrutinib mediated by lysosome disruption in chronic lymphocytic leukemia (CLL) cells","year":2020,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Cancer Research Society","keywords":"Ibrutinib; Bruton's tyrosine kinase; Chronic lymphocytic leukemia; Programmed cell death; Tyrosine kinase; Pharmacology; Cancer research; Apoptosis; Leukemia; Medicine; Immunology; Chemistry; Receptor; Biochemistry; Internal medicine","score_opus":0.04239485212341118,"score_gpt":0.3200529764841595,"score_spread":0.2776581243607483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043664983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987806,0.005046519,0.00053434575,0.00026878252,0.00018179763,0.000043880176,0.00039965802,0.00014631888,0.003500497],"genre_scores_gemma":[0.99688953,0.0011191346,0.00035181144,0.000065816384,0.000018950595,0.00002619693,0.00033224226,0.000007591883,0.0011888429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997795,0.00004892296,0.0000240899,0.00002653531,0.000043045024,0.0000778871],"domain_scores_gemma":[0.99993074,0.00001452041,0.000014364073,0.000010178826,0.000009682656,0.000020456273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002020358,0.0003296074,0.00042991398,0.00020366181,0.00024994166,0.00038303228,0.0003058483,0.00034263154,0.0024060202],"category_scores_gemma":[0.0001384339,0.00012512662,0.00039311044,0.00018690014,0.00019433041,0.0002601713,0.00021633356,0.00075704255,0.00046621304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036505307,0.0004973265,0.0006598101,0.00023665308,0.000066270026,0.00020592802,0.00006598422,0.00031230043,0.9809163,0.00021339268,0.0011655174,0.012009947],"study_design_scores_gemma":[0.0008276467,0.0060817306,0.012534291,0.000026600002,0.00015410686,0.00069091097,0.00016843416,0.0015040259,0.9645639,0.00007891317,0.013348583,0.00002077425],"about_ca_topic_score_codex":0.001211655,"about_ca_topic_score_gemma":0.0025814492,"teacher_disagreement_score":0.0024060202,"about_ca_system_score_codex":0.00030469405,"about_ca_system_score_gemma":0.00029636992,"threshold_uncertainty_score":0.008048952},"labels":[],"label_agreement":null},{"id":"W3081594107","doi":"10.1016/j.leukres.2020.106442","title":"Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies","year":2020,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"University of Ottawa","keywords":"Plerixafor; Medicine; Leukemia; CXCR4; CXCR4 antagonist; Oncology; Transplantation; Acute leukemia; Bone marrow; Context (archaeology); Internal medicine; Hematopoietic stem cell transplantation; Immunology; Biology","score_opus":0.15597014319122254,"score_gpt":0.48267794293402844,"score_spread":0.3267077997428059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081594107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022871383,0.99633694,0.00028114105,0.00010893784,0.0000946657,0.00017565812,0.00047927463,0.000012987859,0.00022319917],"genre_scores_gemma":[0.06798396,0.9281604,0.0014908488,0.0009569937,0.00010073124,0.0004016386,0.00052409526,0.000023197037,0.00035806006],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960681,0.0015076072,0.001331389,0.00047010664,0.00046993134,0.00015267282],"domain_scores_gemma":[0.99250644,0.004780088,0.0019228789,0.0001883595,0.00047945906,0.00012281755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061285323,0.0017484848,0.01190731,0.004192675,0.00037605938,0.0023561374,0.0017328844,0.0015583371,0.0055309325],"category_scores_gemma":[0.013254128,0.00094059476,0.01810031,0.0050227963,0.0005906668,0.0014103848,0.0014402933,0.0016208228,0.00043622396],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020985133,0.000034266777,0.0017061231,0.6593541,0.31075078,0.000085696985,0.00010160108,0.00032212818,0.00047143816,0.00021447316,0.0009739093,0.02388699],"study_design_scores_gemma":[0.0012349838,0.00030690603,0.0029900651,0.05622355,0.93207264,0.000110852605,0.00007584766,0.00010610962,0.0001587241,0.00027199418,0.006413324,0.000035052228],"about_ca_topic_score_codex":0.0049265088,"about_ca_topic_score_gemma":0.018798353,"teacher_disagreement_score":0.01190731,"about_ca_system_score_codex":0.001895513,"about_ca_system_score_gemma":0.0031726572,"threshold_uncertainty_score":0.032411158},"labels":[],"label_agreement":null},{"id":"W3106887103","doi":"10.1016/j.leukres.2020.106489","title":"Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆","year":2020,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche","keywords":"Cytarabine; Medicine; Myeloid leukemia; Adverse effect; Internal medicine; Gastroenterology; Refractory (planetary science); Myeloid; Leukemia; Acute leukemia; Pharmacology; Biology","score_opus":0.10250909267722716,"score_gpt":0.3992120490464178,"score_spread":0.29670295636919064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106887103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481577,0.001866606,0.0006450356,0.00027357467,0.00010097341,0.0002602928,0.00079484633,0.00007688234,0.0011659598],"genre_scores_gemma":[0.9906474,0.0023067575,0.0014806074,0.00019517503,0.00008625577,0.00035842526,0.0023815234,0.00004802693,0.002495864],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997876,0.00007571864,0.000010073689,0.000034028642,0.000029149269,0.000063336774],"domain_scores_gemma":[0.9997873,0.00003804569,0.000044846358,0.00002867056,0.000011129241,0.00009017726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006555836,0.0008477067,0.00090409047,0.00042452812,0.00032999003,0.0005675444,0.00067275116,0.0006611679,0.002190287],"category_scores_gemma":[0.00021264899,0.00028440647,0.0005829689,0.00032233878,0.0006123722,0.00049894996,0.00018980606,0.002129608,0.0004480422],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.099821515,0.023029972,0.0020812363,0.00036847315,0.00040451574,0.0001552167,0.00020077357,0.0016319671,0.82445824,0.0009513371,0.0044434713,0.04245321],"study_design_scores_gemma":[0.082422145,0.38099116,0.026744101,0.000059887112,0.00091226463,0.00090594776,0.0002621833,0.0029768522,0.4839592,0.0005567173,0.020138083,0.00007142077],"about_ca_topic_score_codex":0.0008673386,"about_ca_topic_score_gemma":0.001944904,"teacher_disagreement_score":0.002190287,"about_ca_system_score_codex":0.00052523124,"about_ca_system_score_gemma":0.0007357012,"threshold_uncertainty_score":0.0073272586},"labels":[],"label_agreement":null},{"id":"W3130191480","doi":"10.1016/j.leukres.2021.106538","title":"Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vernon Jubilee Hospital; Richmond Hospital; St. Paul's Hospital; BC Cancer Agency; University of British Columbia, Okanagan Campus; Abbotsford Veterinary Clinic; Kwantlen Polytechnic University; Surrey Memorial Hospital; University of British Columbia; Royal Columbian Hospital; Kelowna General Hospital; Vancouver General Hospital; Columbia Bible College","funders":"","keywords":"Medicine; Fludarabine; Rituximab; Ibrutinib; Chronic lymphocytic leukemia; Internal medicine; Population; Stage (stratigraphy); Leukemia; Chemotherapy; Surgery; Pediatrics; Lymphoma; Cyclophosphamide","score_opus":0.042227606311361854,"score_gpt":0.3518739953660461,"score_spread":0.3096463890546842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130191480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98204184,0.002208023,0.000080350736,0.0019869965,0.00007227501,0.000032008167,0.006512657,0.00001805172,0.0070478544],"genre_scores_gemma":[0.9945257,0.0009698239,0.000065306594,0.00025292864,0.000015925554,0.000011549715,0.0018448596,0.00001327998,0.0023006576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980914,0.00018954536,0.00013279301,0.00017707887,0.00037959957,0.0010296803],"domain_scores_gemma":[0.992979,0.00045336175,0.0012842523,0.00013492872,0.0026497736,0.002498741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071690266,0.00031428662,0.0006319974,0.0013312433,0.0030531278,0.0021288139,0.0018719317,0.0007512745,0.0053777234],"category_scores_gemma":[0.004549924,0.00031315393,0.00090395013,0.0041692443,0.00090871,0.00056407496,0.0012387943,0.0017028133,0.00040778957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019607996,0.000038641192,0.9921095,0.000023915602,0.00006752512,0.00010158399,0.00036109192,0.00022686012,0.00006406254,0.0001606493,0.0026471557,0.0040028803],"study_design_scores_gemma":[0.000015490932,0.00002728554,0.9958646,0.000087673776,0.000056465396,0.000075481046,0.0024010085,0.00023470864,0.000041110132,0.000064721346,0.001113147,0.000018213515],"about_ca_topic_score_codex":0.9941037,"about_ca_topic_score_gemma":0.9975266,"teacher_disagreement_score":0.03974169,"about_ca_system_score_codex":0.03974169,"about_ca_system_score_gemma":0.04626148,"threshold_uncertainty_score":0.28834754},"labels":[],"label_agreement":null},{"id":"W3131490660","doi":"10.1016/j.leukres.2021.106542","title":"Association of insurance disparities and survival in adults with multiple myeloma: A non-concurrent cohort study","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health","funders":"","keywords":"Medicine; Hazard ratio; Medicaid; Marital status; Socioeconomic status; Residence; Confidence interval; Demography; Epidemiology; Cohort; Internal medicine; Environmental health; Population; Health care","score_opus":0.027287999753992848,"score_gpt":0.33705095681831604,"score_spread":0.3097629570643232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131490660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980751,0.00042828856,0.000054332537,0.00012749464,0.00001693561,0.000007091602,0.0009567334,0.0000023734735,0.00033154254],"genre_scores_gemma":[0.9991346,0.0001365095,0.000042708878,0.000043826476,0.000015165521,0.000006991515,0.00042517588,0.0000017866224,0.00019335635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992149,0.00012127059,0.00007980152,0.00023529731,0.00009116001,0.0002575504],"domain_scores_gemma":[0.9984927,0.00014487414,0.0005735178,0.0002062516,0.00019282015,0.00038985113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066959835,0.00032695092,0.0004519172,0.0005225985,0.0010258352,0.001131107,0.00070286973,0.00080231065,0.002244262],"category_scores_gemma":[0.0022110508,0.00049550994,0.0012005246,0.0015534082,0.00029591873,0.0007587705,0.0010969243,0.0014762664,0.00019297161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015146032,0.00006021097,0.9988784,0.000006343745,0.0001604712,0.000030772997,0.00006768139,0.000016290105,0.00009472001,0.000034762266,0.00012930995,0.00036961018],"study_design_scores_gemma":[0.000014402267,0.00005344145,0.99907804,0.0000075560743,0.000114505405,0.00007131268,0.00028387914,0.00013502975,0.000024356857,0.000034660854,0.00017747161,0.0000052457526],"about_ca_topic_score_codex":0.06945589,"about_ca_topic_score_gemma":0.08792445,"teacher_disagreement_score":0.06945589,"about_ca_system_score_codex":0.0006786285,"about_ca_system_score_gemma":0.0012859243,"threshold_uncertainty_score":0.13810325},"labels":[],"label_agreement":null},{"id":"W3141356097","doi":"10.1016/j.leukres.2021.106576","title":"Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Sanofi","keywords":"Pomalidomide; Dexamethasone; Lenalidomide; Refractory (planetary science); Medicine; Internal medicine; Multiple myeloma; Oncology; Materials science","score_opus":0.04205705449643045,"score_gpt":0.34249226574410163,"score_spread":0.3004352112476712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141356097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942808,0.0032497495,0.0001610912,0.00017578194,0.000057521556,0.00026345145,0.0009515714,0.000016772341,0.00084333017],"genre_scores_gemma":[0.99668187,0.00046865628,0.00022644739,0.00019898257,0.00008632292,0.00021193123,0.0016773537,0.0000083479235,0.00044011886],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99908197,0.00036013089,0.00014532589,0.00015142793,0.00008256369,0.00017862115],"domain_scores_gemma":[0.99919766,0.00024013339,0.0001745477,0.00014031805,0.00006202668,0.00018538858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017471786,0.000881329,0.002731585,0.0007368564,0.00028300294,0.0010095629,0.00055572117,0.000737941,0.0021916972],"category_scores_gemma":[0.0017117311,0.00034018685,0.0059179855,0.0007862494,0.00024481147,0.00040522154,0.0005426896,0.0009934925,0.00027192195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6983964,0.0016075051,0.1902066,0.0010091474,0.041504923,0.0006032728,0.00030001448,0.0023532344,0.011432484,0.00019357076,0.0032464867,0.049146306],"study_design_scores_gemma":[0.1825224,0.07660039,0.6391928,0.00033146446,0.07408616,0.0018529895,0.0010195532,0.0096809985,0.0037914352,0.0017072542,0.009004616,0.0002099511],"about_ca_topic_score_codex":0.0018017491,"about_ca_topic_score_gemma":0.0053742095,"teacher_disagreement_score":0.002731585,"about_ca_system_score_codex":0.0006583325,"about_ca_system_score_gemma":0.0008350608,"threshold_uncertainty_score":0.009240031},"labels":[],"label_agreement":null},{"id":"W3169270290","doi":"10.1016/j.leukres.2021.106628","title":"Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"Janssen Canada","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Internal medicine; Gastroenterology; Immunology; Oncology; Leukemia","score_opus":0.034291604812851754,"score_gpt":0.32793218762742576,"score_spread":0.293640582814574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169270290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904502,0.0046569495,0.00040727863,0.0005044089,0.00007532116,0.0000802455,0.00056796125,0.000056541558,0.0032010544],"genre_scores_gemma":[0.9980527,0.00052944454,0.00015764378,0.00013064616,0.000057297922,0.00002638092,0.0004079208,0.0000040096697,0.00063390366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997478,0.000056378645,0.000025073907,0.000040487364,0.000049562557,0.00008073966],"domain_scores_gemma":[0.999238,0.00015637053,0.0002915024,0.000031577278,0.00007603134,0.00020659462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038720877,0.00044700896,0.0006774889,0.00035215833,0.00029689283,0.00047539864,0.00023918712,0.00055578316,0.001521134],"category_scores_gemma":[0.0012856924,0.00015215456,0.00037864782,0.00042394476,0.00022995617,0.00035040354,0.00023830596,0.0012722645,0.00023232172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024326991,0.0010484521,0.8080626,0.0005169378,0.0004547422,0.01015654,0.00045095256,0.0008707946,0.058131497,0.00014780137,0.0025192252,0.09331363],"study_design_scores_gemma":[0.000091230206,0.0014821215,0.9932846,0.000034334065,0.00007382666,0.0023230915,0.00014043535,0.00027427264,0.0012798045,0.000049237915,0.0009561546,0.000011015421],"about_ca_topic_score_codex":0.0019463763,"about_ca_topic_score_gemma":0.0031742076,"teacher_disagreement_score":0.0019463763,"about_ca_system_score_codex":0.00061116,"about_ca_system_score_gemma":0.00033318537,"threshold_uncertainty_score":0.0050887465},"labels":[],"label_agreement":null},{"id":"W3174295420","doi":"10.1016/j.leukres.2021.106650","title":"Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols","year":2021,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation Charles-Bruneau; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Asparaginase; Medicine; Lymphoblastic Leukemia; Immunology; Leukemia; PEGylation; Allele; Human leukocyte antigen; Antigen; PEG ratio; Biology; Gene; Genetics","score_opus":0.051924648371481766,"score_gpt":0.34520293444192146,"score_spread":0.2932782860704397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174295420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68722165,0.002668846,0.0005240398,0.2630707,0.0034543495,0.0001345091,0.00071845023,0.000063704814,0.04214364],"genre_scores_gemma":[0.9171849,0.0015730676,0.0005376678,0.07067946,0.0036950016,0.000069875154,0.00035014795,0.000029436173,0.0058804145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945265,0.00018521762,0.00006134764,0.000057375008,0.00010501917,0.0001384319],"domain_scores_gemma":[0.99867934,0.00067816494,0.0001862198,0.00004134019,0.00011713014,0.00029781772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004892465,0.00021582098,0.00040376742,0.00034910496,0.0009749053,0.00061619584,0.00030678077,0.0028631303,0.0021671257],"category_scores_gemma":[0.0028842553,0.00020654041,0.0002945766,0.00058011356,0.0004651448,0.00030640577,0.00018665224,0.0018790013,0.00037969084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018128636,0.00056932814,0.63892645,0.00011399352,0.000090543734,0.14891274,0.0010103413,0.00076310034,0.006177586,0.004382735,0.15497541,0.042264853],"study_design_scores_gemma":[0.00096869736,0.001923908,0.5590476,0.00039612415,0.00032922567,0.24892864,0.0041869846,0.004268474,0.005260655,0.0069710207,0.16761889,0.00009981717],"about_ca_topic_score_codex":0.005697611,"about_ca_topic_score_gemma":0.009575064,"teacher_disagreement_score":0.005697611,"about_ca_system_score_codex":0.0014324896,"about_ca_system_score_gemma":0.0012976626,"threshold_uncertainty_score":0.011328876},"labels":[],"label_agreement":null},{"id":"W3185598664","doi":"10.1016/j.leukres.2021.106674","title":"Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Alberta Children's Hospital","funders":"Alberta Health Services","keywords":"Medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Internal medicine; Tyrosine kinase; Nilotinib; Oncology; First line; Dasatinib; Cancer; Imatinib; Receptor","score_opus":0.10737315984632013,"score_gpt":0.40013615825058946,"score_spread":0.29276299840426934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185598664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973126,0.00044081925,0.00003525088,0.0001186832,0.000022003822,0.000014041394,0.00044211323,0.000003216448,0.0016112601],"genre_scores_gemma":[0.99795294,0.00020480566,0.000020242007,0.00013120144,0.000031932246,0.000012201353,0.0011184319,0.0000014733362,0.00052690954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983466,0.00001856072,0.000012316712,0.000030367566,0.000023565768,0.000080504076],"domain_scores_gemma":[0.9994166,0.0000916726,0.000168724,0.000013152907,0.0000611381,0.00024879872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015894904,0.00016989169,0.00043898905,0.00029565452,0.00037701864,0.00065035926,0.00015871231,0.00038891513,0.0020864676],"category_scores_gemma":[0.0008629983,0.00007765746,0.00049370737,0.00047322485,0.00021342024,0.00039152618,0.00028419966,0.00058856927,0.0003870855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048909653,0.00031485045,0.9753549,0.000033687687,0.00013341158,0.0013335543,0.00010624952,0.00037150123,0.0015394144,0.000087589295,0.0011484988,0.014685384],"study_design_scores_gemma":[0.00019733018,0.0024449532,0.9924696,0.000023609166,0.00020457213,0.0019159799,0.0003744901,0.00050801644,0.000297107,0.00019052514,0.0013531022,0.000020784768],"about_ca_topic_score_codex":0.001992049,"about_ca_topic_score_gemma":0.00265354,"teacher_disagreement_score":0.0020864676,"about_ca_system_score_codex":0.00044139073,"about_ca_system_score_gemma":0.00032221526,"threshold_uncertainty_score":0.0069798827},"labels":[],"label_agreement":null},{"id":"W3195599002","doi":"10.1016/j.leukres.2021.106690","title":"Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Medicine; Oncology; Reduction (mathematics); Internal medicine; Imatinib; Dasatinib","score_opus":0.030280875152699713,"score_gpt":0.33020283225029673,"score_spread":0.299921957097597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195599002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829155,0.012592426,0.0002562979,0.0006080417,0.000114720846,0.000065204214,0.00045351064,0.00005075195,0.002943506],"genre_scores_gemma":[0.9971311,0.00128504,0.00010204112,0.00024797706,0.00006711559,0.000029913099,0.00041819364,0.000007480436,0.0007110712],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999713,0.00010811482,0.00002014694,0.000043631215,0.000045492416,0.00006952614],"domain_scores_gemma":[0.99967766,0.00010599881,0.00009924704,0.000022112148,0.000025337155,0.000069644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062365754,0.00034624108,0.0010510159,0.00026598977,0.00024979943,0.0005494999,0.00023257747,0.00026821214,0.0017883001],"category_scores_gemma":[0.0011821509,0.00011235692,0.00074048236,0.00027870454,0.00025925363,0.0003581108,0.00014214123,0.0012821087,0.00033149283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2463401,0.004150726,0.05578616,0.00085051265,0.0025798522,0.0004221699,0.00022590016,0.0064983163,0.052214094,0.0004813127,0.0045493585,0.6259015],"study_design_scores_gemma":[0.067227915,0.27473322,0.5931584,0.0004296419,0.0052510393,0.002445458,0.00042379048,0.0072365263,0.025546614,0.0013298515,0.022096917,0.00012062603],"about_ca_topic_score_codex":0.00080318004,"about_ca_topic_score_gemma":0.0017904311,"teacher_disagreement_score":0.0017883001,"about_ca_system_score_codex":0.00060692197,"about_ca_system_score_gemma":0.00040550594,"threshold_uncertainty_score":0.005982399},"labels":[],"label_agreement":null},{"id":"W3200673876","doi":"10.1016/j.leukres.2021.106712","title":"Improved resolution of phenotypic subsets in human T-ALL by incorporation of RNA-seq based developmental profiling","year":2021,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canadian Institutes of Health Research; University of British Columbia; Terry Fox Research Institute","keywords":"Profiling (computer programming); Phenotype; Computational biology; Leukemia; Biology; Genetics; Gene; Computer science","score_opus":0.06967804416424138,"score_gpt":0.34728749848442525,"score_spread":0.27760945432018386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200673876","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08403204,0.021577604,0.0888745,0.73819274,0.037289817,0.00045690718,0.003909087,0.0026013835,0.023065979],"genre_scores_gemma":[0.3525571,0.015896067,0.10635087,0.45889017,0.025443314,0.0011710612,0.0033573164,0.001004056,0.03533016],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894446,0.00033995713,0.00009367528,0.00014127303,0.00036493997,0.00011559038],"domain_scores_gemma":[0.9966653,0.0021818853,0.000099462646,0.0002474531,0.0006231412,0.00018270181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024578024,0.00033077085,0.000579678,0.00027143836,0.00045937597,0.0011659825,0.00061481143,0.0031644097,0.0012633903],"category_scores_gemma":[0.0047834595,0.0003317277,0.00046530622,0.00023477919,0.00054191216,0.0005784243,0.0005674133,0.0056799254,0.0013813607],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014282035,0.00023129485,0.011053207,0.000594413,0.00012168452,0.0019153076,0.00056724745,0.0015647925,0.2676887,0.0075870426,0.41349313,0.29375497],"study_design_scores_gemma":[0.00022355872,0.0005470053,0.016731432,0.0001452124,0.00020057207,0.0048469934,0.0005113641,0.013559702,0.18132044,0.01472496,0.7670818,0.00010686021],"about_ca_topic_score_codex":0.00097589707,"about_ca_topic_score_gemma":0.002839272,"teacher_disagreement_score":0.0031644097,"about_ca_system_score_codex":0.0006305141,"about_ca_system_score_gemma":0.000489876,"threshold_uncertainty_score":0.012998223},"labels":[],"label_agreement":null},{"id":"W3209503376","doi":"10.1016/j.leukres.2021.106735","title":"RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia","year":2021,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Venetoclax; Myeloid leukemia; Medicine; Refractory (planetary science); Myeloid; Oncology; Leukemia; Cancer research; Internal medicine; Biology; Chronic lymphocytic leukemia","score_opus":0.04014037466090893,"score_gpt":0.3415210087808559,"score_spread":0.301380634119947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209503376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66896075,0.010746185,0.0005007797,0.27193567,0.003996326,0.00007193119,0.0012396273,0.00016945983,0.042379256],"genre_scores_gemma":[0.9354615,0.0028892274,0.00081363204,0.045219447,0.005784517,0.000045465393,0.0005843002,0.000044862743,0.009157014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957734,0.000105449,0.000051138093,0.000049997427,0.00012165345,0.00009443439],"domain_scores_gemma":[0.99815327,0.00097375544,0.00025555372,0.00008444678,0.00018867086,0.00034421802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006013305,0.00019792473,0.00059460825,0.0005974803,0.0006460475,0.000800651,0.00045045852,0.0024617547,0.002246221],"category_scores_gemma":[0.0039971387,0.00018511487,0.00029508537,0.0007480301,0.00045563525,0.00041824154,0.00020941834,0.0018941702,0.00069085706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00420011,0.0005846786,0.5117878,0.00019868382,0.00016233587,0.07719387,0.00065014587,0.0008132142,0.011668084,0.0030899986,0.23814519,0.15150598],"study_design_scores_gemma":[0.001066305,0.0022479654,0.6002324,0.00035784315,0.00039971073,0.18076833,0.0015131638,0.0068185586,0.006263479,0.008785028,0.1914206,0.0001265832],"about_ca_topic_score_codex":0.0023198868,"about_ca_topic_score_gemma":0.0063983677,"teacher_disagreement_score":0.0024617547,"about_ca_system_score_codex":0.0013455823,"about_ca_system_score_gemma":0.00078627706,"threshold_uncertainty_score":0.009763002},"labels":[],"label_agreement":null},{"id":"W4206049855","doi":"10.1016/j.leukres.2022.106788","title":"Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study","year":2022,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; University of Ottawa; Queen's University","funders":"","keywords":"Medicine; Grip strength; Internal medicine; Gerontology; Physical therapy","score_opus":0.1357372759358897,"score_gpt":0.38400832411243013,"score_spread":0.24827104817654044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206049855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722037,0.0026089582,0.0001977712,0.017494032,0.00023074234,0.00008563071,0.0032458345,0.0000064384076,0.0039269356],"genre_scores_gemma":[0.98674,0.0016088479,0.0006143649,0.00814345,0.00043717906,0.00010012546,0.0014778213,0.000008380019,0.00086985563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915063,0.0003671302,0.00012983817,0.00007778245,0.00016441657,0.0001102757],"domain_scores_gemma":[0.99663085,0.0011918192,0.00060253794,0.00029549387,0.0006594879,0.0006197206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025662037,0.00029430768,0.00048727522,0.00085386913,0.00060058845,0.0009778584,0.00043616805,0.0013818771,0.0005751764],"category_scores_gemma":[0.008337044,0.00019859184,0.00056968303,0.0019726146,0.00035308363,0.00052819686,0.0007563381,0.0011070531,0.00022659615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002652774,0.00006287481,0.99039066,0.000016377537,0.00006293972,0.00034748888,0.00017814552,0.000036435158,0.00013868445,0.000045110464,0.002717587,0.005738381],"study_design_scores_gemma":[0.00013042826,0.00022783958,0.9935406,0.000061584986,0.00015227814,0.0009960189,0.0008080647,0.00015102107,0.0001491094,0.00022984126,0.0035364307,0.00001669781],"about_ca_topic_score_codex":0.014725957,"about_ca_topic_score_gemma":0.021511152,"teacher_disagreement_score":0.014725957,"about_ca_system_score_codex":0.0005680724,"about_ca_system_score_gemma":0.00101638,"threshold_uncertainty_score":0.029280484},"labels":[],"label_agreement":null},{"id":"W4251910573","doi":"10.1016/j.leukres.2012.09.019","title":"CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Medical Research Council; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Myeloid leukemia; Karyotype; Myeloid; Medicine; Oncology; Leukemia; Biology; Internal medicine; Cancer research; Immunology; Genetics; Chromosome; Gene","score_opus":0.049620682203062864,"score_gpt":0.33658012484074346,"score_spread":0.2869594426376806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251910573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991059,0.00020891536,0.00008035209,0.000051891133,0.000006001469,0.0000031942486,0.00008748086,0.0000037162047,0.00045255094],"genre_scores_gemma":[0.99912554,0.00014507356,0.0001164903,0.000023503777,0.000018241466,0.0000074604964,0.0002888009,0.0000024506098,0.0002723358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997907,0.000050075294,0.00002629297,0.000029627123,0.000040039988,0.00006316024],"domain_scores_gemma":[0.9991423,0.00017388395,0.0003845607,0.000046449048,0.00008545943,0.00016723451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002520949,0.00026507332,0.00023301785,0.0008169256,0.00036178384,0.00068133185,0.00028118966,0.00039748583,0.0018801339],"category_scores_gemma":[0.0013231926,0.00022173856,0.00014228986,0.0007523757,0.0003186481,0.0002640953,0.0004478067,0.0004061127,0.00045355997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044829558,0.000024328228,0.99158186,0.000008647026,0.000026531787,0.00022242774,0.000032414027,0.000059766982,0.0047896006,0.000044581615,0.00020524056,0.0025564155],"study_design_scores_gemma":[0.000012242838,0.00007326939,0.99634886,0.0000060655366,0.00003405563,0.0012793607,0.00018004417,0.0003550916,0.0009714132,0.000121626166,0.00061284,0.0000051070215],"about_ca_topic_score_codex":0.00063080504,"about_ca_topic_score_gemma":0.0011247108,"teacher_disagreement_score":0.0018801339,"about_ca_system_score_codex":0.00020790927,"about_ca_system_score_gemma":0.0001536658,"threshold_uncertainty_score":0.0062897205},"labels":[],"label_agreement":null},{"id":"W4280581414","doi":"10.1016/j.leukres.2022.106858","title":"Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Research Foundation of Korea; Ministry of Health and Welfare; Ministry of Science, ICT and Future Planning; National Natural Science Foundation of China; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation","keywords":"Myeloid leukemia; Cancer research; Myeloid; Biology; Allele; Mutation; Myeloproliferative Disorders; Gene; Spliceosome; Malignant transformation; Internal medicine; Genetics; Oncology; Immunology; Medicine; RNA splicing","score_opus":0.03371642877177031,"score_gpt":0.32196012770747157,"score_spread":0.28824369893570123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280581414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671894,0.00031621568,0.00050607393,0.0000664687,0.000014198088,0.000030450079,0.00027498775,0.000036260342,0.0020364588],"genre_scores_gemma":[0.9982749,0.00016139534,0.0001581145,0.00002607565,0.000005773657,0.000009449091,0.00037002433,0.000012693213,0.000981598],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983203,0.00003713761,0.000019214334,0.000029806552,0.0000370666,0.00004478267],"domain_scores_gemma":[0.99979573,0.0000572232,0.000045470628,0.00001974238,0.000030612377,0.00005118206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013283062,0.00012986305,0.00022382106,0.00077495154,0.00031675413,0.00035321512,0.00017863305,0.00025055796,0.0034099955],"category_scores_gemma":[0.00041947592,0.00013885561,0.00024555388,0.0003328796,0.00021760043,0.00015193071,0.00024054857,0.00032920856,0.00054034987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015067413,0.00019907136,0.0120122405,0.000034352503,0.000028725484,0.0021928803,0.00012391817,0.00012712943,0.9767751,0.0006606033,0.00025116597,0.0060881134],"study_design_scores_gemma":[0.00014008686,0.0012259872,0.3053797,0.000012040667,0.000102650054,0.014052938,0.0005101586,0.0013563546,0.6679893,0.00057766965,0.008636467,0.00001663169],"about_ca_topic_score_codex":0.0009294513,"about_ca_topic_score_gemma":0.0008682746,"teacher_disagreement_score":0.0034099955,"about_ca_system_score_codex":0.00027602815,"about_ca_system_score_gemma":0.00015855349,"threshold_uncertainty_score":0.011407554},"labels":[],"label_agreement":null},{"id":"W4281259838","doi":"10.1016/j.leukres.2022.106869","title":"NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"NPM1; Internal medicine; Oncology; Medicine; Myeloid leukemia; Proportional hazards model; Exact test; Survival analysis; Biology; Genetics; Karyotype; Gene","score_opus":0.10397729320274199,"score_gpt":0.3633612639273743,"score_spread":0.25938397072463226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281259838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962006,0.00024245157,0.00020182035,0.00004780018,0.000011691716,0.000012906916,0.00032577204,0.000017744693,0.0029392387],"genre_scores_gemma":[0.99911016,0.00006365281,0.00014214645,0.000012532655,0.000008645532,0.000003448384,0.0003705019,0.0000042089578,0.00028463814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977916,0.000038672017,0.000022148122,0.0000447459,0.000055030367,0.000060187558],"domain_scores_gemma":[0.99921334,0.00017460472,0.00024137057,0.00007521984,0.000042409694,0.0002531028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026167263,0.00018985911,0.0004494448,0.0006500553,0.00024841004,0.00039246096,0.00020368665,0.00026122143,0.0037409377],"category_scores_gemma":[0.0011001434,0.000059474456,0.00019937524,0.00031401467,0.00026179964,0.00016754423,0.00039772672,0.0002124688,0.00070612354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034466293,0.00019024973,0.8790632,0.000113439506,0.000155792,0.007996007,0.00015564024,0.00054497825,0.07348219,0.0008462715,0.00080890453,0.03319671],"study_design_scores_gemma":[0.00004617711,0.00096318545,0.9518729,0.00002975005,0.00008927497,0.031952612,0.00019592575,0.0007209496,0.010410466,0.0004978047,0.0032080836,0.000012932172],"about_ca_topic_score_codex":0.0008906157,"about_ca_topic_score_gemma":0.0015319661,"teacher_disagreement_score":0.0037409377,"about_ca_system_score_codex":0.0003785545,"about_ca_system_score_gemma":0.00026351455,"threshold_uncertainty_score":0.012514651},"labels":[],"label_agreement":null},{"id":"W4285736749","doi":"10.1016/j.leukres.2022.106919","title":"Patient-driven research: Initial results from a prospective health–related quality of life study performed at the request of patients living with hairy cell leukemia","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Hairy cell leukemia; Prospective cohort study; Activities of daily living; Disease; Leukemia; Cancer; Physical therapy; Longitudinal study; Internal medicine; Pediatrics; Pathology","score_opus":0.12194974847105526,"score_gpt":0.4023675352351923,"score_spread":0.28041778676413703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285736749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627495,0.00041056788,0.00019929743,0.0004566532,0.000011782463,0.00024686696,0.0012630846,0.000005207591,0.0011316587],"genre_scores_gemma":[0.9966653,0.0002585488,0.0006352579,0.00049480074,0.000034481753,0.00029610444,0.0014183142,0.000004025269,0.00019318663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895002,0.007936054,0.00078238396,0.00038596726,0.000992419,0.00040296072],"domain_scores_gemma":[0.974141,0.011812014,0.0067631966,0.0021448885,0.00292765,0.002211226],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014608469,0.00026656353,0.00035646377,0.0008840099,0.0009814061,0.0015065883,0.00041213207,0.00071513676,0.0014333453],"category_scores_gemma":[0.029427243,0.00028536908,0.0007905128,0.0017027273,0.0005869052,0.0011591215,0.0011755807,0.0010158975,0.0004449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000868071,0.00061811216,0.99160707,0.0000611328,0.0001041782,0.00008185264,0.0006987403,0.000064462285,0.0001451164,0.000052170653,0.00044931093,0.0052498668],"study_design_scores_gemma":[0.0002114669,0.001978371,0.99430287,0.000040044666,0.00009906898,0.00021352665,0.0014106112,0.00019587226,0.00018666997,0.00006224513,0.0012793249,0.000019928959],"about_ca_topic_score_codex":0.0033709,"about_ca_topic_score_gemma":0.005351562,"teacher_disagreement_score":0.98539156,"about_ca_system_score_codex":0.00069176627,"about_ca_system_score_gemma":0.0012944809,"threshold_uncertainty_score":0.07725793},"labels":[],"label_agreement":null},{"id":"W4294287236","doi":"10.1016/j.leukres.2022.106943","title":"Corrigendum to “Patient-driven research: Initial results from a prospective health–related quality of life study performed at the request of patients living with hairy cell leukemia” [Leuk. Res. 120 (2022) 106919]","year":2022,"lang":"en","type":"erratum","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Quality of life (healthcare); Medicine; Hairy cell leukemia; Leukemia; Oncology; Gerontology; Internal medicine; Nursing","score_opus":0.13778950801035084,"score_gpt":0.4023719804040977,"score_spread":0.2645824723937469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294287236","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000118454205,0.000939185,0.00024194909,0.11870464,0.86925024,0.000084445746,0.0019914417,0.00039800166,0.008271622],"genre_scores_gemma":[0.003955675,0.0052777925,0.0016910993,0.34536266,0.30629358,0.00060618686,0.0053222873,0.00076254894,0.33072808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931987,0.0012380736,0.0012426572,0.00075269624,0.0028658097,0.00070195075],"domain_scores_gemma":[0.9624441,0.011783819,0.0014311812,0.0018026585,0.020555966,0.001982191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053936513,0.002282791,0.002824032,0.0038821858,0.004134755,0.004087668,0.0037907048,0.010093898,0.10058721],"category_scores_gemma":[0.057173293,0.001586965,0.0027374707,0.003088141,0.0020148626,0.0016226379,0.0025378813,0.011123533,0.08320837],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010796293,0.000006016806,0.000033887794,0.00002527439,0.000003580103,0.00007241279,0.0000048419342,0.000008145591,0.000009205998,0.00007634818,0.99845266,0.0012968011],"study_design_scores_gemma":[0.00011300426,0.00005152426,0.003065851,0.0003679093,0.000051329604,0.00035694087,0.000082875405,0.00021717425,0.00021571737,0.0009052376,0.9944956,0.00007682783],"about_ca_topic_score_codex":0.057822686,"about_ca_topic_score_gemma":0.083958134,"teacher_disagreement_score":0.10058721,"about_ca_system_score_codex":0.0055059413,"about_ca_system_score_gemma":0.00730125,"threshold_uncertainty_score":0.33649778},"labels":[],"label_agreement":null},{"id":"W4303648477","doi":"10.1016/j.leukres.2022.106968","title":"A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML","year":2022,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Canadian Cancer Society; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"Signature (topology); microRNA; Medicine; Oncology; Cancer research; Internal medicine; Biology; Genetics; Gene; Mathematics","score_opus":0.023764915289874976,"score_gpt":0.29264816136749333,"score_spread":0.2688832460776184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303648477","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17849766,0.0069459523,0.004662018,0.7471279,0.03493791,0.00016281974,0.0009980437,0.00025970204,0.026407933],"genre_scores_gemma":[0.59559965,0.0027380965,0.0039790752,0.3263639,0.054727487,0.00022720627,0.0005043821,0.00014883111,0.015711462],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9992059,0.0001998054,0.000120151475,0.0001182066,0.00019840787,0.00015746163],"domain_scores_gemma":[0.99777263,0.0014247731,0.00014102658,0.00010650851,0.0002890299,0.00026594228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012249238,0.0003189803,0.0006541917,0.0004408941,0.00075269194,0.0010397369,0.0004419136,0.0050182967,0.0018770894],"category_scores_gemma":[0.006273195,0.00026485606,0.0003774351,0.00034500004,0.0008353095,0.0005228711,0.00034596256,0.0044395025,0.0010057526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046465234,0.0003119018,0.15806784,0.00026108042,0.00019945775,0.07654707,0.0010666674,0.0012292832,0.04000807,0.013042957,0.5027407,0.20187853],"study_design_scores_gemma":[0.0010039738,0.0017616246,0.12521893,0.0003240219,0.00048254774,0.13463853,0.0018249723,0.016633952,0.039443046,0.03586019,0.6425546,0.0002536882],"about_ca_topic_score_codex":0.0011050139,"about_ca_topic_score_gemma":0.0021616553,"teacher_disagreement_score":0.0050182967,"about_ca_system_score_codex":0.0010251909,"about_ca_system_score_gemma":0.0006538798,"threshold_uncertainty_score":0.007438302},"labels":[],"label_agreement":null},{"id":"W4312129123","doi":"10.1016/j.leukres.2022.107002","title":"Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Internal medicine; Medicine; Trisomy 8; Myeloid; Gastroenterology; Philadelphia chromosome; Oncology; Cytogenetics; Chromosome; Chromosomal translocation; Gene; Biology; Genetics","score_opus":0.027602650302154672,"score_gpt":0.3254544267275147,"score_spread":0.29785177642536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312129123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937796,0.0005713384,0.0016331511,0.00025244526,0.000019536603,0.00005307764,0.00051693985,0.00003346237,0.0031404682],"genre_scores_gemma":[0.99639016,0.00031404887,0.0014211215,0.000060515657,0.000015807225,0.000019391335,0.000883487,0.000008993879,0.0008866007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998216,0.000031595235,0.00002022855,0.000032985266,0.000049291255,0.000044251025],"domain_scores_gemma":[0.9997875,0.000059655293,0.00004082315,0.000022217188,0.000046584748,0.000043161777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016130198,0.0001983169,0.00014823963,0.001330045,0.00022358685,0.0003753187,0.00025583585,0.00031111017,0.002343817],"category_scores_gemma":[0.0004943869,0.00012069521,0.000140499,0.00044259994,0.00023460733,0.00018971217,0.0002455106,0.00033362242,0.00047827722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004970314,0.000103142054,0.026159612,0.000051269806,0.00002495876,0.001647396,0.00008305801,0.00021040296,0.960043,0.0009515249,0.00028118907,0.009947361],"study_design_scores_gemma":[0.00016850585,0.0012639121,0.43256393,0.000026452479,0.00014702164,0.031698704,0.0005969928,0.0035390207,0.5083206,0.0013845509,0.020270798,0.000019517449],"about_ca_topic_score_codex":0.00057210086,"about_ca_topic_score_gemma":0.0006555689,"teacher_disagreement_score":0.002343817,"about_ca_system_score_codex":0.00022530503,"about_ca_system_score_gemma":0.00017074673,"threshold_uncertainty_score":0.007840812},"labels":[],"label_agreement":null},{"id":"W4313575102","doi":"10.1016/j.leukres.2023.107016","title":"Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update","year":2023,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Princess Margaret Cancer Centre; Foothills Medical Centre; Ottawa Hospital; Spinal Cord Injury BC; Jewish General Hospital; CancerCare Manitoba","funders":"","keywords":"Guideline; Chronic lymphocytic leukemia; Front line; Medicine; First line treatment; Leukemia; Family medicine; Intensive care medicine; Internal medicine; Political science; Pathology; Chemotherapy","score_opus":0.2859934808552033,"score_gpt":0.48700136605915856,"score_spread":0.20100788520395524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313575102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001290324,0.978466,0.0005900122,0.0063134935,0.0017918518,0.0004958919,0.0038930424,0.00008093908,0.0082397675],"genre_scores_gemma":[0.0015819614,0.98060614,0.004090726,0.004977573,0.00040823373,0.0004448354,0.0046410817,0.00002638271,0.003223101],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967945,0.0006615775,0.00069155556,0.00018383242,0.0014623499,0.00020613305],"domain_scores_gemma":[0.99322295,0.0015046088,0.0008042132,0.000098284756,0.004119775,0.00025018313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035532755,0.0015859675,0.0033351202,0.009264782,0.00095471536,0.0025664822,0.0039452156,0.0032627208,0.014108241],"category_scores_gemma":[0.01226652,0.0006304597,0.0049853865,0.0100031765,0.0006680233,0.0016119849,0.0011478519,0.0029323867,0.0043821656],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017127482,0.00004948494,0.00036313906,0.12915018,0.00076878583,0.00022619039,0.00015397639,0.0005288322,0.0003399888,0.0036802718,0.50032085,0.3642469],"study_design_scores_gemma":[0.00016839906,0.000027791342,0.0011682446,0.13249484,0.0019756767,0.00036854082,0.000051165556,0.00013070504,0.00009981843,0.0012291156,0.8622501,0.000035606943],"about_ca_topic_score_codex":0.16442148,"about_ca_topic_score_gemma":0.315713,"teacher_disagreement_score":0.8355785,"about_ca_system_score_codex":0.01111078,"about_ca_system_score_gemma":0.04621491,"threshold_uncertainty_score":0.3269289},"labels":[],"label_agreement":null},{"id":"W4362575420","doi":"10.1016/j.leukres.2023.107073","title":"Corrigendum to “Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update” [Leukemia Research 125 (2023) 107016]","year":2023,"lang":"en","type":"erratum","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Princess Margaret Cancer Centre; Foothills Medical Centre; Ottawa Hospital; Spinal Cord Injury BC; Jewish General Hospital; CancerCare Manitoba","funders":"","keywords":"Guideline; Chronic lymphocytic leukemia; Leukemia; Medicine; Internal medicine; Oncology; Cancer research; Pathology","score_opus":0.2076538861783778,"score_gpt":0.4403279693230669,"score_spread":0.2326740831446891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362575420","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013340788,0.058942057,0.0013248253,0.30454752,0.5318014,0.0010337981,0.022902245,0.0006873123,0.078627385],"genre_scores_gemma":[0.0023984965,0.10163409,0.007529932,0.49028686,0.107420236,0.0015529545,0.027820852,0.0007869765,0.26056957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99096,0.0013439266,0.0013527226,0.00046489664,0.0051402524,0.00073816645],"domain_scores_gemma":[0.9553102,0.006174419,0.0018934172,0.0005924,0.034075003,0.0019544545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053046467,0.0020815292,0.0045668287,0.009117109,0.003295511,0.005359144,0.0053067054,0.010751414,0.07925799],"category_scores_gemma":[0.053227052,0.0013948659,0.0045505874,0.0070984955,0.0023696644,0.0020493877,0.0021137241,0.010573202,0.055596422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000072096336,0.0000027556594,0.000014149743,0.00015261653,0.000005362437,0.000017787708,0.000003114945,0.000014938951,0.0000048358665,0.00009673856,0.9962889,0.0033915804],"study_design_scores_gemma":[0.000096946744,0.000010221981,0.00057848403,0.0019266359,0.000077547265,0.00006663433,0.000018901002,0.000050424213,0.000038449387,0.0004660105,0.99663687,0.000032879507],"about_ca_topic_score_codex":0.57116205,"about_ca_topic_score_gemma":0.75410634,"teacher_disagreement_score":0.57116205,"about_ca_system_score_codex":0.020180397,"about_ca_system_score_gemma":0.059228845,"threshold_uncertainty_score":0.8627269},"labels":[],"label_agreement":null},{"id":"W4367601325","doi":"10.1016/j.leukres.2023.107162","title":"Topic: AS02-Epidemiology: TET2 CLONAL HEMATOPOIESIS MUTATIONS ARE ENRICHED AMONG RECIPIENTS OF SOLID-ORGAN TRANSPLANTS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Internal medicine; Medicine; Hazard ratio; Cardiology; Ventricle; Regurgitation (circulation); Pulmonary hypertension; Confidence interval","score_opus":0.1719432447663443,"score_gpt":0.44451773000139005,"score_spread":0.2725744852350458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85851926,0.03225724,0.001860375,0.039819974,0.003471981,0.00016724417,0.030637993,0.00023227926,0.033033557],"genre_scores_gemma":[0.93773997,0.016226342,0.0009507115,0.010739501,0.008908944,0.000113418915,0.01376263,0.00012456297,0.011434009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993315,0.00013951455,0.00009105317,0.00016525065,0.00014109572,0.00013175169],"domain_scores_gemma":[0.99708587,0.0006104501,0.001008371,0.000106151565,0.00053149177,0.00065759727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008719346,0.00020522517,0.00030954008,0.0012897238,0.00051786966,0.001262455,0.0004375859,0.0009101311,0.014972901],"category_scores_gemma":[0.0032072237,0.00009532561,0.00047834654,0.00245723,0.0002260864,0.000586948,0.0007226611,0.00058164826,0.0018387056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025764326,0.00007573722,0.9220153,0.00048605303,0.0002148049,0.00023664192,0.0001881937,0.000061709485,0.0011965607,0.00054344576,0.04080543,0.033918463],"study_design_scores_gemma":[0.00003379726,0.000110344285,0.97680795,0.00035834752,0.00022901161,0.0011783658,0.0005706128,0.00012057113,0.00035769434,0.00051844784,0.019700246,0.0000146555885],"about_ca_topic_score_codex":0.0032629007,"about_ca_topic_score_gemma":0.0031400586,"teacher_disagreement_score":0.014972901,"about_ca_system_score_codex":0.00031908735,"about_ca_system_score_gemma":0.00087160565,"threshold_uncertainty_score":0.0500893},"labels":[],"label_agreement":null},{"id":"W4367601443","doi":"10.1016/j.leukres.2023.107136","title":"Topic: AS01-Diagnosis/AS01a-Cytomorphology: AUTOMATED DIGITAL TOOL FOR MDS AND MDS/MPN CLASSIFICATION USING WHO AND ICC: INTERNATIONAL GUIDELINES WORKING GROUP ON MDS DIAGNOSIS, PROGNOSIS, AND GERMLINE PREDISPOSITION","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Electric Motor Design and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Rotor (electric); Constant (computer programming); Squirrel-cage rotor; Copper loss; Thermal; Variable (mathematics); Core (optical fiber); Computer science; Applied mathematics; Mathematics; Physics; Mathematical analysis; Thermodynamics; Mechanical engineering; Electrical engineering; Engineering; Telecommunications; Induction motor","score_opus":0.12145867541619708,"score_gpt":0.37773132607085985,"score_spread":0.25627265065466276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601443","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014135422,0.11296358,0.0176027,0.19416189,0.388364,0.00294652,0.021543883,0.0044835242,0.2437985],"genre_scores_gemma":[0.047184896,0.0962742,0.016377065,0.048925582,0.34789112,0.0014398532,0.03112675,0.0018183744,0.4089621],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999124,0.00012464596,0.00014223276,0.000103050515,0.00043646677,0.00006953946],"domain_scores_gemma":[0.995719,0.00066468265,0.0003731872,0.00012040525,0.0026312033,0.0004914659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020607891,0.00052870385,0.0006409599,0.00273821,0.00058630697,0.0020708188,0.0006396244,0.0020519178,0.06661466],"category_scores_gemma":[0.0049490635,0.00017693349,0.0006509685,0.0011067215,0.0005377093,0.0017089222,0.0011696812,0.00083248946,0.032514498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065707485,0.000035136283,0.0011878056,0.00086747657,0.000006143467,0.00007732479,0.00003105116,0.00006948584,0.00089640636,0.0008468305,0.8645427,0.1313739],"study_design_scores_gemma":[0.000029145702,0.00007973795,0.005279956,0.001531206,0.000020125815,0.00089854735,0.00013831486,0.0002230536,0.001680371,0.0015464653,0.9885522,0.00002085213],"about_ca_topic_score_codex":0.0012650682,"about_ca_topic_score_gemma":0.0017005744,"teacher_disagreement_score":0.06661466,"about_ca_system_score_codex":0.0007879636,"about_ca_system_score_gemma":0.0018369708,"threshold_uncertainty_score":0.22284824},"labels":[],"label_agreement":null},{"id":"W4367601728","doi":"10.1016/j.leukres.2023.107271","title":"Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; Phase (matter); Medicine; Biology; Chemistry","score_opus":0.6696574450061488,"score_gpt":0.6687300280735872,"score_spread":0.0009274169325615977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67209953,0.10999782,0.005369068,0.096402615,0.006313257,0.021384956,0.036115143,0.0011623567,0.051155288],"genre_scores_gemma":[0.7551161,0.04975856,0.021031408,0.058519103,0.011041525,0.013749868,0.043911774,0.0005005641,0.046371076],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99890924,0.00060164183,0.00010272109,0.00009159391,0.00014877939,0.00014598387],"domain_scores_gemma":[0.9971745,0.0006839822,0.00076020026,0.00014576926,0.0004569916,0.00077857636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005324386,0.0006638729,0.0013082075,0.00036634586,0.000509798,0.0015763313,0.00091664906,0.0020089191,0.0084128585],"category_scores_gemma":[0.0032005736,0.0002540951,0.0016698558,0.0004658916,0.00043519933,0.0007309354,0.00045256127,0.0024049538,0.0025636188],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19431771,0.010287467,0.012769142,0.007948238,0.0024176575,0.0005181074,0.00043177512,0.001561348,0.04554587,0.002508916,0.22172329,0.49997056],"study_design_scores_gemma":[0.27999187,0.21027793,0.050640535,0.0025993583,0.0031729136,0.0017648761,0.00034672688,0.0019055255,0.029513028,0.0034473182,0.41620192,0.00013805093],"about_ca_topic_score_codex":0.0007147783,"about_ca_topic_score_gemma":0.0030058417,"teacher_disagreement_score":0.0084128585,"about_ca_system_score_codex":0.001290729,"about_ca_system_score_gemma":0.0025216723,"threshold_uncertainty_score":0.028158367},"labels":[],"label_agreement":null},{"id":"W4367601910","doi":"10.1016/j.leukres.2023.107277","title":"Topic: AS08-Treatment/AS08j-Supportive care, transfusion medicine and MDS, iron overload: MDS CLEARPATH: A WEB-BASED EDUCATIONAL ALGORITHM FOR THE DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM THE CANADIAN CONSORTIUM ON MDS (CCMDS); 2023 UPDATE","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Elbow and Forearm Trauma Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Juravinski Cancer Centre; St. Paul's Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Intraclass correlation; Kappa; Orthopedic surgery; Surgery","score_opus":0.05455240344001887,"score_gpt":0.3387365405749015,"score_spread":0.2841841371348826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601910","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057907864,0.5028435,0.005977607,0.22442009,0.05873363,0.0014398189,0.023847355,0.003134419,0.1738128],"genre_scores_gemma":[0.014417403,0.7001248,0.025675016,0.09570889,0.052015085,0.0010695641,0.03807364,0.0004845618,0.07243107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992124,0.00011617624,0.00015117454,0.00004627478,0.00040325627,0.00007073606],"domain_scores_gemma":[0.99376017,0.0014954035,0.0008307179,0.00007009166,0.0028094065,0.0010341804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020804815,0.0007457756,0.0011851048,0.004006229,0.000527917,0.0021152997,0.0013250641,0.00277061,0.019153863],"category_scores_gemma":[0.009772065,0.00037653124,0.00087215565,0.0023042064,0.00037915172,0.0020317517,0.001634244,0.0032507188,0.0103047835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034501623,0.00007296503,0.0013279051,0.00097320427,0.00002648959,0.00004943704,0.000028764543,0.00015960755,0.0000636734,0.00033531085,0.69991213,0.297016],"study_design_scores_gemma":[0.000099018136,0.00004160616,0.004622433,0.0052863746,0.000096719865,0.00043413157,0.00005588068,0.00019345127,0.000095972035,0.00043326875,0.9886191,0.000022139619],"about_ca_topic_score_codex":0.027479809,"about_ca_topic_score_gemma":0.06579786,"teacher_disagreement_score":0.9968272,"about_ca_system_score_codex":0.0031728034,"about_ca_system_score_gemma":0.0053232247,"threshold_uncertainty_score":0.064076066},"labels":[],"label_agreement":null},{"id":"W4367602086","doi":"10.1016/j.leukres.2023.107274","title":"Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation – Post-transplantation treatment: IN VIVO DUAL T CELL DEPLETION (TCD) IMPROVES TRANSPLANT OUTCOMES IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WHO UNDERGO MATCHED UNRELATED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Transplantation; Hematopoietic cell; Medicine; Hematopoietic stem cell transplantation; Haematopoiesis; Intensive care medicine; Stem cell; Internal medicine; Biology","score_opus":0.024924774068694554,"score_gpt":0.3027709996817769,"score_spread":0.27784622561308236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367602086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6225916,0.21631186,0.0032756932,0.058843445,0.028802976,0.0020667934,0.0048802844,0.00088617596,0.062341172],"genre_scores_gemma":[0.75480556,0.094589636,0.0049176496,0.03519827,0.038206305,0.0014918768,0.0059026266,0.00014829804,0.06473979],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998698,0.000039471663,0.000015394655,0.000023251112,0.000025786754,0.000026276399],"domain_scores_gemma":[0.99981767,0.00004106022,0.000044116012,0.000008604523,0.000028510425,0.00006011438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047236923,0.0003044957,0.00068078004,0.00023471203,0.00029598788,0.0006061609,0.00028013272,0.0011370406,0.010576256],"category_scores_gemma":[0.00030350045,0.0000758863,0.00055417954,0.00017827556,0.00029010055,0.00023513986,0.00018705364,0.000886216,0.0020380283],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051771324,0.006569915,0.006682521,0.0045827385,0.00059467234,0.00061231153,0.000099881305,0.0004326113,0.04521575,0.0018617881,0.20000574,0.68157077],"study_design_scores_gemma":[0.048761535,0.07021258,0.07376672,0.0023820384,0.0031800396,0.004954914,0.00047768332,0.0015852368,0.09623332,0.0026129894,0.69571793,0.00011494988],"about_ca_topic_score_codex":0.00022641127,"about_ca_topic_score_gemma":0.00065402273,"teacher_disagreement_score":0.010576256,"about_ca_system_score_codex":0.0002886978,"about_ca_system_score_gemma":0.00072117435,"threshold_uncertainty_score":0.03538108},"labels":[],"label_agreement":null},{"id":"W4367603471","doi":"10.1016/j.leukres.2023.107239","title":"Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: THE IMPACT OF CHIP ON CHEMOTHERAPY-RELATED OUTCOMES AND CLONAL DYNAMICS IN OLDER LYMPHOMA PATIENTS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Kingston Health Sciences Centre; Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Arch; Lymphoma; Medicine; Business; Intensive care medicine; Engineering; Structural engineering; Pathology","score_opus":0.02424807262812283,"score_gpt":0.3532056420237922,"score_spread":0.32895756939566934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367603471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34333697,0.28354937,0.0011954864,0.188832,0.026221681,0.0008737687,0.07734954,0.0004686515,0.078172505],"genre_scores_gemma":[0.6534776,0.1257522,0.0025926742,0.051169258,0.09446562,0.0008185153,0.049581353,0.00035132602,0.021791454],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99942833,0.000121898694,0.00010042186,0.00011126737,0.00012147302,0.00011650205],"domain_scores_gemma":[0.9964581,0.0009591304,0.0010107883,0.00009131018,0.00061322143,0.00086743804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014796124,0.00022492449,0.0007024341,0.0009673416,0.00050880184,0.0018429682,0.0004607238,0.001094204,0.018337585],"category_scores_gemma":[0.0062711416,0.00013463976,0.0007511553,0.0017364575,0.0002925316,0.0011162694,0.0009131743,0.0008879658,0.0034109503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00140112,0.00011513905,0.33107588,0.0026348769,0.00039786455,0.00028159976,0.0002809765,0.00019851678,0.00034426828,0.0013314022,0.49912047,0.16281784],"study_design_scores_gemma":[0.00042006958,0.000268431,0.7544798,0.006522684,0.00079171977,0.0019903197,0.0014476716,0.00043755723,0.00032706614,0.0025676072,0.23068552,0.000061380895],"about_ca_topic_score_codex":0.003923043,"about_ca_topic_score_gemma":0.007458698,"teacher_disagreement_score":0.018337585,"about_ca_system_score_codex":0.00088870846,"about_ca_system_score_gemma":0.0019256391,"threshold_uncertainty_score":0.06134528},"labels":[],"label_agreement":null},{"id":"W4367604386","doi":"10.1016/j.leukres.2023.107164","title":"Topic: AS03-Health Economics &amp; Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Innovative concrete reinforcement materials","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Slab; Materials science; Polypropylene; Aggregate (composite); Ductility (Earth science); Mortar; Composite material; Deformation (meteorology); Structural engineering; Stiffness; Load bearing; Compressive strength; Building material; Engineering","score_opus":0.2964000057462181,"score_gpt":0.45964660385170747,"score_spread":0.16324659810548936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604386","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002846881,0.019643277,0.00057197164,0.84026027,0.058246154,0.00042405844,0.0046362034,0.00014226425,0.07322901],"genre_scores_gemma":[0.047247708,0.08446544,0.007136868,0.42942306,0.2353084,0.0018108684,0.0140171815,0.0005658705,0.18002455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943347,0.0019849099,0.0006671023,0.0002706849,0.0020598215,0.00068282377],"domain_scores_gemma":[0.9473027,0.012968339,0.0047369488,0.0010239877,0.022082232,0.01188578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013722024,0.00047289976,0.0010556943,0.0017571386,0.0012845846,0.0066775256,0.0014205546,0.008057467,0.10436727],"category_scores_gemma":[0.033701565,0.00024003585,0.0013854674,0.0022719447,0.0011358275,0.0028154335,0.002010478,0.003462038,0.029728293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007229934,0.00010266336,0.0011102557,0.0004301172,0.000011381069,0.000023861034,0.000018515047,0.00004917478,0.000059868962,0.0034671298,0.9587631,0.035891578],"study_design_scores_gemma":[0.00027214576,0.00023355888,0.012157029,0.004329137,0.00004970404,0.000206757,0.00043427118,0.00038625707,0.0004016645,0.0092402445,0.9722481,0.000041152452],"about_ca_topic_score_codex":0.0052667446,"about_ca_topic_score_gemma":0.009442384,"teacher_disagreement_score":0.10436727,"about_ca_system_score_codex":0.005510601,"about_ca_system_score_gemma":0.020424956,"threshold_uncertainty_score":0.34914333},"labels":[],"label_agreement":null},{"id":"W4367604542","doi":"10.1016/j.leukres.2023.107181","title":"Topic: AS04-MDS Biology and Pathogenesis/AS04c-MDS Mouse models (GEMMS, PDX): MAMMALIAN DIAPHANOUS-RELATED FORMIN 1 IS REQUIRED FOR MAINTAINING HEMATOPOIETIC STEM CELL QUIESCENCE AND SURVIVAL VIA REGULATING MITOCHONDRIA OXIDATIVE METABOLIC PATHWAY","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Biology; Genotype; Allele; Genotyping; SNP; Odds ratio; Single-nucleotide polymorphism; Pathogenesis; Genetics; Immunology; Internal medicine; Gene; Medicine","score_opus":0.058768967771025166,"score_gpt":0.3408956397664792,"score_spread":0.28212667199545405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28675786,0.25823963,0.025837878,0.17377865,0.09012367,0.0016466982,0.01216893,0.0050271247,0.14641955],"genre_scores_gemma":[0.39619023,0.13628477,0.018753843,0.027937563,0.08548364,0.0010332572,0.010335318,0.00058370177,0.32339767],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998266,0.000019056633,0.00001542744,0.000044524113,0.000067177236,0.000027209751],"domain_scores_gemma":[0.99977773,0.000019969993,0.000057305617,0.000008964816,0.00004854493,0.000087474764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043479443,0.0005778474,0.0003377021,0.00103638,0.0005074904,0.0008455024,0.00046985774,0.0014163279,0.011455933],"category_scores_gemma":[0.00023208927,0.00017837365,0.00047088496,0.0004116263,0.00051922246,0.00050476013,0.00047505487,0.0012271508,0.0027502247],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002132406,0.0005698625,0.0048017036,0.0026501059,0.00012456923,0.002046076,0.0001589886,0.0003723908,0.37513283,0.018222332,0.43122834,0.16256043],"study_design_scores_gemma":[0.0004984325,0.00087801664,0.01330176,0.00045425052,0.00031185488,0.006908395,0.0002504042,0.0011758666,0.13047974,0.0060275174,0.8396712,0.000042585707],"about_ca_topic_score_codex":0.00028493354,"about_ca_topic_score_gemma":0.0004904841,"teacher_disagreement_score":0.011455933,"about_ca_system_score_codex":0.00055967545,"about_ca_system_score_gemma":0.00058479677,"threshold_uncertainty_score":0.03832388},"labels":[],"label_agreement":null},{"id":"W4367604579","doi":"10.1016/j.leukres.2023.107270","title":"Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Gynecology","score_opus":0.15669092100183316,"score_gpt":0.5137303052899491,"score_spread":0.357039384288116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9280498,0.01007057,0.003426161,0.007609796,0.0013277113,0.017453205,0.017850699,0.00081863784,0.013393349],"genre_scores_gemma":[0.8827851,0.008085422,0.018253539,0.011299792,0.0017432538,0.027700968,0.023214951,0.00030787164,0.026609037],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990607,0.00061360473,0.00004088757,0.00010258648,0.0000663176,0.000115907525],"domain_scores_gemma":[0.9985532,0.00029604748,0.00038635076,0.00013899796,0.00014796015,0.00047732823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035168484,0.0016799266,0.0024007189,0.00042131176,0.00048024365,0.0013811581,0.0010081409,0.0022542311,0.012056164],"category_scores_gemma":[0.0019597646,0.00059929304,0.0022538977,0.00039310835,0.00090931717,0.0010211943,0.00037304073,0.0038059473,0.002898288],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8639409,0.016678475,0.0027267698,0.0016338844,0.002200102,0.00012392647,0.000109249,0.0016774854,0.015526677,0.00090697367,0.02540049,0.06907515],"study_design_scores_gemma":[0.9068468,0.08056054,0.0025969478,0.00007315195,0.0005537316,0.0001092421,0.000023429337,0.0005845301,0.0012054141,0.00048629774,0.006937774,0.00002215505],"about_ca_topic_score_codex":0.00064708525,"about_ca_topic_score_gemma":0.0024025112,"teacher_disagreement_score":0.012056164,"about_ca_system_score_codex":0.000947773,"about_ca_system_score_gemma":0.0019784528,"threshold_uncertainty_score":0.0403319},"labels":[],"label_agreement":null},{"id":"W4367604632","doi":"10.1016/j.leukres.2023.107278","title":"Topic: AS09-Quality of life-Disease experiences: LONGITUDINAL TRAJECTORY OF QUALITY OF LIFE IN MDS AND IMPACT OF PATIENT-RELATED FACTORS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Graphite, nuclear technology, radiation studies","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Vancouver General Hospital; Princess Margaret Cancer Centre; McGill University Health Centre; McGill University; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; University of British Columbia; CancerCare Manitoba; Saskatchewan Cancer Agency; University of Alberta Hospital; Capital District Health Authority; Health Sciences Centre; Ottawa Hospital; Jewish General Hospital; Juravinski Cancer Centre; Ontario Institute for Cancer Research; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Pyrolysis; Thermogravimetric analysis; Charcoal; Chemistry; Inductively coupled plasma mass spectrometry; Yield (engineering); Residue (chemistry); Chromium; Inductively coupled plasma; Mass spectrometry; Boron; Metal; Nuclear chemistry; Materials science; Metallurgy; Chromatography; Organic chemistry; Plasma","score_opus":0.139468826652494,"score_gpt":0.4213634889614625,"score_spread":0.2818946623089685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41890928,0.13032247,0.0011061666,0.24946442,0.027966192,0.0019744607,0.08045484,0.0002617545,0.08954047],"genre_scores_gemma":[0.7319755,0.090585396,0.0026803133,0.024850147,0.040139508,0.002958239,0.05291424,0.00020056995,0.053696133],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9993036,0.00024494648,0.00009213955,0.000085722044,0.00015138916,0.00012224994],"domain_scores_gemma":[0.996902,0.00095734745,0.00045688197,0.00006861231,0.0006520087,0.0009632352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022160355,0.00028935476,0.00074346864,0.001148284,0.0009726079,0.0020216587,0.0004523799,0.0013214855,0.028048329],"category_scores_gemma":[0.005372291,0.00008886967,0.0008153232,0.0022765421,0.00030617742,0.0010560851,0.001407603,0.0009591815,0.0040967492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009473996,0.00080923404,0.31101835,0.004839931,0.00025003732,0.00030968836,0.0020440475,0.00028977837,0.00068776857,0.002836284,0.43052992,0.24543752],"study_design_scores_gemma":[0.00014582784,0.000811753,0.8035612,0.0034051617,0.00016250407,0.0006812152,0.0032860886,0.00023949784,0.00040720493,0.0013184459,0.1859297,0.00005138398],"about_ca_topic_score_codex":0.003678682,"about_ca_topic_score_gemma":0.006628859,"teacher_disagreement_score":0.028048329,"about_ca_system_score_codex":0.0012052796,"about_ca_system_score_gemma":0.0030858184,"threshold_uncertainty_score":0.09383106},"labels":[],"label_agreement":null},{"id":"W4367604905","doi":"10.1016/j.leukres.2023.107230","title":"Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS – AN ANALYSIS OF THE IWG-PM DATABASE","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; International Prognostic Scoring System; Myelodysplastic syndromes; Risk stratification; Prognostic model; Intensive care medicine; Internal medicine; Oncology; Overall survival","score_opus":0.17792482982712265,"score_gpt":0.44826791603131505,"score_spread":0.2703430862041924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604905","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06928425,0.008166129,0.014645399,0.02185359,0.0016505728,0.00059782946,0.87216854,0.0013746852,0.010258911],"genre_scores_gemma":[0.2326498,0.0052393833,0.02373567,0.0033782544,0.0024818133,0.0009777348,0.72274816,0.0012718958,0.0075173974],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.993378,0.003783063,0.0005920277,0.00070551125,0.0013026119,0.00023881879],"domain_scores_gemma":[0.9656793,0.021930646,0.003269174,0.0037334354,0.004083218,0.0013042786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015555033,0.000581839,0.001223986,0.0019411294,0.0003689468,0.002926252,0.001830514,0.0014348788,0.024184238],"category_scores_gemma":[0.05553774,0.0002692786,0.0022187403,0.0037232048,0.0002643956,0.0013555055,0.0014898926,0.0011698623,0.006796692],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002154759,0.00023711605,0.1377183,0.0018789106,0.0013713406,0.00011130791,0.00011948681,0.01588364,0.00033375833,0.00749664,0.7568798,0.07581501],"study_design_scores_gemma":[0.0030356217,0.00081343116,0.249324,0.0026373174,0.0013473618,0.00085682503,0.0003620178,0.07834817,0.0022683174,0.022966761,0.6378275,0.00021271296],"about_ca_topic_score_codex":0.0061870734,"about_ca_topic_score_gemma":0.005203051,"teacher_disagreement_score":0.024184238,"about_ca_system_score_codex":0.0009222984,"about_ca_system_score_gemma":0.0024016541,"threshold_uncertainty_score":0.08226389},"labels":[],"label_agreement":null},{"id":"W4367605072","doi":"10.1016/j.leukres.2023.107160","title":"Topic: AS02-Epidemiology: EVALUATION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE COHORT STUDY FROM THE CANADIAN MDS REGISTRY","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Polymer Foaming and Composites","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Vancouver General Hospital; Ontario Institute for Cancer Research; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; University of British Columbia; University of Manitoba; Juravinski Cancer Centre; CancerCare Manitoba; Saskatchewan Cancer Agency; Ottawa Hospital; Université Laval; Dalhousie University; University of Winnipeg","funders":"","keywords":"Flexural strength; Photovoltaics; Renewable energy; Sunlight; Photovoltaic system; Ultimate tensile strength; Solar energy; Epoxy; Materials science; Environmental science; Composite material; Optics; Engineering; Electrical engineering; Physics","score_opus":0.08483279196042659,"score_gpt":0.37583843988746923,"score_spread":0.29100564792704264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9183901,0.005108856,0.00030016594,0.0017588881,0.0001023617,0.00023395236,0.06760779,0.0000435077,0.00645429],"genre_scores_gemma":[0.97544247,0.0035620816,0.0003556888,0.0005198577,0.00011990195,0.000109560686,0.018388562,0.000017045819,0.0014848124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851316,0.000105334926,0.00017188706,0.0002045643,0.00057016884,0.00043485087],"domain_scores_gemma":[0.99648064,0.00013840594,0.0011765795,0.00018379015,0.001464563,0.00055598066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010142645,0.00042256893,0.00049078977,0.0031286327,0.0017143486,0.00122059,0.001217451,0.0006473797,0.0026418488],"category_scores_gemma":[0.003660335,0.00032113332,0.0009411595,0.007987703,0.00038612675,0.0004913025,0.00082927034,0.00078316743,0.00028193166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027111219,0.000013633767,0.99629337,0.000028427898,0.00005115982,0.000034182904,0.000085790714,0.000024851593,0.00004647771,0.000052643147,0.0019167404,0.0014256196],"study_design_scores_gemma":[0.000005150669,0.0000114821405,0.99821836,0.000032538795,0.000029792976,0.00008939474,0.00021697964,0.00004744424,0.000023961416,0.000013160548,0.001304945,0.0000068834497],"about_ca_topic_score_codex":0.9174619,"about_ca_topic_score_gemma":0.92915845,"teacher_disagreement_score":0.08253813,"about_ca_system_score_codex":0.0079334555,"about_ca_system_score_gemma":0.025596319,"threshold_uncertainty_score":0.16604835},"labels":[],"label_agreement":null},{"id":"W4367605323","doi":"10.1016/j.leukres.2023.107206","title":"Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: NEPHROTIC SYNDROME IN MDS: A CASE REPORT AND REVIEW OF THE LITERATURE","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Tetanus; Diphtheria; Pillar; Humanities; Vaccination; Immunology; Art","score_opus":0.06468935058154511,"score_gpt":0.3882240475445291,"score_spread":0.323534696962984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605323","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026729437,0.9541707,0.0014936032,0.007953813,0.0023356478,0.00005216783,0.00021431281,0.00008863508,0.0069616935],"genre_scores_gemma":[0.16213997,0.78845733,0.0026988066,0.005635,0.03473078,0.000051375166,0.0005913108,0.00002590082,0.005669474],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99973816,0.000038286482,0.00007637922,0.000053360047,0.000059288916,0.000034582223],"domain_scores_gemma":[0.999663,0.00012306432,0.00011366696,0.000010467522,0.000043912758,0.000045924684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002681472,0.00051750155,0.00093138026,0.0025595776,0.0003956261,0.0011806138,0.00066928094,0.0017014957,0.0024634674],"category_scores_gemma":[0.0006371254,0.00016243364,0.00044497105,0.0018467508,0.0007792743,0.0014331732,0.00058832753,0.00085878355,0.0008177018],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033885878,0.0001934771,0.04137798,0.018303167,0.00033510427,0.40294766,0.0013495523,0.0009170681,0.017731797,0.0105757415,0.11351932,0.39241034],"study_design_scores_gemma":[0.00003245507,0.00006881775,0.008883904,0.00179063,0.00025452412,0.76878077,0.0010482307,0.0005066752,0.0019359546,0.0037937423,0.21285184,0.00005250584],"about_ca_topic_score_codex":0.00032618162,"about_ca_topic_score_gemma":0.00043083137,"teacher_disagreement_score":0.0025595776,"about_ca_system_score_codex":0.0003915398,"about_ca_system_score_gemma":0.0004750347,"threshold_uncertainty_score":0.008241117},"labels":[],"label_agreement":null},{"id":"W4367605563","doi":"10.1016/j.leukres.2023.107131","title":"EXCELLENT TRANSPLANT OUTCOMES WITH FLUDARABINE-TREOSULFAN (FT) REDUCED-TOXICITY CONDITIONING (RTC) IN COMBINATION WITH DUALT-CELL DEPLETION (TCD) IN MYELOABLATIVE CONDITIONING (MAC)-INELIGIBLE PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Vehicle emissions and performance","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Diesel fuel; Environmental science; Gasoline; Oxygenate; Waste management; Greenhouse gas; Truck; Fossil fuel; Automotive engineering; Engineering; Chemistry","score_opus":0.016846390854373304,"score_gpt":0.26135251437839274,"score_spread":0.24450612352401943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991134,0.0031808591,0.0022019073,0.00021284044,0.000062244,0.00006983107,0.00022279423,0.00006601537,0.0028494594],"genre_scores_gemma":[0.99843067,0.00039998317,0.00034531055,0.00008041734,0.00003521586,0.000015510746,0.0003032734,0.000008218267,0.00038133733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99990654,0.000028464488,0.0000103111115,0.000016218748,0.000011787659,0.000026615808],"domain_scores_gemma":[0.99986804,0.000023095312,0.000029491363,0.000017315977,0.000008467979,0.000053642423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046910637,0.00020194892,0.00028442737,0.00012357968,0.00016504766,0.000314548,0.00013228988,0.00012106948,0.0015548429],"category_scores_gemma":[0.00032612815,0.00003903941,0.00028296112,0.000120591096,0.00014800997,0.00019986875,0.00015664741,0.00035372173,0.0001936355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058054708,0.005675577,0.09243422,0.00038604785,0.00092202896,0.0011658379,0.0002630567,0.006015269,0.10405692,0.0012570431,0.0038143364,0.7259549],"study_design_scores_gemma":[0.0087766405,0.1996182,0.68295246,0.00028946318,0.003425968,0.008126806,0.0003609329,0.0067146774,0.059714876,0.0027851942,0.02717768,0.000057073958],"about_ca_topic_score_codex":0.00030813384,"about_ca_topic_score_gemma":0.0006652254,"teacher_disagreement_score":0.0015548429,"about_ca_system_score_codex":0.00021999217,"about_ca_system_score_gemma":0.00023246664,"threshold_uncertainty_score":0.005201459},"labels":[],"label_agreement":null},{"id":"W4367605663","doi":"10.1016/j.leukres.2023.107226","title":"Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS)","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Peripheral blood mononuclear cell; CD8; Biology; In vitro; Immunology; Molecular biology; Cell growth; Red blood cell; Cytotoxic T cell; T lymphocyte; Lymphocyte; CD28; Andrology; Immune system; Medicine; Biochemistry","score_opus":0.06853498855850935,"score_gpt":0.39882189748701885,"score_spread":0.3302869089285095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605663","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038437557,0.1249746,0.004864823,0.6374193,0.19253884,0.00037547614,0.005105334,0.00024081036,0.030637056],"genre_scores_gemma":[0.03767032,0.12163712,0.013129648,0.13368554,0.63180345,0.0006024626,0.011137241,0.0004247734,0.04990948],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9958389,0.0018941218,0.000652662,0.00053194276,0.0008319516,0.00025045648],"domain_scores_gemma":[0.97949195,0.0070069986,0.00165662,0.0008323957,0.008428083,0.0025839922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011259738,0.00075644616,0.0015971086,0.0020227174,0.0011269378,0.00568169,0.0012149093,0.00606671,0.021811495],"category_scores_gemma":[0.02320692,0.0003256919,0.0012203192,0.0017970392,0.0018146434,0.0028403061,0.002594627,0.0053308625,0.012291531],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022187378,0.00008357587,0.0041014487,0.0016503872,0.000068116366,0.00010197743,0.00009516062,0.00015958122,0.00034181407,0.011437542,0.8721462,0.1095924],"study_design_scores_gemma":[0.00013575728,0.00020678,0.013228254,0.0048281658,0.00013827467,0.0009246838,0.00037416763,0.0008452154,0.0004864753,0.030587772,0.94819796,0.00004646796],"about_ca_topic_score_codex":0.0019574994,"about_ca_topic_score_gemma":0.0020984334,"teacher_disagreement_score":0.021811495,"about_ca_system_score_codex":0.0018695706,"about_ca_system_score_gemma":0.0068881144,"threshold_uncertainty_score":0.072966695},"labels":[],"label_agreement":null},{"id":"W4376869035","doi":"10.1016/j.leukres.2023.107315","title":"Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"Leukemia and Lymphoma Society of Canada","keywords":"Chronic lymphocytic leukemia; Immune system; Immunology; Disease; Medicine; Leukemia; Tumor microenvironment; Cancer research; Pathology","score_opus":0.029947984987117895,"score_gpt":0.3184048372239828,"score_spread":0.2884568522368649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376869035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988361,0.00050988526,0.00018127628,0.000020220024,0.0000054006236,0.0000036434365,0.00015764433,0.000010109081,0.00027579427],"genre_scores_gemma":[0.9987902,0.00021402689,0.0002515437,0.00001429223,0.000018148668,0.000011079508,0.00032430838,0.0000053985063,0.00037112963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997874,0.000048487796,0.000021227339,0.00003543024,0.0000464895,0.00006106257],"domain_scores_gemma":[0.99920267,0.00009060999,0.0004457078,0.000046551504,0.000059009253,0.00015549062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023790912,0.00019631027,0.00023564775,0.00092243985,0.00021678762,0.00061677874,0.00014799305,0.00025346526,0.0017077773],"category_scores_gemma":[0.000560838,0.00019550163,0.00012379682,0.0007630985,0.00027260414,0.0002840488,0.00037166895,0.000359606,0.0003137609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026162863,0.000092081864,0.64513695,0.00007428015,0.00006833813,0.00048710464,0.00016055301,0.0001335344,0.3436375,0.00012129562,0.00020265284,0.007269417],"study_design_scores_gemma":[0.00003548378,0.0002522877,0.97853047,0.000011398331,0.0000424964,0.0015307853,0.0002910401,0.00041767128,0.01739529,0.00017596655,0.0013071679,0.0000099707995],"about_ca_topic_score_codex":0.00031175447,"about_ca_topic_score_gemma":0.00039582624,"teacher_disagreement_score":0.0017077773,"about_ca_system_score_codex":0.00018415399,"about_ca_system_score_gemma":0.00014976141,"threshold_uncertainty_score":0.0057130456},"labels":[],"label_agreement":null},{"id":"W4377695552","doi":"10.1016/j.leukres.2023.107324","title":"Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Confidence interval; Incidence (geometry); Meta-analysis; Randomized controlled trial; Odds ratio; Adverse effect; Oncology; Clinical endpoint; Clinical trial; Gastroenterology","score_opus":0.13460659739632136,"score_gpt":0.3991285932244679,"score_spread":0.26452199582814656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377695552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008377453,0.98992175,0.0003093058,0.000114463015,0.00012041273,0.00008149352,0.0008764124,0.000019736144,0.00017897917],"genre_scores_gemma":[0.32123548,0.6734178,0.0016694021,0.0013299142,0.0002728714,0.00035995778,0.0012044916,0.000043761524,0.0004663138],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950895,0.0015584575,0.0017741068,0.00085056847,0.0004809657,0.00024635554],"domain_scores_gemma":[0.9916528,0.005350715,0.0019754055,0.00032034912,0.000559398,0.00014143101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049020713,0.0020763236,0.012994607,0.004689094,0.00047232152,0.0024946802,0.0017730193,0.002324069,0.004154328],"category_scores_gemma":[0.014169928,0.0016975728,0.035325915,0.0066113174,0.00060391135,0.0015693068,0.0017402687,0.0020169176,0.00036313786],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001776301,0.000024377596,0.015203044,0.25928152,0.71396697,0.0001509002,0.00010009513,0.00031663798,0.00023454695,0.00008826139,0.00074981555,0.008107513],"study_design_scores_gemma":[0.0004566158,0.00010373119,0.008838851,0.010882035,0.97804344,0.00012680488,0.00006022769,0.00010058652,0.000056544588,0.00010545549,0.0011954148,0.00003032062],"about_ca_topic_score_codex":0.0076180007,"about_ca_topic_score_gemma":0.021603795,"teacher_disagreement_score":0.012994607,"about_ca_system_score_codex":0.0014799273,"about_ca_system_score_gemma":0.002158873,"threshold_uncertainty_score":0.025924921},"labels":[],"label_agreement":null},{"id":"W4384038204","doi":"10.1016/j.leukres.2023.107354","title":"Changing frontline AML treatment patterns from 2013 to 2022","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; Pediatrics","score_opus":0.08757382435923698,"score_gpt":0.39717534999691767,"score_spread":0.3096015256376807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384038204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55149853,0.02245055,0.0059031122,0.21162874,0.004860667,0.00029164125,0.101406455,0.0011413208,0.10081899],"genre_scores_gemma":[0.8878502,0.008282715,0.003365717,0.039029974,0.0014897396,0.00029771216,0.03525521,0.00044089826,0.02398787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997122,0.00039767055,0.0004113145,0.00035948594,0.0006862087,0.0010233338],"domain_scores_gemma":[0.9917603,0.00077314227,0.0027805145,0.00016039792,0.0024838473,0.002041893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017896813,0.0001609669,0.00038428622,0.0016521377,0.000660237,0.0022070105,0.00077048806,0.00078293425,0.013003399],"category_scores_gemma":[0.010462523,0.00020478378,0.00078805484,0.0030264317,0.0003093489,0.0013147896,0.0010267181,0.0018357919,0.0021862658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018754463,0.0002543327,0.3919741,0.00066664023,0.00025744177,0.0003075891,0.00084706047,0.0018177924,0.0017528993,0.0101318555,0.30213892,0.2879759],"study_design_scores_gemma":[0.00010829401,0.00016551805,0.6610746,0.000701214,0.00014630842,0.00089296134,0.0026375041,0.0014516576,0.0017370487,0.0015590031,0.3294757,0.000050232262],"about_ca_topic_score_codex":0.0852732,"about_ca_topic_score_gemma":0.16882321,"teacher_disagreement_score":0.0852732,"about_ca_system_score_codex":0.007788602,"about_ca_system_score_gemma":0.010646663,"threshold_uncertainty_score":0.1695537},"labels":[],"label_agreement":null},{"id":"W4385998043","doi":"10.1016/j.leukres.2023.107372","title":"Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Toronto; Spinal Cord Injury BC; Jewish General Hospital; Health Sciences Centre; CancerCare Manitoba; Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; Ottawa Hospital; Foothills Medical Centre","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Guideline; Refractory (planetary science); Internal medicine; Intensive care medicine; Oncology; Leukemia; Pathology","score_opus":0.15840194623129275,"score_gpt":0.4246529317459071,"score_spread":0.26625098551461435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385998043","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016920132,0.5939818,0.0114938505,0.19268797,0.01891832,0.0071868775,0.033919565,0.0007325478,0.13938701],"genre_scores_gemma":[0.03833854,0.5647662,0.1386166,0.13970071,0.0060744663,0.008492901,0.05341633,0.00038959127,0.050204657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98516685,0.0035011065,0.0040776934,0.00067938515,0.0055725686,0.0010024315],"domain_scores_gemma":[0.9689077,0.004217739,0.0028665473,0.00038606528,0.02175296,0.0018690062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009679478,0.001720761,0.003941206,0.0071268114,0.0028357396,0.0037703896,0.00943403,0.006568878,0.007929771],"category_scores_gemma":[0.030138517,0.00095124287,0.0061718104,0.00734437,0.0017937339,0.0015285071,0.0017292134,0.009130389,0.0029910398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022784606,0.00011174328,0.0014537688,0.017026275,0.0005992574,0.00025833884,0.00021723297,0.0014261209,0.00043082677,0.007203053,0.8376437,0.13340183],"study_design_scores_gemma":[0.0010633619,0.00010002425,0.0092910305,0.06838455,0.0019077295,0.00045570644,0.00021699336,0.00071298133,0.00031027896,0.0046914774,0.9127094,0.00015650758],"about_ca_topic_score_codex":0.7238184,"about_ca_topic_score_gemma":0.8513648,"teacher_disagreement_score":0.27618158,"about_ca_system_score_codex":0.04233857,"about_ca_system_score_gemma":0.15095805,"threshold_uncertainty_score":0.55561614},"labels":[],"label_agreement":null},{"id":"W4386071245","doi":"10.1016/j.leukres.2023.107374","title":"Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Dr. Georges-L.-Dumont University Hospital Centre; Ottawa Hospital; Princess Margaret Cancer Centre; Kingston General Hospital; London Health Sciences Centre; Brampton Civic Hospital; Université de Sherbrooke; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal","funders":"Princess Margaret Cancer Foundation","keywords":"Tolerability; Medicine; Myeloid leukemia; Cumulative incidence; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Adverse effect; Gastroenterology; Oncology; Cohort; Cancer; Receptor","score_opus":0.05328367278869478,"score_gpt":0.3594598913470843,"score_spread":0.3061762185583895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386071245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93464476,0.0077852737,0.00046370592,0.012153783,0.0002060467,0.00023536907,0.004280106,0.000037211576,0.040193677],"genre_scores_gemma":[0.9876062,0.004951267,0.00072054425,0.0020815716,0.00012602506,0.00003880655,0.0020705739,0.000028429438,0.002376674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993259,0.00010675124,0.000039874507,0.000063986736,0.00022321937,0.00024026408],"domain_scores_gemma":[0.99759763,0.00020728282,0.00034582656,0.000033131582,0.0005691464,0.0012469178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058266695,0.00027029123,0.0003998642,0.00030342955,0.0032311878,0.0014003549,0.0006822408,0.0006684618,0.0046402556],"category_scores_gemma":[0.0028303568,0.00017930454,0.00040756105,0.0016332982,0.0008164879,0.0003533495,0.0007665378,0.0012714518,0.00031136416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012313864,0.002814352,0.6310783,0.00148718,0.0008851605,0.016715499,0.009753845,0.0068037896,0.0042486615,0.006263018,0.10961882,0.19801761],"study_design_scores_gemma":[0.001731338,0.0028503237,0.7592623,0.0007039168,0.0006679309,0.010973906,0.014182139,0.0030619765,0.0009614357,0.0010582827,0.20423353,0.000312988],"about_ca_topic_score_codex":0.8663939,"about_ca_topic_score_gemma":0.95396096,"teacher_disagreement_score":0.13360608,"about_ca_system_score_codex":0.026428193,"about_ca_system_score_gemma":0.025677294,"threshold_uncertainty_score":0.26878577},"labels":[],"label_agreement":null},{"id":"W4386258431","doi":"10.1016/j.leukres.2023.107376","title":"AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"CEBPA; Medicine; Internal medicine; Oncology; Mutation; Cohort; Hazard ratio; Genetics; Gene; Biology; Confidence interval","score_opus":0.06746631063902843,"score_gpt":0.4179117202482542,"score_spread":0.35044540960922577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386258431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939838,0.0005135532,0.0002273557,0.00006882511,0.000013298909,0.000018169516,0.00048385223,0.000016192605,0.0046749525],"genre_scores_gemma":[0.9988097,0.00011852642,0.00015467843,0.000027116235,0.0000147411265,0.0000125912575,0.0006011563,0.000009259612,0.0002522429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919885,0.00015716603,0.000117126045,0.00015868188,0.00017501565,0.0001932648],"domain_scores_gemma":[0.99748373,0.00076203386,0.0007733222,0.00011521636,0.0003160608,0.0005496167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011046113,0.00032903597,0.0005479303,0.0029301834,0.00042130717,0.0010316564,0.0005370475,0.0007078396,0.0025736403],"category_scores_gemma":[0.004347085,0.00019890662,0.00046772577,0.0012273899,0.0004522613,0.0007152986,0.0011297738,0.0005149804,0.0006593601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011706938,0.000026864844,0.99391186,0.0000179664,0.000044347544,0.00019458361,0.00010907804,0.00012414907,0.0009877314,0.00009532474,0.00022774287,0.0030896915],"study_design_scores_gemma":[0.000037036087,0.0002519669,0.9949234,0.000031086965,0.00009089548,0.0016800734,0.0007460224,0.00072339416,0.0003718627,0.00014735105,0.0009833596,0.000013576058],"about_ca_topic_score_codex":0.0031979217,"about_ca_topic_score_gemma":0.00377967,"teacher_disagreement_score":0.0031979217,"about_ca_system_score_codex":0.0004311366,"about_ca_system_score_gemma":0.00054073834,"threshold_uncertainty_score":0.0086096525},"labels":[],"label_agreement":null},{"id":"W4386574131","doi":"10.1016/j.leukres.2023.107387","title":"Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Extracorporeal Photopheresis; Medicine; Photopheresis; Immunosuppression; Graft-versus-host disease; Refractory (planetary science); Surgery; Internal medicine; Complication; Retrospective cohort study; Gastroenterology; Disease","score_opus":0.04202740629419695,"score_gpt":0.33033963935682126,"score_spread":0.2883122330626243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386574131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872917,0.00058159506,0.000088664594,0.000015098755,0.0000047198373,0.000021767206,0.00026810647,0.0000024644207,0.0002884018],"genre_scores_gemma":[0.9993168,0.00016994863,0.00006369076,0.000033058466,0.000013948211,0.0000128613165,0.0003140298,0.0000027990814,0.00007277189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990578,0.00019427524,0.00016980902,0.00029374243,0.00012566282,0.00015872548],"domain_scores_gemma":[0.99802846,0.0004450242,0.0009026625,0.00016669193,0.00014438646,0.00031265468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004532231,0.00029797578,0.00074320583,0.00087323535,0.00048358052,0.0010346476,0.0003501818,0.0005589382,0.0023863462],"category_scores_gemma":[0.0018724415,0.00034579195,0.00076629606,0.0017607881,0.00049807585,0.00036860319,0.0005599065,0.00039915697,0.00031583835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011555853,0.00007283654,0.99392796,0.000076827346,0.00022494495,0.0015024401,0.00013908399,0.000060556045,0.0005123061,0.000037385606,0.00012166099,0.0021683453],"study_design_scores_gemma":[0.00006858842,0.000963237,0.99361885,0.000026899372,0.0001824758,0.003936228,0.00042247362,0.00012275839,0.00015803248,0.000027523305,0.00045804767,0.000014814584],"about_ca_topic_score_codex":0.0035147772,"about_ca_topic_score_gemma":0.0031685142,"teacher_disagreement_score":0.0035147772,"about_ca_system_score_codex":0.0006514073,"about_ca_system_score_gemma":0.00078406907,"threshold_uncertainty_score":0.0079830885},"labels":[],"label_agreement":null},{"id":"W4386886967","doi":"10.1016/j.leukres.2023.107390","title":"Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; Janssen Research and Development","keywords":"Myelodysplastic syndromes; Methyltransferase; Arginine; Medicine; Internal medicine; Oncology; Chemistry; Methylation; Biochemistry; Gene; Amino acid","score_opus":0.020881035359742617,"score_gpt":0.3224272566979904,"score_spread":0.30154622133824777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386886967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335927,0.0016471116,0.00047359022,0.00056043174,0.00015540358,0.0012387013,0.00086084555,0.00007213283,0.0016325623],"genre_scores_gemma":[0.98601216,0.0023165182,0.0014107963,0.0012985324,0.00020812829,0.0020715154,0.002525356,0.000049822283,0.0041071665],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99962306,0.00015653302,0.000013350528,0.00006241988,0.000030673364,0.000113974056],"domain_scores_gemma":[0.9994904,0.000081481776,0.00007652387,0.000038530914,0.000036668476,0.00027642376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194436,0.0017205824,0.002570006,0.00058318174,0.00058016,0.0011599007,0.0008416758,0.0015914608,0.0032624605],"category_scores_gemma":[0.0008583586,0.00075264816,0.0013587103,0.00042336402,0.0009634881,0.0007768947,0.00030608955,0.0035623903,0.00079688523],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72721356,0.09846895,0.011189904,0.0006538389,0.0021214394,0.00038528242,0.00047353836,0.00438175,0.059997518,0.000644527,0.0056682774,0.088801414],"study_design_scores_gemma":[0.5474188,0.43277097,0.011340305,0.000031573334,0.0007523638,0.000215197,0.000105674604,0.0009931283,0.0031920737,0.0002537584,0.0028875796,0.000038621125],"about_ca_topic_score_codex":0.0022980825,"about_ca_topic_score_gemma":0.00473985,"teacher_disagreement_score":0.0032624605,"about_ca_system_score_codex":0.00086385966,"about_ca_system_score_gemma":0.00180329,"threshold_uncertainty_score":0.010914028},"labels":[],"label_agreement":null},{"id":"W4386987507","doi":"10.1016/j.leukres.2023.107401","title":"Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Myelodysplastic syndromes; Immunophenotyping; Cytopenia; Chronic myelomonocytic leukemia; Medicine; Myeloid; Bone marrow; Population; Progenitor cell; International Prognostic Scoring System; Leukocytosis; Pathology; Internal medicine; Oncology; Immunology; Stem cell; Flow cytometry; Biology; Genetics","score_opus":0.044005983657383944,"score_gpt":0.3429631793028866,"score_spread":0.29895719564550266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386987507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360234,0.0007658568,0.002567933,0.000049240938,0.0000059799936,0.000026989323,0.00013874595,0.00002316485,0.0028198517],"genre_scores_gemma":[0.99552286,0.00047203564,0.002701176,0.000048790404,0.0000069207626,0.000018853032,0.00024207044,0.000008255357,0.0009791206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986696,0.000029247098,0.000013778035,0.000017623199,0.000039114067,0.00003318042],"domain_scores_gemma":[0.9998945,0.000025976833,0.00001662338,0.000009824233,0.000024291638,0.000028826355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002645903,0.00017890272,0.00014654499,0.0009118171,0.00018081453,0.00032335296,0.00018573314,0.00019893183,0.0014385635],"category_scores_gemma":[0.00025852918,0.00011326526,0.00010144974,0.00030513766,0.0002177204,0.00017437017,0.00042761065,0.00024953543,0.0002338284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000599906,0.000044656543,0.0486175,0.00006722064,0.000032180367,0.0011308007,0.00018611651,0.00023434557,0.9254474,0.0012407902,0.00017037852,0.022228634],"study_design_scores_gemma":[0.00010925602,0.0012757966,0.47853082,0.000079694175,0.00022277984,0.021594275,0.0014880493,0.0069045317,0.46858314,0.0031535763,0.018034386,0.000023798855],"about_ca_topic_score_codex":0.00038406483,"about_ca_topic_score_gemma":0.0006223254,"teacher_disagreement_score":0.0014385635,"about_ca_system_score_codex":0.0001244161,"about_ca_system_score_gemma":0.000121324425,"threshold_uncertainty_score":0.004812479},"labels":[],"label_agreement":null},{"id":"W4392888281","doi":"10.1016/j.leukres.2024.107485","title":"Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier Universitaire Sainte-Justine; McGill University Health Centre; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; CHU Sainte-Justine Foundation; Cole Foundation; Fonds de Recherche du Québec - Santé; Fondation de l'Hôpital de Montréal pour enfants; Leukemia and Lymphoma Society of Canada","keywords":"Myeloid leukemia; Population; Medicine; Stem cell; Haematopoiesis; Cytarabine; Oncology; Pharmacology; Myeloid; Internal medicine; Cancer research; Biology","score_opus":0.10147604319015943,"score_gpt":0.3924380663267607,"score_spread":0.29096202313660124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392888281","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13600934,0.0043034055,0.7767754,0.0066183223,0.00043628173,0.00017272375,0.0004364763,0.00021367424,0.075034365],"genre_scores_gemma":[0.93378115,0.0019874407,0.026510047,0.00047554998,0.00012377053,0.00019246306,0.00014201274,0.00007583727,0.036711693],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99967134,0.00012348317,0.000011088861,0.000040083996,0.00008215953,0.00007194959],"domain_scores_gemma":[0.9991254,0.0005097801,0.00015457615,0.000025868012,0.000110478075,0.00007384335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074196607,0.0006302852,0.0009075194,0.00062529213,0.00045212294,0.00161246,0.0013093848,0.0017235252,0.004200185],"category_scores_gemma":[0.0028297054,0.00041300515,0.00082750217,0.00049693487,0.0011818086,0.0010264727,0.00097478705,0.0012836208,0.00042161407],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023811137,0.000027557755,0.00023348063,0.000046086036,0.00001296796,0.000067273075,0.00004782219,0.88551515,0.0011910441,0.10792507,0.0009752716,0.003934427],"study_design_scores_gemma":[0.0000075875423,0.000018421022,0.000074326905,0.000007711337,0.0000066202824,0.000027491045,0.000014962508,0.97821724,0.00013644759,0.020485777,0.0009971511,0.000006113186],"about_ca_topic_score_codex":0.0065311044,"about_ca_topic_score_gemma":0.0038998856,"teacher_disagreement_score":0.0065311044,"about_ca_system_score_codex":0.00179255,"about_ca_system_score_gemma":0.0011979509,"threshold_uncertainty_score":0.01405102},"labels":[],"label_agreement":null},{"id":"W4393230660","doi":"10.1016/j.leukres.2024.107497","title":"Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; Bristol-Myers Squibb","keywords":"IDH2; Neuroblastoma RAS viral oncogene homolog; Internal medicine; Medicine; Oncology; Mutation; Myeloid; IDH1; Biology; Gene; Genetics; KRAS","score_opus":0.03134948617511376,"score_gpt":0.35570727734812685,"score_spread":0.3243577911730131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393230660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985404,0.0006731237,0.000096620446,0.00006453717,0.0000048542843,0.0000037749219,0.00016323487,0.00000494412,0.00044858074],"genre_scores_gemma":[0.9992975,0.00016380561,0.0000692506,0.000037342936,0.000010791557,0.0000028908316,0.00024035467,0.00000334339,0.00017458346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999778,0.00006591297,0.000021405749,0.00006211895,0.00004197202,0.00003065697],"domain_scores_gemma":[0.99954176,0.00015546657,0.00015380837,0.000036064263,0.000027261443,0.00008565151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005344827,0.00013804792,0.00030538213,0.00017145395,0.00010786437,0.00046715414,0.00015798786,0.00019259425,0.0014563175],"category_scores_gemma":[0.0012596173,0.00008692052,0.00026571017,0.00023940594,0.00014939002,0.0002720887,0.00025244823,0.00038470497,0.00018908859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059059877,0.00014307663,0.938198,0.000055933833,0.00038502438,0.00024240612,0.000097815006,0.0010099156,0.010582297,0.00015098709,0.00050070655,0.04272779],"study_design_scores_gemma":[0.00008090699,0.0005868243,0.99369663,0.000013905314,0.00022706838,0.00048122343,0.00007554095,0.0015289086,0.001857562,0.0002673132,0.0011758228,0.000008343613],"about_ca_topic_score_codex":0.0005281853,"about_ca_topic_score_gemma":0.0013714926,"teacher_disagreement_score":0.0014563175,"about_ca_system_score_codex":0.00019381267,"about_ca_system_score_gemma":0.00018667981,"threshold_uncertainty_score":0.004871905},"labels":[],"label_agreement":null},{"id":"W4401752195","doi":"10.1016/j.leukres.2024.107560","title":"Cost-effectiveness of blinatumomab for the treatment of B‑precursor acute lymphoblastic leukemia pediatric patients with high‑risk first‑relapse in Mexico","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Blinatumomab; Lymphoblastic Leukemia; Medicine; Oncology; Leukemia; Internal medicine","score_opus":0.03311726518485927,"score_gpt":0.34277513827120726,"score_spread":0.309657873086348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401752195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810962,0.005588597,0.0044852938,0.0031340565,0.000050921022,0.00029125105,0.0018406423,0.000050426166,0.003462755],"genre_scores_gemma":[0.99676204,0.0010277373,0.0010192129,0.00013989555,0.00001156688,0.00010475453,0.0005425094,0.000004234882,0.00038812208],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9995049,0.00032462864,0.000015826228,0.00004680404,0.000036922087,0.000070859816],"domain_scores_gemma":[0.9986834,0.00082075875,0.00030169965,0.000019977779,0.0000473918,0.00012684132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014918433,0.00046479708,0.00067253836,0.00044255055,0.00020864344,0.0011657858,0.0006600476,0.0007737188,0.0042100707],"category_scores_gemma":[0.003883949,0.00026152574,0.0013253626,0.00037782177,0.00024202828,0.0005712846,0.0005146617,0.000881368,0.00009231913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019390952,0.0011383622,0.08256424,0.0010738743,0.0021025205,0.0006919456,0.0001596767,0.7861314,0.0012407139,0.007291593,0.005005172,0.093209684],"study_design_scores_gemma":[0.004190563,0.0064038644,0.06274746,0.0009204369,0.0036279531,0.00082939764,0.0004562048,0.9074578,0.0011426655,0.0046230047,0.007536121,0.00006455608],"about_ca_topic_score_codex":0.015905794,"about_ca_topic_score_gemma":0.011536406,"teacher_disagreement_score":0.015905794,"about_ca_system_score_codex":0.004939157,"about_ca_system_score_gemma":0.0024530594,"threshold_uncertainty_score":0.03583622},"labels":[],"label_agreement":null},{"id":"W4402731040","doi":"10.1016/j.leukres.2024.107586","title":"Outcome of adolescents and young adult acute myeloid leukemia patients compared with middle-aged patients: A single centre retrospective experience","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Retrospective cohort study; Pediatrics; Young adult; Internal medicine","score_opus":0.038281070651816275,"score_gpt":0.3206665925156642,"score_spread":0.2823855218638479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402731040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995284,0.00016502426,0.000017891232,0.000008729741,0.0000022349275,0.0000037475284,0.00007329936,5.383269e-7,0.00020019992],"genre_scores_gemma":[0.9995659,0.00015419586,0.000019290215,0.000012547846,0.000006020999,0.000004163773,0.00016553311,9.022567e-7,0.00007135063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996277,0.00009595389,0.000059455844,0.00006514062,0.000043840326,0.00010787336],"domain_scores_gemma":[0.9992065,0.00016202888,0.00026550834,0.000029278133,0.00007536854,0.00026136532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037860344,0.00020247104,0.00051777886,0.00079527014,0.000535039,0.00077676435,0.0002339147,0.00039096933,0.0015818373],"category_scores_gemma":[0.00115935,0.00019376,0.00036137176,0.00091945776,0.00037938778,0.0005394593,0.00060999003,0.00032430506,0.00024850338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016780988,0.000033835462,0.9980475,0.000008722145,0.000018602062,0.0006316639,0.00021753377,0.00001394126,0.00014365166,0.000020514928,0.000030416377,0.00066586095],"study_design_scores_gemma":[0.0000112512025,0.00051247556,0.99429554,0.000011559294,0.00003634774,0.0025410883,0.0022283066,0.00005208222,0.00007081676,0.000025602503,0.00020894072,0.000005896578],"about_ca_topic_score_codex":0.0045003192,"about_ca_topic_score_gemma":0.0032268218,"teacher_disagreement_score":0.0045003192,"about_ca_system_score_codex":0.00041462333,"about_ca_system_score_gemma":0.0003760255,"threshold_uncertainty_score":0.0089482665},"labels":[],"label_agreement":null},{"id":"W4407687743","doi":"10.1016/j.leukres.2025.107665","title":"Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusion","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"breakpoint cluster region; Phenotype; Fusion gene; Cancer research; Genetics; Biology; Gene","score_opus":0.018717936051413576,"score_gpt":0.3272520593277069,"score_spread":0.3085341232762933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407687743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940439,0.0003102338,0.002045855,0.0002268531,0.000017245511,0.00005274324,0.0007721708,0.000073041636,0.00245787],"genre_scores_gemma":[0.99699235,0.00011945174,0.0011649812,0.00005299497,0.000008120138,0.000019199162,0.0007551905,0.000013961282,0.0008737522],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998661,0.0000119569195,0.000014079696,0.000033822493,0.000040261424,0.000033777495],"domain_scores_gemma":[0.9998771,0.000031106767,0.000034684603,0.000015221799,0.000013797307,0.000028045757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012676544,0.0002588476,0.00014472638,0.00047061263,0.00027847427,0.00035680374,0.0002369572,0.00039997362,0.0030622636],"category_scores_gemma":[0.0002657487,0.000121743135,0.00022881472,0.00029080946,0.00027236642,0.0002596049,0.00037793882,0.00042646858,0.0006751614],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002875763,0.000081617596,0.009915409,0.00004466462,0.000016415876,0.0066753686,0.000077566,0.00024118125,0.97662634,0.0010731573,0.00033816652,0.0046225036],"study_design_scores_gemma":[0.00011312644,0.0008528429,0.13936634,0.000018079596,0.00013671184,0.09035154,0.0004708004,0.0057948693,0.73932135,0.0010952019,0.022455836,0.000023246366],"about_ca_topic_score_codex":0.00048341317,"about_ca_topic_score_gemma":0.00048456353,"teacher_disagreement_score":0.0030622636,"about_ca_system_score_codex":0.00032462025,"about_ca_system_score_gemma":0.00015373762,"threshold_uncertainty_score":0.0102443695},"labels":[],"label_agreement":null},{"id":"W4409174715","doi":"10.1016/j.leukres.2025.107690","title":"Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Pharma; Astellas Pharma US","keywords":"Tolerability; Pharmacokinetics; Myeloid leukemia; Medicine; Refractory (planetary science); Pharmacology; Oncology; Internal medicine; Adverse effect; Materials science","score_opus":0.05871529485145651,"score_gpt":0.4337909477996639,"score_spread":0.3750756529482074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409174715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949817,0.001687311,0.0005320878,0.000193291,0.000034857854,0.0008809333,0.0006473715,0.000078271914,0.0009641733],"genre_scores_gemma":[0.99347866,0.0017931462,0.00084436807,0.00056476396,0.000069372116,0.0006999109,0.0013578625,0.000030063502,0.0011618208],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996383,0.00019020394,0.000017454335,0.000050309274,0.000049319595,0.000054410993],"domain_scores_gemma":[0.99957937,0.00006262984,0.00012269757,0.000030172947,0.00003424666,0.00017090961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001019379,0.0010330564,0.0014535319,0.0002425379,0.0002699639,0.0006987259,0.000563674,0.0007802232,0.0023408795],"category_scores_gemma":[0.00077129283,0.000311355,0.00097046595,0.0002802361,0.00046553512,0.00057223235,0.0001946605,0.0017612735,0.0006645034],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54191005,0.07916436,0.009003453,0.0016301617,0.002336591,0.00077722425,0.00044216978,0.0052786847,0.1199544,0.00057063426,0.008907559,0.23002464],"study_design_scores_gemma":[0.33192852,0.62177414,0.0250231,0.00007571309,0.00076566025,0.0009804555,0.0000915003,0.0040726163,0.009652923,0.00034314333,0.005221945,0.00007024756],"about_ca_topic_score_codex":0.00056463486,"about_ca_topic_score_gemma":0.0010680128,"teacher_disagreement_score":0.0023408795,"about_ca_system_score_codex":0.0005669068,"about_ca_system_score_gemma":0.0007791154,"threshold_uncertainty_score":0.007831037},"labels":[],"label_agreement":null},{"id":"W4413389037","doi":"10.1016/j.leukres.2025.108087","title":"Pilot study: A prospective, real-world, feasibility study testing a decreased frequency paradigm in treatment free remission in chronic myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Windsor Regional Hospital","funders":"","keywords":"Myeloid leukemia; Medicine; Oncology; Internal medicine; Leukemia; Complete remission; Prospective cohort study; Chemotherapy","score_opus":0.12377204351037173,"score_gpt":0.4169045640463377,"score_spread":0.29313252053596595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413389037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992823,0.000053927695,0.0008937642,0.00019882614,0.000058490194,0.005133913,0.00026790472,0.000035544977,0.0005345595],"genre_scores_gemma":[0.97793764,0.00014534003,0.0059629288,0.0007625687,0.00013779875,0.013461788,0.0005734627,0.00002218174,0.0009963482],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99754554,0.001598714,0.00012930266,0.00026076994,0.00020333705,0.0002623141],"domain_scores_gemma":[0.99556583,0.0017122444,0.00054028863,0.00068366725,0.0004034828,0.0010945052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046414738,0.001028275,0.0010168639,0.0003645614,0.0016249261,0.0007794868,0.0011490186,0.0013971113,0.0043578697],"category_scores_gemma":[0.006110794,0.00048776966,0.00081367395,0.00030853215,0.0015591757,0.0014170646,0.00081683655,0.0024394637,0.0010728937],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21203277,0.66975385,0.034389876,0.0006557306,0.00039447035,0.0003916879,0.0023060297,0.001824451,0.019413695,0.00061422936,0.0025396815,0.05568357],"study_design_scores_gemma":[0.06605461,0.8976078,0.03132507,0.00002928344,0.0001526534,0.00012827446,0.0006171959,0.00097110955,0.0014237983,0.00034784715,0.0012879978,0.000054307722],"about_ca_topic_score_codex":0.0024287389,"about_ca_topic_score_gemma":0.0031522557,"teacher_disagreement_score":0.0046414738,"about_ca_system_score_codex":0.000828207,"about_ca_system_score_gemma":0.002338432,"threshold_uncertainty_score":0.024546742},"labels":[],"label_agreement":null},{"id":"W4414096472","doi":"10.1016/j.leukres.2025.107905","title":"TREATMENT - CURRENT TREATMENT OPTIONS - HIGHER RISK MDS","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Current (fluid); MEDLINE; Risk assessment; Clinical trial","score_opus":0.5899221020561286,"score_gpt":0.564459568485141,"score_spread":0.0254625335709876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096472","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2861467,0.24383084,0.019704668,0.2729862,0.0031454423,0.000376683,0.007813258,0.00017224246,0.16582407],"genre_scores_gemma":[0.94357765,0.029305417,0.002833655,0.011865621,0.0039925533,0.000102074584,0.0013804561,0.000051656167,0.006890922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826103,0.00090179633,0.00017707096,0.00019673453,0.00029526366,0.0001681635],"domain_scores_gemma":[0.99186885,0.0038798524,0.0025109001,0.00026915307,0.0005454232,0.00092579063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029790478,0.00023573785,0.00062651176,0.0008135678,0.00048187407,0.002560453,0.0004321033,0.0008820372,0.02215793],"category_scores_gemma":[0.016623184,0.0001265466,0.0009540638,0.0011951352,0.0008584478,0.002706282,0.0010672723,0.0023041351,0.0009304406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029893634,0.000573595,0.11948651,0.0024865174,0.00084161735,0.00070179236,0.00039195878,0.0064723827,0.0007550961,0.20114458,0.04038125,0.62377536],"study_design_scores_gemma":[0.00086796476,0.0012428078,0.16875069,0.0065222858,0.001240636,0.0073031955,0.0018235593,0.008329459,0.0011761663,0.61457807,0.18802845,0.0001366951],"about_ca_topic_score_codex":0.0015077249,"about_ca_topic_score_gemma":0.0029806388,"teacher_disagreement_score":0.9778421,"about_ca_system_score_codex":0.0020356383,"about_ca_system_score_gemma":0.0013256896,"threshold_uncertainty_score":0.07412571},"labels":[],"label_agreement":null},{"id":"W4414096542","doi":"10.1016/j.leukres.2025.107876","title":"OUTCOME RESEARCH (INCLUDING QUALITY OF LIFE) AND HEALTH ECONOMICS - PATIENT-REPORTED OUTCOMES &amp; QUALITY OF LIFE","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada)","funders":"","keywords":"Outcome (game theory); Health economics; Quality of life (healthcare); Quality (philosophy); Quality-adjusted life year; Health related quality of life; Outcomes research","score_opus":0.6938777666991559,"score_gpt":0.6695954740101862,"score_spread":0.024282292688969753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096542","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43946987,0.20631696,0.024289485,0.10096311,0.0054286476,0.0019291905,0.049547266,0.00025519248,0.1718002],"genre_scores_gemma":[0.94726986,0.02250661,0.006992587,0.005192313,0.0026260905,0.0010508079,0.0074876016,0.00006138559,0.0068126386],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9697058,0.018415315,0.004311669,0.0012406883,0.0048607853,0.0014656516],"domain_scores_gemma":[0.9310286,0.030845277,0.024194298,0.0023825257,0.008605639,0.0029435577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.027708327,0.00078818173,0.0014159455,0.0072079212,0.0009940919,0.004010459,0.0010348276,0.0011347467,0.012655181],"category_scores_gemma":[0.05895801,0.00018280202,0.0030269497,0.012289795,0.0021320519,0.0033620063,0.0021818837,0.0021344868,0.0015768801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008177004,0.001685725,0.69791186,0.0054211966,0.0024991524,0.00015884874,0.00082977023,0.0014721695,0.00033656033,0.023981694,0.013389523,0.25149593],"study_design_scores_gemma":[0.0001766419,0.0017549801,0.91417176,0.004356378,0.001389941,0.0007104169,0.002050777,0.0016123658,0.0011786155,0.02436501,0.048097283,0.00013587617],"about_ca_topic_score_codex":0.0041756597,"about_ca_topic_score_gemma":0.006260515,"teacher_disagreement_score":0.9873448,"about_ca_system_score_codex":0.0030276119,"about_ca_system_score_gemma":0.0040673474,"threshold_uncertainty_score":0.14653736},"labels":[],"label_agreement":null},{"id":"W4414096581","doi":"10.1016/j.leukres.2025.107906","title":"TREATMENT - CURRENT TREATMENT OPTIONS - HIGHER RISK MDS","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Current (fluid); MEDLINE; Risk assessment; Clinical trial","score_opus":0.5899221020561286,"score_gpt":0.564459568485141,"score_spread":0.0254625335709876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096581","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2861467,0.24383084,0.019704668,0.2729862,0.0031454423,0.000376683,0.007813258,0.00017224246,0.16582407],"genre_scores_gemma":[0.94357765,0.029305417,0.002833655,0.011865621,0.0039925533,0.000102074584,0.0013804561,0.000051656167,0.006890922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826103,0.00090179633,0.00017707096,0.00019673453,0.00029526366,0.0001681635],"domain_scores_gemma":[0.99186885,0.0038798524,0.0025109001,0.00026915307,0.0005454232,0.00092579063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029790478,0.00023573785,0.00062651176,0.0008135678,0.00048187407,0.002560453,0.0004321033,0.0008820372,0.02215793],"category_scores_gemma":[0.016623184,0.0001265466,0.0009540638,0.0011951352,0.0008584478,0.002706282,0.0010672723,0.0023041351,0.0009304406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029893634,0.000573595,0.11948651,0.0024865174,0.00084161735,0.00070179236,0.00039195878,0.0064723827,0.0007550961,0.20114458,0.04038125,0.62377536],"study_design_scores_gemma":[0.00086796476,0.0012428078,0.16875069,0.0065222858,0.001240636,0.0073031955,0.0018235593,0.008329459,0.0011761663,0.61457807,0.18802845,0.0001366951],"about_ca_topic_score_codex":0.0015077249,"about_ca_topic_score_gemma":0.0029806388,"teacher_disagreement_score":0.9778421,"about_ca_system_score_codex":0.0020356383,"about_ca_system_score_gemma":0.0013256896,"threshold_uncertainty_score":0.07412571},"labels":[],"label_agreement":null},{"id":"W4414570461","doi":"10.1016/j.leukres.2025.108113","title":"Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemia","year":2025,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Bristol-Myers Squibb","keywords":"Chronic lymphocytic leukemia; Surrogate endpoint; Clinical endpoint; Confidence interval; Randomized controlled trial; Odds ratio; Proportional hazards model","score_opus":0.22145760030301562,"score_gpt":0.5080526382068011,"score_spread":0.2865950379037855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414570461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026301222,0.96691215,0.0026523862,0.00071513734,0.00027846094,0.0015628588,0.0007147013,0.000021544127,0.0008415198],"genre_scores_gemma":[0.6728157,0.30819464,0.008028092,0.0028391392,0.00058990775,0.005873379,0.0011976934,0.000026614087,0.00043489086],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95722926,0.030106995,0.008743901,0.0016396511,0.002002044,0.000278094],"domain_scores_gemma":[0.92810047,0.05661986,0.011334695,0.0015104418,0.0021254518,0.00030915707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042720288,0.0011955007,0.0063556125,0.0031544066,0.00026935918,0.0017468701,0.0010803271,0.0017857798,0.0012923613],"category_scores_gemma":[0.07214618,0.00049178867,0.013040003,0.0029173668,0.0008839656,0.0013877183,0.0008206551,0.0015449948,0.00014505132],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017915946,0.0002506732,0.0132006705,0.5132219,0.34829652,0.0001615347,0.00023961598,0.0016779251,0.001079183,0.0013782965,0.0012374491,0.10134026],"study_design_scores_gemma":[0.018767951,0.01225797,0.028387126,0.10459147,0.80968416,0.0006244905,0.00026372832,0.0023263567,0.0015121574,0.0039035236,0.017514246,0.00016692824],"about_ca_topic_score_codex":0.0014905717,"about_ca_topic_score_gemma":0.0030457017,"teacher_disagreement_score":0.042720288,"about_ca_system_score_codex":0.0014484974,"about_ca_system_score_gemma":0.0019706667,"threshold_uncertainty_score":0.2259292},"labels":[],"label_agreement":null},{"id":"W7115707592","doi":"10.1016/j.leukres.2025.108155","title":"Frequency and prognostic significance of RAS pathway alterations in adult acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation of China; Saint Mary’s University","keywords":"PTPN11; KRAS; Clinical significance; Multivariate analysis; Survival analysis; Lymphoblastic Leukemia","score_opus":0.02401054487492874,"score_gpt":0.33368733018252633,"score_spread":0.30967678530759757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115707592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788,0.00076654635,0.000103206374,0.00005280765,0.0000049393752,0.0000031296702,0.00028857018,0.000011803258,0.0008891016],"genre_scores_gemma":[0.9993812,0.00020879543,0.000058950318,0.000010009533,0.000010526268,0.0000022473873,0.00015478465,0.000002142211,0.00017145372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996724,0.00008258035,0.00003975333,0.00005588476,0.00006974738,0.00007963456],"domain_scores_gemma":[0.9991085,0.0002749025,0.00035715217,0.000073657124,0.000079387384,0.00010631416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026603416,0.00015571309,0.0001786053,0.00128313,0.00023491798,0.00049784256,0.00020003063,0.00036484544,0.0020140968],"category_scores_gemma":[0.0014998856,0.0001269631,0.00013695915,0.0010960741,0.0002841303,0.0003237237,0.00029815253,0.0002924521,0.00034789825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072546344,0.000021195236,0.9814534,0.00002280782,0.000032754328,0.00036244144,0.00005669348,0.000093890485,0.0063490304,0.00012161149,0.0001667236,0.010593889],"study_design_scores_gemma":[0.000009929941,0.00009760783,0.994238,0.000007155038,0.00004752569,0.0028837458,0.0001656792,0.00034304982,0.0011241308,0.00018586664,0.00089314475,0.0000041501744],"about_ca_topic_score_codex":0.00055468763,"about_ca_topic_score_gemma":0.0008274012,"teacher_disagreement_score":0.0020140968,"about_ca_system_score_codex":0.00013554211,"about_ca_system_score_gemma":0.00015475172,"threshold_uncertainty_score":0.0067378283},"labels":[],"label_agreement":null}]}